<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Int J Mol Sci</journal-id>
<journal-id journal-id-type="iso-abbrev">Int J Mol Sci</journal-id>
<journal-id journal-id-type="publisher-id">ijms</journal-id>
<journal-title-group>
<journal-title>International Journal of Molecular Sciences</journal-title>
</journal-title-group>
<issn pub-type="epub">1422-0067</issn>
<publisher>
<publisher-name>MDPI</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31752183</article-id>
<article-id pub-id-type="pmc">6888477</article-id>
<article-id pub-id-type="doi">10.3390/ijms20225797</article-id>
<article-id pub-id-type="publisher-id">ijms-20-05797</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>B Vitamins and Fatty Acids: What Do They Share with Small Vessel Disease-Related Dementia?</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-9731-2697</contrib-id>
<name>
<surname>Moretti</surname>
<given-names>Rita</given-names>
</name>
<xref ref-type="corresp" rid="c1-ijms-20-05797">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Peinkhofer</surname>
<given-names>Costanza</given-names>
</name>
</contrib>
</contrib-group>
<aff id="af1-ijms-20-05797">Neurology Clinic, Department of Medical, Surgical and Health Sciences, University of Trieste, 34149 Trieste, Italy; <email>costa.peinkhofer@gmail.com</email></aff>
<author-notes>
<corresp id="c1-ijms-20-05797"><label>*</label>Correspondence: <email>moretti@units.it</email>; Tel.: +39-0403-994-282</corresp>
</author-notes>
<pub-date pub-type="epub">
<day>18</day>
<month>11</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="collection">
<month>11</month>
<year>2019</year>
</pub-date>
<volume>20</volume>
<issue>22</issue>
<elocation-id>5797</elocation-id>
<history>
<date date-type="received">
<day>21</day>
<month>9</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>12</day>
<month>11</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>© 2019 by the authors.</copyright-statement>
<copyright-year>2019</copyright-year>
<license license-type="open-access">
<license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p>
</license>
</permissions>
<abstract>
<p>Many studies have been written on vitamin supplementation, fatty acid, and dementia, but results are still under debate, and no definite conclusion has yet been drawn. Nevertheless, a significant amount of lab evidence confirms that vitamins of the B group are tightly related to gene control for endothelium protection, act as antioxidants, play a co-enzymatic role in the most critical biochemical reactions inside the brain, and cooperate with many other elements, such as choline, for the synthesis of polyunsaturated phosphatidylcholine, through S-adenosyl-methionine (SAM) methyl donation. B-vitamins have anti-inflammatory properties and act in protective roles against neurodegenerative mechanisms, for example, through modulation of the glutamate currents and a reduction of the calcium currents. In addition, they also have extraordinary antioxidant properties. However, laboratory data are far from clinical practice. Many studies have tried to apply these results in everyday clinical activity, but results have been discouraging and far from a possible resolution of the associated mysteries, like those represented by Alzheimer’s disease (AD) or small vessel disease dementia. Above all, two significant problems emerge from the research: No consensus exists on general diagnostic criteria—MCI or AD? Which diagnostic criteria should be applied for small vessel disease-related dementia? In addition, no general schema exists for determining a possible correct time of implementation to have effective results. Here we present an up-to-date review of the literature on such topics, shedding some light on the possible interaction of vitamins and phosphatidylcholine, and their role in brain metabolism and catabolism. Further studies should take into account all of these questions, with well-designed and world-homogeneous trials.</p>
</abstract>
<kwd-group>
<kwd>small vessel disease</kwd>
<kwd>vascular dementia</kwd>
<kwd>vitamins B</kwd>
<kwd>homocysteine</kwd>
<kwd>fatty acids</kwd>
<kwd>neuroinflammation</kwd>
<kwd>redox</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="sec1-ijms-20-05797" sec-type="intro">
<title>1. Introduction</title>
<p>Discussion of vitamins and vascular dementia is akin to opening Pandora’s box. Much has been written on vitamin supplementation and dementia, but results are still under debate, and no real conclusion has yet been drawn [<xref ref-type="bibr" rid="B1-ijms-20-05797">1</xref>]. Above all, two of the most significant problems have emerged from the debate. The first is that, from the hundreds of relevant studies, no consensus on the application of standard diagnostic criteria has been reached between Alzheimer’s disease (AD) or MCI, nor on the best term to diagnose small vessel disease-related dementia. The second problem is that a possible correct time of implementation has yet to be determined to have the most effective clinical result. Nevertheless, as no specific therapeutic options have been discovered for the two most globally relevant forms of dementia (AD and small vessel disease-related dementia), different risk factors for cognitive impairment have been researched, and vitamin supply and fatty acids could be a potential therapy.</p>
</sec>
<sec id="sec2-ijms-20-05797">
<title>2. Vascular Dementia and Small Vessel Disease-Related Dementia</title>
<p>Vascular dementia should be one of the simplest diagnosed pathologies due to the apparent temporal correlation between an acute vascular brain lesion and its onset. Nonetheless, consensus criteria for vascular cognitive impairment remain under debate, which began in 1983 when NINDS-AIREN criteria were written [<xref ref-type="bibr" rid="B2-ijms-20-05797">2</xref>]. These criteria have been partially modified by the ICD-0 [<xref ref-type="bibr" rid="B3-ijms-20-05797">3</xref>]. Despite multiple attempts, the current clinical diagnostic criteria for vascular dementia are still being debated. They lack a definite morphological substrate for the different types of cognitive disruption due to vascular causes. In fact, three different subtypes have been recognized: Genetic type of vascular dementia (CADASIL or CARASIL), macrovascular type of dementia (multi-infarct dementia or strategic infarct dementia), and microvascular type of dementia (subcortical vascular dementia or, more appropriately, small vessel disease-related dementia) [<xref ref-type="bibr" rid="B4-ijms-20-05797">4</xref>,<xref ref-type="bibr" rid="B5-ijms-20-05797">5</xref>,<xref ref-type="bibr" rid="B6-ijms-20-05797">6</xref>].</p>
<p>The most recent effort to categorize vascular impairment relies on DSM V [<xref ref-type="bibr" rid="B7-ijms-20-05797">7</xref>,<xref ref-type="bibr" rid="B8-ijms-20-05797">8</xref>]. In the same year, the Standards for Reporting Vascular changes on Neuroimaging (STRIVE) study provided the same guidelines for recommended standards for research on vascular dementia with MRI and CT [<xref ref-type="bibr" rid="B9-ijms-20-05797">9</xref>]. For the first time, a panel completed a standard advisory about the terms and definitions for features visible on MRI and minimum standards for image acquisition. Signs of small vessel disease include, in a conventional MRI, recent subcortical infarcts, white matter hyperintensities, lacunes, prominent perivascular spaces, and cerebral microbleeds, with possible consequent atrophy (see below for a more accurate description).</p>
<p>Small vessel disease (SVD) results from damage to the small penetrating arteries and arterioles in the pial and lepto-meningeal circulation, along with penetrating and parenchymal arteries and arterioles, pericytes, capillaries, and venules [<xref ref-type="bibr" rid="B10-ijms-20-05797">10</xref>]. The prevalence of SVD increases exponentially with aging. A review of pathologic studies shows enormous differences in the incidence of subcortical vascular dementia (sVaD) ranging from 0.03% to 85.2%, with means around 11%, while in a series of recent autopsies from Japanese geriatric hospitals it was 23.6% to 35%. In Europe, prevalence rates of SVD-related dementia estimated between ages 65–69 to 80+ years ranged from 2.2% to 16.3% [<xref ref-type="bibr" rid="B11-ijms-20-05797">11</xref>,<xref ref-type="bibr" rid="B12-ijms-20-05797">12</xref>,<xref ref-type="bibr" rid="B13-ijms-20-05797">13</xref>,<xref ref-type="bibr" rid="B14-ijms-20-05797">14</xref>]. Aging is the most critical risk factor in developing small vessel disease; it leads to the loss of arterial elasticity. This fact causes a reduction of arterial compliance due to the altered mechanical small vessel walls [<xref ref-type="bibr" rid="B15-ijms-20-05797">15</xref>]. The effect is the loss of the autoregulatory capabilities of cerebral arteries; as a consequence, the brain suffers from a higher vulnerability to hypotension, with possible major ischemia, when the systemic blood pressure dips below a critical threshold [<xref ref-type="bibr" rid="B16-ijms-20-05797">16</xref>,<xref ref-type="bibr" rid="B17-ijms-20-05797">17</xref>,<xref ref-type="bibr" rid="B18-ijms-20-05797">18</xref>]. Arteriosclerosis and cerebral amyloid angiopathy (CAA) [<xref ref-type="bibr" rid="B19-ijms-20-05797">19</xref>,<xref ref-type="bibr" rid="B20-ijms-20-05797">20</xref>,<xref ref-type="bibr" rid="B21-ijms-20-05797">21</xref>,<xref ref-type="bibr" rid="B22-ijms-20-05797">22</xref>] are the most crucial pathogenic expressions of small vessel disease. The mechanism here described is supported by the concomitant age-related impairment of vascular autoregulation; it has been described as the low-level functioning of the autonomic nervous system, with direct and endothelium-mediated altered baroreflex activity [<xref ref-type="bibr" rid="B23-ijms-20-05797">23</xref>,<xref ref-type="bibr" rid="B24-ijms-20-05797">24</xref>,<xref ref-type="bibr" rid="B25-ijms-20-05797">25</xref>,<xref ref-type="bibr" rid="B26-ijms-20-05797">26</xref>]. Small vessel disease, due to the primary localization of the white matter hyperintensities, may affect the integrity of the adjacent medial cholinergic pathway [<xref ref-type="bibr" rid="B27-ijms-20-05797">27</xref>] or could develop from the deafferentation of the basal forebrain cholinergic system to the tubero-mamillary tracts [<xref ref-type="bibr" rid="B28-ijms-20-05797">28</xref>,<xref ref-type="bibr" rid="B29-ijms-20-05797">29</xref>], observing, therefore, perverse procrastination of the hypoperfusion. Neural activity is typically supplemented by increased blood flow, originated by a retrograde vascular dilatation of upstream arterioles outside the activated area [<xref ref-type="bibr" rid="B30-ijms-20-05797">30</xref>]. The altered “retrograde vasodilatation system” (which occurs in small vessel disease-related dementia) could be another factor that worsens vessel dysregulation [<xref ref-type="bibr" rid="B30-ijms-20-05797">30</xref>].</p>
<p>Cerebral small vessel disease includes a neuroimaging and a combined pathological description, which comprise different imaging changes in the white matter and subcortical grey matter, including small subcortical infarct, lacunes, white matter hyperintensities (WMHs), prominent perivascular spaces (PVS), cerebral microbleeds (CMBs), and atrophy. Lacunes derive from a complete occlusion of the small arteries, leading to an infarct in a specific area (basal ganglia, capsule, pons). Moreover, SVD is characterized by an associated hypoperfusion progression, causing incomplete ischemia of the deep white matter [<xref ref-type="bibr" rid="B31-ijms-20-05797">31</xref>,<xref ref-type="bibr" rid="B32-ijms-20-05797">32</xref>,<xref ref-type="bibr" rid="B33-ijms-20-05797">33</xref>,<xref ref-type="bibr" rid="B34-ijms-20-05797">34</xref>] accompanied by inflammation, diffuse rarefaction of myelin sheaths, axonal disruption, and astrocyte gliosis [<xref ref-type="bibr" rid="B26-ijms-20-05797">26</xref>]. In small vessel disease, occlusion of the deep periventricular-draining veins is also evident [<xref ref-type="bibr" rid="B35-ijms-20-05797">35</xref>], with the disruption of the blood-brain barrier (BBB) as a consequence. The BBB disruption leads to a consequent leakage of fluid and plasma cells, which eventually potentiates the perivascular inflammation, the demyelination process, and gliosis, gathering a multifactorial genesis for white matter alterations [<xref ref-type="bibr" rid="B36-ijms-20-05797">36</xref>,<xref ref-type="bibr" rid="B37-ijms-20-05797">37</xref>,<xref ref-type="bibr" rid="B38-ijms-20-05797">38</xref>]. Cerebral small vessel disease is what we define to as a “progressive disease” [<xref ref-type="bibr" rid="B26-ijms-20-05797">26</xref>]. Lesions progress over time, and the long-term outcome and impact on brain damage vary. Recent studies indicated that the strongest predictor of white matter progression is the high density, at baseline, of the white matter hyperintensity, with a rapid confluence of the lesions [<xref ref-type="bibr" rid="B39-ijms-20-05797">39</xref>,<xref ref-type="bibr" rid="B40-ijms-20-05797">40</xref>,<xref ref-type="bibr" rid="B41-ijms-20-05797">41</xref>,<xref ref-type="bibr" rid="B42-ijms-20-05797">42</xref>]. Nonetheless, one of the most unsolved doubts is which is the determinant factor for an acceleration process that mediates the transition from small vessel disease toward the subcortical dementia process? The burden of lacunes and a profound amount of white matter alterations (WMLs) [<xref ref-type="bibr" rid="B43-ijms-20-05797">43</xref>,<xref ref-type="bibr" rid="B44-ijms-20-05797">44</xref>,<xref ref-type="bibr" rid="B45-ijms-20-05797">45</xref>] are two suitable candidates.</p>
<p>The cognitive alterations are determined by the specific point-to-point impairment, but also by the interruptions of the frontal and prefrontal-thalamus and thalamus-frontal and basal forebrain networks [<xref ref-type="bibr" rid="B46-ijms-20-05797">46</xref>,<xref ref-type="bibr" rid="B47-ijms-20-05797">47</xref>], which can also lead to functional cortical deafferentation. The caudate nucleus is the most precociously affected region by chronic hypoperfusion, followed by the putamen, insula, precentral gyrus, inferior frontal gyrus, and middle frontal gyrus. All these regions require, at steady state, more than 20% of the metabolic request compared to other brain areas [<xref ref-type="bibr" rid="B48-ijms-20-05797">48</xref>,<xref ref-type="bibr" rid="B49-ijms-20-05797">49</xref>,<xref ref-type="bibr" rid="B50-ijms-20-05797">50</xref>,<xref ref-type="bibr" rid="B51-ijms-20-05797">51</xref>,<xref ref-type="bibr" rid="B52-ijms-20-05797">52</xref>,<xref ref-type="bibr" rid="B53-ijms-20-05797">53</xref>,<xref ref-type="bibr" rid="B54-ijms-20-05797">54</xref>,<xref ref-type="bibr" rid="B55-ijms-20-05797">55</xref>]. Reduced metabolic rate of oxygen (estimated of about 35% in white matter) [<xref ref-type="bibr" rid="B56-ijms-20-05797">56</xref>,<xref ref-type="bibr" rid="B57-ijms-20-05797">57</xref>] has been found in patients with small vessel disease-related dementia; moreover, an incongruity between the brain oxygen supply and its consumption has been described in sVaD, which determines an altered neurovascular coupling and altered vasomotor reactivity [<xref ref-type="bibr" rid="B26-ijms-20-05797">26</xref>,<xref ref-type="bibr" rid="B58-ijms-20-05797">58</xref>,<xref ref-type="bibr" rid="B59-ijms-20-05797">59</xref>,<xref ref-type="bibr" rid="B60-ijms-20-05797">60</xref>,<xref ref-type="bibr" rid="B61-ijms-20-05797">61</xref>,<xref ref-type="bibr" rid="B62-ijms-20-05797">62</xref>,<xref ref-type="bibr" rid="B63-ijms-20-05797">63</xref>].</p>
<p>Neuropsychological pattern profiles of sVaD are related to the subcortical-cortical loop deafferentation and are distinguished by poor executive function, poor planning, working memory alterations, loss of inhibition, reduced mental flexibility, multitasking procedures invalidation, and decrease speed of executive process [<xref ref-type="bibr" rid="B64-ijms-20-05797">64</xref>,<xref ref-type="bibr" rid="B65-ijms-20-05797">65</xref>,<xref ref-type="bibr" rid="B66-ijms-20-05797">66</xref>,<xref ref-type="bibr" rid="B67-ijms-20-05797">67</xref>,<xref ref-type="bibr" rid="B68-ijms-20-05797">68</xref>,<xref ref-type="bibr" rid="B69-ijms-20-05797">69</xref>,<xref ref-type="bibr" rid="B70-ijms-20-05797">70</xref>].</p>
<p>No specific treatment has been discovered, either as pathogenic or highly standard recommended for this condition.</p>
</sec>
<sec id="sec3-ijms-20-05797">
<title>3. State-Of-The-Art: What Do We Know about Nutrients and Brain Degenerative Diseases?</title>
<p>Decades have passed since the first descriptions of how vitamins can affect brain networks [<xref ref-type="bibr" rid="B71-ijms-20-05797">71</xref>], but results remain compelling. Cummings [<xref ref-type="bibr" rid="B72-ijms-20-05797">72</xref>] suggested that the nutraceutical approach might have an effect on synaptic integrity, and therefore, it could be useful in many different clinical conditions, such as AD, vascular disease, traumatic brain injury, and Parkinson’s disease. Choline is an essential nutrient for humans. It is a precursor of the synthesis of all the membrane phospholipids (e.g., phosphatidylcholine (PC)), the neurotransmitter acetylcholine, and via betaine, the methyl group donor S-adenosylmethionine. High choline intake during gestation and in the soon-after postnatal period, in animal models, improves cognitive function in adulthood. It has been associated with a prevention of age-related memory decline, and of the neuropathological changes associated with AD, epilepsy, fetal alcohol syndrome, and inherited conditions such as Down and Rett syndromes, but also with stroke and, recently, vascular-risk conditions [<xref ref-type="bibr" rid="B73-ijms-20-05797">73</xref>,<xref ref-type="bibr" rid="B74-ijms-20-05797">74</xref>]. Choline and its metabolites are differently associated with cardiometabolic risk factors, history of cardiovascular disease, and MRI-documented cerebrovascular disease in older adults. [<xref ref-type="bibr" rid="B75-ijms-20-05797">75</xref>]. Choline might modify the DNA methylation in the brain and may induce alterations in the expression of genes that encode proteins essential for learning and memory processing, suggesting a possible epigenomic mechanism of action [<xref ref-type="bibr" rid="B75-ijms-20-05797">75</xref>]. Prenatal choline supplementation has been demonstrated to show a three-day advancement in hippocampal development [<xref ref-type="bibr" rid="B76-ijms-20-05797">76</xref>]. This effect on adult neurogenesis has been observed together with a local increment of other trophic factors: nerve growth factor, brain-derived neurotrophic factor, insulin-like growth factor 2, and vascular endothelial growth factor [<xref ref-type="bibr" rid="B77-ijms-20-05797">77</xref>,<xref ref-type="bibr" rid="B78-ijms-20-05797">78</xref>]. A concomitant enlarged dimension of the basal forebrain cholinergic neurons has also been observed [<xref ref-type="bibr" rid="B79-ijms-20-05797">79</xref>], with a concomitant increase of acetylcholine production [<xref ref-type="bibr" rid="B80-ijms-20-05797">80</xref>].</p>
<p>Choline influences, as a cofactor of methyl donors, the DNA methylation process (in addition to folate and vitamin B12; see elsewhere in this manuscript). Choline is a strong determining factor of transcriptional regulation and the methylation process of different regions of insulin growth factor 2 gene [<xref ref-type="bibr" rid="B81-ijms-20-05797">81</xref>,<xref ref-type="bibr" rid="B82-ijms-20-05797">82</xref>], and many others fundamental for synaptic plasticity, with the cascade of dynamic processes highly dependent on it, i.e., learning and memory [<xref ref-type="bibr" rid="B83-ijms-20-05797">83</xref>,<xref ref-type="bibr" rid="B84-ijms-20-05797">84</xref>,<xref ref-type="bibr" rid="B85-ijms-20-05797">85</xref>,<xref ref-type="bibr" rid="B86-ijms-20-05797">86</xref>,<xref ref-type="bibr" rid="B87-ijms-20-05797">87</xref>,<xref ref-type="bibr" rid="B88-ijms-20-05797">88</xref>].</p>
<p>Choline also is a precursor of phosphatidylcholine, the principal constituent of all biological membranes, including the polarized ones, such as neurons and astrocytes. Evidence that phospholipid metabolism is abnormal in AD originated with postmortem brain sample studies [<xref ref-type="bibr" rid="B75-ijms-20-05797">75</xref>,<xref ref-type="bibr" rid="B89-ijms-20-05797">89</xref>]. These studies showed reduced levels of phosphatidylcholine and phosphatidylethanolamine, and increased levels of their metabolites, glycerophosphocholine, and glycerophosphoethanolamine, in the cerebral cortex of AD patients compared to age-matched controls [<xref ref-type="bibr" rid="B89-ijms-20-05797">89</xref>,<xref ref-type="bibr" rid="B90-ijms-20-05797">90</xref>]. These variations have also been observed in brain regions free of plaques and tangles [<xref ref-type="bibr" rid="B90-ijms-20-05797">90</xref>]. Therefore, this data suggests that the defect does not rely on an amyloid-related process but is widespread through the AD brain. More recently, reduced levels of phosphatidylcholine and phosphatidylethanolamine and increased levels of their metabolites, glycerophosphocholine and glycerophosphoethanolamine, have been reported in vascular-risk factors conditions, such as fatty liver disease [<xref ref-type="bibr" rid="B91-ijms-20-05797">91</xref>], obesity, and insulin resistance [<xref ref-type="bibr" rid="B92-ijms-20-05797">92</xref>,<xref ref-type="bibr" rid="B93-ijms-20-05797">93</xref>].</p>
<p>Furthermore, a substantial reduction in molecular species of phosphatidylcholine containing docosahexaenoic acid (PC-DHA) levels has been observed in the temporal cortex gray matter of AD patients [<xref ref-type="bibr" rid="B94-ijms-20-05797">94</xref>]. These markers have been observed in AD brains but also AD peripheral blood plasma [<xref ref-type="bibr" rid="B95-ijms-20-05797">95</xref>,<xref ref-type="bibr" rid="B96-ijms-20-05797">96</xref>,<xref ref-type="bibr" rid="B97-ijms-20-05797">97</xref>]. All these findings support another theory for AD pathogenesis: Lipid altered or defective production [<xref ref-type="bibr" rid="B75-ijms-20-05797">75</xref>,<xref ref-type="bibr" rid="B98-ijms-20-05797">98</xref>,<xref ref-type="bibr" rid="B99-ijms-20-05797">99</xref>]. Healthy old subjects with a lower level of erythrocyte phospholipid n-3 fatty acid (eicosapentaenoic (EPA, 20:5n-3)) are more prone to faster cognitive alteration, compared to healthy old subjects with normal levels of erythrocyte phospholipid n-3 fatty acid (eicosapentaenoic (EPA, 20:5n-3)) [<xref ref-type="bibr" rid="B100-ijms-20-05797">100</xref>]. Docosahexaenoic acid and erythrocyte phospholipid n-3 fatty acid (eicosapentaenoic acid) are transported through the BBE as lysophosphatidylcholines by a specific transporter [<xref ref-type="bibr" rid="B101-ijms-20-05797">101</xref>,<xref ref-type="bibr" rid="B102-ijms-20-05797">102</xref>]. Therefore, it has been argued that low plasma levels of lysophosphatidylcholine might reduce fatty acids inside the brain in AD patients [<xref ref-type="bibr" rid="B97-ijms-20-05797">97</xref>,<xref ref-type="bibr" rid="B103-ijms-20-05797">103</xref>].</p>
<p>Hence, medical supplementation of food, including with phosphatide precursors (docosahexaenoic and eicosapentaenoic acid, phospholipids, choline, uridine monophosphate, vitamin E, vitamin C, and vitamins B12, B6, and B9) has been employed in different clinical trials [<xref ref-type="bibr" rid="B104-ijms-20-05797">104</xref>,<xref ref-type="bibr" rid="B105-ijms-20-05797">105</xref>]. The second study has two outcomes: The primary aim is to demonstrate an improvement of memory scores in specific tests in mild AD when compared to placebo. Secondary outcomes include different sub-scores of neuropsychological battery and EEG measures, including relative and absolute power in alpha, beta, theta, and delta frequency bands, associated with the phase lag index in each of the frequency bands. The study achieved its primary outcome, showing significantly better performance in memory in the treated mild AD group. It did not obtain any significant measure in the second neuropsychological outcome, but showed that peak frequency and phase lag index of the delta frequency showed a drug/placebo difference in favor of the treated group [<xref ref-type="bibr" rid="B105-ijms-20-05797">105</xref>]. Three other studies continued from these finding [<xref ref-type="bibr" rid="B106-ijms-20-05797">106</xref>,<xref ref-type="bibr" rid="B107-ijms-20-05797">107</xref>,<xref ref-type="bibr" rid="B108-ijms-20-05797">108</xref>]. Rijpma et al. [<xref ref-type="bibr" rid="B106-ijms-20-05797">106</xref>] demonstrated that prolonged diet supplementation could increase circulating levels of fatty acid levels and uridine monophosphate. Uridine, together with docosahexaenoic and eicosapentaenoic acids, is a rate-limiting precursor via the Kennedy pathway for the synthesis of phospholipids in neuronal membranes.</p>
<p>A recent review of the studies on food supplementation [<xref ref-type="bibr" rid="B109-ijms-20-05797">109</xref>] has drawn hopeful conclusions: early interventions work better, and mildly affected patients improve memory scores in specific tests. Moreover, their caregivers perceive an amelioration (even if not significantly) of AD behavior, and these supplementations might potentially delay or ameliorate the pathogenetic process in AD and small vessel disease [<xref ref-type="bibr" rid="B110-ijms-20-05797">110</xref>,<xref ref-type="bibr" rid="B111-ijms-20-05797">111</xref>,<xref ref-type="bibr" rid="B112-ijms-20-05797">112</xref>,<xref ref-type="bibr" rid="B113-ijms-20-05797">113</xref>].</p>
</sec>
<sec id="sec4-ijms-20-05797">
<title>4. Vitamin B1 (Thiamine)</title>
<p>Thiamine is probably one of the most studied vitamins related to Wernicke encephalopathy and Korsakoff syndrome, which have been thoroughly studied for decades [<xref ref-type="bibr" rid="B114-ijms-20-05797">114</xref>,<xref ref-type="bibr" rid="B115-ijms-20-05797">115</xref>]. Nevertheless, recent data emphasizes the role of thiamine, due to the massive increase of alcoholism in Western countries [<xref ref-type="bibr" rid="B116-ijms-20-05797">116</xref>,<xref ref-type="bibr" rid="B117-ijms-20-05797">117</xref>,<xref ref-type="bibr" rid="B118-ijms-20-05797">118</xref>], in addition to the finding that thiamine defects are frequently found in association with dialyzed patients, hyperemesis gravidarum, malignancy with or without therapy, sleeve gastrectomy, magnesium depletion, AIDS, etc. [<xref ref-type="bibr" rid="B119-ijms-20-05797">119</xref>,<xref ref-type="bibr" rid="B120-ijms-20-05797">120</xref>,<xref ref-type="bibr" rid="B121-ijms-20-05797">121</xref>,<xref ref-type="bibr" rid="B122-ijms-20-05797">122</xref>,<xref ref-type="bibr" rid="B123-ijms-20-05797">123</xref>].</p>
<p>Thiamine, also called vitamin B1, is a labile quaternary ammonia compound, not produced in humans. It is found as unphosphorylated thiamine (i.e., free TH) and as phosphorylated derivates, with magnesium as a cofactor: Thiamine monophosphate (THMP), thiamine diphosphate (THDP, aka TH pyrophosphate), and thiamine triphosphate (THTP) [<xref ref-type="bibr" rid="B124-ijms-20-05797">124</xref>,<xref ref-type="bibr" rid="B125-ijms-20-05797">125</xref>].</p>
<p>Thiamine acts as a cofactor in three key-enzymatic reactions: The conversion of pyruvate to acetyl-CoA, the conversion of alpha-ketoglutarate to succinate, in the Kreb’s cycle, and the catalysis by transketolase in the pentose monophosphate shunt [<xref ref-type="bibr" rid="B125-ijms-20-05797">125</xref>]. Lack of alpha-ketoglutarate dehydrogenase interrupts the Kreb’s cycle, essential for ATP production in the brain; the loss of ATP induces a quick increment of the calcium inflow, with consequent induction of neuronal apoptosis and an abrupt growth of the glutamate currents [<xref ref-type="bibr" rid="B125-ijms-20-05797">125</xref>,<xref ref-type="bibr" rid="B126-ijms-20-05797">126</xref>]. The loss of alpha-ketoglutarate dehydrogenase causes a decrease of the aspartate and GABA brain concentration, a decrement of the reduced oxidative phosphorylation, and an increment of lactate [<xref ref-type="bibr" rid="B127-ijms-20-05797">127</xref>,<xref ref-type="bibr" rid="B128-ijms-20-05797">128</xref>,<xref ref-type="bibr" rid="B129-ijms-20-05797">129</xref>,<xref ref-type="bibr" rid="B130-ijms-20-05797">130</xref>]. Diminished transketolase activity leads to a loss of sphingolipid synthesis, an overproduction of branched-chain amino acids, and an altered pentose phosphate shunt [<xref ref-type="bibr" rid="B131-ijms-20-05797">131</xref>,<xref ref-type="bibr" rid="B132-ijms-20-05797">132</xref>,<xref ref-type="bibr" rid="B133-ijms-20-05797">133</xref>,<xref ref-type="bibr" rid="B134-ijms-20-05797">134</xref>]. Until the last decade, there were limited works describing the causative role of brain damage induced by thiamine loss per se; usually, thiamine defects have been tightly related to alcohol addiction, the former being recognized as the causative factor of the neural alterations, rather than the alcohol by itself.</p>
<p>Moreover, it has been observed that in alcohol-addiction there is an altered gene expression of two proteins, carriers for thiamine, THTR1 and THTR2 (not known if genetically or epigenetically transformed) [<xref ref-type="bibr" rid="B135-ijms-20-05797">135</xref>,<xref ref-type="bibr" rid="B136-ijms-20-05797">136</xref>,<xref ref-type="bibr" rid="B137-ijms-20-05797">137</xref>], suggesting a possible superimposed damage factor. Thus, genetic predisposition of thiamine transporter reduced efficacy is currently more accepted as a potentiating effect of brain damage, even in well-nourished patients. Animal models have been used to prove that severe isolated thiamine deprivation brings a significant alteration of the inferior colliculus and the medial vestibular nucleus over a one-week period. More prolonged thiamine depletion caused severe basal ganglia impairment and, in the final period of observation, functional alteration of the mammillary bodies and the dorsal medial nucleus of the thalamus [<xref ref-type="bibr" rid="B138-ijms-20-05797">138</xref>]. Some studies suggested a possible relationship between a loss of thiamine and a macroscopic decrease of the endorphinergic system [<xref ref-type="bibr" rid="B139-ijms-20-05797">139</xref>], but this data remains isolated because it has been observed in many patients, with a contemporary loss of thiamine and heavy alcohol consumption. The principal cause of the observed data remains a mystery (alcohol induction of endorphin depletion has been positively documented) [<xref ref-type="bibr" rid="B130-ijms-20-05797">130</xref>]. The loss of the activity of the three thiamine enzymes in the brain (the conversion of pyruvate to acetyl-CoA, the active participation in the conversion of alpha-ketoglutarate to succinate, in the Kreb’s cycle, and the catalysis by transketolase in the pentose monophosphate shunt) has been observed in many neurodegenerative conditions [<xref ref-type="bibr" rid="B140-ijms-20-05797">140</xref>,<xref ref-type="bibr" rid="B141-ijms-20-05797">141</xref>,<xref ref-type="bibr" rid="B142-ijms-20-05797">142</xref>,<xref ref-type="bibr" rid="B143-ijms-20-05797">143</xref>,<xref ref-type="bibr" rid="B144-ijms-20-05797">144</xref>]. The administration of benfotiamine induced a mild inhibition of cholinesterase, leading to a significant amount of acetylcholine in the post-synaptic space and determining a reduction of amyloid plaques and tau tangles, probably reducing the cascade of neuroinflammation, which promotes the hyperphosphorylation process [<xref ref-type="bibr" rid="B145-ijms-20-05797">145</xref>,<xref ref-type="bibr" rid="B146-ijms-20-05797">146</xref>,<xref ref-type="bibr" rid="B147-ijms-20-05797">147</xref>,<xref ref-type="bibr" rid="B148-ijms-20-05797">148</xref>].</p>
<p>Thiamine also has a non-coenzymatic function [<xref ref-type="bibr" rid="B149-ijms-20-05797">149</xref>]; its effects on the axonal conductance and the release of different neurotransmitters, such as acetylcholine, dopamine, and noradrenaline, has been described [<xref ref-type="bibr" rid="B149-ijms-20-05797">149</xref>,<xref ref-type="bibr" rid="B150-ijms-20-05797">150</xref>,<xref ref-type="bibr" rid="B151-ijms-20-05797">151</xref>]. These data have been supported by the findings of a rapid change of thiamine status (the so-called mobile thiamine pool) [<xref ref-type="bibr" rid="B150-ijms-20-05797">150</xref>,<xref ref-type="bibr" rid="B151-ijms-20-05797">151</xref>] in different neural networks. In particular, oxythiamine stimulates potassium-evoked acetylcholine release in the presence of calcium [<xref ref-type="bibr" rid="B152-ijms-20-05797">152</xref>,<xref ref-type="bibr" rid="B153-ijms-20-05797">153</xref>]. By definition, thiamine exerts a refining system able to protect the hippocampal neurons cultured with an excess of glutamate [<xref ref-type="bibr" rid="B154-ijms-20-05797">154</xref>]. On the contrary, thiamine deficiency also induces an excess of glutamate release, diminished by a glutamatergic blocking action with an N-methyl-D-aspartate (NMDA) antagonist (similar to memantine) [<xref ref-type="bibr" rid="B155-ijms-20-05797">155</xref>,<xref ref-type="bibr" rid="B156-ijms-20-05797">156</xref>]. These studies have not yet been applied in clinical practice [<xref ref-type="bibr" rid="B157-ijms-20-05797">157</xref>].</p>
</sec>
<sec id="sec5-ijms-20-05797">
<title>5. Vitamin B2 (Riboflavin)</title>
<p>Riboflavin, or B2, is mainly dependent on dietary intake. It is active in different forms, as riboflavin, or as coenzymes for several reactions, namely, flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD). Riboflavin is involved in a large variety of processes and has a critical neuroprotective function [<xref ref-type="bibr" rid="B158-ijms-20-05797">158</xref>]. It is a primary antioxidant; thus, B2 is involved in glutathione reduction, where FAD is a co-factor, forming reduced, active glutathione, which acts against oxidative stress and lipid peroxidation. Vitamin B2 increases the activity of antioxidant enzymes, such as the superoxide dismutase (SOD) and catalase [<xref ref-type="bibr" rid="B158-ijms-20-05797">158</xref>,<xref ref-type="bibr" rid="B159-ijms-20-05797">159</xref>,<xref ref-type="bibr" rid="B160-ijms-20-05797">160</xref>,<xref ref-type="bibr" rid="B161-ijms-20-05797">161</xref>], additionally. Riboflavin seems to also reduce the oxidative damage after reperfusion, through a direct action on free radicals, as shown by studies on rabbits’ hearts after infarction [<xref ref-type="bibr" rid="B162-ijms-20-05797">162</xref>], mice ischemic liver cells [<xref ref-type="bibr" rid="B163-ijms-20-05797">163</xref>], and rats’ brains [<xref ref-type="bibr" rid="B164-ijms-20-05797">164</xref>]. In these cases, vitamin B2 reduces edema and neuronal death after traumatic brain injury [<xref ref-type="bibr" rid="B151-ijms-20-05797">151</xref>,<xref ref-type="bibr" rid="B160-ijms-20-05797">160</xref>,<xref ref-type="bibr" rid="B164-ijms-20-05797">164</xref>,<xref ref-type="bibr" rid="B165-ijms-20-05797">165</xref>]. Riboflavin, together with folate, lowers homocysteine levels, hence helping to avoid vascular and toxic damages: FAD is needed in the one-carbon metabolism cycle to reduce 5,10-methylenetetrahydrofolate (5,10-MTHF) to 5-methyl THF which, in turn, provides the methyl group for homocysteine re-methylation to methionine [<xref ref-type="bibr" rid="B158-ijms-20-05797">158</xref>,<xref ref-type="bibr" rid="B161-ijms-20-05797">161</xref>,<xref ref-type="bibr" rid="B166-ijms-20-05797">166</xref>]. This vitamin might play a role in the reduction of glutamate excitotoxicity via direct inhibition of glutamate neuronal release, as evidenced in animal studies [<xref ref-type="bibr" rid="B167-ijms-20-05797">167</xref>,<xref ref-type="bibr" rid="B168-ijms-20-05797">168</xref>]; further, it is crucial for the tryptophan-kynurenine pathway, where neuroactive compounds that might influence glutamate receptors are produced [<xref ref-type="bibr" rid="B158-ijms-20-05797">158</xref>]. In addition, B2 seems to have a direct anti-inflammatory ability, through inhibition of NF-kB and high-mobility group protein B1 (HMGB1) [<xref ref-type="bibr" rid="B158-ijms-20-05797">158</xref>,<xref ref-type="bibr" rid="B169-ijms-20-05797">169</xref>], and it is involved in mitochondrial functioning, FAD and FMN being co-factors for complex I and complex II of the electron transport chain [<xref ref-type="bibr" rid="B158-ijms-20-05797">158</xref>,<xref ref-type="bibr" rid="B159-ijms-20-05797">159</xref>]. Lastly, some of these functions are shared with the B6 vitamin; B6 requires the active form of B2, FMN, as a co-factor, in order to be transformed into its active form pyridoxal 5′ phosphate (PLP) [<xref ref-type="bibr" rid="B170-ijms-20-05797">170</xref>].</p>
<p>Riboflavin deficiency derives from inadequate dietary intake, mainly derived from a rice-based diet, poor animal proteins [<xref ref-type="bibr" rid="B171-ijms-20-05797">171</xref>], or in conditions of higher demand, e.g., pregnancy, childhood, aging [<xref ref-type="bibr" rid="B159-ijms-20-05797">159</xref>], genetic disorders, or malabsorption conditions. Deficiency is also related to drug and substance interaction, e.g., furosemide or alcohol, contributes to riboflavin reduction [<xref ref-type="bibr" rid="B172-ijms-20-05797">172</xref>]. Lack of riboflavin is recognized in starvation and lower income groups, but it has also been found in adolescents with low milk consumption [<xref ref-type="bibr" rid="B166-ijms-20-05797">166</xref>], and a recent study showed that in the Western world, including Europe, North America, Australia, and New Zealand, 40% of people older than 65 years are below the estimated average requirement [<xref ref-type="bibr" rid="B173-ijms-20-05797">173</xref>]. A suboptimal, subclinical level of B2 is likely more common than previously thought and might affect all ages [<xref ref-type="bibr" rid="B174-ijms-20-05797">174</xref>]. Further studies, based on biomarkers more than simple dietary intake surveys, are required for more reliable data and a better knowledge of this crucial vitamin deficiency [<xref ref-type="bibr" rid="B170-ijms-20-05797">170</xref>].</p>
<p>Ariboflavinosis may lead to several conditions, such as anemia, cheilosis, glossitis, angular stomatitis, cataract, and seborrheic dermatitis [<xref ref-type="bibr" rid="B159-ijms-20-05797">159</xref>,<xref ref-type="bibr" rid="B174-ijms-20-05797">174</xref>,<xref ref-type="bibr" rid="B175-ijms-20-05797">175</xref>]. It is frequently associated with other vitamin deficiencies, and signs and symptoms are rarely isolated [<xref ref-type="bibr" rid="B170-ijms-20-05797">170</xref>]. Impaired nerve function has also been correlated to riboflavin insufficiency, both as acquired [<xref ref-type="bibr" rid="B174-ijms-20-05797">174</xref>,<xref ref-type="bibr" rid="B176-ijms-20-05797">176</xref>,<xref ref-type="bibr" rid="B177-ijms-20-05797">177</xref>] and genetic disorders, i.e., Brown–Vialetto–Van Laere neuropathy [<xref ref-type="bibr" rid="B178-ijms-20-05797">178</xref>].</p>
<p>Subclinical levels of riboflavin might be related to different neurological diseases, such as Parkinson’s disease, migraines, and multiple sclerosis, due to the multiple roles discussed above [<xref ref-type="bibr" rid="B158-ijms-20-05797">158</xref>,<xref ref-type="bibr" rid="B161-ijms-20-05797">161</xref>]. Thus, when implemented, riboflavin seems to have neuroprotective functions, and clinical trials have reported how a high intake of this vitamin reduced motor impairment in patients with Parkinson’s disease (PD) and proved to be useful for migraine prophylaxis in adults [<xref ref-type="bibr" rid="B179-ijms-20-05797">179</xref>,<xref ref-type="bibr" rid="B180-ijms-20-05797">180</xref>,<xref ref-type="bibr" rid="B181-ijms-20-05797">181</xref>].</p>
<p>On the contrary, the direct relationship between riboflavin and dementia, mainly the so-called small vessel disease/subcortical vascular dementia, has been rarely investigated, even if vitamin B2 is related to endothelial release of nitric oxide [<xref ref-type="bibr" rid="B166-ijms-20-05797">166</xref>] and to the catabolism of homocysteine, both of which are related to cerebral small vessel disease [<xref ref-type="bibr" rid="B159-ijms-20-05797">159</xref>,<xref ref-type="bibr" rid="B182-ijms-20-05797">182</xref>,<xref ref-type="bibr" rid="B183-ijms-20-05797">183</xref>,<xref ref-type="bibr" rid="B184-ijms-20-05797">184</xref>,<xref ref-type="bibr" rid="B185-ijms-20-05797">185</xref>].</p>
<p>Some studies have analyzed the relationship between B2 and cognitive decline [<xref ref-type="bibr" rid="B186-ijms-20-05797">186</xref>,<xref ref-type="bibr" rid="B187-ijms-20-05797">187</xref>,<xref ref-type="bibr" rid="B188-ijms-20-05797">188</xref>,<xref ref-type="bibr" rid="B189-ijms-20-05797">189</xref>] without investigating possible direct molecular mechanisms. In one study, the authors enrolled a cohort of 70-year-old subjects, who had previously been assessed for intelligent quotient at age 11 years. At 70 years, participants underwent a range of neuropsychological tests, including the Mini-Mental State Examination (MMSE), and the National Adult Reading Test (NART), and completed food questionnaires regarding the intake of several nutrients, including B vitamins and riboflavin [<xref ref-type="bibr" rid="B187-ijms-20-05797">187</xref>]. No significant association was found between diet and cognitive performances [<xref ref-type="bibr" rid="B187-ijms-20-05797">187</xref>]. In line with this, a Korean observational study [<xref ref-type="bibr" rid="B188-ijms-20-05797">188</xref>] explored the association between intake of B vitamins, including riboflavin, and cognition in three groups of subjects over 60 years: Normal, mild cognitive impairment, and with Alzheimer’s disease. Riboflavin intake was positively correlated to cognitive test scores, e.g., MMSE for Koreans (MMSE-K) and the Boston Naming Test, in both the AD group and the MCI group, whereas no correlation was found in healthy subjects [<xref ref-type="bibr" rid="B188-ijms-20-05797">188</xref>]. Of note, there was no significant difference in vitamin intake among the three groups when comparing AD patients with controls, as also noted by other authors [<xref ref-type="bibr" rid="B190-ijms-20-05797">190</xref>]. Another Korean study found an association between poor cognitive performance, scored with MMSE-K, and riboflavin intake [<xref ref-type="bibr" rid="B189-ijms-20-05797">189</xref>], although herein, the correlation was also positive in subjects with average scores. Two earlier studies [<xref ref-type="bibr" rid="B191-ijms-20-05797">191</xref>,<xref ref-type="bibr" rid="B192-ijms-20-05797">192</xref>] investigating subjects free of cognitive impairment reported a better memory function with higher riboflavin levels and an absence of correlation between cognitive performances and B2.</p>
<p>These results show how riboflavin might be related to cognition, although the reasons are yet to be proven. Two well-established risk factors for cerebrovascular damage and small vessel disease are hyperhomocysteinemia, acting via endothelial impairment, ischemia, and oxidative damage [<xref ref-type="bibr" rid="B182-ijms-20-05797">182</xref>], and advanced glycation end product (AGE) formation, which can lead to micro and macrovascular damage, accelerating AD [<xref ref-type="bibr" rid="B193-ijms-20-05797">193</xref>]. Riboflavin is an independent determinant of homocysteine levels [<xref ref-type="bibr" rid="B184-ijms-20-05797">184</xref>,<xref ref-type="bibr" rid="B194-ijms-20-05797">194</xref>], and its deficiency is related to higher homocysteine levels, increasing vascular complications. B2 is also essential for vitamin B6 activation. The latter is a powerful anti-glycation agent, preventing AGE formation, thus protecting blood vessels [<xref ref-type="bibr" rid="B195-ijms-20-05797">195</xref>,<xref ref-type="bibr" rid="B196-ijms-20-05797">196</xref>,<xref ref-type="bibr" rid="B197-ijms-20-05797">197</xref>]. Furthermore, these findings suggest that B2 levels might differ even with a similar dietary intake [<xref ref-type="bibr" rid="B166-ijms-20-05797">166</xref>,<xref ref-type="bibr" rid="B179-ijms-20-05797">179</xref>]. However, additional studies, using more robust biomarkers, i.e., plasma levels instead of food intake questionnaires, and experimental approaches are required to better evaluate the role of B2 in cognitive decline.</p>
</sec>
<sec id="sec6-ijms-20-05797">
<title>6. Vitamin B3 (Niacin)</title>
<p>The vitamin B3 family consists of three different molecules: Niacin or nicotinic acid, nicotinamide, and nicotinamide riboside (NR) [<xref ref-type="bibr" rid="B198-ijms-20-05797">198</xref>,<xref ref-type="bibr" rid="B199-ijms-20-05797">199</xref>]. Together with tryptophan, they are essential for the synthesis of nicotinamide adenine dinucleotide (NAD+) and nicotinamide adenine dinucleotide phosphate (NADP+), and their reduced forms NADH and NADPH [<xref ref-type="bibr" rid="B198-ijms-20-05797">198</xref>]. These co-factors play a fundamental role in several cellular processes and are essential for cells’ survival [<xref ref-type="bibr" rid="B198-ijms-20-05797">198</xref>,<xref ref-type="bibr" rid="B199-ijms-20-05797">199</xref>,<xref ref-type="bibr" rid="B200-ijms-20-05797">200</xref>]. They are involved in vital redox reactions, such as glycolysis and gluconeogenesis, beta-fatty oxidation, and steroid anabolism, thus, protecting cells from oxidative damage. They are crucial for mitochondrial respiration and ATP formation, and are strongly demanded in the citric acid cycle. The vitamin B3 family interacts in the inflammatory cascade, promoting calcium signaling and acting as a direct neurotransmitter via the purine receptor.</p>
<p>Furthermore, the NAD+ pool influences genetic stability and epigenetic variability; it is the main co-factor of poly (ADP-ribose) polymerases (PARPs), ADP-ribose transferases (ATRDs), and sirtuins. These enzymes regulate the DNA repair process, transcription, chromatin expression, cellular death, and senescence regulating some vias, e.g., the telomere length [<xref ref-type="bibr" rid="B198-ijms-20-05797">198</xref>,<xref ref-type="bibr" rid="B199-ijms-20-05797">199</xref>,<xref ref-type="bibr" rid="B200-ijms-20-05797">200</xref>,<xref ref-type="bibr" rid="B201-ijms-20-05797">201</xref>].</p>
<p>Vitamin B3 compounds derive from different food sources, such as beans, meat, fish, milk, mushrooms, and enriched flour. However, malnutrition, alcohol abuse, and infectious/autoimmune processes might cause insufficient vitamin levels. The main consequence of acute B3 deficiency, leading to a lack of NAD, is pellagra. This disease is mostly present in emerging nations, where starvation or very poor corn-based diets are dominant. In countries with niacin-fortified food (i.e., flour and grain), pellagra can be only observed in alcohol addicted, immunosuppressed, and cachectic patients. Symptoms of pellagra include diarrhea, dermatitis, and neurological disorders such as anxiety, depression, and dementia [<xref ref-type="bibr" rid="B199-ijms-20-05797">199</xref>,<xref ref-type="bibr" rid="B201-ijms-20-05797">201</xref>,<xref ref-type="bibr" rid="B202-ijms-20-05797">202</xref>].</p>
<p>Due to the above-explained different functions exerted by vitamin B3, suboptimal B3 levels might lead to cellular dysfunction, including early cell death, changes in cellular metabolism, and aging, increasing the chances of misfolding and telomeric alteration, even promoting neoplastic degeneration [<xref ref-type="bibr" rid="B199-ijms-20-05797">199</xref>,<xref ref-type="bibr" rid="B203-ijms-20-05797">203</xref>]. Some subgroups, such as the elderly, pregnant women, or patients undergoing DNA damaging treatments, are at a higher risk of suboptimal levels because of increased body requests, despite an adequate vitamin intake [<xref ref-type="bibr" rid="B199-ijms-20-05797">199</xref>].</p>
<p>The role of B3 in the brain has been studied for more than 70 years [<xref ref-type="bibr" rid="B204-ijms-20-05797">204</xref>,<xref ref-type="bibr" rid="B205-ijms-20-05797">205</xref>,<xref ref-type="bibr" rid="B206-ijms-20-05797">206</xref>], but only recently has the focus shifted from considering vitamin B3 as a determinant factor for cell survival, to the extension to be an essential neuronal and vessel protector [<xref ref-type="bibr" rid="B200-ijms-20-05797">200</xref>,<xref ref-type="bibr" rid="B201-ijms-20-05797">201</xref>,<xref ref-type="bibr" rid="B202-ijms-20-05797">202</xref>,<xref ref-type="bibr" rid="B203-ijms-20-05797">203</xref>,<xref ref-type="bibr" rid="B204-ijms-20-05797">204</xref>,<xref ref-type="bibr" rid="B205-ijms-20-05797">205</xref>,<xref ref-type="bibr" rid="B206-ijms-20-05797">206</xref>,<xref ref-type="bibr" rid="B207-ijms-20-05797">207</xref>,<xref ref-type="bibr" rid="B208-ijms-20-05797">208</xref>,<xref ref-type="bibr" rid="B209-ijms-20-05797">209</xref>]. Some of the most critical neuroprotective mechanisms have been primarily investigated in animal models but not yet reproduced in humans. It has been shown that B3, mainly as NAD+, might reduce the lesion size in global [<xref ref-type="bibr" rid="B210-ijms-20-05797">210</xref>,<xref ref-type="bibr" rid="B211-ijms-20-05797">211</xref>] or focal cerebral ischemia [<xref ref-type="bibr" rid="B199-ijms-20-05797">199</xref>,<xref ref-type="bibr" rid="B200-ijms-20-05797">200</xref>], as well as in transient cerebral ischemia [<xref ref-type="bibr" rid="B212-ijms-20-05797">212</xref>,<xref ref-type="bibr" rid="B213-ijms-20-05797">213</xref>], and might ameliorate the primary outcome, after traumatic brain injury [<xref ref-type="bibr" rid="B214-ijms-20-05797">214</xref>,<xref ref-type="bibr" rid="B215-ijms-20-05797">215</xref>,<xref ref-type="bibr" rid="B216-ijms-20-05797">216</xref>,<xref ref-type="bibr" rid="B217-ijms-20-05797">217</xref>,<xref ref-type="bibr" rid="B218-ijms-20-05797">218</xref>]. Indeed, neuronal death, derived in acute conditions by necrosis and apoptosis, could be prevented via several mechanisms, such as oxidative stress protection [<xref ref-type="bibr" rid="B219-ijms-20-05797">219</xref>,<xref ref-type="bibr" rid="B220-ijms-20-05797">220</xref>,<xref ref-type="bibr" rid="B221-ijms-20-05797">221</xref>], control over PARP-1 activity thus preserving energy levels [<xref ref-type="bibr" rid="B211-ijms-20-05797">211</xref>,<xref ref-type="bibr" rid="B222-ijms-20-05797">222</xref>], and direct inhibition of pro-inflammatory cytokines [<xref ref-type="bibr" rid="B223-ijms-20-05797">223</xref>]. Further, B3, primarily as NR, protects neurons from axonal degeneration, derived from excitotoxicity, due to significant ischemic condition [<xref ref-type="bibr" rid="B224-ijms-20-05797">224</xref>].</p>
<p>The same neuroprotective neuro-vascular pathways seem to also influence neurodegenerative pathologies [<xref ref-type="bibr" rid="B225-ijms-20-05797">225</xref>]. Animal models show niacin’s role in Huntington’s disease (HD) [<xref ref-type="bibr" rid="B226-ijms-20-05797">226</xref>], Parkinson’s disease [<xref ref-type="bibr" rid="B227-ijms-20-05797">227</xref>], and Alzheimer’s disease [<xref ref-type="bibr" rid="B228-ijms-20-05797">228</xref>]. It is likely that in PD and HD, nicotinamide supply might increase NAD+ and ATP levels, improving mitochondrial functioning, impaired in both pathologies [<xref ref-type="bibr" rid="B229-ijms-20-05797">229</xref>]. Additionally, PD patients benefit from B3 supplementation, which reflects the improvement of some symptoms due to its interaction with the NIACR1 receptor, enhancing the availability of NAD+ by either the use of a diet supplemented with NAD+ precursors or the inhibition of NAD+-dependent enzymes, such as PARPs, which compete with mitochondria for NAD+. This could be a viable approach to preventing neurotoxicity associated with mitochondrial defects [<xref ref-type="bibr" rid="B201-ijms-20-05797">201</xref>,<xref ref-type="bibr" rid="B230-ijms-20-05797">230</xref>,<xref ref-type="bibr" rid="B231-ijms-20-05797">231</xref>,<xref ref-type="bibr" rid="B232-ijms-20-05797">232</xref>].</p>
<p>In dementias, the neuroprotective action of niacin is related to its effects on cerebral microvascular endothelial cells (ECs) and neurons. It protects both types of cells from oxidative damage, ischemic insults, and senescence, and influences inflammatory processes, primarily related to microglial functions. ECs are basal cells to brain homeostasis and regulate both blood flow and the blood–brain barrier [<xref ref-type="bibr" rid="B200-ijms-20-05797">200</xref>,<xref ref-type="bibr" rid="B233-ijms-20-05797">233</xref>]. They are injured in clinical stroke but are also altered in subclinical, chronic ischemic insults. Experimental studies on rats have shown how ischemic/hypoxic or direct damage from nitric oxide (NO) induces apoptosis in ECs [<xref ref-type="bibr" rid="B233-ijms-20-05797">233</xref>,<xref ref-type="bibr" rid="B234-ijms-20-05797">234</xref>]. Niacin protects ECs and neurons from apoptotic injury, preventing the exposure of membrane phosphatidylserine (PS) residues, which act as a phagocytosis signal, inducing the DNA fragmentation [<xref ref-type="bibr" rid="B200-ijms-20-05797">200</xref>,<xref ref-type="bibr" rid="B207-ijms-20-05797">207</xref>]. B3 interacts with different pathways that activate apoptosis, including caspase 1, 3, 8, PARP-1 activity and protein kinase B (Akt). The latter maintains mitochondrial polarization, avoiding cytochrome C release, and inhibiting the activation of the caspase [<xref ref-type="bibr" rid="B207-ijms-20-05797">207</xref>,<xref ref-type="bibr" rid="B234-ijms-20-05797">234</xref>].</p>
<p>More interestingly, exposure of PS leads to a loss of anticoagulant membrane components, increasing the risks of secondary thrombosis, clot aggregation, and inflammation [<xref ref-type="bibr" rid="B200-ijms-20-05797">200</xref>,<xref ref-type="bibr" rid="B207-ijms-20-05797">207</xref>,<xref ref-type="bibr" rid="B229-ijms-20-05797">229</xref>]. Furthermore, it has been demonstrated that niacin also reduces atheroma formation, decreasing the total amount of lipoproteins and increasing the incidence of high-density lipoproteins (HDL) [<xref ref-type="bibr" rid="B235-ijms-20-05797">235</xref>].</p>
<p>Dysfunctional ECs are determined more often by the normal processes of senescence. Indeed, dysfunction leads to an altered proliferation of ECs, associated with an increment of pro-inflammatory factors, impaired proliferation, higher rates of apoptosis, and increased permeability of the BBB due to the loss of the tight junctions [<xref ref-type="bibr" rid="B236-ijms-20-05797">236</xref>,<xref ref-type="bibr" rid="B237-ijms-20-05797">237</xref>,<xref ref-type="bibr" rid="B238-ijms-20-05797">238</xref>]. Sirtuin1, a component of the sirtuins family, is an NAD+ enzyme involved in several functions, such as the senescence process, gene expression/regulation, and cell death, and it is primarily represented in neurons and ECs. A single study showed a decline in Sirt1 expression and activity in aged mice and aged humans’ ECs in vitro [<xref ref-type="bibr" rid="B236-ijms-20-05797">236</xref>]. In this study, the authors demonstrated the underlying relationship between Sirt1 depletion and BBB increased permeability [<xref ref-type="bibr" rid="B236-ijms-20-05797">236</xref>]. Since Sirt1 depends on NAD+ activity, one animal study showed that nicotinamide supplementation reversed age-related vascular EC dysfunction [<xref ref-type="bibr" rid="B239-ijms-20-05797">239</xref>]. In humans, a phase II randomized clinical trial investigated the effects of Resveratrol, a Sirt1 agonist, in AD patients with promising results [<xref ref-type="bibr" rid="B240-ijms-20-05797">240</xref>], but more studies are needed [<xref ref-type="bibr" rid="B241-ijms-20-05797">241</xref>].</p>
<p>To the best of our knowledge, we might hypothesize that low B3 levels are frequent in the elderly, and this may influence the development of small vessel disease and subcortical vascular dementia, switching ECs towards a procoagulant state, increasing plaque deposition, reducing Sirt1 expression, and promoting senescence mechanisms, such as apoptosis, neuroinflammation (through Sirt1 and PARP, 200, 242, 243), ECs, and neuronal death. Niacin modulates neuroinflammation in several ways. It regulates microglial activation, known to promote oxidative stress and inflammation, avoiding PS exposure, a trigger of microglial function and proliferation [<xref ref-type="bibr" rid="B200-ijms-20-05797">200</xref>]. It modulates PARP-1 activity, involved in NF-kb transcription, which, in turn, regulates the secretion of cytokines and chemokines, and it may also inhibit some pro-inflammatory cytokines, such as interleukin (IL)-1β, IL 6, IL8, and TNF-α directly [<xref ref-type="bibr" rid="B223-ijms-20-05797">223</xref>,<xref ref-type="bibr" rid="B242-ijms-20-05797">242</xref>].</p>
<p>Nicotinamide restriction has been shown to increase NADPH oxidase, and reactive oxygen species (ROS) release in human keratinocytes [<xref ref-type="bibr" rid="B243-ijms-20-05797">243</xref>]. High ROS levels are associated with the oxidative cascade of events, determining many neurodegenerative disorders, due to neuronal and EC loss [<xref ref-type="bibr" rid="B244-ijms-20-05797">244</xref>,<xref ref-type="bibr" rid="B245-ijms-20-05797">245</xref>]. Nicotinamide has proved to be a powerful antioxidant in animal models, maintaining brain mitochondrial homeostasis and reducing neuronal and EC oxidative stress [<xref ref-type="bibr" rid="B220-ijms-20-05797">220</xref>,<xref ref-type="bibr" rid="B239-ijms-20-05797">239</xref>,<xref ref-type="bibr" rid="B242-ijms-20-05797">242</xref>].</p>
<p>Nicotinamide supplementation has been tested in animals and humans with AD yielding promising but still incomplete results. In AD model mice, NR prevented Aβ accumulation and hippocampal astrocyte loss [<xref ref-type="bibr" rid="B228-ijms-20-05797">228</xref>,<xref ref-type="bibr" rid="B246-ijms-20-05797">246</xref>,<xref ref-type="bibr" rid="B247-ijms-20-05797">247</xref>], attenuating cognitive decline and improving selective cognitive impairment [<xref ref-type="bibr" rid="B228-ijms-20-05797">228</xref>,<xref ref-type="bibr" rid="B246-ijms-20-05797">246</xref>]. The same benefits have not been confirmed in clinical trials yet, despite past and ongoing attempts [<xref ref-type="bibr" rid="B242-ijms-20-05797">242</xref>]. Further, dietary intake of B3 was associated with lower cognitive decline and seemed to have protective effects on the development of AD [<xref ref-type="bibr" rid="B248-ijms-20-05797">248</xref>]. More clinical trials are currently investigating nicotinamide supplementation in AD patients and will soon add new knowledge regarding its efficacy in neurodegenerative diseases. However, since vitamin B3 is involved in vital pathways of both neurons and cerebrovascular endothelial cells, an association with dementia is likely, and its supplementation in subclinical conditions might improve not only AD but also vascular dementia outcomes and disease progression [<xref ref-type="bibr" rid="B249-ijms-20-05797">249</xref>].</p>
</sec>
<sec id="sec7-ijms-20-05797">
<title>7. Vitamin B5 (Pantothenic Acid)</title>
<p>Vitamin B5, also called pantothenic acid/pantothenate, is the primary precursor of coenzyme A (CoA), crucial in several cellular processes. As wither the direct form (CoA) or the acetylated form (acetyl-CoA), this coenzyme is involved in energy production and respiration, via the citric acid cycle. It is essential for fatty acid synthesis and β-oxidation, and for cholesterol, lipid, and sphingolipid biosynthesis, as well as for the production of steroid hormones and neurotransmitters, i.e., acetylcholine [<xref ref-type="bibr" rid="B195-ijms-20-05797">195</xref>,<xref ref-type="bibr" rid="B201-ijms-20-05797">201</xref>,<xref ref-type="bibr" rid="B250-ijms-20-05797">250</xref>,<xref ref-type="bibr" rid="B251-ijms-20-05797">251</xref>]. Further, acetyl-CoA plays a role in global histone acetylation, modulating gene expression, cell growth, and proliferation [<xref ref-type="bibr" rid="B252-ijms-20-05797">252</xref>,<xref ref-type="bibr" rid="B253-ijms-20-05797">253</xref>]. Pantothenic acid, due to the increase of CoA, exerts an antioxidative property [<xref ref-type="bibr" rid="B254-ijms-20-05797">254</xref>,<xref ref-type="bibr" rid="B255-ijms-20-05797">255</xref>,<xref ref-type="bibr" rid="B256-ijms-20-05797">256</xref>] and influences inflammatory factors, such as C-reactive protein (CRP) [<xref ref-type="bibr" rid="B257-ijms-20-05797">257</xref>]. Indeed, it has been shown in vitro that pantothenic acid might enhance glutathione levels [<xref ref-type="bibr" rid="B254-ijms-20-05797">254</xref>,<xref ref-type="bibr" rid="B255-ijms-20-05797">255</xref>,<xref ref-type="bibr" rid="B256-ijms-20-05797">256</xref>] and, in animal models, high concentrations protect neurons from radiation damages [<xref ref-type="bibr" rid="B255-ijms-20-05797">255</xref>].</p>
<p>Moreover, pantothenic acid exerts an antioxidative pathway through cysteamine, a product of CoA degradation. This catabolic reaction is handled by a family of enzymes, called vanins, and vanin-1 is upregulated in oxidative stress. Hence, it seems plausible that the presence of high CoA turnover in some tissues demonstrates a protective role against oxidative injury [<xref ref-type="bibr" rid="B253-ijms-20-05797">253</xref>].</p>
<p>Some pantothenic acid derivatives, such as panthenol and pantetheine, the dimeric form of endogenous pantetheine produced from pantothenic acid and cysteamine, modulate and interact with the cholesterol metabolism, lowering low-density lipoproteins (LDL) and enhancing HDL [<xref ref-type="bibr" rid="B258-ijms-20-05797">258</xref>,<xref ref-type="bibr" rid="B259-ijms-20-05797">259</xref>,<xref ref-type="bibr" rid="B260-ijms-20-05797">260</xref>]. The exact mechanism underlying these processes is still unknown, and a correlation with homocysteine has been hypothesized, involving both CoA biosynthesis and atherosclerosis [<xref ref-type="bibr" rid="B259-ijms-20-05797">259</xref>].</p>
<p>Vitamin B5 is present in almost every food, being an essential compound for all forms of life [<xref ref-type="bibr" rid="B253-ijms-20-05797">253</xref>,<xref ref-type="bibr" rid="B261-ijms-20-05797">261</xref>]. Significant sources of pantothenic acid are broccoli, meat, whole grains, cereals, and avocado. It is worth mentioning that commensal bacteria, such as <italic>Escherichia coli</italic>, can produce and secrete pantothenate directly in the gut, increasing the availability of this vitamin [<xref ref-type="bibr" rid="B195-ijms-20-05797">195</xref>,<xref ref-type="bibr" rid="B253-ijms-20-05797">253</xref>,<xref ref-type="bibr" rid="B255-ijms-20-05797">255</xref>]. Therefore, despite low oral intake, B5 deficiencies have been rarely described in humans. The described symptoms of pantothenic acid deficiency include numbness and paresthesia, insomnia, and irritability, as well as nausea, vomiting, and non-specific cardiovascular alterations [<xref ref-type="bibr" rid="B195-ijms-20-05797">195</xref>,<xref ref-type="bibr" rid="B201-ijms-20-05797">201</xref>,<xref ref-type="bibr" rid="B261-ijms-20-05797">261</xref>].</p>
<p>Pantothenic acid is well represented in the central nervous system (CNS) and is more concentrated in the brain than in the plasma [<xref ref-type="bibr" rid="B255-ijms-20-05797">255</xref>,<xref ref-type="bibr" rid="B262-ijms-20-05797">262</xref>]. Several old studies focused on its transportation and function in the CNS [<xref ref-type="bibr" rid="B263-ijms-20-05797">263</xref>,<xref ref-type="bibr" rid="B264-ijms-20-05797">264</xref>,<xref ref-type="bibr" rid="B265-ijms-20-05797">265</xref>,<xref ref-type="bibr" rid="B266-ijms-20-05797">266</xref>,<xref ref-type="bibr" rid="B267-ijms-20-05797">267</xref>], but it has not been investigated as much as the other B vitamins, likely because very few studies described its deprivation.</p>
<p>Vitamin B5 is known to be related to a rare neurodegenerative autosomal recessive disorder, called pantothenate kinase-associated neurodegeneration (PKAN), due to genetic mutations in the pantothenate kinase-2 (PANK-2), an enzyme responsible for the phosphorylation of pantothenate, the first reaction of the CoA biosynthetic pathway [<xref ref-type="bibr" rid="B250-ijms-20-05797">250</xref>,<xref ref-type="bibr" rid="B268-ijms-20-05797">268</xref>,<xref ref-type="bibr" rid="B269-ijms-20-05797">269</xref>,<xref ref-type="bibr" rid="B270-ijms-20-05797">270</xref>,<xref ref-type="bibr" rid="B271-ijms-20-05797">271</xref>].</p>
<p>Nevertheless, a recent study demonstrated that low levels of B5 were found in post-mortem brain tissue of Huntington’s disease (HD) patients as opposed to matched healthy controls [<xref ref-type="bibr" rid="B252-ijms-20-05797">252</xref>]. The authors hypothesized that a B5 deficiency might be involved in the alteration of citric acid cycles, leading to inadequate energy levels, as frequently reported in HD patients.</p>
<p>Additionally, investigators have speculated on the role of acetyl-CoA. Acetyl-CoA is fundamental to several cellular pathways, including gene expression, which is strictly dependent on CoA levels, and its activity might be impaired due to a B5 insufficiency [<xref ref-type="bibr" rid="B252-ijms-20-05797">252</xref>].</p>
<p>Only one study has tried to assess the role of pantothenic acid in cognition with unexpected results [<xref ref-type="bibr" rid="B272-ijms-20-05797">272</xref>]. Indeed, the authors found that a higher dietary intake of B5 correlates to an increased burden of cerebral amyloid in patients with subjective cognitive impairment and MCI, both conditions that might precede AD development. The reason might be related to inappropriate usage of defense factors, such as pro-inflammatory cytokines, as a result of normally adequate levels of CoA [<xref ref-type="bibr" rid="B257-ijms-20-05797">257</xref>,<xref ref-type="bibr" rid="B272-ijms-20-05797">272</xref>]. Nonetheless, CoA has high turnover rates in several tissues [<xref ref-type="bibr" rid="B253-ijms-20-05797">253</xref>], and its cytosolic and plasma levels might differ from pantothenic acid dietary intake, i.e., a high oral intake of vitamin B5 does not necessarily correspond to higher CoA cellular levels, also determined by the feedback inhibition regulating CoA production [<xref ref-type="bibr" rid="B273-ijms-20-05797">273</xref>]. Additionally, it seems more plausible that insufficient CoA levels, essential for acetyl-CoA and, hence, acetylcholine synthesis, might influence cholinergic neurons and in such a way be associated with neurological diseases, including AD [<xref ref-type="bibr" rid="B252-ijms-20-05797">252</xref>,<xref ref-type="bibr" rid="B274-ijms-20-05797">274</xref>].</p>
<p>In conclusion, a lack of CoA seems to be related to neurodegenerative disorders, due to its antioxidative and anti-inflammatory properties, but its clinical effect has never been demonstrated.</p>
</sec>
<sec id="sec8-ijms-20-05797">
<title>8. Vitamin B6 (Pyridoxine)</title>
<p>Vitamin B6 has six different forms in mammals, including pyridoxamine, pyridoxal, and pyridoxine. These three compounds are converted into pyridoxal 5′-phosphate (PLP), which is the biologically active derivative of vitamin B6. PLP is a co-factor for more than 140 enzymes and accounts for almost 4% of humans’ enzymatic activities [<xref ref-type="bibr" rid="B275-ijms-20-05797">275</xref>,<xref ref-type="bibr" rid="B276-ijms-20-05797">276</xref>]. It is involved in amino acid, glucose, and lipid metabolism, as well as heme and hormone synthesis. In the brain, it is essential for sphingolipid formation for myelin and several neurotransmitters, such as serotonin, norepinephrine, dopamine, and GABA [<xref ref-type="bibr" rid="B201-ijms-20-05797">201</xref>,<xref ref-type="bibr" rid="B275-ijms-20-05797">275</xref>]. PLP is mostly known for its involvement in the one-carbon metabolism and its link to homocysteine regulation [<xref ref-type="bibr" rid="B170-ijms-20-05797">170</xref>,<xref ref-type="bibr" rid="B195-ijms-20-05797">195</xref>,<xref ref-type="bibr" rid="B276-ijms-20-05797">276</xref>]. Further, B6 is also interacting with the immune systems, through NF-kB downregulation, CRP levels, and peripheric lymphocyte proliferation [<xref ref-type="bibr" rid="B195-ijms-20-05797">195</xref>,<xref ref-type="bibr" rid="B277-ijms-20-05797">277</xref>,<xref ref-type="bibr" rid="B278-ijms-20-05797">278</xref>]. It has antioxidative activities, acting both as a scavenger of reactive oxygen species and as a coenzyme for cysteine, a precursor of glutathione, and it protects blood vessels from AGE accumulation [<xref ref-type="bibr" rid="B195-ijms-20-05797">195</xref>,<xref ref-type="bibr" rid="B201-ijms-20-05797">201</xref>,<xref ref-type="bibr" rid="B276-ijms-20-05797">276</xref>].</p>
<p>Vitamin B6 is mostly available from natural sources, and a varied diet is a sufficient condition for its adequate intake. It is present in meat, fish, nuts, potatoes, bananas, and fortified cereals [<xref ref-type="bibr" rid="B275-ijms-20-05797">275</xref>,<xref ref-type="bibr" rid="B279-ijms-20-05797">279</xref>].</p>
<p>A severe B6 deficiency is a rare medical condition, leading to microcytic anemia due to an impaired hemoglobin synthesis [<xref ref-type="bibr" rid="B201-ijms-20-05797">201</xref>,<xref ref-type="bibr" rid="B275-ijms-20-05797">275</xref>]. General symptoms include irritability, depression, migraines, neuropathy, and sleep disorders, and are likely associated with impaired synthesis of neurotransmitters and hormones, especially GABA and melatonin [<xref ref-type="bibr" rid="B170-ijms-20-05797">170</xref>,<xref ref-type="bibr" rid="B201-ijms-20-05797">201</xref>]. In infants, an inborn error affecting PLP production pathways, might generate acute B6 insufficiency and provoke neonatal epileptic encephalopathies [<xref ref-type="bibr" rid="B275-ijms-20-05797">275</xref>]. Marginal and subclinical B6 deficiency is rather common in the general population, and it has been associated with higher cardiovascular risk and chronic inflammatory diseases, including rheumatoid arthritis, chronic bowel disease, diabetes, psychiatric disorders, and cognitive decline [<xref ref-type="bibr" rid="B170-ijms-20-05797">170</xref>,<xref ref-type="bibr" rid="B277-ijms-20-05797">277</xref>,<xref ref-type="bibr" rid="B280-ijms-20-05797">280</xref>]. Several subgroups are at risk of suboptimal B6 levels, independent of their dietary intake, due to increased requests, reduced absorption, or metabolic interactions. Indeed, an inadequate status is frequent in the elderly, as shown by extensive population studies in Europe, UK, and the US, even though body changes more than age itself seem to be determinant, and in alcoholics and women taking low-dosage of oral contraceptives [<xref ref-type="bibr" rid="B170-ijms-20-05797">170</xref>,<xref ref-type="bibr" rid="B276-ijms-20-05797">276</xref>,<xref ref-type="bibr" rid="B281-ijms-20-05797">281</xref>,<xref ref-type="bibr" rid="B282-ijms-20-05797">282</xref>].</p>
<p>Vitamin B6 and PLP are deeply associated with normal brain function. Beyond the synthesis of neurotransmitters, B6 compounds are involved in protecting neurons and ECS from oxidative damages and atherosclerosis, maintaining the BBB integrity, regulating inflammatory processes, and regulating homocysteine synthesis [<xref ref-type="bibr" rid="B282-ijms-20-05797">282</xref>,<xref ref-type="bibr" rid="B283-ijms-20-05797">283</xref>,<xref ref-type="bibr" rid="B284-ijms-20-05797">284</xref>,<xref ref-type="bibr" rid="B285-ijms-20-05797">285</xref>,<xref ref-type="bibr" rid="B286-ijms-20-05797">286</xref>].</p>
<p>Several neurological conditions involve B6 compounds to various extents. Infants and children might develop the so-called pyridoxine-responsive epilepsies, originating mostly from rare recessive mutations in genes codifying for B6 metabolism’s enzymes [<xref ref-type="bibr" rid="B287-ijms-20-05797">287</xref>,<xref ref-type="bibr" rid="B288-ijms-20-05797">288</xref>]. In animal models with induced Streptococcus pneumoniae-related meningitis, B6 pre-treatment might reduce hippocampal neuronal loss [<xref ref-type="bibr" rid="B289-ijms-20-05797">289</xref>,<xref ref-type="bibr" rid="B290-ijms-20-05797">290</xref>]. Low levels of B6 seem to be associated with a higher risk of developing PD; it has been argued that PLP is a coenzyme of dopa-decarboxylase, which converts levodopa to dopamine [<xref ref-type="bibr" rid="B284-ijms-20-05797">284</xref>,<xref ref-type="bibr" rid="B291-ijms-20-05797">291</xref>,<xref ref-type="bibr" rid="B292-ijms-20-05797">292</xref>].</p>
<p>The relationship between vitamin B6 and cardiovascular disease (CVD), including significant stroke and small vessel disease, both possibly inducing vascular dementia, depends on various processes in which B6 actively participates. These are inflammation, oxidative metabolism, glycation, and the B6 capacity to lower homocysteine. The latter is a well-known risk factor for endothelial damage and atherosclerosis, and seems to be involved in SVD and subcortical vascular dementia through endothelial damage [<xref ref-type="bibr" rid="B293-ijms-20-05797">293</xref>,<xref ref-type="bibr" rid="B294-ijms-20-05797">294</xref>]. Indeed, hyperhomocysteinemia in mice, resulting from a diet poor in B vitamins (namely, B6, folate, and B12) led to a vascular dementia model, characterized by microhemorrhages and neuroinflammation [<xref ref-type="bibr" rid="B280-ijms-20-05797">280</xref>], and to severe neuronal degeneration, vascular dysfunction, BBB leakage, and memory loss [<xref ref-type="bibr" rid="B295-ijms-20-05797">295</xref>]. In addition to lowering homocysteine [<xref ref-type="bibr" rid="B296-ijms-20-05797">296</xref>,<xref ref-type="bibr" rid="B297-ijms-20-05797">297</xref>,<xref ref-type="bibr" rid="B298-ijms-20-05797">298</xref>], B6 might have an independent role in CVD through antioxidative and anti-inflammatory proprieties.</p>
<p>Vitamin B6 protects cerebral endothelial cells from oxidative damage and prevents atherosclerosis and BBB dysfunction. B6 avoids EC apoptosis induced by homocysteine in animal models and reduces endothelial progenitor cells’ apoptosis in stroke patients, likely through inhibition of caspase activity (which in the ischemic condition is enhanced by higher homocysteine levels) [<xref ref-type="bibr" rid="B299-ijms-20-05797">299</xref>,<xref ref-type="bibr" rid="B300-ijms-20-05797">300</xref>]. Pyridoxamine, pyridoxine, and pyridoxal phosphate reduce superoxide anion and lipid peroxidation, generated by hydrogen peroxide even if it does not prevent the direct cellular damage of these reactive compounds [<xref ref-type="bibr" rid="B301-ijms-20-05797">301</xref>]. Pyridoxine interacts with LDL-induced endothelial dysfunction, restoring eNOS activity, NO levels, and cGMP [<xref ref-type="bibr" rid="B302-ijms-20-05797">302</xref>,<xref ref-type="bibr" rid="B303-ijms-20-05797">303</xref>]. One study reported that subjects receiving supplementation of several vitamins, including B6, had less oxidative stress in the brain measured by the established neural biomarkers [<xref ref-type="bibr" rid="B304-ijms-20-05797">304</xref>]. Furthermore, all B6 compounds, particularly pyridoxamine, are active in the degradation of AGE products, reducing the risk of atherosclerosis and the production of free radicals, and perhaps, positively influencing Aβ deposition in AD [<xref ref-type="bibr" rid="B193-ijms-20-05797">193</xref>,<xref ref-type="bibr" rid="B195-ijms-20-05797">195</xref>,<xref ref-type="bibr" rid="B304-ijms-20-05797">304</xref>,<xref ref-type="bibr" rid="B305-ijms-20-05797">305</xref>,<xref ref-type="bibr" rid="B306-ijms-20-05797">306</xref>].</p>
<p>In the context of inflammation, PLP levels are inversely related to inflammatory markers in several inflammation-related pathologies, such as rheumatoid arthritis and CVD [<xref ref-type="bibr" rid="B277-ijms-20-05797">277</xref>]. In particular, low PLP has been related to high CRP in the general population, and high CRP, in turn, is a known risk factor of CVD [<xref ref-type="bibr" rid="B285-ijms-20-05797">285</xref>,<xref ref-type="bibr" rid="B307-ijms-20-05797">307</xref>,<xref ref-type="bibr" rid="B308-ijms-20-05797">308</xref>]. Several studies reviewed by Lotto et al. [<xref ref-type="bibr" rid="B277-ijms-20-05797">277</xref>] have found low B6 status in patients with coronary artery disease, myocardial infarction, and stroke, strengthening the hypothesis of an inflammatory link between atherosclerosis-based pathologies and B6. Furthermore, higher intakes of this vitamin have shown protective effects against inflammation. This is not surprising since PLP (B6 active form) influences the cytokine release and the lymphocyte proliferation [<xref ref-type="bibr" rid="B278-ijms-20-05797">278</xref>,<xref ref-type="bibr" rid="B307-ijms-20-05797">307</xref>,<xref ref-type="bibr" rid="B309-ijms-20-05797">309</xref>].</p>
<p>A recent human study showed that in acute ischemic stroke, patients receiving supplementation of B vitamins, including B6, within 12 h after the beginning event, had decreased lipid peroxidation and inflammation, measured as CRP levels, independent from homocysteine levels [<xref ref-type="bibr" rid="B283-ijms-20-05797">283</xref>].</p>
<p>Several authors have investigated the association between CVD and low B6 in humans. In a case-control study, low B6 levels were independently associated with the risk of stroke or transient ischemic attacks [<xref ref-type="bibr" rid="B310-ijms-20-05797">310</xref>]. In a cohort of patients with silent brain impairments and cognitive decline, brain atrophy was significantly related to low PLP levels, while homocysteine had no significant relationship [<xref ref-type="bibr" rid="B311-ijms-20-05797">311</xref>]. Further, in AD patients, white matter hyperintensities (WMH), markers of SVD, were associated with B6 deficiencies, independently of homocysteine concentrations [<xref ref-type="bibr" rid="B312-ijms-20-05797">312</xref>,<xref ref-type="bibr" rid="B313-ijms-20-05797">313</xref>]. Miller et al. [<xref ref-type="bibr" rid="B314-ijms-20-05797">314</xref>] also found reduced levels of PLP in AD patients as opposed to healthy controls. Alternatively, in contrast with these results, Malaguarnera et al. [<xref ref-type="bibr" rid="B315-ijms-20-05797">315</xref>] did not find any difference in B6 levels between VaD patients, AD, and healthy controls, but samples were small, and the mean levels of the three groups were not reported [<xref ref-type="bibr" rid="B315-ijms-20-05797">315</xref>]. Another study by Nelson et al. [<xref ref-type="bibr" rid="B316-ijms-20-05797">316</xref>] did not find any significant relationship between dietary B6 intake and AD risk, but plasma biomarkers were not investigated [<xref ref-type="bibr" rid="B285-ijms-20-05797">285</xref>]. Hence, despite some negative findings, a relationship between B6 and dementia progression cannot be excluded.</p>
<p>Several clinical trials tried to assess the benefits of supplementation of B6, B12, and folate on the risk of major vascular diseases, including stroke, coronary artery disease, myocardial infarction, and neurodegenerative conditions, such as AD and VaD, due to SVD.</p>
<p>In the VISP study, Toole et al. [<xref ref-type="bibr" rid="B317-ijms-20-05797">317</xref>] enrolled 3680 subjects from Canada, the US, and Scotland with previous non-disabling stroke. Participants received either a low or a high dose of vitamins B6, B12, and folic acid supplementation in a randomized, double-blind procedure. After two years of follow up, the trial was stopped for ineffectiveness: Vitamins, despite the lowering effect on homocysteine, did not reduce the rate of recurrent stroke, coronary artery disease, and death following vascular events [<xref ref-type="bibr" rid="B317-ijms-20-05797">317</xref>]. However, several factors might have affected these results, including the deficient baseline homocysteine level, the short follow up time, and the small sample size for the conditions of study [<xref ref-type="bibr" rid="B318-ijms-20-05797">318</xref>]. Another multi-centric randomized, double-blind placebo-controlled trial was carried out by the VITATOPS group [<xref ref-type="bibr" rid="B319-ijms-20-05797">319</xref>]. Here, 8164 participants with ischemic stroke, TIA, or intracerebral hemorrhage, and from four different continents, were included in the final analysis and had randomly received either placebo or a vitamin supplementation of B6, B12, and folic acid. The primary outcomes were a non-fatal stroke, non-fatal myocardial infarction, and death of vascular origin. There was no significative difference in the two groups after a mean follow up of 3–4 years. However, the authors observed that in a subgroup analysis of patients with symptomatic SVD, the group who received the vitamins seemed to have better outcomes. According to this result, Cavalieri et al. [<xref ref-type="bibr" rid="B320-ijms-20-05797">320</xref>] analyzed the effect of the same vitamin formulation versus placebo on MRI changes in patients with cerebral SVD. They did not find any difference in terms of lacunar infarct and WMH in the general group; yet, in a specific subgroup with severe SVD at baseline, the supplementation slowed the progression of WMH [<xref ref-type="bibr" rid="B320-ijms-20-05797">320</xref>]. According to this, two other studies on healthy elderly showed that supplementation of B6 and B12 [<xref ref-type="bibr" rid="B321-ijms-20-05797">321</xref>] or higher intake of vitamin B6 [<xref ref-type="bibr" rid="B322-ijms-20-05797">322</xref>] were related to a higher gray matter volume, in specific brain regions, and also showed better cortical preservation. Another study on healthy and relatively young subjects (mean age around 45 years) investigated possible MRI differences in terms of WMH and brain atrophy, according to the assumption of B6 and folic acid or placebo, over two years. The authors noticed a mild but not significant improvement in MRI parameters in the group with the supplementation [<xref ref-type="bibr" rid="B323-ijms-20-05797">323</xref>].</p>
<p>Other studies, involving different vitamin formulation (not including B6), have been conducted and meta-analyzed by the VITATOPS group [<xref ref-type="bibr" rid="B319-ijms-20-05797">319</xref>]. Supplementary vitamins do not seem to reduce the risk of CVD in the general population with major vascular events. Nevertheless, particular subgroups, e.g., with severe cerebral SVD, might benefit from vitamin intake and, in the healthy elderly, an adequate vitamin level might help preserve brain integrity.</p>
<p>The association between cognitive function and B6 has been well investigated, with discordant results.</p>
<p>Low PLP levels have been associated with cognitive decline over two years in a Boston-Puerto Rican population, with a stronger link in the older participants [<xref ref-type="bibr" rid="B324-ijms-20-05797">324</xref>]. Higher intakes of B6 showed a positive correlation with memory, psychomotor abilities, and verbal fluency [<xref ref-type="bibr" rid="B325-ijms-20-05797">325</xref>,<xref ref-type="bibr" rid="B326-ijms-20-05797">326</xref>,<xref ref-type="bibr" rid="B327-ijms-20-05797">327</xref>]. Conversely, one study on healthy elderly subjects, despite an association between low B6 levels and poor baseline cognition, reported a loss of correlation after adjustment for covariates and other vitamins. Jannusch et al. [<xref ref-type="bibr" rid="B322-ijms-20-05797">322</xref>] did not find any link between B6 and cognition in healthy subjects with normal to high levels. Hence, they suggested the existence of a “ceiling effect” [<xref ref-type="bibr" rid="B322-ijms-20-05797">322</xref>]: When normal-high vitamin B6 levels have been reached, the effect on cognition after a supplementation might vanish.</p>
<p>Supplementation studies with cognitive function as primary outcome yielded similarly inconsistent results. In patients with mild-moderate AD, a high dosage of B6–B9 and B12, as opposed to a placebo, did not improve or slow down cognitive decline [<xref ref-type="bibr" rid="B328-ijms-20-05797">328</xref>,<xref ref-type="bibr" rid="B329-ijms-20-05797">329</xref>], despite a definite lowering of homocysteine levels. Similarly, patients with past ischemic vascular events who received B6 supplements did not show any change in cognitive function over 12 months [<xref ref-type="bibr" rid="B330-ijms-20-05797">330</xref>]. A recent metanalysis, from 2017 [<xref ref-type="bibr" rid="B331-ijms-20-05797">331</xref>], reported the lack of evidence on the therapeutic effects of vitamin supplementation on cognitive function in subjects with cognitive impairment due to AD or other dementias [<xref ref-type="bibr" rid="B331-ijms-20-05797">331</xref>]. In healthy subjects, a significant effect on cognition was not reported either, despite a slight improvement in memory, and particularly of long-term memory [<xref ref-type="bibr" rid="B332-ijms-20-05797">332</xref>,<xref ref-type="bibr" rid="B333-ijms-20-05797">333</xref>,<xref ref-type="bibr" rid="B334-ijms-20-05797">334</xref>].</p>
<p>More studies focusing on single vitamins, specific subgroup analysis, and longer follow-ups are still required to prove B6 involvement and potential benefits on cognitive decline. To the best of our knowledge, no study has yet reported breakthrough results, but, in light of current findings, there is a strong need for more specific and dedicated investigation [<xref ref-type="bibr" rid="B335-ijms-20-05797">335</xref>].</p>
</sec>
<sec id="sec9-ijms-20-05797">
<title>9. Vitamin B7 (Biotin)</title>
<p>Vitamin B7, also called biotin or vitamin H (hair), is widely known for its role as co-factor for four carboxylases: acetyl-CoA, pyruvate carboxylase, beta-methylcrotonyl-CoA carboxylase, and propionyl-CoA carboxylase, essential for the synthesis of fatty acid, amino acids catabolism, the citric acid cycle, energy production, and gluconeogenesis [<xref ref-type="bibr" rid="B336-ijms-20-05797">336</xref>,<xref ref-type="bibr" rid="B337-ijms-20-05797">337</xref>,<xref ref-type="bibr" rid="B338-ijms-20-05797">338</xref>].</p>
<p>Recently, the role of biotin has been extended to epigenetic modulation through histones biotinylation, gene expression, and cellular signaling [<xref ref-type="bibr" rid="B338-ijms-20-05797">338</xref>,<xref ref-type="bibr" rid="B339-ijms-20-05797">339</xref>,<xref ref-type="bibr" rid="B340-ijms-20-05797">340</xref>]. In particular, it has been found that biotin regulates the synthesis of enzymes involved in the glucose homeostasis, such as glucokinase and phosphoenolpyruvate carboxykinase, and stimulates soluble guanylate cyclase (sGC), boosting cGMP concentrations [<xref ref-type="bibr" rid="B201-ijms-20-05797">201</xref>,<xref ref-type="bibr" rid="B339-ijms-20-05797">339</xref>,<xref ref-type="bibr" rid="B341-ijms-20-05797">341</xref>].</p>
<p>Biotin is also involved in inflammatory processes and is a critical factor for NF-κB expression in lymphoid cells [<xref ref-type="bibr" rid="B336-ijms-20-05797">336</xref>]. Further, it seems to have a role as an antioxidant, likely interacting with PARP1, reducing pro-inflammatory cytokines and apoptosis, as shown in hippocampal neurons receiving γ-irradiation [<xref ref-type="bibr" rid="B342-ijms-20-05797">342</xref>,<xref ref-type="bibr" rid="B343-ijms-20-05797">343</xref>].</p>
<p>Biotin levels depend on dietary intake and partially on gut flora production. Various foods are rich in this vitamin, such as liver, egg yolks, soybeans, fish, and leafy vegetables [<xref ref-type="bibr" rid="B201-ijms-20-05797">201</xref>,<xref ref-type="bibr" rid="B337-ijms-20-05797">337</xref>]. Severe biotin deficiency is uncommon and is usually related to malnutrition or a lack of biotinidase, involved in biotin recycling [<xref ref-type="bibr" rid="B338-ijms-20-05797">338</xref>]. Clinical symptoms include alopecia, dermatitis, ketolactic acidosis, skin infection, ataxia, hypotonia, sensory loss, hallucination, and lethargy [<xref ref-type="bibr" rid="B337-ijms-20-05797">337</xref>,<xref ref-type="bibr" rid="B338-ijms-20-05797">338</xref>,<xref ref-type="bibr" rid="B344-ijms-20-05797">344</xref>]. Indeed, neuronal cells and skin cells seem more sensitive to biotin deficiency than other cells, like fibroblasts [<xref ref-type="bibr" rid="B345-ijms-20-05797">345</xref>]. Low biotin levels might be found in individuals with type II diabetes or poor glucose-regulation and pregnancy, perhaps due to constant increased metabolic requests [<xref ref-type="bibr" rid="B201-ijms-20-05797">201</xref>,<xref ref-type="bibr" rid="B337-ijms-20-05797">337</xref>]. Interestingly, unlike other B vitamins, B7 levels in the elderly seem to be in range or even higher as opposed to youngsters [<xref ref-type="bibr" rid="B346-ijms-20-05797">346</xref>,<xref ref-type="bibr" rid="B347-ijms-20-05797">347</xref>]; hence, more investigations are needed.</p>
<p>Biotin concentrations in the CNS are higher than in the plasma and are located in specific brain regions, mostly the diencephalic area and cerebellar motor nuclei [<xref ref-type="bibr" rid="B348-ijms-20-05797">348</xref>]. A saturable transport system handles the transportation of B7 through the BBB, depending on a free carboxylic acid group, which, if necessary, can enhance biotin concentration in the cerebrospinal fluid to levels of 50%–250% more than the plasma [<xref ref-type="bibr" rid="B348-ijms-20-05797">348</xref>,<xref ref-type="bibr" rid="B349-ijms-20-05797">349</xref>,<xref ref-type="bibr" rid="B350-ijms-20-05797">350</xref>]. Indeed, moderate B7 deficiency does not typically lead to neurological symptoms and is related to healthy brain carboxylase function [<xref ref-type="bibr" rid="B338-ijms-20-05797">338</xref>].</p>
<p>The most common severe conditions related to biotin lack are the genetically determinant defects in biotin metabolism or transportation enzymes, e.g., biotin-responsive basal ganglia disease. These disorders are rare, mostly affecting children and adolescents, and could be potentially fatal if not adequately replaced with a high dosage of biotin [<xref ref-type="bibr" rid="B338-ijms-20-05797">338</xref>,<xref ref-type="bibr" rid="B351-ijms-20-05797">351</xref>].</p>
<p>In addition to genetic alterations, biotin might play a role in some chronic diseases and have neuroprotective functions. Indeed, in the 1980s, biotin was reported to improve diabetic neuropathy, as well as uremic neurological complications in a small number of subjects [<xref ref-type="bibr" rid="B352-ijms-20-05797">352</xref>,<xref ref-type="bibr" rid="B353-ijms-20-05797">353</xref>]. More recently, a study showed that biotin administration in multiple sclerosis patients slows the disability progression and ameliorates the global clinical impression compared with placebo [<xref ref-type="bibr" rid="B336-ijms-20-05797">336</xref>]. No benefit was reported in a cohort of older patients with different patterns of progressive MS [<xref ref-type="bibr" rid="B354-ijms-20-05797">354</xref>], and more investigations are certainly required.</p>
<p>Two mechanisms might be behind the biotin effect observed in MS. Through the potentiation of the carboxylases activity, biotin might enhance fatty acid synthesis and, thus, increase re-myelination and energy production in neurons, protecting against myelin loss and hypoxia-driven degeneration [<xref ref-type="bibr" rid="B354-ijms-20-05797">354</xref>,<xref ref-type="bibr" rid="B355-ijms-20-05797">355</xref>]. By a direct stimulation of the sGC, biotin might increase the brain production of cGMP, which is involved in survival, plasticity, and protective pathways [<xref ref-type="bibr" rid="B341-ijms-20-05797">341</xref>].</p>
<p>To the best of our knowledge, biotin might play a role in chronic neurodegenerative disorders, such as AD, where patients have low cerebrospinal fluid cGMP levels, as well as in vascular dementia associated with SVD due to cGMP having an anti-inflammatory activity on the cerebral microvasculature, and in stroke due to cGMP anti-atherosclerotic proprieties [<xref ref-type="bibr" rid="B341-ijms-20-05797">341</xref>,<xref ref-type="bibr" rid="B356-ijms-20-05797">356</xref>,<xref ref-type="bibr" rid="B357-ijms-20-05797">357</xref>]. Interestingly, one study on stroke-prone rats reported a decreased systolic blood pressure and a lower stroke incidence (0%) in the animals that received a saline solution with biotin, as opposed to the group that received the solution without biotin (20% of stroke incidence) [<xref ref-type="bibr" rid="B344-ijms-20-05797">344</xref>]. Furthermore, B7 might play a role in stroke induction, through the regulation of NF-kB expression, and neuronal apoptosis [<xref ref-type="bibr" rid="B338-ijms-20-05797">338</xref>,<xref ref-type="bibr" rid="B358-ijms-20-05797">358</xref>].</p>
<p>Biotin might be involved and improve several acute and chronic neurological conditions, but the interest in its neuroprotective function is recent and more studies investigating possible pathways and mechanisms of action in vitro, as well as in vivo, are needed to clarify its role in the brain [<xref ref-type="bibr" rid="B359-ijms-20-05797">359</xref>].</p>
</sec>
<sec id="sec10-ijms-20-05797">
<title>10. Vitamin B9 (Folic Acid) and Vitamin B12: Separate or Coexistent Realities?</title>
<p>Folic acid derives its name from the Latin word, folium, meaning leaf, and the active form of vitamin B9 is folate known as levomefolic acid or 5-methyltetrahydrofolate (5-MTHF). Dietary folic acid predominantly exists as polyglutamate, which have to be hydrolyzed to mono-glutamates in order to be available [<xref ref-type="bibr" rid="B182-ijms-20-05797">182</xref>,<xref ref-type="bibr" rid="B360-ijms-20-05797">360</xref>]. Folic acid is hydrolyzed in the gut, and mono-glutamylated folates are absorbed in the duodenum and the first part of the jejunum by a high-affinity receptor, (PCFT1) [<xref ref-type="bibr" rid="B361-ijms-20-05797">361</xref>,<xref ref-type="bibr" rid="B362-ijms-20-05797">362</xref>]. Folic acid exerts its action mainly through its participation in the so-called histidine cycle (deamination of histidine, production of urocanic acid, and generation of fomiminoglutamate, fundamental for all the glutamic acid cycles), serine and glycine cycle, thymidylate cycle, and purine cycle. A quantity of 5–10 methylene tetrahydrofolate provides a hydroxymethyl group to glycine residues in order to produce serine, the principal donor of the one-carbon unit. The methylation process will be further explained in the text below. Folate is involved in the thymidylate synthase, which is fundamental in cell replication [<xref ref-type="bibr" rid="B363-ijms-20-05797">363</xref>]. Finally, tetrahydrofolate derivatives are employed in two reaction steps of the de novo synthesis of purine.</p>
<p>There are different conditions which cause folate depletion; some are physiological, such as aging or pregnancy, while some are para-physiological, such as the recovery from wounds or systemic illness [<xref ref-type="bibr" rid="B364-ijms-20-05797">364</xref>,<xref ref-type="bibr" rid="B365-ijms-20-05797">365</xref>,<xref ref-type="bibr" rid="B366-ijms-20-05797">366</xref>,<xref ref-type="bibr" rid="B367-ijms-20-05797">367</xref>]. Dietary low intake, alcoholism, malabsorption, diffuse inflammatory disease of the small intestine, Crohn’s disease, coeliac disease, chronic liver disease, kidney failure, and medications (i.e., phenytoin, carbamazepine, metformin, methotrexate, and sulfasalazine) reduce the activity of pteroyl polyglutamate, a specific hydrolase required for folate absorption, and thereby leading to folate deficiency [<xref ref-type="bibr" rid="B368-ijms-20-05797">368</xref>,<xref ref-type="bibr" rid="B369-ijms-20-05797">369</xref>,<xref ref-type="bibr" rid="B370-ijms-20-05797">370</xref>]. Some specific hematological conditions (occurring as an isolated deficit of homocysteine methyltransferase or a combined B12-homocysteine methyltransferase defect) lead to a clinical situation defined as methyl trap of tetrahydrofolate (THF). This active metabolic form of folic acid is converted to act as a donor of methyl-THF, and acid folic cannot be employed differently [<xref ref-type="bibr" rid="B368-ijms-20-05797">368</xref>].</p>
<p>Curiously enough, even vitamin B12, also called cobalamin, is not produced by human beings. Approximately 20 human genes are known to be involved in the absorption, transport, and employment of vitamin B12 acquired from the diet [<xref ref-type="bibr" rid="B371-ijms-20-05797">371</xref>]. This aspect gives the reason for the two fundamental cofactor roles of vitamin B12. It is required for the correct functions of the cytosolic methionine synthase and the mitochondrial methyl malonyl-CoA mutase. In particular, cobalamin helps the catalysis process, fundamental for the conversion of L-methyl malonyl-CoA to succinyl-CoA [<xref ref-type="bibr" rid="B371-ijms-20-05797">371</xref>]. This reaction is fundamental in the catabolism of the side chain of cholesterol, of the catabolism of the branched-chain amino acids and odd-chain fatty acids. The cytosolic methionine synthase employs the methylated cobalamin for the remethylation of homocysteine to methionine, which we discuss later [<xref ref-type="bibr" rid="B372-ijms-20-05797">372</xref>].</p>
<p>A congenital deficit of vitamin B12 is associated with destructive alteration of brain functions [<xref ref-type="bibr" rid="B373-ijms-20-05797">373</xref>,<xref ref-type="bibr" rid="B374-ijms-20-05797">374</xref>], although different causes precipitate vitamin B12 levels (the most normal aging process, per se) [<xref ref-type="bibr" rid="B360-ijms-20-05797">360</xref>]. Some authors converge the aging process with a consequent reduction of intrinsic factor, primary or secondary to atrophic gastritis or hypochlorhydria [<xref ref-type="bibr" rid="B373-ijms-20-05797">373</xref>,<xref ref-type="bibr" rid="B374-ijms-20-05797">374</xref>]. Other clinical conditions of cobalamin defects are: Genetic deficiency of transcobalamin II, an inadequate intake (vegans, starvation, alcohol addiction, sleeve gastrectomy), malabsorption (inadequate production of intrinsic factors, terminal ileum inflammation, Crohn’s disease, small bowel syndrome, celiac disease), and drugs (pump proton inhibitors, metformin, antiepileptic drugs, chemotherapies, etc.) [<xref ref-type="bibr" rid="B369-ijms-20-05797">369</xref>,<xref ref-type="bibr" rid="B375-ijms-20-05797">375</xref>]. Vitamin B12 is used by the body in two forms, either as methylcobalamin or five deoxyadenosine cobalamin. The enzyme methionine synthase needs methylcobalamin as a cofactor. This enzyme is generally involved in the conversion of the amino acid homocysteine into methionine, while methionine, in turn, is required for DNA methylation [<xref ref-type="bibr" rid="B371-ijms-20-05797">371</xref>]. The cofactor 5 deoxyadenosyl cobalamin is needed by the enzyme that converts l methyl malonyl CoA to succinyl CoA. This stage leads to an extraction of energy from proteins and fats. In addition, succinyl CoA is necessary for the production of hemoglobin, which is the vehicle for oxygen in red blood cells [<xref ref-type="bibr" rid="B376-ijms-20-05797">376</xref>]. The loss of vitamin B12 leads to an impairment of Kreb’s cycle, with a reduction of efficacy of the conversion of succinate to fumarate, malate, and the end product of the cycle, rendered less efficacious in energy production [<xref ref-type="bibr" rid="B377-ijms-20-05797">377</xref>,<xref ref-type="bibr" rid="B378-ijms-20-05797">378</xref>]. Due to the lack of vitamin B12, there is an impairment in gluconeogenesis [<xref ref-type="bibr" rid="B379-ijms-20-05797">379</xref>].</p>
<p>Folate and B12 are intimately bound in the methylation reactions, which we discuss in the following section. It is an old axiomatic teaching that treating a B12 deficient patient with folate or conversely a folate-deficient patient with B12 may exacerbate the neurologic consequences of either deficiency; therefore, cyanocobalamin deficiencies should be excluded before folate supplementation is commenced or, if necessary, it should be appropriate to supplement folate and vitamin B12 together [<xref ref-type="bibr" rid="B360-ijms-20-05797">360</xref>,<xref ref-type="bibr" rid="B380-ijms-20-05797">380</xref>,<xref ref-type="bibr" rid="B381-ijms-20-05797">381</xref>,<xref ref-type="bibr" rid="B382-ijms-20-05797">382</xref>,<xref ref-type="bibr" rid="B383-ijms-20-05797">383</xref>,<xref ref-type="bibr" rid="B384-ijms-20-05797">384</xref>].</p>
<p>This axiom is not fully understood; nevertheless, it has been recently rewritten by the NIH [<xref ref-type="bibr" rid="B385-ijms-20-05797">385</xref>]. The recommendation implies that supplementation of large amounts of folic acid can mask the damaging effects of vitamin B12 deficiency and, therefore, NIH recommends that folic acid intake from fortified food and supplements should not exceed 1000 μg daily in healthy adults. Other recent data suggested that although an estimated 9–12% of older people in the UK suffering from folate deficiency, due to their everyday dietary intake, there is an excess of folic acid intake in young people, due to promotional and commercial purposes, even if there is “insufficient evidence that folic fortification could promote cancer” [<xref ref-type="bibr" rid="B170-ijms-20-05797">170</xref>]. No precise rule has emerged, although as concluded by Porter et al., “those contemplating public health issues worldwide deed to consider a balanced approach and should endeavor to achieve the optimal status of all relevant B-vitamins, throughout all stages of life” [<xref ref-type="bibr" rid="B170-ijms-20-05797">170</xref>]. The other emerging problem is new diet habits, i.e., vegetarians, vegans, and patients with an inferior diet (polished rice and nothing more) [<xref ref-type="bibr" rid="B386-ijms-20-05797">386</xref>]. In the USA, good clinical practice, as stated by the Institute of Medicine and the Harvard TH Chan School of Public Health [<xref ref-type="bibr" rid="B387-ijms-20-05797">387</xref>], recommends a general intake of 400 micrograms per day of folate, suggesting that people who regularly drink alcohol should intake at least 600 micrograms per day. Food sources of folate are fruits and vegetables, whole grains, beans, cereals, and fortified grain products. The recommended intake of vitamin B12 is 2.4 micrograms per day. It is found in fish, poultry, meat, eggs, dairy, fortified cereals, and enriched soy or rice milk [<xref ref-type="bibr" rid="B360-ijms-20-05797">360</xref>].</p>
<p>Although many studies have been dedicated to the implementation of folic acid, vitamin B12, or both, in vascular condition, AD or advanced dementia patients, or the old population, de facto results have never been reproducible, and the debate thus remains open [<xref ref-type="bibr" rid="B388-ijms-20-05797">388</xref>,<xref ref-type="bibr" rid="B389-ijms-20-05797">389</xref>,<xref ref-type="bibr" rid="B390-ijms-20-05797">390</xref>,<xref ref-type="bibr" rid="B391-ijms-20-05797">391</xref>,<xref ref-type="bibr" rid="B392-ijms-20-05797">392</xref>,<xref ref-type="bibr" rid="B393-ijms-20-05797">393</xref>,<xref ref-type="bibr" rid="B394-ijms-20-05797">394</xref>,<xref ref-type="bibr" rid="B395-ijms-20-05797">395</xref>,<xref ref-type="bibr" rid="B396-ijms-20-05797">396</xref>,<xref ref-type="bibr" rid="B397-ijms-20-05797">397</xref>,<xref ref-type="bibr" rid="B398-ijms-20-05797">398</xref>,<xref ref-type="bibr" rid="B399-ijms-20-05797">399</xref>,<xref ref-type="bibr" rid="B400-ijms-20-05797">400</xref>,<xref ref-type="bibr" rid="B401-ijms-20-05797">401</xref>,<xref ref-type="bibr" rid="B402-ijms-20-05797">402</xref>,<xref ref-type="bibr" rid="B403-ijms-20-05797">403</xref>,<xref ref-type="bibr" rid="B404-ijms-20-05797">404</xref>,<xref ref-type="bibr" rid="B405-ijms-20-05797">405</xref>].</p>
<p>In conclusion, although the complex metabolic process in which vitamin B12 and folate are bound is well known, there is a lack of knowledge of implementation and time onset of supplementation. It appears as if more evidence would result from more advanced study, but strict lab measures, exclusion criteria, and frequent observation should be ethically recommended rules in clinical practice [<xref ref-type="bibr" rid="B360-ijms-20-05797">360</xref>,<xref ref-type="bibr" rid="B406-ijms-20-05797">406</xref>].</p>
</sec>
<sec id="sec11-ijms-20-05797">
<title>11. Homocysteine: The Sharing Process of Vitamin B12 and Folate.</title>
<p>Homocysteine (Hcy) is related to the production of 5,10-methylenetetrahydrofolate, a fundamental step for the synthesis of thymidylate, purines and methionine, employing vitamin B12 and folate as cofactors [<xref ref-type="bibr" rid="B407-ijms-20-05797">407</xref>,<xref ref-type="bibr" rid="B408-ijms-20-05797">408</xref>,<xref ref-type="bibr" rid="B409-ijms-20-05797">409</xref>,<xref ref-type="bibr" rid="B410-ijms-20-05797">410</xref>]. The S-adenosyl-methionine (SAM) to S-adenosyl-L-homocysteine (SAH) ratio defines the methylation potential of a cell [<xref ref-type="bibr" rid="B411-ijms-20-05797">411</xref>]. If homocysteine is allowed to accumulate in normal conditions, it will be rapidly metabolized to SAH [<xref ref-type="bibr" rid="B412-ijms-20-05797">412</xref>]. Whenever there is a methionine deficit, Hcy can be re-methylated to form methionine, by the employment of N5, N10-methylenetetrahydrofolate [<xref ref-type="bibr" rid="B412-ijms-20-05797">412</xref>]. If there is an adequate amount of methionine, Hcy is employed for the production of cysteine, mediated by cystathionine–beta-synthase, with pyridoxine and folate as a cofactor [<xref ref-type="bibr" rid="B182-ijms-20-05797">182</xref>]. Therefore, the accumulation of Hcy is dangerous when it occurs in the absence of folate and vitamin B12 as a cofactor. The causative factors of accumulation of Hcy in healthy adult life can be diverse, due to various genetic defects, or to the defects of vitamin B12 and folate [<xref ref-type="bibr" rid="B182-ijms-20-05797">182</xref>]. A physiological increase of Hcy occurs in the brain (and CSF) and the plasma, within the aging process [<xref ref-type="bibr" rid="B296-ijms-20-05797">296</xref>]. Evidence has showed that the adult life hyperhomocysteine condition is associated with cardiovascular and cerebrovascular diseases [<xref ref-type="bibr" rid="B413-ijms-20-05797">413</xref>,<xref ref-type="bibr" rid="B414-ijms-20-05797">414</xref>]. It has been reported that hyperhomocysteine (HHcy) promotes cerebro/cardiovascular atherosclerosis and instable/ruptured atherothrombotic plaques, upregulating the expression of matrix metalloproteinases-9 (MMP-9) expression [<xref ref-type="bibr" rid="B415-ijms-20-05797">415</xref>,<xref ref-type="bibr" rid="B416-ijms-20-05797">416</xref>].</p>
<p>Homocysteine is a common final pathway of the lack of folate and vitamin B12. Its role has been widely discussed elsewhere [<xref ref-type="bibr" rid="B296-ijms-20-05797">296</xref>]; here, we report the significant and more innovative lines of study of homocysteine in brain vascular alteration, underlying small vessel diseases.</p>
<p>Undoubtedly, the methylation reactions are necessary for the brain, SAM being the sole donor in numerous methylation reactions involving proteins, phospholipids, and biogenic amines [<xref ref-type="bibr" rid="B375-ijms-20-05797">375</xref>], and for packaging of many phospholipids [<xref ref-type="bibr" rid="B417-ijms-20-05797">417</xref>]. Most of the polyunsaturated phosphatidylcholines (PC) in mammals are synthesized by phosphatidylethanolamine N-methyltransferase (PEMT) [<xref ref-type="bibr" rid="B418-ijms-20-05797">418</xref>,<xref ref-type="bibr" rid="B419-ijms-20-05797">419</xref>,<xref ref-type="bibr" rid="B420-ijms-20-05797">420</xref>], which methylates phosphatidylethanolamine to generate phosphatidylcholine using SAM as the methyl donor. The leading site of the PEMT-catalyzed synthesis of PC-DHA is liver, whereas the PEMT activity in the brain is relatively low [<xref ref-type="bibr" rid="B421-ijms-20-05797">421</xref>], and the polyunsaturated species of PC [<xref ref-type="bibr" rid="B422-ijms-20-05797">422</xref>] that are synthesized there are adequate for local needs only. PEMT activity in the brain is higher during the perinatal period and declines in adulthood [<xref ref-type="bibr" rid="B421-ijms-20-05797">421</xref>].</p>
<p>The PEMT reaction consumes three molecules of SAM for every PC molecule produced and generates three molecules of S-adenosyl-L-homocysteine (SAH), which act as an inhibitor of PEMT [<xref ref-type="bibr" rid="B423-ijms-20-05797">423</xref>]. Some of the SAH-derived hepatic homocysteine enters the circulation, determining a link between Hcy and PEMT [<xref ref-type="bibr" rid="B424-ijms-20-05797">424</xref>]. Some studies of AD patients related higher plasma concentration of Hcy to reduced levels of erythrocyte phosphatidylcholine-docosahexaenoic acid [<xref ref-type="bibr" rid="B425-ijms-20-05797">425</xref>]. The role of phosphatidylcholine has been debated in vascular dementia, and citicoline has demonstrated neuroprotective effects in acute stroke and has been shown to improve cognition in patients with chronic cerebrovascular disease and some patients with Alzheimer’s disease. Citicoline has prevented cognitive decline after stroke, exhibiting a neuroprotective effect [<xref ref-type="bibr" rid="B426-ijms-20-05797">426</xref>,<xref ref-type="bibr" rid="B427-ijms-20-05797">427</xref>,<xref ref-type="bibr" rid="B428-ijms-20-05797">428</xref>,<xref ref-type="bibr" rid="B429-ijms-20-05797">429</xref>,<xref ref-type="bibr" rid="B430-ijms-20-05797">430</xref>].</p>
<p>It has been proven that Hcy could be linked to neurodegeneration; Hcy, together with high levels of glycine in the brain, is an agonist of the endogenous NMDA receptors [<xref ref-type="bibr" rid="B431-ijms-20-05797">431</xref>], influencing calcium influx [<xref ref-type="bibr" rid="B432-ijms-20-05797">432</xref>], and exerting a direct activation of the group I metabotropic glutamate receptors [<xref ref-type="bibr" rid="B433-ijms-20-05797">433</xref>]. Hyperhomocysteine (HHcy) upregulates Presenilin 1, which promotes APP synthesis [<xref ref-type="bibr" rid="B434-ijms-20-05797">434</xref>]. The protein phosphatase methyltransferase 1, whose methylation is SAM-dependent, regulates the activity of the protein phosphatase methyltransferase 2A, which acts as a dephosphorylating system for tau protein [<xref ref-type="bibr" rid="B435-ijms-20-05797">435</xref>]. Hence, the reduced methylation capacity increases the hyperphosphorylation of tau protein, determining microtubule disaggregation, and the deposition of the neurofibrillary tangles. Moreover, Hcy potentiates the toxicity of Abeta 42 deposition [<xref ref-type="bibr" rid="B436-ijms-20-05797">436</xref>], in particular, increasing its deleterious effects on the smooth vascular cells in the brain [<xref ref-type="bibr" rid="B437-ijms-20-05797">437</xref>].</p>
<p>Hcy acts as a pro-inflammatory and pro-oxidative factor. The SAM-to SAH ratio is the expression of the methylation potential of a cell; as a consequence, “HHcy tends to decrease the methylation potential” [<xref ref-type="bibr" rid="B412-ijms-20-05797">412</xref>]. Therefore, Hcy can induce a global DNA hypomethylation and suppress the transcription of cyclin A in endothelial cells. Apoptosis of human endothelial cells after growth factor deprivation is associated with rapid and dramatic up-regulation of cyclin A–associated cyclin-dependent kinase 2 activity. Simultaneously, Hcy leads to up-regulation of other genes, causing an increase of p66shc expression in endothelial cells, inducing oxidant stress [<xref ref-type="bibr" rid="B412-ijms-20-05797">412</xref>]. HHcy leads to an induction of mRNA of C-reactive protein (CRP), augmenting the NR1 subunit of NMDA receptor expression. Therefore, Hcy can promote a pro-inflammatory response in vascular smooth muscle cells of small brain arteries by stimulating CRP production, usually enhanced by a combined NMDA-ROS-erk1/2/p38-nfKBeta signal pathway [<xref ref-type="bibr" rid="B438-ijms-20-05797">438</xref>].</p>
<p>Recently, a well-conducted study [<xref ref-type="bibr" rid="B439-ijms-20-05797">439</xref>] demonstrated that cultured cell incubation with Hcy determined cell death at 80 microM Hcy exposure after five days; impressively, cell exposure to Hcy at lower concentrations for five days increased reactive oxygen species (ROS) production 4.4-fold. HHcy induced, in the beginning, endothelial cells to produce nitric oxide (NO) and to yield S-nitrose-Hcy, which acts as a protector of endothelium, although the chronic exposure to Hcy induces a final diminishment of NO [<xref ref-type="bibr" rid="B440-ijms-20-05797">440</xref>]. HHcy acts in a multistep process against the endothelium. Its accumulation leads to a disruption of the cell’s integrity and, then, the HHcy-dependent reduced NO bioavailability induces an altered endothelium relaxation and an urgent inflammatory response of muscle cell arteries, testified by an increase of C-reactive proteins and cysteinyl-leukotrienes and of HMG-CoA reductase [<xref ref-type="bibr" rid="B441-ijms-20-05797">441</xref>]. Finally, HHcy tends to reduce the efficiency of the cystathionine-beta-synthase, which induces altered redox homeostasis, with macroscopic alteration of the oxidative repairing process [<xref ref-type="bibr" rid="B442-ijms-20-05797">442</xref>,<xref ref-type="bibr" rid="B443-ijms-20-05797">443</xref>]. An accelerated lipid peroxidation sequela is the main result, with fatal outcomes for neuronal cells, astrocytes, and neurovascular coupling [<xref ref-type="bibr" rid="B444-ijms-20-05797">444</xref>,<xref ref-type="bibr" rid="B445-ijms-20-05797">445</xref>,<xref ref-type="bibr" rid="B446-ijms-20-05797">446</xref>,<xref ref-type="bibr" rid="B447-ijms-20-05797">447</xref>,<xref ref-type="bibr" rid="B448-ijms-20-05797">448</xref>,<xref ref-type="bibr" rid="B449-ijms-20-05797">449</xref>].</p>
<p>Recently, HHcy by itself (without folate and B12 deficiencies) has been associated with secondary septic status and conditioned poor outcome [<xref ref-type="bibr" rid="B450-ijms-20-05797">450</xref>]. It has been argued that it leads to a direct increase of the macrophage response, with an induced release of ROS, and an altered oxidative repair [<xref ref-type="bibr" rid="B450-ijms-20-05797">450</xref>]. More recently, an induction of B-lymphocyte has been demonstrated by a HHcy, with a macroscopic stimulation of the activity of the pyruvate kinase muscle isozyme 2, which seems to be involved in the acceleration of the atherosclerosis process [<xref ref-type="bibr" rid="B451-ijms-20-05797">451</xref>,<xref ref-type="bibr" rid="B452-ijms-20-05797">452</xref>] and probably the alteration of the transcriptional repression of fibroblast growth factor 2 [<xref ref-type="bibr" rid="B428-ijms-20-05797">428</xref>]. As explained [<xref ref-type="bibr" rid="B296-ijms-20-05797">296</xref>], the promoted HHcy activity on NMDA receptors has been demonstrated not only on neurons but also on neutrophils and macrophages. In this way, HHcy upregulates the nuclear factor-kappa B, one of “the master regulators of the expression of inflammatory genes” [<xref ref-type="bibr" rid="B453-ijms-20-05797">453</xref>,<xref ref-type="bibr" rid="B454-ijms-20-05797">454</xref>].</p>
<p>Even all these positive data, clinical trials, and studies failed to demonstrate conclusive results, either considering HHcy as a deterrence target, or preventing HHcy through supplementation in patients or a healthy population with vitamin B12, folate, or both. Many criticisms may be made of the trials that have been implemented [<xref ref-type="bibr" rid="B455-ijms-20-05797">455</xref>,<xref ref-type="bibr" rid="B456-ijms-20-05797">456</xref>,<xref ref-type="bibr" rid="B457-ijms-20-05797">457</xref>,<xref ref-type="bibr" rid="B458-ijms-20-05797">458</xref>].</p>
</sec>
<sec id="sec12-ijms-20-05797" sec-type="conclusions">
<title>12. Conclusions</title>
<p>The conclusions of the present review can be stated as follows: Vitamins of the B group are tightly related to gene control for endothelium protection and act as antioxidants. They play a co-enzymatic role in a number of ways: conversion of pyruvate to acetyl-CoA; conversion of alpha-ketoglutarate to succinate, in the Kreb’s cycle; catalysis by transketolase in the pentose monophosphate shunt, superoxide dismutase (SOD) and catalase; and, in the one-carbon metabolism cycle, to reduce 5,10-methylenetetrahydrofolate (5,10-MTHF) to 5-methyl THF, which, in turn, provides the methyl group for homocysteine re-methylation to methionine pantothenate kinase-2, acetyl-CoA, pyruvate carboxylase, beta-methylcrotonyl-CoA carboxylase, and propionyl-CoA carboxylase). Often, their role is the most critical in many different biochemical reactions inside the brain, interacting with many other constituents, such as participating in the synthesis of polyunsaturated phosphatidylcholine, through the SAM methyl donation (<xref ref-type="fig" rid="ijms-20-05797-f001">Figure 1</xref>). They have anti-inflammatory properties and play a protective role against neurodegenerative mechanisms, such as by modifying the glutamate currents and reducing calcium currents, as well as showing important antioxidant properties. It has even been argued that they play a direct neuropeptide synthesis promoter role.</p>
<p>However, there remain many coincidences and a significant number of unanswered questions [<xref ref-type="bibr" rid="B459-ijms-20-05797">459</xref>,<xref ref-type="bibr" rid="B460-ijms-20-05797">460</xref>,<xref ref-type="bibr" rid="B461-ijms-20-05797">461</xref>]. Laboratory data are far from providing a clinical resolution of these mysteries, such as in the cases of AD or small vessel disease dementia. However, “one coincidence is just a coincidence, two coincidences are a clue, three coincidences are a proof”; at the moment, all the laboratory analyses are directed without any hesitation towards the data mentioned above. The questions are:<list list-type="order"><list-item><p>Should we apply them to clinical practice?</p></list-item><list-item><p>When should we employ them? Earlier is better, but when is “early” not intelligent or too wasteful?</p></list-item><list-item><p>How can we manage clinical trials to be simultaneously efficacious and objective?</p></list-item><list-item><p>Which are the markers of the evolution from healthy aging towards pathology? In this case, a question that remains open concerns identifying when the small vessel alteration of white matter becomes dementia.</p></list-item></list></p>
<p>Further studies should take into account all these questions, with well-designed and globally homogeneous trials.</p>
</sec>
</body>
<back>
<notes notes-type="COI-statement">
<title>Conflicts of Interest</title>
<p>The authors declare no conflict of interest.</p>
</notes>
<ref-list>
<title>References</title>
<ref id="B1-ijms-20-05797">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Karakis</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Pase</surname>
<given-names>M.P.</given-names>
</name>
<name>
<surname>Beiser</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Booth</surname>
<given-names>S.L.</given-names>
</name>
<name>
<surname>Jacques</surname>
<given-names>P.F.</given-names>
</name>
<name>
<surname>Rogers</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>DeCarli</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Vasan</surname>
<given-names>R.S.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>T.J.</given-names>
</name>
<name>
<surname>Himali</surname>
<given-names>J.J.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Association of serum vitamin D with the risk of incident dementia and subclinical indices of brain aging: The Framingham Heart Study</article-title>
<source/>J. Alzheimer’s Dis.
          <year>2016</year>
<volume>51</volume>
<fpage>451</fpage>
<lpage>461</lpage>
<pub-id pub-id-type="doi">10.3233/JAD-150991</pub-id>
<pub-id pub-id-type="pmid">26890771</pub-id>
</element-citation>
</ref>
<ref id="B2-ijms-20-05797">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Román</surname>
<given-names>G.C.</given-names>
</name>
<name>
<surname>Tatemichi</surname>
<given-names>T.K.</given-names>
</name>
<name>
<surname>Erkinjuntti</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Cummings</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Masdeu</surname>
<given-names>J.C.</given-names>
</name>
<name>
<surname>Garcia</surname>
<given-names>J.H.</given-names>
</name>
<name>
<surname>Amaducci</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Orgogozo</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Brun</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Hofman</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Vascular dementia: Diagnostic criteria for Research studies. Reports of the NINDS-AIREN International Workshop</article-title>
<source/>Neurology
          <year>1993</year>
<volume>43</volume>
<fpage>250</fpage>
<lpage>260</lpage>
<pub-id pub-id-type="doi">10.1212/WNL.43.2.250</pub-id>
<pub-id pub-id-type="pmid">8094895</pub-id>
</element-citation>
</ref>
<ref id="B3-ijms-20-05797">
<label>3.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<collab>World Health Organization for vascular dementia</collab>
</person-group>
<source/>The ICD-10 Classification of Mental and Behavioral Disorders
          <comment>Diagnostic Criteria for Research</comment>
<publisher-name>World Health Organization</publisher-name>
<publisher-loc>Geneva, Switzerland</publisher-loc>
<year>1993</year>
<fpage>48</fpage>
<lpage>50</lpage>
</element-citation>
</ref>
<ref id="B4-ijms-20-05797">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chui</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Vascular dementia, a new beginning: Shifting focus from clinical phenotype to ischemic brain injury</article-title>
<source/>Neurol. Clin.
          <year>2000</year>
<volume>18</volume>
<fpage>951</fpage>
<lpage>978</lpage>
<pub-id pub-id-type="doi">10.1016/S0733-8619(05)70234-6</pub-id>
<pub-id pub-id-type="pmid">11072269</pub-id>
</element-citation>
</ref>
<ref id="B5-ijms-20-05797">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Román</surname>
<given-names>G.C.</given-names>
</name>
<name>
<surname>Goldstein</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>A population-based study of dementia in 85-year-olds</article-title>
<source/>N. Engl. J. Med.
          <year>1993</year>
<volume>329</volume>
<fpage>63</fpage>
</element-citation>
</ref>
<ref id="B6-ijms-20-05797">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shi</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wardlaw</surname>
<given-names>J.M.</given-names>
</name>
</person-group>
<article-title>Update on cerebral small vessel disease. A dynamic whole-brain disease</article-title>
<source/>Stroke Vasc. Neurol.
          <year>2016</year>
<volume>1</volume>
<fpage>83</fpage>
<lpage>92</lpage>
<pub-id pub-id-type="doi">10.1136/svn-2016-000035</pub-id>
<pub-id pub-id-type="pmid">28959468</pub-id>
</element-citation>
</ref>
<ref id="B7-ijms-20-05797">
<label>7.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<collab>American Psychiatric Association</collab>
</person-group>
<article-title>Major or Mild Vascular Neurocognitive disorders</article-title>
<source/>Diagnostic and Statistical Manual of Mental Disorders
          <edition>5th ed.</edition>
<publisher-name>American Psychiatric Publishing</publisher-name>
<publisher-loc>Washington, DC, USA</publisher-loc>
<year>2013</year>
<fpage>612</fpage>
<lpage>615</lpage>
</element-citation>
</ref>
<ref id="B8-ijms-20-05797">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sinha</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Bharath</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Chandra</surname>
<given-names>S.R.</given-names>
</name>
</person-group>
<article-title>DSM-5 in vascular dementia. Comparison with other diagnostic criteria in a retrospective study</article-title>
<source/>EC Neurol.
          <year>2015</year>
<volume>2</volume>
<fpage>135</fpage>
<lpage>143</lpage>
</element-citation>
</ref>
<ref id="B9-ijms-20-05797">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wardlaw</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>E.E.</given-names>
</name>
<name>
<surname>Biessels</surname>
<given-names>G.J.</given-names>
</name>
<name>
<surname>Cordonnier</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Fazekas</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Frayne</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Lindley</surname>
<given-names>R.I.</given-names>
</name>
<name>
<surname>O’Brien</surname>
<given-names>J.T.</given-names>
</name>
<name>
<surname>Barkhof</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Benavente</surname>
<given-names>O.R.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration</article-title>
<source/>Lancet Neurol.
          <year>2013</year>
<volume>12</volume>
<fpage>822</fpage>
<lpage>832</lpage>
<pub-id pub-id-type="doi">10.1016/S1474-4422(13)70124-8</pub-id>
<pub-id pub-id-type="pmid">23867200</pub-id>
</element-citation>
</ref>
<ref id="B10-ijms-20-05797">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Laat</surname>
<given-names>K.F.</given-names>
</name>
<name>
<surname>van Norden</surname>
<given-names>A.G.</given-names>
</name>
<name>
<surname>Gons</surname>
<given-names>R.A.</given-names>
</name>
<name>
<surname>van Oudheusden</surname>
<given-names>L.J.</given-names>
</name>
<name>
<surname>van Uden</surname>
<given-names>I.W.</given-names>
</name>
<name>
<surname>Bloem</surname>
<given-names>B.R.</given-names>
</name>
<name>
<surname>Zwiers</surname>
<given-names>M.P.</given-names>
</name>
<name>
<surname>de Leeuw</surname>
<given-names>F.E.</given-names>
</name>
</person-group>
<article-title>Gait in elderly with cerebral small vessel disease</article-title>
<source/>Stroke
          <year>2010</year>
<volume>41</volume>
<fpage>1652</fpage>
<lpage>1658</lpage>
<pub-id pub-id-type="doi">10.1161/STROKEAHA.110.583229</pub-id>
<pub-id pub-id-type="pmid">20576951</pub-id>
</element-citation>
</ref>
<ref id="B11-ijms-20-05797">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jellinger</surname>
<given-names>K.A.</given-names>
</name>
</person-group>
<article-title>Pathology and pathogenesis of vascular cognitive impairment—Acritical update</article-title>
<source/>Front. Aging Neurosci.
          <year>2013</year>
<volume>5</volume>
<fpage>17</fpage>
<pub-id pub-id-type="doi">10.3389/fnagi.2013.00017</pub-id>
<pub-id pub-id-type="pmid">23596414</pub-id>
</element-citation>
</ref>
<ref id="B12-ijms-20-05797">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Patel</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Markus</surname>
<given-names>H.S.</given-names>
</name>
</person-group>
<article-title>Magnetic resonance imaging in cerebral small vessel disease and its use as a surrogate disease marker</article-title>
<source/>Int. J. Stroke
          <year>2011</year>
<volume>6</volume>
<fpage>47</fpage>
<lpage>59</lpage>
<pub-id pub-id-type="doi">10.1111/j.1747-4949.2010.00552.x</pub-id>
<pub-id pub-id-type="pmid">21205241</pub-id>
</element-citation>
</ref>
<ref id="B13-ijms-20-05797">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Erkinjuntti</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Inzitari</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Pantoni</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Wallin</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Scheltens</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Rockwood</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Roman</surname>
<given-names>G.C.</given-names>
</name>
<name>
<surname>Chui</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Desmond</surname>
<given-names>D.W.</given-names>
</name>
</person-group>
<article-title>Resaerch criteria for subcortical vascular dementia in clinical trials</article-title>
<source/>J. Neural Transm. Suppl.
          <year>2000</year>
<volume>59</volume>
<fpage>23</fpage>
<lpage>30</lpage>
<pub-id pub-id-type="pmid">10961414</pub-id>
</element-citation>
</ref>
<ref id="B14-ijms-20-05797">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roman</surname>
<given-names>G.C.</given-names>
</name>
<name>
<surname>Erkinjunnti</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Wallin</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Pantoni</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Chui</surname>
<given-names>H.C.</given-names>
</name>
</person-group>
<article-title>Subcortical ischemic vascular dementia</article-title>
<source/>Lancet Neurol.
          <year>2002</year>
<volume>1</volume>
<fpage>426</fpage>
<lpage>436</lpage>
<pub-id pub-id-type="doi">10.1016/S1474-4422(02)00190-4</pub-id>
<pub-id pub-id-type="pmid">12849365</pub-id>
</element-citation>
</ref>
<ref id="B15-ijms-20-05797">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jani</surname>
<given-names>B.I.</given-names>
</name>
<name>
<surname>Rajkumar</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Ageing and vascular ageing</article-title>
<source/>Postgrad. Med. J.
          <year>2006</year>
<volume>82</volume>
<fpage>357</fpage>
<lpage>362</lpage>
<pub-id pub-id-type="doi">10.1136/pgmj.2005.036053</pub-id>
<pub-id pub-id-type="pmid">16754702</pub-id>
</element-citation>
</ref>
<ref id="B16-ijms-20-05797">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>De la Torre</surname>
<given-names>J.C.</given-names>
</name>
</person-group>
<article-title>Vascular basis of Alzheimer’s pathogenesis</article-title>
<source/>Ann. N. Y. Acad. Sci.
          <year>2002</year>
<volume>977</volume>
<fpage>196</fpage>
<lpage>215</lpage>
<pub-id pub-id-type="doi">10.1111/j.1749-6632.2002.tb04817.x</pub-id>
<pub-id pub-id-type="pmid">12480752</pub-id>
</element-citation>
</ref>
<ref id="B17-ijms-20-05797">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mathias</surname>
<given-names>C.J.</given-names>
</name>
<name>
<surname>Kimber</surname>
<given-names>J.R.</given-names>
</name>
</person-group>
<article-title>Postural hypotension: Causes, clinical features, investigation, and management</article-title>
<source/>Annu. Rev. Med.
          <year>1999</year>
<volume>50</volume>
<fpage>317</fpage>
<lpage>336</lpage>
<pub-id pub-id-type="doi">10.1146/annurev.med.50.1.317</pub-id>
<pub-id pub-id-type="pmid">10073281</pub-id>
</element-citation>
</ref>
<ref id="B18-ijms-20-05797">
<label>18.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Roriz-Filho</surname>
<given-names>J.S.</given-names>
</name>
<name>
<surname>Bernardes-Silva-Filho</surname>
<given-names>S.R.</given-names>
</name>
<name>
<surname>Rosset</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Roriz-Cruz</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Postural blood pressure dysregulation and dementia: Evidence for a vicious circle and implications for neurocardiovascular rehabilitation</article-title>
<source/>Cardiac Rehabilitation
          <person-group person-group-type="editor">
<name>
<surname>Halliday</surname>
<given-names>J.T.</given-names>
</name>
</person-group>
<publisher-name>Novascience Publisher Inc.</publisher-name>
<publisher-loc>New York, NY, USA</publisher-loc>
<year>2009</year>
<fpage>1</fpage>
<lpage>37</lpage>
<isbn>987-1-60741-918-1</isbn>
</element-citation>
</ref>
<ref id="B19-ijms-20-05797">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pantoni</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Garcia</surname>
<given-names>J.H.</given-names>
</name>
<name>
<surname>Gutierrez</surname>
<given-names>J.A.</given-names>
</name>
</person-group>
<article-title>Cerebral white matter is highly vulnerable to ischemia</article-title>
<source/>Stroke
          <year>1996</year>
<volume>27</volume>
<fpage>1641</fpage>
<lpage>1647</lpage>
<pub-id pub-id-type="doi">10.1161/01.STR.27.9.1641</pub-id>
<pub-id pub-id-type="pmid">8784142</pub-id>
</element-citation>
</ref>
<ref id="B20-ijms-20-05797">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schmidt</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Schmidt</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Haybaeck</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Loitfelder</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Weis</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Cavalieri</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Seiler</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Enzinger</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Ropele</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Erkinjuntti</surname>
<given-names>T.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Heterogeneity in age-related white matter changes</article-title>
<source/>Acta Neuropathol.
          <year>2011</year>
<volume>122</volume>
<fpage>171</fpage>
<lpage>185</lpage>
<pub-id pub-id-type="doi">10.1007/s00401-011-0851-x</pub-id>
<pub-id pub-id-type="pmid">21706175</pub-id>
</element-citation>
</ref>
<ref id="B21-ijms-20-05797">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hommet</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Mondon</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Constans</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Beaufils</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Desmidt</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Camus</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Cottier</surname>
<given-names>J.P.</given-names>
</name>
</person-group>
<article-title>Review of cerebral microangiopathy and Alzheimer’s disease: Relation between white matter hyperintensities and microbleeds</article-title>
<source/>Dement. Geriatr. Cogn. Disord.
          <year>2011</year>
<volume>32</volume>
<fpage>367</fpage>
<lpage>378</lpage>
<pub-id pub-id-type="doi">10.1159/000335568</pub-id>
<pub-id pub-id-type="pmid">22301385</pub-id>
</element-citation>
</ref>
<ref id="B22-ijms-20-05797">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Munoz</surname>
<given-names>D.G.</given-names>
</name>
<name>
<surname>Hastak</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Harper</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Hachinski</surname>
<given-names>V.C.</given-names>
</name>
</person-group>
<article-title>Pathologic correlates of increased signals of the centrum ovale on magnetic resonance imaging</article-title>
<source/>Arch. Neurol.
          <year>1993</year>
<volume>50</volume>
<fpage>492</fpage>
<lpage>497</lpage>
<pub-id pub-id-type="doi">10.1001/archneur.1993.00540050044013</pub-id>
<pub-id pub-id-type="pmid">8489405</pub-id>
</element-citation>
</ref>
<ref id="B23-ijms-20-05797">
<label>23.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Salloway</surname>
<given-names>S.</given-names>
</name>
</person-group>
<source/>Subcortical Vascular Dementia: Binswanger’s and CADASIL
          <publisher-name>American Academy of Neurology (AAN)</publisher-name>
<publisher-loc>Honolulu, HI, USA</publisher-loc>
<year>2003</year>
<fpage>1</fpage>
<lpage>29</lpage>
</element-citation>
</ref>
<ref id="B24-ijms-20-05797">
<label>24.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Mirski</surname>
<given-names>M.A.</given-names>
</name>
</person-group>
<source/>Pharmacology of Blood Pressure Management during Cerebral Ischemia
          <publisher-name>American Academy of Neurology (AAN)</publisher-name>
<publisher-loc>Miami, FL, USA</publisher-loc>
<year>2005</year>
<fpage>456</fpage>
<lpage>469</lpage>
</element-citation>
</ref>
<ref id="B25-ijms-20-05797">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wallin</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Blennow</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Gottfries</surname>
<given-names>C.G.</given-names>
</name>
</person-group>
<article-title>Neurochemical abnormalities in vascular dementia</article-title>
<source/>Dementia
          <year>1989</year>
<volume>1</volume>
<fpage>120</fpage>
<lpage>130</lpage>
</element-citation>
</ref>
<ref id="B26-ijms-20-05797">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moretti</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Caruso</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Small vessel disease to subcortical dementia: A dynamic model, which interfaces aging, cholinergic dysregulation and the neurovascular unit</article-title>
<source/>Vasc. Health Risk Manag.
          <year>2019</year>
<comment>in press</comment>
</element-citation>
</ref>
<ref id="B27-ijms-20-05797">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bohnen</surname>
<given-names>N.I.</given-names>
</name>
<name>
<surname>Muller</surname>
<given-names>M.L.T.M.</given-names>
</name>
<name>
<surname>Kuwabara</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ocnstantien</surname>
<given-names>G.M.</given-names>
</name>
<name>
<surname>Studentski</surname>
<given-names>S.A.</given-names>
</name>
</person-group>
<article-title>Age-associated leukoaraiosis and cortical cholinergic deafferentation</article-title>
<source/>Neurology
          <year>2009</year>
<volume>72</volume>
<fpage>1411</fpage>
<lpage>1416</lpage>
<pub-id pub-id-type="doi">10.1212/WNL.0b013e3181a187c6</pub-id>
<pub-id pub-id-type="pmid">19380700</pub-id>
</element-citation>
</ref>
<ref id="B28-ijms-20-05797">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Román</surname>
<given-names>G.C.</given-names>
</name>
</person-group>
<article-title>Brain hypoperfusion: A critical factor in vascular dementia</article-title>
<source/>Neurol. Res.
          <year>2004</year>
<volume>26</volume>
<fpage>454</fpage>
<lpage>458</lpage>
<pub-id pub-id-type="doi">10.1179/016164104225017686</pub-id>
<pub-id pub-id-type="pmid">15265263</pub-id>
</element-citation>
</ref>
<ref id="B29-ijms-20-05797">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhan</surname>
<given-names>S.S.</given-names>
</name>
<name>
<surname>Beyreuther</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Schmitt</surname>
<given-names>H.P.</given-names>
</name>
</person-group>
<article-title>Synaptophysin immunoreactivity of the cortical neuropil in vascular dementia of Binswanger type compared with the dementia of Alzheimer type and non-demented controls</article-title>
<source/>Dementia
          <year>1994</year>
<volume>5</volume>
<fpage>79</fpage>
<lpage>87</lpage>
<pub-id pub-id-type="doi">10.1159/000106701</pub-id>
<pub-id pub-id-type="pmid">8038870</pub-id>
</element-citation>
</ref>
<ref id="B30-ijms-20-05797">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ahtiluoto</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Polvikoski</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Peltonen</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Solomon</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Tuomilehto</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Winblad</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Sulkava</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Kivipelto</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Diabetes, Alzheimer disease, and vascular dementia: A population-based neuropathologic study</article-title>
<source/>Neurology
          <year>2010</year>
<volume>75</volume>
<fpage>1195</fpage>
<lpage>1202</lpage>
<pub-id pub-id-type="doi">10.1212/WNL.0b013e3181f4d7f8</pub-id>
<pub-id pub-id-type="pmid">20739645</pub-id>
</element-citation>
</ref>
<ref id="B31-ijms-20-05797">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Englund</surname>
<given-names>E.A.</given-names>
</name>
<name>
<surname>Person</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>Correlations between histopathologic white matter changes and proton MR relaxation times in dementia</article-title>
<source/>Alzheimer Dis. Assoc. Disord.
          <year>1987</year>
<volume>1</volume>
<fpage>156</fpage>
<lpage>170</lpage>
<pub-id pub-id-type="doi">10.1097/00002093-198701030-00008</pub-id>
<pub-id pub-id-type="pmid">3453747</pub-id>
</element-citation>
</ref>
<ref id="B32-ijms-20-05797">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Román</surname>
<given-names>G.C.</given-names>
</name>
</person-group>
<article-title>Senile dementia of the Binswanger type: A vascular form of dementia in the elderly</article-title>
<source/>JAMA
          <year>1987</year>
<volume>258</volume>
<fpage>1782</fpage>
<lpage>1788</lpage>
<pub-id pub-id-type="doi">10.1001/jama.1987.03400130096040</pub-id>
<pub-id pub-id-type="pmid">3625988</pub-id>
</element-citation>
</ref>
<ref id="B33-ijms-20-05797">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moody</surname>
<given-names>D.M.</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>W.R.</given-names>
</name>
<name>
<surname>Challa</surname>
<given-names>V.R.</given-names>
</name>
<name>
<surname>Anderson</surname>
<given-names>R.L.</given-names>
</name>
</person-group>
<article-title>Periventricular venous collagenosis: Association with leukoaraiosis</article-title>
<source/>Radiology
          <year>1995</year>
<volume>194</volume>
<fpage>469</fpage>
<lpage>476</lpage>
<pub-id pub-id-type="doi">10.1148/radiology.194.2.7824728</pub-id>
<pub-id pub-id-type="pmid">7824728</pub-id>
</element-citation>
</ref>
<ref id="B34-ijms-20-05797">
<label>34.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vinters</surname>
<given-names>H.V.</given-names>
</name>
<name>
<surname>Ellis</surname>
<given-names>W.G.</given-names>
</name>
<name>
<surname>Zarow</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Zaias</surname>
<given-names>B.W.</given-names>
</name>
<name>
<surname>Jagust</surname>
<given-names>W.J.</given-names>
</name>
<name>
<surname>Mack</surname>
<given-names>W.J.</given-names>
</name>
<name>
<surname>Chui</surname>
<given-names>H.C.</given-names>
</name>
</person-group>
<article-title>Neuropathological substrate of ischemic vascular dementia</article-title>
<source/>J. Neuropathol. Exp. Neurol.
          <year>2000</year>
<volume>59</volume>
<fpage>931</fpage>
<lpage>945</lpage>
<pub-id pub-id-type="doi">10.1093/jnen/59.11.931</pub-id>
<pub-id pub-id-type="pmid">11089571</pub-id>
</element-citation>
</ref>
<ref id="B35-ijms-20-05797">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Garcia</surname>
<given-names>J.H.</given-names>
</name>
<name>
<surname>Lassen</surname>
<given-names>N.A.</given-names>
</name>
<name>
<surname>Weiller</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Sperling</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Nakagawara</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Ischemic stroke and incomplete infarction</article-title>
<source/>Stroke
          <year>1996</year>
<volume>27</volume>
<fpage>761</fpage>
<lpage>765</lpage>
<pub-id pub-id-type="doi">10.1161/01.STR.27.4.761</pub-id>
<pub-id pub-id-type="pmid">8614945</pub-id>
</element-citation>
</ref>
<ref id="B36-ijms-20-05797">
<label>36.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dalkara</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Alarcon-Martinez</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Cerebral micro-vascular signaling in health and disease</article-title>
<source/>Brain Res.
          <year>2015</year>
<volume>1623</volume>
<fpage>3</fpage>
<lpage>17</lpage>
<pub-id pub-id-type="doi">10.1016/j.brainres.2015.03.047</pub-id>
<pub-id pub-id-type="pmid">25862573</pub-id>
</element-citation>
</ref>
<ref id="B37-ijms-20-05797">
<label>37.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Giannakopoulos</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Gold</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Kövari</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>von Gunten</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Imhof</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Bouras</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Hof</surname>
<given-names>P.R.</given-names>
</name>
</person-group>
<article-title>Assessing the cognitive impact of Alzheimer disease pathology and vascular burden in the aging brain: The Geneva experience</article-title>
<source/>Acta Neuropathol.
          <year>2007</year>
<volume>113</volume>
<fpage>1</fpage>
<lpage>12</lpage>
<pub-id pub-id-type="doi">10.1007/s00401-006-0144-y</pub-id>
<pub-id pub-id-type="pmid">17036244</pub-id>
</element-citation>
</ref>
<ref id="B38-ijms-20-05797">
<label>38.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Launer</surname>
<given-names>L.J.</given-names>
</name>
<name>
<surname>Hughes</surname>
<given-names>T.M.</given-names>
</name>
<name>
<surname>White</surname>
<given-names>L.R.</given-names>
</name>
</person-group>
<article-title>Microinfarcts, brain atrophy, and cognitive function: The Honolulu Asia Aging Study Autopsy Study</article-title>
<source/>Ann. Neurol.
          <year>2011</year>
<volume>70</volume>
<fpage>774</fpage>
<lpage>780</lpage>
<pub-id pub-id-type="doi">10.1002/ana.22520</pub-id>
<pub-id pub-id-type="pmid">22162060</pub-id>
</element-citation>
</ref>
<ref id="B39-ijms-20-05797">
<label>39.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Van der Veen</surname>
<given-names>P.H.</given-names>
</name>
<name>
<surname>Muller</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Vincken</surname>
<given-names>K.L.</given-names>
</name>
<name>
<surname>Hendrikse</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Mali</surname>
<given-names>W.P.</given-names>
</name>
<name>
<surname>van der Graaf</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Geerlings</surname>
<given-names>M.I.</given-names>
</name>
</person-group>
<article-title>Longitudinal relationship between cerebral small vessel disease and cerebral blood flow. The second manifestations of arterial disease-magnetic resonance study</article-title>
<source/>Stroke
          <year>2015</year>
<volume>46</volume>
<fpage>1233</fpage>
<lpage>1238</lpage>
<pub-id pub-id-type="doi">10.1161/STROKEAHA.114.008030</pub-id>
<pub-id pub-id-type="pmid">25804924</pub-id>
</element-citation>
</ref>
<ref id="B40-ijms-20-05797">
<label>40.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gouw</surname>
<given-names>A.A.</given-names>
</name>
<name>
<surname>van der Flier</surname>
<given-names>W.M.</given-names>
</name>
<name>
<surname>Fazekas</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>van Straaten</surname>
<given-names>E.C.</given-names>
</name>
<name>
<surname>Pantoni</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Poggesi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Inzitari</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Erkinjuntti</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Wahlund</surname>
<given-names>L.O.</given-names>
</name>
<name>
<surname>Waldemar</surname>
<given-names>G.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Progression of white matter hyperintensities and incidence of new lacunes over a 3-year period: The leukoaraiosis and disability study</article-title>
<source/>Stroke
          <year>2008</year>
<volume>39</volume>
<fpage>1414</fpage>
<lpage>1420</lpage>
<pub-id pub-id-type="doi">10.1161/STROKEAHA.107.498535</pub-id>
<pub-id pub-id-type="pmid">18323505</pub-id>
</element-citation>
</ref>
<ref id="B41-ijms-20-05797">
<label>41.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schmidt</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Seiler</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Loitfelder</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Longitudinal change of small vessel disease related brain abnormalities</article-title>
<source/>J. Cereb. Blood Flow Metab.
          <year>2016</year>
<volume>36</volume>
<fpage>26</fpage>
<lpage>39</lpage>
<pub-id pub-id-type="doi">10.1038/jcbfm.2015.72</pub-id>
<pub-id pub-id-type="pmid">25899293</pub-id>
</element-citation>
</ref>
<ref id="B42-ijms-20-05797">
<label>42.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Muñoz Maniega</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Chappell</surname>
<given-names>F.M.</given-names>
</name>
<name>
<surname>Valdés Hernández</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Armitage</surname>
<given-names>P.A.</given-names>
</name>
<name>
<surname>Makin</surname>
<given-names>S.D.</given-names>
</name>
<name>
<surname>Heye</surname>
<given-names>A.K.</given-names>
</name>
<name>
<surname>Thrippleton</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Sakka</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Shuler</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Dennis</surname>
<given-names>M.S.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Integrity of normal appearing white matter: Influence of age, visible lesion burden and hypertension in patients with small-vessel disease</article-title>
<source/>J. Cereb. Blood Flow Metab.
          <year>2016</year>
<volume>37</volume>
<fpage>644</fpage>
<lpage>656</lpage>
<pub-id pub-id-type="doi">10.1177/0271678X16635657</pub-id>
<pub-id pub-id-type="pmid">26933133</pub-id>
</element-citation>
</ref>
<ref id="B43-ijms-20-05797">
<label>43.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smallwood</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Oulhaj</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Joachim</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Christie</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sloan</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>A.D.</given-names>
</name>
<name>
<surname>Esiri</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Cerebral subcortical small vessel disease and its relation to cognition in elderly subjects: A pathological study in the Oxford Project to Investigate Memory and Ageing (OPTIMA) cohort</article-title>
<source/>Neuropathol. Appl. Neurobiol.
          <year>2012</year>
<volume>38</volume>
<fpage>337</fpage>
<lpage>343</lpage>
<pub-id pub-id-type="doi">10.1111/j.1365-2990.2011.01221.x</pub-id>
<pub-id pub-id-type="pmid">21951164</pub-id>
</element-citation>
</ref>
<ref id="B44-ijms-20-05797">
<label>44.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kramer</surname>
<given-names>J.H.</given-names>
</name>
<name>
<surname>Reed</surname>
<given-names>B.R.</given-names>
</name>
<name>
<surname>Mungas</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Weiner</surname>
<given-names>M.W.</given-names>
</name>
<name>
<surname>Chui</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Executive dysfunction in subcortical ischaemic vascular disease</article-title>
<source/>J. Neurol. Neurosurg. Psychiatry
          <year>2002</year>
<volume>72</volume>
<fpage>217</fpage>
<lpage>220</lpage>
<pub-id pub-id-type="doi">10.1136/jnnp.72.2.217</pub-id>
<pub-id pub-id-type="pmid">11796772</pub-id>
</element-citation>
</ref>
<ref id="B45-ijms-20-05797">
<label>45.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Burton</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Ballard</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Stephens</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kenny</surname>
<given-names>R.A.</given-names>
</name>
<name>
<surname>Kalaria</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Barber</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>O’Brien</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Hyperintensities and fronto-subcortical atrophy on MRI are substrates of mild cognitive deficits after stroke</article-title>
<source/>Dement. Geriatr. Cogn. Disord.
          <year>2003</year>
<volume>16</volume>
<fpage>113</fpage>
<lpage>118</lpage>
<pub-id pub-id-type="doi">10.1159/000070684</pub-id>
<pub-id pub-id-type="pmid">12784036</pub-id>
</element-citation>
</ref>
<ref id="B46-ijms-20-05797">
<label>46.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tullberg</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Fletcher</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>DeCarli</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Mungas</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Reed</surname>
<given-names>B.R.</given-names>
</name>
<name>
<surname>Harvey</surname>
<given-names>D.J.</given-names>
</name>
<name>
<surname>Weiner</surname>
<given-names>M.W.</given-names>
</name>
<name>
<surname>Chui</surname>
<given-names>H.C.</given-names>
</name>
<name>
<surname>Jagust</surname>
<given-names>W.J.</given-names>
</name>
</person-group>
<article-title>White matter lesions impair frontal lobe function regard-less of their location</article-title>
<source/>Neurology
          <year>2004</year>
<volume>63</volume>
<fpage>246</fpage>
<lpage>253</lpage>
<pub-id pub-id-type="doi">10.1212/01.WNL.0000130530.55104.B5</pub-id>
<pub-id pub-id-type="pmid">15277616</pub-id>
</element-citation>
</ref>
<ref id="B47-ijms-20-05797">
<label>47.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gold</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Kövari</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Herrmann</surname>
<given-names>F.R.</given-names>
</name>
<name>
<surname>Canuto</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Hof</surname>
<given-names>P.R.</given-names>
</name>
<name>
<surname>Michel</surname>
<given-names>J.P.</given-names>
</name>
<name>
<surname>Bouras</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Giannakopoulos</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Cognitive consequences of thalamic, basal ganglia, and deep white matter lacunes in brain aging and dementia</article-title>
<source/>Stroke
          <year>2005</year>
<volume>36</volume>
<fpage>1184</fpage>
<lpage>1188</lpage>
<pub-id pub-id-type="doi">10.1161/01.STR.0000166052.89772.b5</pub-id>
<pub-id pub-id-type="pmid">15891000</pub-id>
</element-citation>
</ref>
<ref id="B48-ijms-20-05797">
<label>48.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cheng</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Golsari</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Fiehler</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Rosenkranz</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Gerloff</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Thomalla</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>Dynamics of regional distribution of ischemic lesions in middle cerebral artery trunk occlusion relates to collateral circulation</article-title>
<source/>J. Cereb. Blood Flow Metab.
          <year>2010</year>
<volume>31</volume>
<fpage>36</fpage>
<lpage>40</lpage>
<pub-id pub-id-type="doi">10.1038/jcbfm.2010.185</pub-id>
<pub-id pub-id-type="pmid">20940728</pub-id>
</element-citation>
</ref>
<ref id="B49-ijms-20-05797">
<label>49.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dijkhuizen</surname>
<given-names>R.M.</given-names>
</name>
<name>
<surname>Knollema</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>van der Worp</surname>
<given-names>H.B.</given-names>
</name>
<name>
<surname>Ter Horst</surname>
<given-names>G.J.</given-names>
</name>
<name>
<surname>De Wildt</surname>
<given-names>D.J.</given-names>
</name>
<name>
<surname>Berkelbach van der Sprenkel</surname>
<given-names>J.W.</given-names>
</name>
<name>
<surname>Tulleken</surname>
<given-names>K.A.</given-names>
</name>
<name>
<surname>Nicolay</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Dynamics of cerebral tissue injury and perfusion after temporary hypoxia-ischemia in the rat: Evidence for region-specific sensitivity and delayed damage</article-title>
<source/>Stroke
          <year>1998</year>
<volume>29</volume>
<fpage>695</fpage>
<lpage>704</lpage>
<pub-id pub-id-type="doi">10.1161/01.STR.29.3.695</pub-id>
<pub-id pub-id-type="pmid">9506615</pub-id>
</element-citation>
</ref>
<ref id="B50-ijms-20-05797">
<label>50.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Garcia</surname>
<given-names>J.H.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>K.F.</given-names>
</name>
<name>
<surname>Ye</surname>
<given-names>Z.R.</given-names>
</name>
<name>
<surname>Gutierrez</surname>
<given-names>J.A.</given-names>
</name>
</person-group>
<article-title>Incomplete infarct and delayed neuronal death after transient middle cerebral artery occlusion in rats</article-title>
<source/>Stroke
          <year>1997</year>
<volume>28</volume>
<fpage>2303</fpage>
<lpage>2309</lpage>
<pub-id pub-id-type="doi">10.1161/01.STR.28.11.2303</pub-id>
<pub-id pub-id-type="pmid">9368580</pub-id>
</element-citation>
</ref>
<ref id="B51-ijms-20-05797">
<label>51.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Konaka</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Miyashita</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Naritomi</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Changes in diffusion-weighted magnetic resonance imaging findings in the acute and subacute phases of anoxic encephalopathy</article-title>
<source/>J. Stroke Cerebrovasc. Dis.
          <year>2007</year>
<volume>16</volume>
<fpage>82</fpage>
<lpage>83</lpage>
<pub-id pub-id-type="doi">10.1016/j.jstrokecerebrovasdis.2006.10.007</pub-id>
<pub-id pub-id-type="pmid">17689399</pub-id>
</element-citation>
</ref>
<ref id="B52-ijms-20-05797">
<label>52.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ravens</surname>
<given-names>J.R.</given-names>
</name>
</person-group>
<article-title>Vascular changes in the human senile brain</article-title>
<source/>Adv. Neurol.
          <year>1978</year>
<volume>20</volume>
<fpage>487</fpage>
<lpage>501</lpage>
<pub-id pub-id-type="pmid">676912</pub-id>
</element-citation>
</ref>
<ref id="B53-ijms-20-05797">
<label>53.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Klassen</surname>
<given-names>A.C.</given-names>
</name>
<name>
<surname>Sung</surname>
<given-names>J.H.</given-names>
</name>
<name>
<surname>Stadlan</surname>
<given-names>E.M.</given-names>
</name>
</person-group>
<article-title>Histological changes in cerebral arteries with increasing age</article-title>
<source/>J. Neuropathol. Exp. Neurol.
          <year>1968</year>
<volume>27</volume>
<fpage>607</fpage>
<lpage>623</lpage>
<pub-id pub-id-type="doi">10.1097/00005072-196810000-00006</pub-id>
<pub-id pub-id-type="pmid">5687757</pub-id>
</element-citation>
</ref>
<ref id="B54-ijms-20-05797">
<label>54.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cummings</surname>
<given-names>J.L.</given-names>
</name>
</person-group>
<article-title>Frontal-subcortical circuits and human behavior</article-title>
<source/>Arch. Neurol.
          <year>1993</year>
<volume>50</volume>
<fpage>873</fpage>
<lpage>880</lpage>
<pub-id pub-id-type="doi">10.1001/archneur.1993.00540080076020</pub-id>
<pub-id pub-id-type="pmid">8352676</pub-id>
</element-citation>
</ref>
<ref id="B55-ijms-20-05797">
<label>55.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mega</surname>
<given-names>M.S.</given-names>
</name>
<name>
<surname>Cummings</surname>
<given-names>J.L.</given-names>
</name>
</person-group>
<article-title>Frontal-subcortical circuits and neuropsychiatric disorders</article-title>
<source/>J. Neuropsychiatry Clin. Neurosci.
          <year>1994</year>
<volume>6</volume>
<fpage>358</fpage>
<lpage>370</lpage>
<pub-id pub-id-type="pmid">7841807</pub-id>
</element-citation>
</ref>
<ref id="B56-ijms-20-05797">
<label>56.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yao</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Sadoshima</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kuwabara</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ichiya</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Fujishima</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Cerebral blood flow and oxygen metabolism in patients with vascular dementia of the Binswanger type</article-title>
<source/>Stroke
          <year>1990</year>
<volume>21</volume>
<fpage>1694</fpage>
<lpage>1699</lpage>
<pub-id pub-id-type="doi">10.1161/01.STR.21.12.1694</pub-id>
<pub-id pub-id-type="pmid">2264076</pub-id>
</element-citation>
</ref>
<ref id="B57-ijms-20-05797">
<label>57.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Furuta</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ishii</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Nishihara</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Horie</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Medullary arteries in aging and dementia</article-title>
<source/>Stroke
          <year>1991</year>
<volume>22</volume>
<fpage>442</fpage>
<lpage>446</lpage>
<pub-id pub-id-type="doi">10.1161/01.STR.22.4.442</pub-id>
<pub-id pub-id-type="pmid">2024272</pub-id>
</element-citation>
</ref>
<ref id="B58-ijms-20-05797">
<label>58.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tak</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yoon</surname>
<given-names>S.J.</given-names>
</name>
<name>
<surname>Jang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Yoo</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Jeong</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ye</surname>
<given-names>J.C.</given-names>
</name>
</person-group>
<article-title>Quantitative analysis of hemodynamic and metabolic changes in subcortical vascular dementia using simulataneous near-infrared spectroscopy and FMRI measurements</article-title>
<source/>Neuroimage
          <year>2011</year>
<volume>55</volume>
<fpage>176</fpage>
<lpage>184</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuroimage.2010.11.046</pub-id>
<pub-id pub-id-type="pmid">21094685</pub-id>
</element-citation>
</ref>
<ref id="B59-ijms-20-05797">
<label>59.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schroeter</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Cutini</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wahl</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Scheid</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>von Cramon</surname>
<given-names>D.Y.</given-names>
</name>
</person-group>
<article-title>Neurovascular coupling is impaired in cerebral microangiopathy an event related stroop study</article-title>
<source/>Neuroimage
          <year>2007</year>
<volume>34</volume>
<fpage>26</fpage>
<lpage>34</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuroimage.2006.09.001</pub-id>
<pub-id pub-id-type="pmid">17070070</pub-id>
</element-citation>
</ref>
<ref id="B60-ijms-20-05797">
<label>60.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bar</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Boettger</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Seidler</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Mentzelh</surname>
<given-names>H.J.</given-names>
</name>
<name>
<surname>Terborg</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Sauer</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Influence of galantamine on vasomotor reactivity in AD and vascular dementia due to microangiopathy</article-title>
<source/>Stroke
          <year>2007</year>
<volume>38</volume>
<fpage>3186</fpage>
<lpage>3192</lpage>
<pub-id pub-id-type="doi">10.1161/STROKEAHA.107.492033</pub-id>
<pub-id pub-id-type="pmid">17962592</pub-id>
</element-citation>
</ref>
<ref id="B61-ijms-20-05797">
<label>61.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Reuck</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Decoo</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Marchau</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Santens</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Lemahieu</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Strijckmans</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Positron emission tomography in vascular dementia</article-title>
<source/>J. Neurol. Sci.
          <year>1998</year>
<volume>154</volume>
<fpage>55</fpage>
<lpage>61</lpage>
<pub-id pub-id-type="doi">10.1016/S0022-510X(97)00213-X</pub-id>
<pub-id pub-id-type="pmid">9543322</pub-id>
</element-citation>
</ref>
<ref id="B62-ijms-20-05797">
<label>62.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yoshikawa</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Murase</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Oku</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Kitagawa</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Imaizumi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Takasawa</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Nishikawa</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Matsumoto</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hatazawa</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Hori</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Statistical image analysis of cerebral blood flow in vascular dementia with small-vessel disease</article-title>
<source/>J. Nucl. Med.
          <year>2003</year>
<volume>44</volume>
<fpage>505</fpage>
<lpage>511</lpage>
<pub-id pub-id-type="pmid">12679392</pub-id>
</element-citation>
</ref>
<ref id="B63-ijms-20-05797">
<label>63.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Sohn</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Analysis of cerebral blood flow of subcortical vascular dementia with single photon emission computed tomography: Adaptation of statistical parametric mapping</article-title>
<source/>J. Neurol. Sci.
          <year>2002</year>
<volume>203</volume>
<fpage>199</fpage>
<lpage>205</lpage>
<pub-id pub-id-type="doi">10.1016/S0022-510X(02)00291-5</pub-id>
<pub-id pub-id-type="pmid">12417384</pub-id>
</element-citation>
</ref>
<ref id="B64-ijms-20-05797">
<label>64.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ramirez-Gomez</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Reed</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Kramer</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Mungas</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Zarow</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Vinters</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ringman</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Chui</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Neuropsychological profiles differentiate Alzheimer Disease from Subcortical Ischemic vascular dementia in an autopsy-defined cohort</article-title>
<source/>Dement. Geriatr. Cogn. Disord.
          <year>2017</year>
<volume>44</volume>
<fpage>1</fpage>
<lpage>11</lpage>
<pub-id pub-id-type="doi">10.1159/000477344</pub-id>
<pub-id pub-id-type="pmid">28595184</pub-id>
</element-citation>
</ref>
<ref id="B65-ijms-20-05797">
<label>65.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cummings</surname>
<given-names>J.L.</given-names>
</name>
</person-group>
<article-title>Vascular subcortical dementias: Clinical aspects</article-title>
<source/>Dementia
          <year>1994</year>
<volume>5</volume>
<fpage>177</fpage>
<lpage>180</lpage>
<pub-id pub-id-type="doi">10.1159/000106718</pub-id>
<pub-id pub-id-type="pmid">8087175</pub-id>
</element-citation>
</ref>
<ref id="B66-ijms-20-05797">
<label>66.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Desmond</surname>
<given-names>D.W.</given-names>
</name>
<name>
<surname>Erkinjuntti</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Sano</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Cummings</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Bowler</surname>
<given-names>J.V.</given-names>
</name>
<name>
<surname>Pasquier</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Moroney</surname>
<given-names>J.T.</given-names>
</name>
<name>
<surname>Ferris</surname>
<given-names>S.H.</given-names>
</name>
<name>
<surname>Stern</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Sachdev</surname>
<given-names>P.S.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The cognitive syndrome of vascular dementia: Implications for clinical trials</article-title>
<source/>Alzheimer Dis. Assoc. Disord.
          <year>1999</year>
<volume>13</volume>
<fpage>21</fpage>
<lpage>29</lpage>
<pub-id pub-id-type="doi">10.1097/00002093-199912001-00005</pub-id>
</element-citation>
</ref>
<ref id="B67-ijms-20-05797">
<label>67.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sachdev</surname>
<given-names>P.S.</given-names>
</name>
<name>
<surname>Brodaty</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Valenzuela</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Lorentz</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Looi</surname>
<given-names>J.C.</given-names>
</name>
<name>
<surname>Wen</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Zagami</surname>
<given-names>A.S.</given-names>
</name>
</person-group>
<article-title>The neuropsychological profile of vascular cognitive impairment in stroke and TIA patients</article-title>
<source/>Neurology
          <year>2004</year>
<volume>62</volume>
<pub-id pub-id-type="doi">10.1212/01.WNL.0000115108.65264.4B</pub-id>
<pub-id pub-id-type="pmid">15037692</pub-id>
</element-citation>
</ref>
<ref id="B68-ijms-20-05797">
<label>68.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Traykov</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Baudic</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Thibaudet</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Rigaud</surname>
<given-names>A.S.</given-names>
</name>
<name>
<surname>Samgghe</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Boller</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>Neuropsychological deficit in early subcortical vascular dementia: Comparison to AD</article-title>
<source/>Dement. Geriatr. Cogn. Disord.
          <year>2002</year>
<volume>14</volume>
<fpage>26</fpage>
<lpage>32</lpage>
<pub-id pub-id-type="doi">10.1159/000058330</pub-id>
<pub-id pub-id-type="pmid">12053129</pub-id>
</element-citation>
</ref>
<ref id="B69-ijms-20-05797">
<label>69.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moretti</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Signori</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Neural correlates for apathy: Frontal-prefrontal and parietal cortical-subcortical circuits</article-title>
<source/>Front. Aging Neurosci.
          <year>2016</year>
<volume>9</volume>
<fpage>289</fpage>
<pub-id pub-id-type="doi">10.3389/fnagi.2016.00289</pub-id>
</element-citation>
</ref>
<ref id="B70-ijms-20-05797">
<label>70.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ishii</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Nashihara</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Imamura</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Why do frontal lobe symptoms predominate in vascular dementia with lacunes?</article-title>
<source/>Neurology
          <year>1986</year>
<volume>36</volume>
<fpage>340</fpage>
<lpage>345</lpage>
<pub-id pub-id-type="doi">10.1212/WNL.36.3.340</pub-id>
<pub-id pub-id-type="pmid">3951700</pub-id>
</element-citation>
</ref>
<ref id="B71-ijms-20-05797">
<label>71.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Jager</surname>
<given-names>C.A.</given-names>
</name>
</person-group>
<article-title>Critical levels of brain atrophy associated with homocysteine and cognitive decline</article-title>
<source/>Neurobiol. Ageing
          <year>2014</year>
<volume>35</volume>
<fpage>S35</fpage>
<lpage>S39</lpage>
<pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2014.03.040</pub-id>
</element-citation>
</ref>
<ref id="B72-ijms-20-05797">
<label>72.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cummings</surname>
<given-names>J.L.</given-names>
</name>
</person-group>
<article-title>Food for thought: Souvenaid in mild Alzheimer’s disease</article-title>
<source/>J. Alzheimer’s Dis.
          <year>2012</year>
<volume>31</volume>
<fpage>237</fpage>
<lpage>238</lpage>
<pub-id pub-id-type="doi">10.3233/JAD-2012-121297</pub-id>
<pub-id pub-id-type="pmid">22766771</pub-id>
</element-citation>
</ref>
<ref id="B73-ijms-20-05797">
<label>73.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peng</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>Geriatric Neurology Group; Chinese Society of Geriatrics. Clinical Practice Guideline for Cognitive Impairment of Cerebral Small Vessel Disease Writing Group. Clinical practice guideline for cognitive impairment of cerebral small vessel disease</article-title>
<source/>Aging Med.
          <year>2019</year>
<volume>2</volume>
<fpage>64</fpage>
<lpage>73</lpage>
<pub-id pub-id-type="doi">10.1002/agm2.12073</pub-id>
</element-citation>
</ref>
<ref id="B74-ijms-20-05797">
<label>74.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roe</surname>
<given-names>A.J.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Bhadelia</surname>
<given-names>R.A.</given-names>
</name>
<name>
<surname>Johnson</surname>
<given-names>E.J.</given-names>
</name>
<name>
<surname>Lichtenstein</surname>
<given-names>A.H.</given-names>
</name>
<name>
<surname>Rogers</surname>
<given-names>G.T.</given-names>
</name>
<name>
<surname>Rosenberg</surname>
<given-names>I.H.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>C.E.</given-names>
</name>
<name>
<surname>Zeisel</surname>
<given-names>S.H.</given-names>
</name>
<name>
<surname>Scott</surname>
<given-names>T.S.</given-names>
</name>
</person-group>
<article-title>Choline and its metabolites are differently associated with cardiometabolic risk factors, history of cardiovascular disease, and MRI-documented cerebrovascular disease in older adults</article-title>
<source/>Am. J. Clin. Nutr.
          <year>2017</year>
<volume>105</volume>
<fpage>1283</fpage>
<lpage>1290</lpage>
<pub-id pub-id-type="doi">10.3945/ajcn.116.137158</pub-id>
<pub-id pub-id-type="pmid">28356272</pub-id>
</element-citation>
</ref>
<ref id="B75-ijms-20-05797">
<label>75.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Blusztajn</surname>
<given-names>J.K.</given-names>
</name>
<name>
<surname>Slack</surname>
<given-names>B.E.</given-names>
</name>
<name>
<surname>Mellott</surname>
<given-names>T.J.</given-names>
</name>
</person-group>
<article-title>Neuroprotective Actions of Dietary Choline</article-title>
<source/>Nutrients
          <year>2017</year>
<volume>9</volume>
<elocation-id>815</elocation-id>
<pub-id pub-id-type="doi">10.3390/nu9080815</pub-id>
</element-citation>
</ref>
<ref id="B76-ijms-20-05797">
<label>76.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Castro</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Rudy</surname>
<given-names>J.W.</given-names>
</name>
</person-group>
<article-title>Early-life malnutrition selectively retards the development of distal- but not proximal-cue navigation</article-title>
<source/>Dev. Psychobiol.
          <year>1987</year>
<volume>20</volume>
<fpage>521</fpage>
<lpage>537</lpage>
<pub-id pub-id-type="doi">10.1002/dev.420200506</pub-id>
<pub-id pub-id-type="pmid">3678617</pub-id>
</element-citation>
</ref>
<ref id="B77-ijms-20-05797">
<label>77.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mellott</surname>
<given-names>T.J.</given-names>
</name>
<name>
<surname>Huleatt</surname>
<given-names>O.M.</given-names>
</name>
<name>
<surname>Shade</surname>
<given-names>B.N.</given-names>
</name>
<name>
<surname>Pender</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.B.</given-names>
</name>
<name>
<surname>Slack</surname>
<given-names>B.E.</given-names>
</name>
<name>
<surname>Blusztajn</surname>
<given-names>J.K.</given-names>
</name>
</person-group>
<article-title>Perinatal choline supplementation reduces amyloidosis and increases choline acetyltransferae expression in the hippocampus of the APPswePS1dE9 Alzheimer’s disease model mice</article-title>
<source/>PLoS ONE
          <year>2017</year>
<volume>12</volume>
<elocation-id>e0170450</elocation-id>
<pub-id pub-id-type="pmid">28103298</pub-id>
</element-citation>
</ref>
<ref id="B78-ijms-20-05797">
<label>78.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Napoli</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Blusztajn</surname>
<given-names>J.K.</given-names>
</name>
<name>
<surname>Mellott</surname>
<given-names>T.J.</given-names>
</name>
</person-group>
<article-title>Prenatal choline supplementation in rats increases the expression of IGF2 and its receptor IGF2R and enhances IGF2-induced acetylcholine release in hippocampus and frontal cortex</article-title>
<source/>Brain Res.
          <year>2008</year>
<volume>1237</volume>
<fpage>124</fpage>
<lpage>135</lpage>
<pub-id pub-id-type="doi">10.1016/j.brainres.2008.08.046</pub-id>
<pub-id pub-id-type="pmid">18786520</pub-id>
</element-citation>
</ref>
<ref id="B79-ijms-20-05797">
<label>79.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Williams</surname>
<given-names>C.L.</given-names>
</name>
<name>
<surname>Meck</surname>
<given-names>W.H.</given-names>
</name>
<name>
<surname>Heyer</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Loy</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Hypertrophy of basal forebrain neurons and enhanced visuospatial memory in perinatally choline-supplemented rats</article-title>
<source/>Brain Res.
          <year>1998</year>
<volume>794</volume>
<fpage>225</fpage>
<lpage>238</lpage>
<pub-id pub-id-type="doi">10.1016/S0006-8993(98)00229-7</pub-id>
<pub-id pub-id-type="pmid">9622639</pub-id>
</element-citation>
</ref>
<ref id="B80-ijms-20-05797">
<label>80.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cermak</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Holler</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Jackson</surname>
<given-names>D.A.</given-names>
</name>
<name>
<surname>Blusztajn</surname>
<given-names>J.K.</given-names>
</name>
</person-group>
<article-title>Prenatal availability of choline modifies development of the hippocampal cholinergic system</article-title>
<source/>FASEB J.
          <year>1998</year>
<volume>12</volume>
<fpage>349</fpage>
<lpage>357</lpage>
<pub-id pub-id-type="doi">10.1096/fasebj.12.3.349</pub-id>
<pub-id pub-id-type="pmid">9506479</pub-id>
</element-citation>
</ref>
<ref id="B81-ijms-20-05797">
<label>81.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kovacheva</surname>
<given-names>V.P.</given-names>
</name>
<name>
<surname>Mellott</surname>
<given-names>T.J.</given-names>
</name>
<name>
<surname>Davison</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Wagner</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Lopez-Coviella</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Schnitzler</surname>
<given-names>A.C.</given-names>
</name>
<name>
<surname>Blusztajn</surname>
<given-names>J.K.</given-names>
</name>
</person-group>
<article-title>Gestational choline deficiency causes global and Igf2 gene DNA hypermethylation by up-regulation of Dnmt1 expression</article-title>
<source/>J. Biol. Chem.
          <year>2007</year>
<volume>282</volume>
<fpage>31777</fpage>
<lpage>31788</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M705539200</pub-id>
<pub-id pub-id-type="pmid">17724018</pub-id>
</element-citation>
</ref>
<ref id="B82-ijms-20-05797">
<label>82.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lopes</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lewis</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Hajkova</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Dean</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Oswald</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Forne</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Murrell</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Constancia</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Bartolomei</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Walter</surname>
<given-names>J.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Epigenetic modifications in an imprinting cluster are controlled by a hierarchy of DMRs suggesting long-range chromatin interactions</article-title>
<source/>Hum. Mol. Genet.
          <year>2003</year>
<volume>12</volume>
<fpage>295</fpage>
<lpage>305</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/ddg022</pub-id>
<pub-id pub-id-type="pmid">12554683</pub-id>
</element-citation>
</ref>
<ref id="B83-ijms-20-05797">
<label>83.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Levenson</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Roth</surname>
<given-names>T.L.</given-names>
</name>
<name>
<surname>Lubin</surname>
<given-names>F.D.</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>I.C.</given-names>
</name>
<name>
<surname>Desai</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Malone</surname>
<given-names>L.M.</given-names>
</name>
<name>
<surname>Sweatt</surname>
<given-names>J.D.</given-names>
</name>
</person-group>
<article-title>Evidence that DNA (cytosine-5) methyltransferase regulates synaptic plasticity in the hippocampus</article-title>
<source/>J. Biol. Chem.
          <year>2006</year>
<volume>281</volume>
<fpage>15763</fpage>
<lpage>15773</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M511767200</pub-id>
<pub-id pub-id-type="pmid">16606618</pub-id>
</element-citation>
</ref>
<ref id="B84-ijms-20-05797">
<label>84.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yossifoff</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kisliouk</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Meiri</surname>
<given-names>N.</given-names>
</name>
</person-group>
<article-title>Dynamic changes in DNA methylation during thermal control establishment affect CREB binding to the brain-derived neurotrophic factor promoter</article-title>
<source/>Eur. J. Neurosci.
          <year>2008</year>
<volume>28</volume>
<fpage>2267</fpage>
<lpage>2277</lpage>
<pub-id pub-id-type="doi">10.1111/j.1460-9568.2008.06532.x</pub-id>
<pub-id pub-id-type="pmid">19046370</pub-id>
</element-citation>
</ref>
<ref id="B85-ijms-20-05797">
<label>85.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lubin</surname>
<given-names>F.D.</given-names>
</name>
<name>
<surname>Roth</surname>
<given-names>T.L.</given-names>
</name>
<name>
<surname>Sweatt</surname>
<given-names>J.D.</given-names>
</name>
</person-group>
<article-title>Epigenetic regulation of BDNF gene transcription in the consolidation of fear memory</article-title>
<source/>J. Neurosci.
          <year>2008</year>
<volume>28</volume>
<fpage>10576</fpage>
<lpage>10586</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.1786-08.2008</pub-id>
<pub-id pub-id-type="pmid">18923034</pub-id>
</element-citation>
</ref>
<ref id="B86-ijms-20-05797">
<label>86.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Feng</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Campbell</surname>
<given-names>S.L.</given-names>
</name>
<name>
<surname>Le</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Sweatt</surname>
<given-names>J.D.</given-names>
</name>
<name>
<surname>Silva</surname>
<given-names>A.J.</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>Dnmt1 and Dnmt3a maintain DNA methylation and regulate synaptic function in adult forebrain neurons</article-title>
<source/>Nat. Neurosci.
          <year>2010</year>
<volume>13</volume>
<fpage>423</fpage>
<lpage>430</lpage>
<pub-id pub-id-type="doi">10.1038/nn.2514</pub-id>
<pub-id pub-id-type="pmid">20228804</pub-id>
</element-citation>
</ref>
<ref id="B87-ijms-20-05797">
<label>87.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Webb</surname>
<given-names>W.M.</given-names>
</name>
<name>
<surname>Sanchez</surname>
<given-names>R.G.</given-names>
</name>
<name>
<surname>Perez</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Butler</surname>
<given-names>A.A.</given-names>
</name>
<name>
<surname>Hauser</surname>
<given-names>R.M.</given-names>
</name>
<name>
<surname>Rich</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>O’Bierne</surname>
<given-names>A.L.</given-names>
</name>
<name>
<surname>Jarome</surname>
<given-names>T.J.</given-names>
</name>
<name>
<surname>Lubin</surname>
<given-names>F.D.</given-names>
</name>
</person-group>
<article-title>Dynamic association of epigenetic H3K4me3 and DNA 5hmC marks in the dorsal hippocampus and anterior cingulate cortex following reactivation of a fear memory</article-title>
<source/>Neurobiol. Learn. Mem.
          <year>2017</year>
<volume>142</volume>
<fpage>66</fpage>
<lpage>78</lpage>
<pub-id pub-id-type="doi">10.1016/j.nlm.2017.02.010</pub-id>
<pub-id pub-id-type="pmid">28232238</pub-id>
</element-citation>
</ref>
<ref id="B88-ijms-20-05797">
<label>88.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kennedy</surname>
<given-names>A.J.</given-names>
</name>
<name>
<surname>Rahn</surname>
<given-names>E.J.</given-names>
</name>
<name>
<surname>Paulukaitis</surname>
<given-names>B.S.</given-names>
</name>
<name>
<surname>Savell</surname>
<given-names>K.E.</given-names>
</name>
<name>
<surname>Kordasiewicz</surname>
<given-names>H.B.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lewis</surname>
<given-names>J.W.</given-names>
</name>
<name>
<surname>Posey</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Strange</surname>
<given-names>S.K.</given-names>
</name>
<name>
<surname>Guzman-Karlsson</surname>
<given-names>M.C.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Tcf4 Regulates Synaptic Plasticity, DNA Methylation, and Memory Function</article-title>
<source/>Cell Rep.
          <year>2016</year>
<volume>16</volume>
<fpage>2666</fpage>
<lpage>2685</lpage>
<pub-id pub-id-type="doi">10.1016/j.celrep.2016.08.004</pub-id>
<pub-id pub-id-type="pmid">27568567</pub-id>
</element-citation>
</ref>
<ref id="B89-ijms-20-05797">
<label>89.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barany</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>Y.C.</given-names>
</name>
<name>
<surname>Arus</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Rustan</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Frey</surname>
<given-names>W.H.</given-names>
</name>
</person-group>
<article-title>Increased glycerol-3-phosphorylcholine in post-mortem Alzheimer’s brain</article-title>
<source/>Lancet
          <year>1985</year>
<volume>1</volume>
<fpage>517</fpage>
<pub-id pub-id-type="doi">10.1016/S0140-6736(85)92114-2</pub-id>
</element-citation>
</ref>
<ref id="B90-ijms-20-05797">
<label>90.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Blusztajn</surname>
<given-names>J.K.</given-names>
</name>
<name>
<surname>Gonzalez-Coviella</surname>
<given-names>I.L.</given-names>
</name>
<name>
<surname>Logue</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Growdon</surname>
<given-names>J.H.</given-names>
</name>
<name>
<surname>Wurtman</surname>
<given-names>R.J.</given-names>
</name>
</person-group>
<article-title>Levels of phospholipid catabolic intermediates, glycerophosphocholine and glycerophosphoethanolamine, are elevated in brains of Alzheimer’s disease but not of Down’s syndrome patients</article-title>
<source/>Brain Res.
          <year>1990</year>
<volume>536</volume>
<fpage>240</fpage>
<lpage>244</lpage>
<pub-id pub-id-type="doi">10.1016/0006-8993(90)90030-F</pub-id>
<pub-id pub-id-type="pmid">2150771</pub-id>
</element-citation>
</ref>
<ref id="B91-ijms-20-05797">
<label>91.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Corbin</surname>
<given-names>K.D.</given-names>
</name>
<name>
<surname>Zeisel</surname>
<given-names>S.H.</given-names>
</name>
</person-group>
<article-title>Choline metabolism provides novel insights into nonalcoholic fatty liver disease and its progression</article-title>
<source/>Curr. Opin. Gastroeneterol.
          <year>2012</year>
<volume>28</volume>
<fpage>159</fpage>
<lpage>165</lpage>
<pub-id pub-id-type="doi">10.1097/MOG.0b013e32834e7b4b</pub-id>
</element-citation>
</ref>
<ref id="B92-ijms-20-05797">
<label>92.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Karaca</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Schram</surname>
<given-names>M.T.</given-names>
</name>
<name>
<surname>Houben</surname>
<given-names>A.J.</given-names>
</name>
<name>
<surname>Muris</surname>
<given-names>D.M.</given-names>
</name>
<name>
<surname>Stehouwer</surname>
<given-names>C.D.</given-names>
</name>
</person-group>
<article-title>Microvascular dysfunction as a link between obesity, insulin resistance and hypertension</article-title>
<source/>Diabetes Res. Clin. Pract.
          <year>2014</year>
<volume>103</volume>
<fpage>382</fpage>
<lpage>387</lpage>
<pub-id pub-id-type="doi">10.1016/j.diabres.2013.12.012</pub-id>
<pub-id pub-id-type="pmid">24438874</pub-id>
</element-citation>
</ref>
<ref id="B93-ijms-20-05797">
<label>93.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roberson</surname>
<given-names>L.L.</given-names>
</name>
<name>
<surname>Aneni</surname>
<given-names>E.C.</given-names>
</name>
<name>
<surname>Maziak</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Agatston</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Feldman</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Rouseff</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tran</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Blaha</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Santos</surname>
<given-names>R.D.</given-names>
</name>
<name>
<surname>Sposito</surname>
<given-names>A.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Beyond BMI: The metabolically healthy obese phenotype and its association with clinical/subclinical cardiovascular disease all-cause mortality; a systematic review</article-title>
<source/>BMC Public Health
          <year>2014</year>
<volume>14</volume>
<elocation-id>14</elocation-id>
<pub-id pub-id-type="doi">10.1186/1471-2458-14-14</pub-id>
<pub-id pub-id-type="pmid">24400816</pub-id>
</element-citation>
</ref>
<ref id="B94-ijms-20-05797">
<label>94.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yuki</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Sugiura</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zaima</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Akatsu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Takei</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yao</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Maesako</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kinoshita</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Yamamoto</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kon</surname>
<given-names>R.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>DHA-PC and PSD-95 decrease after loss of synaptophysin and before neuronal loss in patients with Alzheimer’s disease</article-title>
<source/>Sci. Rep.
          <year>2014</year>
<volume>4</volume>
<elocation-id>7130</elocation-id>
<pub-id pub-id-type="doi">10.1038/srep07130</pub-id>
<pub-id pub-id-type="pmid">25410733</pub-id>
</element-citation>
</ref>
<ref id="B95-ijms-20-05797">
<label>95.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schaefer</surname>
<given-names>E.J.</given-names>
</name>
<name>
<surname>Bongard</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Beiser</surname>
<given-names>A.S.</given-names>
</name>
<name>
<surname>Lamon-Fava</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Robins</surname>
<given-names>S.J.</given-names>
</name>
<name>
<surname>Au</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Tucker</surname>
<given-names>K.L.</given-names>
</name>
<name>
<surname>Kyle</surname>
<given-names>D.J.</given-names>
</name>
<name>
<surname>Wilson</surname>
<given-names>P.W.</given-names>
</name>
<name>
<surname>Wolf</surname>
<given-names>P.A.</given-names>
</name>
</person-group>
<article-title>Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: The Framingham Heart Study</article-title>
<source/>Arch. Neurol.
          <year>2006</year>
<volume>63</volume>
<fpage>1545</fpage>
<lpage>1550</lpage>
<pub-id pub-id-type="doi">10.1001/archneur.63.11.1545</pub-id>
<pub-id pub-id-type="pmid">17101822</pub-id>
</element-citation>
</ref>
<ref id="B96-ijms-20-05797">
<label>96.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Trushina</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Dutta</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Persson</surname>
<given-names>X.M.</given-names>
</name>
<name>
<surname>Mielke</surname>
<given-names>M.M.</given-names>
</name>
<name>
<surname>Petersen</surname>
<given-names>R.C.</given-names>
</name>
</person-group>
<article-title>Identification of altered metabolic pathways in plasma and CSF in mild cognitive impairment and Alzheimer’s disease using metabolomics</article-title>
<source/>PLoS ONE
          <year>2013</year>
<volume>8</volume>
<elocation-id>e63644</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0063644</pub-id>
<pub-id pub-id-type="pmid">23700429</pub-id>
</element-citation>
</ref>
<ref id="B97-ijms-20-05797">
<label>97.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gonzalez-Dominguez</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Garcia-Barrera</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Gomez-Ariza</surname>
<given-names>J.L.</given-names>
</name>
</person-group>
<article-title>Combination of metabolomic and phospholipid-profiling approaches for the study of Alzheimer’s disease</article-title>
<source/>J. Proteom.
          <year>2014</year>
<volume>104</volume>
<fpage>37</fpage>
<lpage>47</lpage>
<pub-id pub-id-type="doi">10.1016/j.jprot.2014.01.014</pub-id>
<pub-id pub-id-type="pmid">24473279</pub-id>
</element-citation>
</ref>
<ref id="B98-ijms-20-05797">
<label>98.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fiandaca</surname>
<given-names>M.S.</given-names>
</name>
<name>
<surname>Zhong</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Cheema</surname>
<given-names>A.K.</given-names>
</name>
<name>
<surname>Orquiza</surname>
<given-names>M.H.</given-names>
</name>
<name>
<surname>Chidambaram</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>M.T.</given-names>
</name>
<name>
<surname>Gresenz</surname>
<given-names>C.R.</given-names>
</name>
<name>
<surname>Fitzgerald</surname>
<given-names>K.T.</given-names>
</name>
<name>
<surname>Nalls</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Singleton</surname>
<given-names>A.B.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Plasma 24-metabolite Panel Predicts Preclinical Transition to Clinical Stages of Alzheimer’s Disease</article-title>
<source/>Front. Neurol.
          <year>2015</year>
<volume>6</volume>
<fpage>237</fpage>
<pub-id pub-id-type="doi">10.3389/fneur.2015.00237</pub-id>
<pub-id pub-id-type="pmid">26617567</pub-id>
</element-citation>
</ref>
<ref id="B99-ijms-20-05797">
<label>99.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Proitsi</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Whiley</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Simmons</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Sattlecker</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Velayudhan</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Lupton</surname>
<given-names>M.K.</given-names>
</name>
<name>
<surname>Soininen</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Kloszewska</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Mecocci</surname>
<given-names>P.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Association of blood lipids with Alzheimer’s disease: A comprehensive lipidomics analysis</article-title>
<source/>Alzheimers Dement.
          <year>2016</year>
<volume>13</volume>
<fpage>140</fpage>
<lpage>151</lpage>
<pub-id pub-id-type="doi">10.1016/j.jalz.2016.08.003</pub-id>
<pub-id pub-id-type="pmid">27693183</pub-id>
</element-citation>
</ref>
<ref id="B100-ijms-20-05797">
<label>100.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Heude</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Ducimetiere</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Berr</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Cognitive decline and fatty acid composition of erythrocyte membranes—The EVA Study</article-title>
<source/>Am. J. Clin. Nutr.
          <year>2003</year>
<volume>77</volume>
<fpage>803</fpage>
<lpage>808</lpage>
<pub-id pub-id-type="doi">10.1093/ajcn/77.4.803</pub-id>
<pub-id pub-id-type="pmid">12663275</pub-id>
</element-citation>
</ref>
<ref id="B101-ijms-20-05797">
<label>101.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nguyen</surname>
<given-names>L.N.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Shui</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Cazenave-Gassiot</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wenk</surname>
<given-names>M.R.</given-names>
</name>
<name>
<surname>Goh</surname>
<given-names>E.L.</given-names>
</name>
<name>
<surname>Silver</surname>
<given-names>D.L.</given-names>
</name>
</person-group>
<article-title>Mfsd2a is a transporter for the essential omega-3 fatty acid docosahexaenoic acid</article-title>
<source/>Nature
          <year>2014</year>
<volume>509</volume>
<fpage>503</fpage>
<lpage>506</lpage>
<pub-id pub-id-type="doi">10.1038/nature13241</pub-id>
<pub-id pub-id-type="pmid">24828044</pub-id>
</element-citation>
</ref>
<ref id="B102-ijms-20-05797">
<label>102.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guemez-Gamboa</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Nguyen</surname>
<given-names>L.N.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zaki</surname>
<given-names>M.S.</given-names>
</name>
<name>
<surname>Kara</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ben-Omran</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Akizu</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Rosti</surname>
<given-names>R.O.</given-names>
</name>
<name>
<surname>Rosti</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Scott</surname>
<given-names>E.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Inactivating mutations in MFSD2A, required for omega-3 fatty acid transport in brain, cause a lethal microcephaly syndrome</article-title>
<source/>Nat. Genet.
          <year>2015</year>
<volume>47</volume>
<fpage>809</fpage>
<lpage>813</lpage>
<pub-id pub-id-type="doi">10.1038/ng.3311</pub-id>
<pub-id pub-id-type="pmid">26005868</pub-id>
</element-citation>
</ref>
<ref id="B103-ijms-20-05797">
<label>103.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goedecke</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Fernadnez-Hernando</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>MicroRNAs: A connection between cholesterol metabolism and neurodegeneration</article-title>
<source/>Neurobiol. Dis.
          <year>2014</year>
<volume>72</volume>
<fpage>48</fpage>
<lpage>53</lpage>
<pub-id pub-id-type="doi">10.1016/j.nbd.2014.05.034</pub-id>
<pub-id pub-id-type="pmid">24907491</pub-id>
</element-citation>
</ref>
<ref id="B104-ijms-20-05797">
<label>104.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Scheltens</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Kamphuis</surname>
<given-names>P.J.</given-names>
</name>
<name>
<surname>Verhey</surname>
<given-names>F.R.</given-names>
</name>
<name>
<surname>Olde Rikkert</surname>
<given-names>M.G.M.</given-names>
</name>
<name>
<surname>Wurtman</surname>
<given-names>R.J.</given-names>
</name>
<name>
<surname>Wilkinson</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Twisk</surname>
<given-names>J.W.R.</given-names>
</name>
<name>
<surname>Kurz</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Efficacy of a medical food in mild Alzheimer’s Disease: A randomized, controlled trial</article-title>
<source/>Alzheimer’s Dement.
          <year>2010</year>
<volume>6</volume>
<fpage>1</fpage>
<lpage>10</lpage>
<pub-id pub-id-type="doi">10.1016/j.jalz.2009.10.003</pub-id>
<pub-id pub-id-type="pmid">20129316</pub-id>
</element-citation>
</ref>
<ref id="B105-ijms-20-05797">
<label>105.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Scheltens</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Twisk</surname>
<given-names>J.W.R.</given-names>
</name>
<name>
<surname>Blesa</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Scarpini</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>von Arnim</surname>
<given-names>C.A.F.</given-names>
</name>
<name>
<surname>Bongers</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Harrison</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Swinkels</surname>
<given-names>S.H.N.</given-names>
</name>
<name>
<surname>Stam</surname>
<given-names>C.J.</given-names>
</name>
<name>
<surname>de Waal</surname>
<given-names>H.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Efficacy of Souvenaid in mild Alzheimer’s disease: Results from a randomized, controlled trial</article-title>
<source/>J. Alzheimer’s Dis.
          <year>2014</year>
<volume>31</volume>
<fpage>225</fpage>
<lpage>226</lpage>
<pub-id pub-id-type="doi">10.3233/JAD-2012-121189</pub-id>
</element-citation>
</ref>
<ref id="B106-ijms-20-05797">
<label>106.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rijpma</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Meulenbroek</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>van Hees</surname>
<given-names>A.M.J.</given-names>
</name>
<name>
<surname>Sijben</surname>
<given-names>J.W.C.</given-names>
</name>
<name>
<surname>Vellas</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Shah</surname>
<given-names>R.C.</given-names>
</name>
<name>
<surname>Bennett</surname>
<given-names>D.A.</given-names>
</name>
<name>
<surname>Scheltens</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Olde Rikkert</surname>
<given-names>M.G.M.</given-names>
</name>
</person-group>
<article-title>Effects of Souvenaid on plasma micronutiren levels and fatty acid profiles in mild and mild-to-mderate AD</article-title>
<source/>Alzheimer’s Res. Ther.
          <year>2015</year>
<volume>7</volume>
<fpage>51</fpage>
<pub-id pub-id-type="doi">10.1186/s13195-015-0134-1</pub-id>
<pub-id pub-id-type="pmid">26213579</pub-id>
</element-citation>
</ref>
<ref id="B107-ijms-20-05797">
<label>107.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Olde Rikkert</surname>
<given-names>M.G.</given-names>
</name>
<name>
<surname>Verhey</surname>
<given-names>F.R.</given-names>
</name>
<name>
<surname>Blesa</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>von Arnim</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Bongers</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Harrison</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Sijben</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Scarpini</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Vandewoude</surname>
<given-names>M.F.</given-names>
</name>
<name>
<surname>Vellas</surname>
<given-names>B.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Tolerability and safety of Souvenaid in Patients with Mild Alzheimer’s Disease: Results of multi center, 24-week, open label extension study</article-title>
<source/>J. Alzheimer’s Dis.
          <year>2015</year>
<volume>44</volume>
<fpage>471</fpage>
<lpage>480</lpage>
<pub-id pub-id-type="doi">10.3233/JAD-141305</pub-id>
<pub-id pub-id-type="pmid">25322923</pub-id>
</element-citation>
</ref>
<ref id="B108-ijms-20-05797">
<label>108.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bianchetti</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Perotta</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Cravello</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Ranieri</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Trabucchi</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Effectiveness of a specific nutritional supplement on cognitive, behavioral and functional sympotms in mild cognitive impairment and AD: caregivers’ judgements. Results of an observational survey</article-title>
<source/>JGG
          <year>2018</year>
<volume>66</volume>
<fpage>68</fpage>
<lpage>74</lpage>
</element-citation>
</ref>
<ref id="B109-ijms-20-05797">
<label>109.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yanai</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Effects of N-3 Polyunsaturated Fatty Acids on Dementia</article-title>
<source/>J. Clin. Med. Res.
          <year>2017</year>
<volume>9</volume>
<fpage>1</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="doi">10.14740/jocmr2815w</pub-id>
<pub-id pub-id-type="pmid">27924168</pub-id>
</element-citation>
</ref>
<ref id="B110-ijms-20-05797">
<label>110.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morris</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Schneider</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Tangney</surname>
<given-names>C.C.</given-names>
</name>
</person-group>
<article-title>Thoughts on B-vitamins and dementia</article-title>
<source/>J. Alzheimer’s Dis.
          <year>2006</year>
<volume>9</volume>
<fpage>429</fpage>
<lpage>433</lpage>
<pub-id pub-id-type="doi">10.3233/JAD-2006-9409</pub-id>
<pub-id pub-id-type="pmid">16917152</pub-id>
</element-citation>
</ref>
<ref id="B111-ijms-20-05797">
<label>111.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Suwa</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Yamaguchi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Komori</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kajimoto</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kino</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>The Association between Cerebral White Matter Lesions and Plasma Omega-3 to Omega-6 Polyunsaturated Fatty Acids Ratio to Cognitive Impairment Development</article-title>
<source/>Biomed Res. Int.
          <year>2015</year>
<volume>2015</volume>
<elocation-id>153437</elocation-id>
<pub-id pub-id-type="doi">10.1155/2015/153437</pub-id>
<pub-id pub-id-type="pmid">26583090</pub-id>
</element-citation>
</ref>
<ref id="B112-ijms-20-05797">
<label>112.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bowman</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Silbert</surname>
<given-names>L.C.</given-names>
</name>
<name>
<surname>Dodge</surname>
<given-names>H.H.</given-names>
</name>
<name>
<surname>Lahna</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Hagen</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Murchison</surname>
<given-names>C.F.</given-names>
</name>
<name>
<surname>Howieson</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Kaye</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Quinn</surname>
<given-names>J.F.</given-names>
</name>
<name>
<surname>Shinto</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Randomized Trial of Marine n-3 Polyunsaturated Fatty Acids for the Prevention of Cerebral Small Vessel Disease and Inflammation in Aging (PUFA Trial): Rationale, Design and Baseline Results</article-title>
<source/>Nutrients
          <year>2019</year>
<volume>11</volume>
<elocation-id>735</elocation-id>
<pub-id pub-id-type="doi">10.3390/nu11040735</pub-id>
</element-citation>
</ref>
<ref id="B113-ijms-20-05797">
<label>113.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luo</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Ren</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Yao</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>J.X.</given-names>
</name>
<name>
<surname>Wan</surname>
<given-names>J.B.</given-names>
</name>
<name>
<surname>Pei</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Su</surname>
<given-names>K.P.</given-names>
</name>
<name>
<surname>Su</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Enriched Brain Omega-3 Polyunsaturated Fatty Acids Confer Neuroprotection against Microinfarction</article-title>
<source/>EBioMedicine
          <year>2018</year>
<volume>32</volume>
<fpage>50</fpage>
<lpage>61</lpage>
<pub-id pub-id-type="doi">10.1016/j.ebiom.2018.05.028</pub-id>
<pub-id pub-id-type="pmid">29880270</pub-id>
</element-citation>
</ref>
<ref id="B114-ijms-20-05797">
<label>114.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Victor</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Adam</surname>
<given-names>R.D.</given-names>
</name>
<name>
<surname>Collins</surname>
<given-names>G.H.</given-names>
</name>
</person-group>
<source/>The Wernicke-Korsakoff Syndrome and Related Neurologic Disorders Due to Alcoholism and Malnutrition
          <edition>2nd ed.</edition>
<publisher-name>Davis Publications</publisher-name>
<publisher-loc>Philadelphia, PA, USA</publisher-loc>
<year>1989</year>
</element-citation>
</ref>
<ref id="B115-ijms-20-05797">
<label>115.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Victor</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Adams</surname>
<given-names>R.D.</given-names>
</name>
<name>
<surname>Collins</surname>
<given-names>G.H.</given-names>
</name>
</person-group>
<article-title>The Wernicke-Korsakoff syndrome. A clinical and pathological study of 245 patients, 82 with post-mortem examinations</article-title>
<source/>Contemp. Neurol. Ser.
          <year>1971</year>
<volume>7</volume>
<fpage>201</fpage>
<lpage>206</lpage>
</element-citation>
</ref>
<ref id="B116-ijms-20-05797">
<label>116.</label>
<element-citation publication-type="web">
<person-group person-group-type="author">
<collab>Alzheimer’s Society</collab>
</person-group>
<article-title>What is alcohol-related brain damage</article-title>
<source/>Factsheet 438LP
          <year>2015</year>
<comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://www.alzheimers.org.uk">https://www.alzheimers.org.uk</ext-link></comment>
<date-in-citation content-type="access-date" iso-8601-date="2019-11-15">(accessed on 15 November 2019)</date-in-citation>
</element-citation>
</ref>
<ref id="B117-ijms-20-05797">
<label>117.</label>
<element-citation publication-type="gov">
<article-title>UK Chief Medical Officers’ Alcohol Guidelines Review</article-title>
<comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/489795/summary.pdf">https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/489795/summary.pdf</ext-link></comment>
<date-in-citation content-type="access-date" iso-8601-date="2016-09-15">(accessed on 15 September 2016)</date-in-citation>
</element-citation>
</ref>
<ref id="B118-ijms-20-05797">
<label>118.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gupta</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Warner</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Alcohol-related dementia: A 21st-century silent epidemic?</article-title>
<source/>Br. J. Psychiatry
          <year>2008</year>
<volume>193</volume>
<fpage>351</fpage>
<lpage>353</lpage>
<pub-id pub-id-type="doi">10.1192/bjp.bp.108.051425</pub-id>
<pub-id pub-id-type="pmid">18978310</pub-id>
</element-citation>
</ref>
<ref id="B119-ijms-20-05797">
<label>119.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sechi</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Serra</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Wernicke’s encephalopathy: New clinical settings and recent advances in diagnosis and management</article-title>
<source/>Lancet Neurol.
          <year>2007</year>
<volume>6</volume>
<fpage>442</fpage>
<lpage>455</lpage>
<pub-id pub-id-type="doi">10.1016/S1474-4422(07)70104-7</pub-id>
<pub-id pub-id-type="pmid">17434099</pub-id>
</element-citation>
</ref>
<ref id="B120-ijms-20-05797">
<label>120.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pech</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Meyer</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Lippert</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Manger</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Stroh</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Complications, reoperations, and nutrient deficiencies two years after sleeve gastrectomy</article-title>
<source/>J. Obes.
          <year>2012</year>
<volume>2012</volume>
<elocation-id>828737</elocation-id>
<pub-id pub-id-type="doi">10.1155/2012/828737</pub-id>
<pub-id pub-id-type="pmid">22685635</pub-id>
</element-citation>
</ref>
<ref id="B121-ijms-20-05797">
<label>121.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Harper</surname>
<given-names>C.G.</given-names>
</name>
<name>
<surname>Sheedy</surname>
<given-names>D.L.</given-names>
</name>
<name>
<surname>Lara</surname>
<given-names>A.I.</given-names>
</name>
<name>
<surname>Garrick</surname>
<given-names>T.M.</given-names>
</name>
<name>
<surname>Hilton</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Raisanen</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Prevalence of Wernicke-Korsakoff syndrome in Australia: Has thiamine fortification made a difference?</article-title>
<source/>Med. J. Aust.
          <year>1998</year>
<volume>168</volume>
<fpage>542</fpage>
<lpage>545</lpage>
<pub-id pub-id-type="doi">10.5694/j.1326-5377.1998.tb139081.x</pub-id>
<pub-id pub-id-type="pmid">9640303</pub-id>
</element-citation>
</ref>
<ref id="B122-ijms-20-05797">
<label>122.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thomson</surname>
<given-names>A.D.</given-names>
</name>
</person-group>
<article-title>Mechanisms of vitamin deficiency in chronic alcohol misusers and the development of the Wernicke-Korsakoff syndrome</article-title>
<source/>Alcohol Alcohol. Oxf. Suppl.
          <year>2000</year>
<volume>35</volume>
<fpage>2</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="doi">10.1093/alcalc/35.Supplement_1.2</pub-id>
<pub-id pub-id-type="pmid">11304071</pub-id>
</element-citation>
</ref>
<ref id="B123-ijms-20-05797">
<label>123.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Majchrzak</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Singer</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Männer</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Rust</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Genser</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Wagner</surname>
<given-names>K.H.</given-names>
</name>
<name>
<surname>Elmadfa</surname>
<given-names>I.</given-names>
</name>
</person-group>
<article-title>B-vitamin status and concentrations of homocysteine in Austrian omnivores, vegetarians and vegans</article-title>
<source/>Ann. Nutr. Metab.
          <year>2006</year>
<volume>50</volume>
<fpage>485</fpage>
<lpage>491</lpage>
<pub-id pub-id-type="doi">10.1159/000095828</pub-id>
<pub-id pub-id-type="pmid">16988496</pub-id>
</element-citation>
</ref>
<ref id="B124-ijms-20-05797">
<label>124.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moretti</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Caruso</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Dal Ben</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Gazzin</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Tiribelli</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Thiamine and alcohol for brain pathology: Super-imposing or different causative factors for brain damage?</article-title>
<source/>Curr. Drug Abuse Rev.
          <year>2017</year>
<volume>10</volume>
<fpage>44</fpage>
<lpage>51</lpage>
<pub-id pub-id-type="doi">10.2174/1874473711666180402142012</pub-id>
<pub-id pub-id-type="pmid">29714153</pub-id>
</element-citation>
</ref>
<ref id="B125-ijms-20-05797">
<label>125.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Butterworth</surname>
<given-names>R.F.</given-names>
</name>
<name>
<surname>Giguère</surname>
<given-names>J.F.</given-names>
</name>
<name>
<surname>Besnard</surname>
<given-names>A.M.</given-names>
</name>
</person-group>
<article-title>Activities of thiamine-dependent enzymes in two experimental models of thiamine-deficiency encephalopathy 2 alpha-Ketoglutarate dehydrogenase</article-title>
<source/>Neurochem. Res.
          <year>1986</year>
<volume>11</volume>
<fpage>567</fpage>
<lpage>577</lpage>
<pub-id pub-id-type="doi">10.1007/BF00965326</pub-id>
<pub-id pub-id-type="pmid">3724963</pub-id>
</element-citation>
</ref>
<ref id="B126-ijms-20-05797">
<label>126.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dreyfus</surname>
<given-names>P.M.</given-names>
</name>
</person-group>
<article-title>Clinical application of blood transketolase determinations</article-title>
<source/>N. Engl. J. Med.
          <year>1962</year>
<volume>267</volume>
<fpage>596</fpage>
<lpage>598</lpage>
<pub-id pub-id-type="doi">10.1056/NEJM196209202671204</pub-id>
<pub-id pub-id-type="pmid">13887848</pub-id>
</element-citation>
</ref>
<ref id="B127-ijms-20-05797">
<label>127.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hazell</surname>
<given-names>A.S.</given-names>
</name>
<name>
<surname>Todd</surname>
<given-names>K.G.</given-names>
</name>
<name>
<surname>Butterworth</surname>
<given-names>R.F.</given-names>
</name>
</person-group>
<article-title>Mechanisms of neuronal cell death in Wernicke’s encephalopathy</article-title>
<source/>Metab. Brain Dis.
          <year>1998</year>
<volume>13</volume>
<fpage>97</fpage>
<lpage>122</lpage>
<pub-id pub-id-type="doi">10.1023/A:1020657129593</pub-id>
<pub-id pub-id-type="pmid">9699919</pub-id>
</element-citation>
</ref>
<ref id="B128-ijms-20-05797">
<label>128.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Butterworth</surname>
<given-names>R.F.</given-names>
</name>
<name>
<surname>Kril</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>Harper</surname>
<given-names>C.G.</given-names>
</name>
</person-group>
<article-title>Thiamine-dependent enzyme changes in the brains of alcoholics: Relationship to the Wernicke-Korsakoff syndrome</article-title>
<source/>Alcohol. Clin. Exp. Res.
          <year>1993</year>
<volume>17</volume>
<fpage>1084</fpage>
<lpage>1088</lpage>
<pub-id pub-id-type="doi">10.1111/j.1530-0277.1993.tb05668.x</pub-id>
<pub-id pub-id-type="pmid">8279670</pub-id>
</element-citation>
</ref>
<ref id="B129-ijms-20-05797">
<label>129.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peterson</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Héroux</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lavoie</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Butterworth</surname>
<given-names>R.F.</given-names>
</name>
</person-group>
<article-title>Loss of (3H) kainate and of NMDA-displaceable (3H)glutamate binding sites in brain in thiamine deficiency: Results of a quantitative autoradiographic study</article-title>
<source/>Neurochem. Res.
          <year>1995</year>
<volume>20</volume>
<fpage>1155</fpage>
<lpage>1160</lpage>
<pub-id pub-id-type="doi">10.1007/BF00995378</pub-id>
<pub-id pub-id-type="pmid">8746800</pub-id>
</element-citation>
</ref>
<ref id="B130-ijms-20-05797">
<label>130.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mousseau</surname>
<given-names>D.D.</given-names>
</name>
<name>
<surname>Rao</surname>
<given-names>V.L.</given-names>
</name>
<name>
<surname>Butterworth</surname>
<given-names>R.F.</given-names>
</name>
</person-group>
<article-title>Alterations in serotonin parameters in brain of thiamine-deficient rats are evident prior to the appearance of neurological symptoms</article-title>
<source/>J. Neurochem.
          <year>1996</year>
<volume>67</volume>
<fpage>1113</fpage>
<lpage>1123</lpage>
<pub-id pub-id-type="doi">10.1046/j.1471-4159.1996.67031113.x</pub-id>
<pub-id pub-id-type="pmid">8752118</pub-id>
</element-citation>
</ref>
<ref id="B131-ijms-20-05797">
<label>131.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Todd</surname>
<given-names>K.G.</given-names>
</name>
<name>
<surname>Butterworth</surname>
<given-names>R.F.</given-names>
</name>
</person-group>
<article-title>Evaluation of the role of NMDA-mediated excitotoxicity in the selective neuronal loss in experimental Wernicke encephalopathy</article-title>
<source/>Exp. Neurol.
          <year>1998</year>
<volume>149</volume>
<fpage>130</fpage>
<lpage>138</lpage>
<pub-id pub-id-type="doi">10.1006/exnr.1997.6677</pub-id>
<pub-id pub-id-type="pmid">9454622</pub-id>
</element-citation>
</ref>
<ref id="B132-ijms-20-05797">
<label>132.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jhala</surname>
<given-names>S.S.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Hazell</surname>
<given-names>A.S.</given-names>
</name>
</person-group>
<article-title>Thiamine deficiency results in release of soluble factors that disrupt mitochondrial membrane potential and downregulate the glutamate transporter splice-variant GLT-1b in cultured astrocytes</article-title>
<source/>Biochem. Biophys. Res. Commun.
          <year>2014</year>
<volume>6</volume>
<fpage>335</fpage>
<lpage>341</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbrc.2014.04.017</pub-id>
</element-citation>
</ref>
<ref id="B133-ijms-20-05797">
<label>133.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sheng</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>McFadden</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Greenberg</surname>
<given-names>M.E.</given-names>
</name>
</person-group>
<article-title>Membrane depolarization and calcium induce c-fos transcription via phosphorylation of transcription factor CREB</article-title>
<source/>Neuron
          <year>1990</year>
<volume>4</volume>
<fpage>571</fpage>
<lpage>582</lpage>
<pub-id pub-id-type="doi">10.1016/0896-6273(90)90115-V</pub-id>
<pub-id pub-id-type="pmid">2157471</pub-id>
</element-citation>
</ref>
<ref id="B134-ijms-20-05797">
<label>134.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Estus</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zaks</surname>
<given-names>W.J.</given-names>
</name>
<name>
<surname>Freeman</surname>
<given-names>R.S.</given-names>
</name>
<name>
<surname>Gruda</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Bravo</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Johnson</surname>
<given-names>E.M.</given-names>
</name>
</person-group>
<article-title>Altered gene expression in neurons during programmed cell death: Identification of c-jun as necessary for neuronal apoptosis</article-title>
<source/>J. Cell. Biol.
          <year>1994</year>
<volume>127</volume>
<fpage>1717</fpage>
<lpage>1727</lpage>
<pub-id pub-id-type="doi">10.1083/jcb.127.6.1717</pub-id>
<pub-id pub-id-type="pmid">7798322</pub-id>
</element-citation>
</ref>
<ref id="B135-ijms-20-05797">
<label>135.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guerrini</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Thomson</surname>
<given-names>A.D.</given-names>
</name>
<name>
<surname>Cook</surname>
<given-names>C.C.</given-names>
</name>
<name>
<surname>McQuillin</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Sharma</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Kopelman</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Reynolds</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Jauhar</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Harper</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Gurling</surname>
<given-names>H.M.</given-names>
</name>
</person-group>
<article-title>Direct genomic PCR sequencing of the high affinity thiamine transporter (SLC19A2) gene identifies three genetic variants in Wernicke Korsakoff syndrome (WKS)</article-title>
<source/>Am. J. Med. Genet B Neuropsychiatr. Genet.
          <year>2005</year>
<volume>137</volume>
<fpage>17</fpage>
<pub-id pub-id-type="doi">10.1002/ajmg.b.30194</pub-id>
</element-citation>
</ref>
<ref id="B136-ijms-20-05797">
<label>136.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guerrini</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Cook</surname>
<given-names>C.C.</given-names>
</name>
<name>
<surname>Kest</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Devitgh</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>McQuillin</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Curtis</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Gurling</surname>
<given-names>H.M.</given-names>
</name>
</person-group>
<article-title>Genetic linkage analysis supports the presence of two susceptibility loci for alcoholism and heavy drinking on chromosome 1p22.1-11.2 and 1q21.3-24.2</article-title>
<source/>BMC Genet.
          <year>2005</year>
<volume>6</volume>
<elocation-id>11</elocation-id>
<pub-id pub-id-type="doi">10.1186/1471-2156-6-11</pub-id>
<pub-id pub-id-type="pmid">15740611</pub-id>
</element-citation>
</ref>
<ref id="B137-ijms-20-05797">
<label>137.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guerrini</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Thomson</surname>
<given-names>A.D.</given-names>
</name>
<name>
<surname>Gurling</surname>
<given-names>H.M.</given-names>
</name>
</person-group>
<article-title>Molecular genetics of alcohol related brain damage</article-title>
<source/>Alcohol Alcohol.
          <year>2009</year>
<volume>44</volume>
<fpage>166</fpage>
<lpage>170</lpage>
<pub-id pub-id-type="doi">10.1093/alcalc/agn101</pub-id>
<pub-id pub-id-type="pmid">19096015</pub-id>
</element-citation>
</ref>
<ref id="B138-ijms-20-05797">
<label>138.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Witt</surname>
<given-names>E.D.</given-names>
</name>
<name>
<surname>Goldman-Rakic</surname>
<given-names>P.S.</given-names>
</name>
</person-group>
<article-title>Intermittent thiamine deficiency in the rhesus monkey. I. Progression of neurological signs and neuroanatomical lesions</article-title>
<source/>Ann. Neurol.
          <year>1983</year>
<volume>13</volume>
<fpage>376</fpage>
<lpage>395</lpage>
<pub-id pub-id-type="doi">10.1002/ana.410130404</pub-id>
<pub-id pub-id-type="pmid">6838173</pub-id>
</element-citation>
</ref>
<ref id="B139-ijms-20-05797">
<label>139.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Summers</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Pullan</surname>
<given-names>P.T.</given-names>
</name>
<name>
<surname>Kril</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>Harper</surname>
<given-names>C.G.</given-names>
</name>
</person-group>
<article-title>Increased central immunoreactive beta-endorphin content in patients with Wernicke-Korsakoff syndrome and in alcoholics</article-title>
<source/>J. Clin. Pathol.
          <year>1991</year>
<volume>44</volume>
<fpage>126</fpage>
<lpage>129</lpage>
<pub-id pub-id-type="doi">10.1136/jcp.44.2.126</pub-id>
<pub-id pub-id-type="pmid">1650797</pub-id>
</element-citation>
</ref>
<ref id="B140-ijms-20-05797">
<label>140.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gibson</surname>
<given-names>G.E.</given-names>
</name>
<name>
<surname>Hirsch</surname>
<given-names>J.H.</given-names>
</name>
<name>
<surname>Fonzetti</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Jordon</surname>
<given-names>B.D.</given-names>
</name>
<name>
<surname>Cirio</surname>
<given-names>R.T.</given-names>
</name>
<name>
<surname>Elder</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Vitamin B1 and dementia</article-title>
<source/>Ann. N. Y. Acad. Sci.
          <year>2016</year>
<volume>1367</volume>
<fpage>21</fpage>
<lpage>30</lpage>
<pub-id pub-id-type="doi">10.1111/nyas.13031</pub-id>
<pub-id pub-id-type="pmid">26971083</pub-id>
</element-citation>
</ref>
<ref id="B141-ijms-20-05797">
<label>141.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gold</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hauser</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Plasma thiamine deficiency associated with Alzheimer’s disease but not Parkinson’s Disease</article-title>
<source/>Met. Brain Dis.
          <year>1998</year>
<volume>13</volume>
<fpage>43</fpage>
<lpage>53</lpage>
<pub-id pub-id-type="doi">10.1023/A:1020678912330</pub-id>
<pub-id pub-id-type="pmid">9570639</pub-id>
</element-citation>
</ref>
<ref id="B142-ijms-20-05797">
<label>142.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pan</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Fei</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Pan</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Sang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>W.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Measurement of blood thiamine metabolites for Alzheimer’s Disease Diagnosis</article-title>
<source/>Ebiomedicine
          <year>2016</year>
<volume>3</volume>
<fpage>155</fpage>
<lpage>162</lpage>
<pub-id pub-id-type="doi">10.1016/j.ebiom.2015.11.039</pub-id>
<pub-id pub-id-type="pmid">26870826</pub-id>
</element-citation>
</ref>
<ref id="B143-ijms-20-05797">
<label>143.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chari</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Ali</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Gupta</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Reversible dementia in elderly: Really uncommon?</article-title>
<source/>J. Geriatr. Ment. Health
          <year>2015</year>
<volume>2</volume>
<fpage>30</fpage>
<lpage>37</lpage>
</element-citation>
</ref>
<ref id="B144-ijms-20-05797">
<label>144.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morris</surname>
<given-names>M.S.</given-names>
</name>
</person-group>
<article-title>The Role of B Vitamins in Preventing and Treating Cognitive Impairment and Decline</article-title>
<source/>Adv. Nutr.
          <year>2012</year>
<volume>3</volume>
<fpage>801</fpage>
<lpage>812</lpage>
<pub-id pub-id-type="doi">10.3945/an.112.002535</pub-id>
<pub-id pub-id-type="pmid">23153734</pub-id>
</element-citation>
</ref>
<ref id="B145-ijms-20-05797">
<label>145.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bunik</surname>
<given-names>V.I.</given-names>
</name>
</person-group>
<article-title>Thiamin-dependent enzymes: New perspectives from the interface between chemistry and biology</article-title>
<source/>FEBS J.
          <year>2013</year>
<volume>280</volume>
<fpage>6373</fpage>
<pub-id pub-id-type="doi">10.1111/febs.12589</pub-id>
<pub-id pub-id-type="pmid">24286623</pub-id>
</element-citation>
</ref>
<ref id="B146-ijms-20-05797">
<label>146.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Szutowicz</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Bielarczyk</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Jankowska-Kulawy</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Pawelczyk</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Ronowska</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Acetyl CoA, the key factor for survival or death of cholinergic neurons in course of neurodegenerative diseases</article-title>
<source/>Neurochem. Res.
          <year>2013</year>
<volume>38</volume>
<fpage>1523</fpage>
<lpage>1542</lpage>
<pub-id pub-id-type="doi">10.1007/s11064-013-1060-x</pub-id>
<pub-id pub-id-type="pmid">23677775</pub-id>
</element-citation>
</ref>
<ref id="B147-ijms-20-05797">
<label>147.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pan</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Gong</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Gu</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Lei</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>Z.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Powerful beneficial effects of benfotiamine on cognitive impairment and b-amyloid deposition in amyloid precursor protein/presenilin-1transgenic mice</article-title>
<source/>Brain
          <year>2010</year>
<volume>133</volume>
<fpage>1342</fpage>
<lpage>1352</lpage>
<pub-id pub-id-type="doi">10.1093/brain/awq069</pub-id>
<pub-id pub-id-type="pmid">20385653</pub-id>
</element-citation>
</ref>
<ref id="B148-ijms-20-05797">
<label>148.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Calingasan</surname>
<given-names>N.Y.</given-names>
</name>
<name>
<surname>Gandy</surname>
<given-names>S.E.</given-names>
</name>
<name>
<surname>Baker</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Sheu</surname>
<given-names>K.F.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>K.S.</given-names>
</name>
<name>
<surname>Wisniewski</surname>
<given-names>H.M.</given-names>
</name>
<name>
<surname>Gibson</surname>
<given-names>G.E.</given-names>
</name>
</person-group>
<article-title>Accumulation of amyloid precursor protein-like immunoreactivity in rat brain in response to thiamine deficiency</article-title>
<source/>Brain Res.
          <year>1995</year>
<volume>677</volume>
<fpage>50</fpage>
<lpage>60</lpage>
<pub-id pub-id-type="doi">10.1016/0006-8993(95)00136-E</pub-id>
<pub-id pub-id-type="pmid">7606469</pub-id>
</element-citation>
</ref>
<ref id="B149-ijms-20-05797">
<label>149.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bettendorff</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Wins</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Biological functions of thiamine derivatives: Focus on non-coenzyme roles</article-title>
<source/>Biochemistry
          <year>2013</year>
<volume>1</volume>
<fpage>10</fpage>
</element-citation>
</ref>
<ref id="B150-ijms-20-05797">
<label>150.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Parkhomenko</surname>
<given-names>Y.M.</given-names>
</name>
<name>
<surname>Pavlova</surname>
<given-names>A.S.</given-names>
</name>
<name>
<surname>Mezhenskaya</surname>
<given-names>O.A.</given-names>
</name>
</person-group>
<article-title>Mechanisms responsible for the high sensitivity of neural cells to vitamin B1 deficiency</article-title>
<source/>Neurophysiology
          <year>2016</year>
<volume>48</volume>
<fpage>429</fpage>
<lpage>448</lpage>
<pub-id pub-id-type="doi">10.1007/s11062-017-9620-3</pub-id>
</element-citation>
</ref>
<ref id="B151-ijms-20-05797">
<label>151.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mkrtchyan</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Aleshin</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Parkhomenko</surname>
<given-names>Y.M.</given-names>
</name>
<name>
<surname>Kaehne</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Disalvo</surname>
<given-names>M.L.</given-names>
</name>
<name>
<surname>Parroni</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Contestabile</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Vovk</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Bettendorf</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Bunik</surname>
<given-names>V.</given-names>
</name>
</person-group>
<article-title>Molecular mechanisms of the non-coenzyme action of thiamin in brain: Biochemical, structural and pathway analysis</article-title>
<source/>Sci. Rep.
          <year>2015</year>
<volume>27</volume>
<elocation-id>12583</elocation-id>
<pub-id pub-id-type="doi">10.1038/srep12583</pub-id>
<pub-id pub-id-type="pmid">26212886</pub-id>
</element-citation>
</ref>
<ref id="B152-ijms-20-05797">
<label>152.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Frederich</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Delvaux</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Gigliobianc</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Gangolf</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Dive</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Mazzucchelli</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>Thiaminylated adenine nucleotides. Chemical synthesis, structural characterization and natural occurrence</article-title>
<source/>FEBS J.
          <year>2009</year>
<volume>276</volume>
<fpage>3256</fpage>
<lpage>3268</lpage>
<pub-id pub-id-type="doi">10.1111/j.1742-4658.2009.07040.x</pub-id>
<pub-id pub-id-type="pmid">19438713</pub-id>
</element-citation>
</ref>
<ref id="B153-ijms-20-05797">
<label>153.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hirsch</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Parrott</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>New considerations on the neuromodulatory role of thiamine</article-title>
<source/>Pharmcology
          <year>2012</year>
<volume>89</volume>
<fpage>111</fpage>
<lpage>116</lpage>
<pub-id pub-id-type="doi">10.1159/000336339</pub-id>
<pub-id pub-id-type="pmid">22398704</pub-id>
</element-citation>
</ref>
<ref id="B154-ijms-20-05797">
<label>154.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Geng</surname>
<given-names>M.Y.</given-names>
</name>
<name>
<surname>Saito</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Katsuki</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>The effects of thiamine and oxythiamine on the survival of cultured brain neurons</article-title>
<source/>Jpn. J. Pharmacol.
          <year>1995</year>
<volume>68</volume>
<fpage>349</fpage>
<lpage>352</lpage>
<pub-id pub-id-type="doi">10.1254/jjp.68.349</pub-id>
<pub-id pub-id-type="pmid">7474559</pub-id>
</element-citation>
</ref>
<ref id="B155-ijms-20-05797">
<label>155.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Langlais</surname>
<given-names>P.J.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>S.X.</given-names>
</name>
</person-group>
<article-title>Extracellular Glutamate Is Increased in Thalamus During Thiamine Deficiency-Induced Lesions and Is Blocked by MK-801</article-title>
<source/>J. Neurochem.
          <year>1993</year>
<volume>61</volume>
<fpage>2175</fpage>
<lpage>2182</lpage>
<pub-id pub-id-type="doi">10.1111/j.1471-4159.1993.tb07457.x</pub-id>
<pub-id pub-id-type="pmid">8245970</pub-id>
</element-citation>
</ref>
<ref id="B156-ijms-20-05797">
<label>156.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hazell</surname>
<given-names>A.S.</given-names>
</name>
<name>
<surname>Butterworth</surname>
<given-names>R.F.</given-names>
</name>
<name>
<surname>Hakim</surname>
<given-names>A.M.</given-names>
</name>
</person-group>
<article-title>Cerebral vulnerability is associated with selective increase in extracellular glutamate concentration in experimental thiamine deficiency</article-title>
<source/>J. Neurochem.
          <year>1993</year>
<volume>61</volume>
<fpage>1155</fpage>
<lpage>1158</lpage>
<pub-id pub-id-type="doi">10.1111/j.1471-4159.1993.tb03635.x</pub-id>
<pub-id pub-id-type="pmid">8103080</pub-id>
</element-citation>
</ref>
<ref id="B157-ijms-20-05797">
<label>157.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chou</surname>
<given-names>W.P.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>Y.H.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>H.C.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>Y.H.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y.Y.</given-names>
</name>
<name>
<surname>Ko</surname>
<given-names>C.H.</given-names>
</name>
</person-group>
<article-title>Thiamine for preventing dementia development among patients with alcohol use disorder: A nationwide population-based cohort study</article-title>
<source/>Clin. Nutr.
          <year>2019</year>
<volume>38</volume>
<fpage>1269</fpage>
<lpage>1273</lpage>
<pub-id pub-id-type="doi">10.1016/j.clnu.2018.05.009</pub-id>
<pub-id pub-id-type="pmid">29843940</pub-id>
</element-citation>
</ref>
<ref id="B158-ijms-20-05797">
<label>158.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marashly</surname>
<given-names>E.T.</given-names>
</name>
<name>
<surname>Bohlega</surname>
<given-names>S.A.</given-names>
</name>
</person-group>
<article-title>Riboflavin has neuroprotective potential: Focus on Parkinson’s disease and migraine</article-title>
<source/>Front. Neurol.
          <year>2017</year>
<volume>8</volume>
<fpage>333</fpage>
<pub-id pub-id-type="doi">10.3389/fneur.2017.00333</pub-id>
<pub-id pub-id-type="pmid">28775706</pub-id>
</element-citation>
</ref>
<ref id="B159-ijms-20-05797">
<label>159.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thakur</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Tomar</surname>
<given-names>S.K.</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>A.K.</given-names>
</name>
<name>
<surname>Mandal</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Arora</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Riboflavin and health: A review of recent human Research</article-title>
<source/>Crit. Rev. Food Sci. Nutr.
          <year>2017</year>
<volume>57</volume>
<fpage>3650</fpage>
<lpage>3660</lpage>
<pub-id pub-id-type="doi">10.1080/10408398.2016.1145104</pub-id>
<pub-id pub-id-type="pmid">27029320</pub-id>
</element-citation>
</ref>
<ref id="B160-ijms-20-05797">
<label>160.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ashoori</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Saedisomeolia</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Riboflavin (Vitamin B2) and Oxidative Stress: A Review</article-title>
<source/>Br. J. Nutr.
          <year>2014</year>
<volume>111</volume>
<fpage>1985</fpage>
<lpage>1991</lpage>
<pub-id pub-id-type="doi">10.1017/S0007114514000178</pub-id>
<pub-id pub-id-type="pmid">24650639</pub-id>
</element-citation>
</ref>
<ref id="B161-ijms-20-05797">
<label>161.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saedisomeolia</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ashoori</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Riboflavin in Human Health: A Review of Current Evidences</article-title>
<source/>Adv. Food Nutr. Res.
          <year>2018</year>
<volume>83</volume>
<fpage>57</fpage>
<lpage>81</lpage>
<pub-id pub-id-type="doi">10.1016/bs.afnr.2017.11.002</pub-id>
<pub-id pub-id-type="pmid">29477226</pub-id>
</element-citation>
</ref>
<ref id="B162-ijms-20-05797">
<label>162.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nadh</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>To</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Christensen</surname>
<given-names>H.N.</given-names>
</name>
</person-group>
<article-title>Riboflavin Can Protect Tissue from Oxidative Injury</article-title>
<source/>Nutr. Rev.
          <year>1993</year>
<volume>51</volume>
<fpage>149</fpage>
<lpage>150</lpage>
<pub-id pub-id-type="doi">10.1111/j.1753-4887.1993.tb03092.x</pub-id>
<pub-id pub-id-type="pmid">8332286</pub-id>
</element-citation>
</ref>
<ref id="B163-ijms-20-05797">
<label>163.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sanches</surname>
<given-names>S.C.</given-names>
</name>
<name>
<surname>Ramalho</surname>
<given-names>L.N.Z.</given-names>
</name>
<name>
<surname>Mendes-Braz</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Terra</surname>
<given-names>V.A.V.A.</given-names>
</name>
<name>
<surname>Cecchini</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Augusto</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Ramalho</surname>
<given-names>F.S.</given-names>
</name>
</person-group>
<article-title>Riboflavin (Vitamin B-2) Reduces Hepatocellular Injury Following Liver Ischaemia and Reperfusion in Mice</article-title>
<source/>Food Chem. Toxicol.
          <year>2014</year>
<volume>67</volume>
<fpage>65</fpage>
<lpage>71</lpage>
<pub-id pub-id-type="doi">10.1016/j.fct.2014.02.013</pub-id>
<pub-id pub-id-type="pmid">24560968</pub-id>
</element-citation>
</ref>
<ref id="B164-ijms-20-05797">
<label>164.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Betz</surname>
<given-names>A.L.</given-names>
</name>
<name>
<surname>Ren</surname>
<given-names>X.D.</given-names>
</name>
<name>
<surname>Ennis</surname>
<given-names>S.R.</given-names>
</name>
<name>
<surname>Hultquist</surname>
<given-names>D.E.</given-names>
</name>
</person-group>
<article-title>Riboflavin Reduces Edema in Focal Cerebral Ischemia</article-title>
<source/>Brain Edema IX
          <year>1994</year>
<volume>60</volume>
<fpage>314</fpage>
<lpage>317</lpage>
</element-citation>
</ref>
<ref id="B165-ijms-20-05797">
<label>165.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peraza</surname>
<given-names>A.V.</given-names>
</name>
<name>
<surname>Guzmán</surname>
<given-names>D.C.</given-names>
</name>
<name>
<surname>Brizuela</surname>
<given-names>N.O.</given-names>
</name>
<name>
<surname>Herrera</surname>
<given-names>M.O.</given-names>
</name>
<name>
<surname>Olguín</surname>
<given-names>H.J.</given-names>
</name>
<name>
<surname>Silva</surname>
<given-names>M.L.</given-names>
</name>
<name>
<surname>Tapia</surname>
<given-names>B.J.</given-names>
</name>
<name>
<surname>Mejía</surname>
<given-names>G.B.</given-names>
</name>
</person-group>
<article-title>Riboflavin and pyridoxine restore dopamine levels and reduce oxidative stress in brain of rats</article-title>
<source/>BMC Neurosci.
          <year>2018</year>
<volume>19</volume>
<elocation-id>71</elocation-id>
<pub-id pub-id-type="doi">10.1186/s12868-018-0474-4</pub-id>
<pub-id pub-id-type="pmid">30413185</pub-id>
</element-citation>
</ref>
<ref id="B166-ijms-20-05797">
<label>166.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moat</surname>
<given-names>S.J.</given-names>
</name>
<name>
<surname>Ashfield-watt</surname>
<given-names>P.A.L.</given-names>
</name>
<name>
<surname>Powers</surname>
<given-names>H.J.</given-names>
</name>
<name>
<surname>Newcombe</surname>
<given-names>R.G.</given-names>
</name>
<name>
<surname>Mcdowell</surname>
<given-names>I.F.W.</given-names>
</name>
</person-group>
<article-title>Effect of Riboflavin Status on the Homocysteine-Lowering Effect of Folate in Relation to the MTHFR (C677T) Genotype</article-title>
<source/>Clin. Chem.
          <year>2003</year>
<volume>302</volume>
<fpage>295</fpage>
<lpage>302</lpage>
<pub-id pub-id-type="doi">10.1373/49.2.295</pub-id>
</element-citation>
</ref>
<ref id="B167-ijms-20-05797">
<label>167.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>S.J.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>W.M.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>F.L.</given-names>
</name>
<name>
<surname>Hsu</surname>
<given-names>G.S.W.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>C.Y.</given-names>
</name>
</person-group>
<article-title>Vitamin B2 Inhibits Glutamate Release from Rat Cerebrocortical Nerve Terminals</article-title>
<source/>Neuroreport
          <year>2008</year>
<volume>19</volume>
<fpage>1335</fpage>
<lpage>1338</lpage>
<pub-id pub-id-type="doi">10.1097/WNR.0b013e32830b8afa</pub-id>
<pub-id pub-id-type="pmid">18695519</pub-id>
</element-citation>
</ref>
<ref id="B168-ijms-20-05797">
<label>168.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lin</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Desbois</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Hou</surname>
<given-names>S.T.</given-names>
</name>
</person-group>
<article-title>Group B Vitamins Protect Murine Cerebellar Granule Cells from Glutamate/NMDA Toxicity</article-title>
<source/>Neuroreport
          <year>2004</year>
<volume>15</volume>
<fpage>2241</fpage>
<lpage>2244</lpage>
<pub-id pub-id-type="doi">10.1097/00001756-200410050-00020</pub-id>
<pub-id pub-id-type="pmid">15371742</pub-id>
</element-citation>
</ref>
<ref id="B169-ijms-20-05797">
<label>169.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mazur-Bialy</surname>
<given-names>A.I.</given-names>
</name>
<name>
<surname>Pocheć</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>HMGB1 Inhibition During Zymosan-Induced Inflammation: The Potential Therapeutic Action of Riboflavin</article-title>
<source/>Arch. Immunol. Ther. Exp.
          <year>2016</year>
<volume>64</volume>
<fpage>171</fpage>
<lpage>176</lpage>
<pub-id pub-id-type="doi">10.1007/s00005-015-0366-6</pub-id>
<pub-id pub-id-type="pmid">26445809</pub-id>
</element-citation>
</ref>
<ref id="B170-ijms-20-05797">
<label>170.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Porter</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Hoey</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Hughes</surname>
<given-names>C.F.</given-names>
</name>
<name>
<surname>Ward</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>McNulty</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Causes, Consequences and Public Health Implications of Low B-Vitamin Status in Ageing</article-title>
<source/>Nutrients
          <year>2016</year>
<volume>8</volume>
<elocation-id>725</elocation-id>
<pub-id pub-id-type="doi">10.3390/nu8110725</pub-id>
<pub-id pub-id-type="pmid">27854316</pub-id>
</element-citation>
</ref>
<ref id="B171-ijms-20-05797">
<label>171.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boisvert</surname>
<given-names>W.A.</given-names>
</name>
<name>
<surname>Castaneda</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Mendoza</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Langeloh</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Solomons</surname>
<given-names>N.W.</given-names>
</name>
<name>
<surname>Gershoff</surname>
<given-names>S.N.</given-names>
</name>
<name>
<surname>Russell</surname>
<given-names>R.M.</given-names>
</name>
<name>
<surname>Soloinons</surname>
<given-names>W.</given-names>
</name>
</person-group>
<article-title>Prevalence of Riboflavin Deficiency among Guatemalan Elderly People and Its Relationship to Milk Intake</article-title>
<source/>Am. J. Clin. Nutr.
          <year>1993</year>
<volume>58</volume>
<fpage>85</fpage>
<lpage>90</lpage>
<pub-id pub-id-type="doi">10.1093/ajcn/58.1.85</pub-id>
<pub-id pub-id-type="pmid">8317395</pub-id>
</element-citation>
</ref>
<ref id="B172-ijms-20-05797">
<label>172.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Essama-Tjani</surname>
<given-names>J.C.</given-names>
</name>
<name>
<surname>Guilland</surname>
<given-names>J.C.</given-names>
</name>
<name>
<surname>Fuchs</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Lombard</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Richard</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>Changes in Thiamin, Riboflavin, Niacin, Beta-Carotene, Vitamins, C, A, D and E Status of French Elderly Subjects during the First Year of Institutionalization</article-title>
<source/>Int. J. Vitam. Nutr. Res.
          <year>2000</year>
<volume>70</volume>
<fpage>54</fpage>
<lpage>64</lpage>
<pub-id pub-id-type="doi">10.1024/0300-9831.70.2.54</pub-id>
<pub-id pub-id-type="pmid">10804457</pub-id>
</element-citation>
</ref>
<ref id="B173-ijms-20-05797">
<label>173.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ter Borg</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Verlaan</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Hemsworth</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Mijnarends</surname>
<given-names>D.M.</given-names>
</name>
<name>
<surname>Schols</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Luiking</surname>
<given-names>Y.C.</given-names>
</name>
<name>
<surname>De Groot</surname>
<given-names>L.C.</given-names>
</name>
</person-group>
<article-title>Micronutrient Intakes and Potential Inadequacies of Community-Dwelling Older Adults: A Systematic Review</article-title>
<source/>Br. J. Nutr.
          <year>2015</year>
<volume>113</volume>
<fpage>1195</fpage>
<lpage>1206</lpage>
<pub-id pub-id-type="doi">10.1017/S0007114515000203</pub-id>
<pub-id pub-id-type="pmid">25822905</pub-id>
</element-citation>
</ref>
<ref id="B174-ijms-20-05797">
<label>174.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Powers</surname>
<given-names>H.J.</given-names>
</name>
</person-group>
<article-title>Riboflavin (Vitamin B-2) and Health</article-title>
<source/>Am. J. Clin. Nutr.
          <year>2003</year>
<volume>77</volume>
<fpage>1352</fpage>
<lpage>1360</lpage>
<pub-id pub-id-type="doi">10.1093/ajcn/77.6.1352</pub-id>
<pub-id pub-id-type="pmid">12791609</pub-id>
</element-citation>
</ref>
<ref id="B175-ijms-20-05797">
<label>175.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Skalka</surname>
<given-names>H.W.</given-names>
</name>
<name>
<surname>Prchal</surname>
<given-names>J.T.</given-names>
</name>
</person-group>
<article-title>Cataracts and Riboflavin Deficiency</article-title>
<source/>Am. J. Clin. Nutr.
          <year>1981</year>
<volume>34</volume>
<fpage>861</fpage>
<lpage>863</lpage>
<pub-id pub-id-type="doi">10.1093/ajcn/34.5.861</pub-id>
<pub-id pub-id-type="pmid">7234715</pub-id>
</element-citation>
</ref>
<ref id="B176-ijms-20-05797">
<label>176.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Leshner</surname>
<given-names>R.T.</given-names>
</name>
</person-group>
<article-title>Riboflavin deficiency—A reversible neurodegenerative disease</article-title>
<source/>Ann. Neurol.
          <year>1981</year>
<volume>10</volume>
<fpage>294</fpage>
<lpage>295</lpage>
</element-citation>
</ref>
<ref id="B177-ijms-20-05797">
<label>177.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Norton</surname>
<given-names>W.N.</given-names>
</name>
<name>
<surname>Daskal</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Savage</surname>
<given-names>H.E.</given-names>
</name>
<name>
<surname>Seibert</surname>
<given-names>R.A.</given-names>
</name>
<name>
<surname>Lane</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Effects of Riboflavin Deficiency on the Ultrastructure of Rat Sciatic Nerve Fibers</article-title>
<source/>Am. J. Pathol.
          <year>1976</year>
<volume>85</volume>
<fpage>651</fpage>
<lpage>660</lpage>
<pub-id pub-id-type="doi">10.3177/jnsv.22.135</pub-id>
<pub-id pub-id-type="pmid">998735</pub-id>
</element-citation>
</ref>
<ref id="B178-ijms-20-05797">
<label>178.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Manole</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Jaunmuktane</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Hargreaves</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Ludtmann</surname>
<given-names>M.H.R.</given-names>
</name>
<name>
<surname>Salpietro</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Bello</surname>
<given-names>O.D.</given-names>
</name>
<name>
<surname>Pope</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Pandraud</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Horga</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Scalco</surname>
<given-names>R.S.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Clinical, Pathological and Functional Characterization of Riboflavin-Responsive Neuropathy</article-title>
<source/>Brain
          <year>2017</year>
<volume>140</volume>
<fpage>2820</fpage>
<lpage>2837</lpage>
<pub-id pub-id-type="doi">10.1093/brain/awx231</pub-id>
<pub-id pub-id-type="pmid">29053833</pub-id>
</element-citation>
</ref>
<ref id="B179-ijms-20-05797">
<label>179.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Coimbra</surname>
<given-names>C.G.</given-names>
</name>
<name>
<surname>Junqueira</surname>
<given-names>V.B.C.</given-names>
</name>
</person-group>
<article-title>High Doses of Riboflavin and the Elimination of Dietary Red Meat Promote the Recovery of Some Motor Functions in Parkinson’s Disease Patients</article-title>
<source/>Braz. J. Med. Biol. Res.
          <year>2003</year>
<volume>36</volume>
<fpage>1409</fpage>
<lpage>1417</lpage>
<pub-id pub-id-type="doi">10.1590/S0100-879X2003001000019</pub-id>
<pub-id pub-id-type="pmid">14502375</pub-id>
</element-citation>
</ref>
<ref id="B180-ijms-20-05797">
<label>180.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thompson</surname>
<given-names>D.F.</given-names>
</name>
<name>
<surname>Saluja</surname>
<given-names>H.S.</given-names>
</name>
</person-group>
<article-title>Prophylaxis of Migraine Headaches with Riboflavin: A Systematic Review</article-title>
<source/>J. Clin. Pharm. Ther.
          <year>2017</year>
<volume>42</volume>
<fpage>394</fpage>
<lpage>403</lpage>
<pub-id pub-id-type="doi">10.1111/jcpt.12548</pub-id>
<pub-id pub-id-type="pmid">28485121</pub-id>
</element-citation>
</ref>
<ref id="B181-ijms-20-05797">
<label>181.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boehnke</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Reuter</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Flach</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Schuh-Hofer</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Einhaupl</surname>
<given-names>K.M.</given-names>
</name>
<name>
<surname>Arnold</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>High-Dose Riboflavin Treatment Is Efficacious in Migraine Prophylaxis: An Open Study in a Tertiary Care Centre</article-title>
<source/>Eur. J. Neurol.
          <year>2004</year>
<volume>11</volume>
<fpage>475</fpage>
<lpage>477</lpage>
<pub-id pub-id-type="doi">10.1111/j.1468-1331.2004.00813.x</pub-id>
<pub-id pub-id-type="pmid">15257686</pub-id>
</element-citation>
</ref>
<ref id="B182-ijms-20-05797">
<label>182.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smith</surname>
<given-names>A.D.</given-names>
</name>
<name>
<surname>Refsum</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Homocysteine, B Vitamins, and Cognitive Impairment</article-title>
<source/>Annu. Rev. Nutr.
          <year>2016</year>
<volume>36</volume>
<fpage>211</fpage>
<lpage>239</lpage>
<pub-id pub-id-type="doi">10.1146/annurev-nutr-071715-050947</pub-id>
<pub-id pub-id-type="pmid">27431367</pub-id>
</element-citation>
</ref>
<ref id="B183-ijms-20-05797">
<label>183.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hainsworth</surname>
<given-names>A.H.</given-names>
</name>
<name>
<surname>Yeo</surname>
<given-names>N.E.</given-names>
</name>
<name>
<surname>Weekman</surname>
<given-names>E.M.</given-names>
</name>
<name>
<surname>Wilcock</surname>
<given-names>D.M.</given-names>
</name>
</person-group>
<article-title>Homocysteine, Hyperhomocysteinemia and Vascular Contributions to Cognitive Impairment and Dementia (VCID)</article-title>
<source/>Biochim. Biophys. Acta
          <year>2015</year>
<volume>1862</volume>
<fpage>1008</fpage>
<lpage>1017</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbadis.2015.11.015</pub-id>
<pub-id pub-id-type="pmid">26689889</pub-id>
</element-citation>
</ref>
<ref id="B184-ijms-20-05797">
<label>184.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hustad</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ueland</surname>
<given-names>P.M.</given-names>
</name>
<name>
<surname>Vollset</surname>
<given-names>S.E.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Bjorke-Monsen</surname>
<given-names>A.L.</given-names>
</name>
<name>
<surname>Schneede</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Riboflavin as a Determinant of Plasma Total Homocysteine: Effect Modification by the Methylenetetrahydrofolate Reductase C677T Polymorphism</article-title>
<source/>Clin. Chem.
          <year>2000</year>
<volume>46</volume>
<fpage>1065</fpage>
<lpage>1071</lpage>
<pub-id pub-id-type="pmid">10926884</pub-id>
</element-citation>
</ref>
<ref id="B185-ijms-20-05797">
<label>185.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Udhayabanu</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Manole</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Rajeshwari</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Varalakshmi</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Houlden</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ashokkumar</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>Riboflavin Responsive Mitochondrial Dysfunction in Neurodegenerative Diseases</article-title>
<source/>J. Clin. Med.
          <year>2017</year>
<volume>6</volume>
<elocation-id>52</elocation-id>
<pub-id pub-id-type="doi">10.3390/jcm6050052</pub-id>
</element-citation>
</ref>
<ref id="B186-ijms-20-05797">
<label>186.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xiu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Wahlqvist</surname>
<given-names>M.L.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>R.C.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>Low and High Homocysteine Are Associated with Mortality Independent of B Group Vitamins but Interactive with Cognitive Status in a Free-Living Elderly Cohort</article-title>
<source/>Nutr. Res.
          <year>2012</year>
<volume>32</volume>
<fpage>928</fpage>
<lpage>939</lpage>
<pub-id pub-id-type="doi">10.1016/j.nutres.2012.09.005</pub-id>
<pub-id pub-id-type="pmid">23244538</pub-id>
</element-citation>
</ref>
<ref id="B187-ijms-20-05797">
<label>187.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McNeill</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Jia</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Whalley</surname>
<given-names>L.J.</given-names>
</name>
<name>
<surname>Fox</surname>
<given-names>H.C.</given-names>
</name>
<name>
<surname>Corley</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Gow</surname>
<given-names>A.J.</given-names>
</name>
<name>
<surname>Brett</surname>
<given-names>C.E.</given-names>
</name>
<name>
<surname>Starr</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Deary</surname>
<given-names>I.J.</given-names>
</name>
</person-group>
<article-title>Antioxidant and B Vitamin Intake in Relation to Cognitive Function in Later Life in the Lothian Birth Cohort 1936</article-title>
<source/>Eur. J. Clin. Nutr.
          <year>2011</year>
<volume>65</volume>
<fpage>619</fpage>
<lpage>626</lpage>
<pub-id pub-id-type="doi">10.1038/ejcn.2011.2</pub-id>
<pub-id pub-id-type="pmid">21346712</pub-id>
</element-citation>
</ref>
<ref id="B188-ijms-20-05797">
<label>188.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Jang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>S.Y.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>N.</given-names>
</name>
</person-group>
<article-title>Association between Intake of B Vitamins and Cognitive Function in Elderly Koreans with Cognitive Impairment</article-title>
<source/>Nutr. J.
          <year>2014</year>
<volume>13</volume>
<fpage>118</fpage>
<pub-id pub-id-type="doi">10.1186/1475-2891-13-118</pub-id>
<pub-id pub-id-type="pmid">25516359</pub-id>
</element-citation>
</ref>
<ref id="B189-ijms-20-05797">
<label>189.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>S.A.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>H.O.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>B.H.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>J.S.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>J.H.</given-names>
</name>
<name>
<surname>Jung</surname>
<given-names>I.K.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>Y.J.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>J.E.</given-names>
</name>
</person-group>
<article-title>Relationships between Dietary Intake and Cognitive Function Level in Korean Elderly People</article-title>
<source/>Public Health
          <year>2001</year>
<volume>115</volume>
<fpage>133</fpage>
<lpage>138</lpage>
<pub-id pub-id-type="doi">10.1016/S0033-3506(01)00432-2</pub-id>
<pub-id pub-id-type="pmid">11406779</pub-id>
</element-citation>
</ref>
<ref id="B190-ijms-20-05797">
<label>190.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cunha</surname>
<given-names>N.M.D.</given-names>
</name>
<name>
<surname>Georgousopoulou</surname>
<given-names>E.N.</given-names>
</name>
<name>
<surname>Boyd</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Sturm</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Brien</surname>
<given-names>B.O.</given-names>
</name>
<name>
<surname>Lucock</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Mckune</surname>
<given-names>A.J.</given-names>
</name>
<name>
<surname>Mellor</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Roach</surname>
<given-names>P.D.</given-names>
</name>
<name>
<surname>Naumovski</surname>
<given-names>N.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Relationship Between B-Vitamin Biomarkers and Dietary Intake with Apolipoprotein E Є4 in Alzheimer’s Disease Dietary Intake with Apolipoprotein E ¾ 4 in</article-title>
<source/>J. Nutr. Gerontol. Geriatr.
          <year>2019</year>
<volume>38</volume>
<fpage>173</fpage>
<lpage>195</lpage>
<pub-id pub-id-type="doi">10.1080/21551197.2019.1590287</pub-id>
</element-citation>
</ref>
<ref id="B191-ijms-20-05797">
<label>191.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tucker</surname>
<given-names>D.M.</given-names>
</name>
<name>
<surname>Penland</surname>
<given-names>J.G.</given-names>
</name>
<name>
<surname>Sandstead</surname>
<given-names>H.H.</given-names>
</name>
<name>
<surname>Milne</surname>
<given-names>D.B.</given-names>
</name>
<name>
<surname>Heck</surname>
<given-names>D.G.</given-names>
</name>
<name>
<surname>Klevay</surname>
<given-names>L.M.</given-names>
</name>
<name>
<surname>Tucker</surname>
<given-names>D.M.</given-names>
</name>
<name>
<surname>Pen</surname>
<given-names>J.G.</given-names>
</name>
<name>
<surname>Heck</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Klevay</surname>
<given-names>L.M.</given-names>
</name>
</person-group>
<article-title>Nutrition Status and Brain Function in Aging</article-title>
<source/>Am. J. Clin. Nutr.
          <year>1990</year>
<volume>52</volume>
<fpage>93</fpage>
<lpage>102</lpage>
<pub-id pub-id-type="doi">10.1093/ajcn/52.1.93</pub-id>
<pub-id pub-id-type="pmid">2360555</pub-id>
</element-citation>
</ref>
<ref id="B192-ijms-20-05797">
<label>192.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ortega</surname>
<given-names>R.M.</given-names>
</name>
<name>
<surname>Requejo</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Andrés</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Sobaler</surname>
<given-names>A.M.L.</given-names>
</name>
<name>
<surname>Quintas</surname>
<given-names>M.E.</given-names>
</name>
<name>
<surname>Redondo</surname>
<given-names>M.R.</given-names>
</name>
<name>
<surname>Navia</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Rivas</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Dietary Intake and Cognitive Function in A Group of Elderly People</article-title>
<source/>Am. J. Clin. Nutr.
          <year>1997</year>
<volume>66</volume>
<fpage>803</fpage>
<lpage>809</lpage>
<pub-id pub-id-type="doi">10.1093/ajcn/66.4.803</pub-id>
<pub-id pub-id-type="pmid">9322553</pub-id>
</element-citation>
</ref>
<ref id="B193-ijms-20-05797">
<label>193.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lubitz</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Ricny</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Atrakchi-Baranes</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Shemesh</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Kravitz</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Liraz-zaltsman</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Maksin-matveev</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Cooper</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Leibowitz</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Uribarri</surname>
<given-names>J.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>High Dietary Advanced Glycation End Products Are Associated with Poorer Spatial Learning and Accelerated Aβ Deposition in an Alzheimer Mouse Model</article-title>
<source/>Aging Cell
          <year>2016</year>
<volume>15</volume>
<fpage>309</fpage>
<lpage>316</lpage>
<pub-id pub-id-type="doi">10.1111/acel.12436</pub-id>
<pub-id pub-id-type="pmid">26781037</pub-id>
</element-citation>
</ref>
<ref id="B194-ijms-20-05797">
<label>194.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jacques</surname>
<given-names>P.F.</given-names>
</name>
<name>
<surname>Kalmbach</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Bagley</surname>
<given-names>P.J.</given-names>
</name>
<name>
<surname>Russo</surname>
<given-names>G.T.</given-names>
</name>
<name>
<surname>Rogers</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Wilson</surname>
<given-names>P.W.F.</given-names>
</name>
<name>
<surname>Rosenberg</surname>
<given-names>I.H.</given-names>
</name>
<name>
<surname>Selhub</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>The Relationship between Riboflavin and Plasma Total Homocysteine in the Framingham Offspring Cohort Is Influenced by Folate Status and the C677T Transition in the Methylenetetrahydrofolate Reductase Gene</article-title>
<source/>J. Nutr.
          <year>2002</year>
<volume>132</volume>
<fpage>283</fpage>
<lpage>288</lpage>
<pub-id pub-id-type="doi">10.1093/jn/132.2.283</pub-id>
<pub-id pub-id-type="pmid">11823591</pub-id>
</element-citation>
</ref>
<ref id="B195-ijms-20-05797">
<label>195.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mikkelsen</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Apostolopoulos</surname>
<given-names>V.</given-names>
</name>
</person-group>
<article-title>B Vitamins and Ageing</article-title>
<source/>Subcell. Biochem.
          <year>2018</year>
<volume>90</volume>
<fpage>451</fpage>
<lpage>470</lpage>
<pub-id pub-id-type="doi">10.1007/978-981-13-2835-0_15</pub-id>
<pub-id pub-id-type="pmid">30779018</pub-id>
</element-citation>
</ref>
<ref id="B196-ijms-20-05797">
<label>196.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pantoni</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Cerebral Small Vessel Disease: From Pathogenesis and Clinical Characteristics to Therapeutic Challenges</article-title>
<source/>Lancet Neurol.
          <year>2010</year>
<volume>9</volume>
<fpage>689</fpage>
<lpage>701</lpage>
<pub-id pub-id-type="doi">10.1016/S1474-4422(10)70104-6</pub-id>
<pub-id pub-id-type="pmid">20610345</pub-id>
</element-citation>
</ref>
<ref id="B197-ijms-20-05797">
<label>197.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yin</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Sancheti</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Patil</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Cadenas</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Energy Metabolism and Inflammation in Brain Aging and Alzheimer’s Disease</article-title>
<source/>Free Radic. Biol. Med.
          <year>2016</year>
<volume>100</volume>
<fpage>108</fpage>
<lpage>122</lpage>
<pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2016.04.200</pub-id>
<pub-id pub-id-type="pmid">27154981</pub-id>
</element-citation>
</ref>
<ref id="B198-ijms-20-05797">
<label>198.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Makarov</surname>
<given-names>M.V.</given-names>
</name>
<name>
<surname>Trammell</surname>
<given-names>S.A.J.</given-names>
</name>
<name>
<surname>Migaud</surname>
<given-names>M.E.</given-names>
</name>
</person-group>
<article-title>The Chemistry of the Vitamin B3 Metabolome</article-title>
<source/>Biochem. Soc. Trans.
          <year>2019</year>
<volume>47</volume>
<fpage>131</fpage>
<lpage>147</lpage>
<pub-id pub-id-type="doi">10.1042/BST20180420</pub-id>
<pub-id pub-id-type="pmid">30559273</pub-id>
</element-citation>
</ref>
<ref id="B199-ijms-20-05797">
<label>199.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kirkland</surname>
<given-names>J.B.</given-names>
</name>
<name>
<surname>Meyer-Ficca</surname>
<given-names>M.L.</given-names>
</name>
</person-group>
<article-title>Niacin</article-title>
<source/>Adv. Food Nutr. Res.
          <year>2018</year>
<volume>83</volume>
<fpage>83</fpage>
<lpage>149</lpage>
<pub-id pub-id-type="doi">10.1016/bs.afnr.2017.11.003</pub-id>
<pub-id pub-id-type="pmid">29477227</pub-id>
</element-citation>
</ref>
<ref id="B200-ijms-20-05797">
<label>200.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Chong</surname>
<given-names>Z.Z.</given-names>
</name>
<name>
<surname>Maiese</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Navigating novel mechanisms of cellular plasticity with the nad+ precursor and nutrient nicotinamide</article-title>
<source/>Front. Biosci.
          <year>2004</year>
<volume>9</volume>
<fpage>2500</fpage>
<lpage>2520</lpage>
<pub-id pub-id-type="doi">10.2741/1412</pub-id>
<pub-id pub-id-type="pmid">15353303</pub-id>
</element-citation>
</ref>
<ref id="B201-ijms-20-05797">
<label>201.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kennedy</surname>
<given-names>D.O.</given-names>
</name>
</person-group>
<article-title>B Vitamins and the Brain: Mechanisms, Dose and Efficacy—A Review</article-title>
<source/>Nutrients
          <year>2016</year>
<volume>8</volume>
<elocation-id>68</elocation-id>
<pub-id pub-id-type="doi">10.3390/nu8020068</pub-id>
<pub-id pub-id-type="pmid">26828517</pub-id>
</element-citation>
</ref>
<ref id="B202-ijms-20-05797">
<label>202.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sharma</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Sannegowda</surname>
<given-names>R.B.</given-names>
</name>
<name>
<surname>Jain</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Dubey</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Prakash</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>A rare case of alcoholic pellagra encephalopathy with startle myoclonus and marked response to niacin therapy: Time for a new dictum?</article-title>
<source/>BMJ Case Rep.
          <year>2013</year>
<pub-id pub-id-type="doi">10.1136/bcr-2013-008906</pub-id>
</element-citation>
</ref>
<ref id="B203-ijms-20-05797">
<label>203.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>S.W.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>J.H.</given-names>
</name>
<name>
<surname>Moon</surname>
<given-names>J.H.</given-names>
</name>
<name>
<surname>Nazim</surname>
<given-names>U.M.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>Y.J.</given-names>
</name>
<name>
<surname>Seol</surname>
<given-names>J.W.</given-names>
</name>
<name>
<surname>Hur</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Eo</surname>
<given-names>S.K.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>J.H.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>S.Y.</given-names>
</name>
</person-group>
<article-title>Niacin alleviates TRAIL-mediated colon cancer cell death via autophagy flux activation</article-title>
<source/>Oncotarget
          <year>2016</year>
<volume>7</volume>
<fpage>4356</fpage>
<lpage>4368</lpage>
<pub-id pub-id-type="doi">10.18632/oncotarget.5374</pub-id>
<pub-id pub-id-type="pmid">26517672</pub-id>
</element-citation>
</ref>
<ref id="B204-ijms-20-05797">
<label>204.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kelley</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Niacin and niacinamide accumulation by rabbit brain slices and choroid plexus</article-title>
<source/>J. Neurochem.
          <year>1979</year>
<volume>33</volume>
<fpage>291</fpage>
<lpage>298</lpage>
<pub-id pub-id-type="pmid">156782</pub-id>
</element-citation>
</ref>
<ref id="B205-ijms-20-05797">
<label>205.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Murthy</surname>
<given-names>M.R.</given-names>
</name>
<name>
<surname>Rappoport</surname>
<given-names>D.A.</given-names>
</name>
</person-group>
<article-title>Biochemistry of the developing rat brain. Iv. Effect of nicotinamide on brain and liver mitochondria</article-title>
<source/>Biochim. Biophys. Acta
          <year>1963</year>
<volume>78</volume>
<fpage>71</fpage>
<lpage>76</lpage>
<pub-id pub-id-type="doi">10.1016/0006-3002(63)91610-X</pub-id>
<pub-id pub-id-type="pmid">14098185</pub-id>
</element-citation>
</ref>
<ref id="B206-ijms-20-05797">
<label>206.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Deguchi</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Ichiyama</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Nishizuka</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Hayaishi</surname>
<given-names>O.</given-names>
</name>
</person-group>
<article-title>Studies on the biosynthesis of nicotinamide-adenine dinucleotide in the brain</article-title>
<source/>Biochim. Biophys. Acta
          <year>1968</year>
<volume>158</volume>
<fpage>382</fpage>
<lpage>393</lpage>
<pub-id pub-id-type="doi">10.1016/0304-4165(68)90292-4</pub-id>
<pub-id pub-id-type="pmid">4298234</pub-id>
</element-citation>
</ref>
<ref id="B207-ijms-20-05797">
<label>207.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maiese</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Chong</surname>
<given-names>Z.Z.</given-names>
</name>
</person-group>
<article-title>Nicotinamide: Necessary Nutrient Emerges as a Novel Cytoprotectant for the Brain</article-title>
<source/>Trends Pharmacol. Sci.
          <year>2003</year>
<volume>24</volume>
<fpage>228</fpage>
<lpage>232</lpage>
<pub-id pub-id-type="doi">10.1016/S0165-6147(03)00078-6</pub-id>
<pub-id pub-id-type="pmid">12767721</pub-id>
</element-citation>
</ref>
<ref id="B208-ijms-20-05797">
<label>208.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Park</surname>
<given-names>J.H.</given-names>
</name>
<name>
<surname>Long</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Owens</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Kristian</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Nicotinamide Mononucleotide Inhibits Post-Ischemic NAD+ Degradation and Dramatically Ameliorates Brain Damage Following Global Cerebral Ischemia</article-title>
<source/>Neurobiol. Dis.
          <year>2016</year>
<volume>95</volume>
<fpage>102</fpage>
<lpage>110</lpage>
<pub-id pub-id-type="doi">10.1016/j.nbd.2016.07.018</pub-id>
<pub-id pub-id-type="pmid">27425894</pub-id>
</element-citation>
</ref>
<ref id="B209-ijms-20-05797">
<label>209.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Klaidman</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Morales</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kem</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Adams</surname>
<given-names>J.D.</given-names>
</name>
</person-group>
<article-title>Nicotinamide Offers Multiple Protective Mechanisms in Stroke as a Precursor for NAD+, as a PARP Inhibitor and by Partial Restoration of Mitochondrial Function</article-title>
<source/>Pharmacology
          <year>2003</year>
<volume>69</volume>
<fpage>150</fpage>
<lpage>157</lpage>
<pub-id pub-id-type="doi">10.1159/000072668</pub-id>
<pub-id pub-id-type="pmid">14512702</pub-id>
</element-citation>
</ref>
<ref id="B210-ijms-20-05797">
<label>210.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sadanaga-Akiyoshi</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Yao</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Tanuma</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Nakahara</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Hong</surname>
<given-names>J.S.</given-names>
</name>
<name>
<surname>Ibayashi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Uchimura</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Fujishima</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Nicotinamide Attenuates Focal Ischemic Brain Injury in Rats: With Special Reference to Changes in Nicotinamide and NAD+ Levels in Ischemic Core and Penumbra</article-title>
<source/>Neurochem. Res.
          <year>2003</year>
<volume>28</volume>
<fpage>1227</fpage>
<lpage>1234</lpage>
<pub-id pub-id-type="doi">10.1023/A:1024236614015</pub-id>
<pub-id pub-id-type="pmid">12834263</pub-id>
</element-citation>
</ref>
<ref id="B211-ijms-20-05797">
<label>211.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Maynard</surname>
<given-names>K.I.</given-names>
</name>
</person-group>
<article-title>Delayed Treatment with Nicotinamide Inhibits Brain Energy Depletion, Improves Cerebral Microperfusion, Reduces Brain Infarct Volume, but Does Not Alter Neurobehavioral Outcome Following Permanent Focal Cerebral Ischemia in Sprague Dawley Rats</article-title>
<source/>Curr. Nurovasc. Res.
          <year>2006</year>
<volume>3</volume>
<fpage>203</fpage>
<lpage>213</lpage>
<pub-id pub-id-type="doi">10.2174/156720206778018749</pub-id>
<pub-id pub-id-type="pmid">16918384</pub-id>
</element-citation>
</ref>
<ref id="B212-ijms-20-05797">
<label>212.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Klaidman</surname>
<given-names>L.K.</given-names>
</name>
<name>
<surname>Ling</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kem</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sugawara</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Chan</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Adams</surname>
<given-names>J.D.</given-names>
</name>
</person-group>
<article-title>Nicotinamide Therapy Protects against Both Necrosis and Apoptosis in a Stroke Model</article-title>
<source/>Pharmacol. Biochem. Behav.
          <year>2002</year>
<volume>73</volume>
<fpage>901</fpage>
<lpage>910</lpage>
<pub-id pub-id-type="doi">10.1016/S0091-3057(02)00939-5</pub-id>
<pub-id pub-id-type="pmid">12213537</pub-id>
</element-citation>
</ref>
<ref id="B213-ijms-20-05797">
<label>213.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Klaidman</surname>
<given-names>L.K.</given-names>
</name>
<name>
<surname>Nalbandian</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Oliver</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>M.L.</given-names>
</name>
<name>
<surname>Chan</surname>
<given-names>P.H.</given-names>
</name>
<name>
<surname>Adams</surname>
<given-names>J.D.</given-names>
</name>
</person-group>
<article-title>The effects of nicotinamide on energy metabolism following transient focal cerebral ischemia in Wistar rats</article-title>
<source/>Neurosci. Lett.
          <year>2002</year>
<volume>333</volume>
<fpage>91</fpage>
<lpage>94</lpage>
<pub-id pub-id-type="doi">10.1016/S0304-3940(02)01005-4</pub-id>
<pub-id pub-id-type="pmid">12419488</pub-id>
</element-citation>
</ref>
<ref id="B214-ijms-20-05797">
<label>214.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoane</surname>
<given-names>M.R.</given-names>
</name>
<name>
<surname>Akstulewicz</surname>
<given-names>S.L.</given-names>
</name>
<name>
<surname>Toppen</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Treatment with Vitamin B 3 Improves Functional Recovery and Reduces GFAP Expression Following Traumatic Brain Injury in Rats</article-title>
<source/>J. Neurotrauma
          <year>2003</year>
<volume>20</volume>
<fpage>1189</fpage>
<lpage>1199</lpage>
<pub-id pub-id-type="doi">10.1089/089771503770802871</pub-id>
<pub-id pub-id-type="pmid">14651806</pub-id>
</element-citation>
</ref>
<ref id="B215-ijms-20-05797">
<label>215.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shear</surname>
<given-names>D.A.</given-names>
</name>
<name>
<surname>Dixon</surname>
<given-names>C.E.</given-names>
</name>
<name>
<surname>Bramlett</surname>
<given-names>H.M.</given-names>
</name>
<name>
<surname>Mondello</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Dietrich</surname>
<given-names>W.D.</given-names>
</name>
<name>
<surname>Deng-Bryant</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Schmid</surname>
<given-names>K.E.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>K.K.W.</given-names>
</name>
<name>
<surname>Hayes</surname>
<given-names>R.L.</given-names>
</name>
<name>
<surname>Povlishock</surname>
<given-names>J.T.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Nicotinamide Treatment in Traumatic Brain Injury: Operation Brain Trauma Therapy</article-title>
<source/>J. Neurotrauma
          <year>2015</year>
<volume>33</volume>
<fpage>523</fpage>
<lpage>537</lpage>
<pub-id pub-id-type="doi">10.1089/neu.2015.4115</pub-id>
</element-citation>
</ref>
<ref id="B216-ijms-20-05797">
<label>216.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoane</surname>
<given-names>M.R.</given-names>
</name>
<name>
<surname>Gilbert</surname>
<given-names>D.R.</given-names>
</name>
<name>
<surname>Holland</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Pierce</surname>
<given-names>J.L.</given-names>
</name>
</person-group>
<article-title>Nicotinamide Reduces Acute Cortical Neuronal Death and Edema in the Traumatically Injured Brain</article-title>
<source/>Neurosci. Lett.
          <year>2006</year>
<volume>408</volume>
<fpage>35</fpage>
<lpage>39</lpage>
<pub-id pub-id-type="doi">10.1016/j.neulet.2006.07.011</pub-id>
<pub-id pub-id-type="pmid">16987607</pub-id>
</element-citation>
</ref>
<ref id="B217-ijms-20-05797">
<label>217.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goffus</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Anderson</surname>
<given-names>G.D.</given-names>
</name>
<name>
<surname>Hoane</surname>
<given-names>M.R.</given-names>
</name>
</person-group>
<article-title>Sustained Delivery of Nicotinamide Limits Cortical Injury and Improves Functional Recovery Following Traumatic Brain Injury</article-title>
<source/>Oxidative Med. Cell. Longev.
          <year>2010</year>
<volume>3</volume>
<fpage>145</fpage>
<lpage>152</lpage>
<pub-id pub-id-type="doi">10.4161/oxim.3.2.11315</pub-id>
</element-citation>
</ref>
<ref id="B218-ijms-20-05797">
<label>218.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Haar</surname>
<given-names>C.V.</given-names>
</name>
<name>
<surname>Anderson</surname>
<given-names>G.D.</given-names>
</name>
<name>
<surname>Hoane</surname>
<given-names>M.R.</given-names>
</name>
</person-group>
<article-title>Continuous Nicotinamide Administration Improves Behavioral Recovery and Reduces Lesion Size Following Bilateral Frontal Controlled Cortical Impact Injury</article-title>
<source/>Behav. Brain Res.
          <year>2011</year>
<volume>224</volume>
<fpage>311</fpage>
<lpage>317</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbr.2011.06.009</pub-id>
<pub-id pub-id-type="pmid">21704653</pub-id>
</element-citation>
</ref>
<ref id="B219-ijms-20-05797">
<label>219.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Klaidman</surname>
<given-names>L.K.</given-names>
</name>
<name>
<surname>Mukherjee</surname>
<given-names>S.K.</given-names>
</name>
<name>
<surname>Adams</surname>
<given-names>J.D.</given-names>
<suffix>Jr.</suffix>
</name>
</person-group>
<article-title>Oxidative Changes in Brain Pyridine Nucleotides and Neuroprotection Using Nicotinamide</article-title>
<source/>Biochim. Biophys. Acta
          <year>2001</year>
<volume>1525</volume>
<fpage>136</fpage>
<lpage>148</lpage>
<pub-id pub-id-type="doi">10.1016/S0304-4165(00)00181-1</pub-id>
<pub-id pub-id-type="pmid">11342263</pub-id>
</element-citation>
</ref>
<ref id="B220-ijms-20-05797">
<label>220.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kamat</surname>
<given-names>J.P.</given-names>
</name>
<name>
<surname>Devasagayam</surname>
<given-names>T.P.A.</given-names>
</name>
</person-group>
<article-title>Nicotinamide (Vitamin B 3) as an Effective Antioxidant against Oxidative Damage in Rat Brain Mitochondria</article-title>
<source/>Redox Rep.
          <year>1999</year>
<volume>4</volume>
<fpage>179</fpage>
<lpage>184</lpage>
<pub-id pub-id-type="doi">10.1179/135100099101534882</pub-id>
<pub-id pub-id-type="pmid">10658823</pub-id>
</element-citation>
</ref>
<ref id="B221-ijms-20-05797">
<label>221.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shetty</surname>
<given-names>P.K.</given-names>
</name>
<name>
<surname>Galef</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Turner</surname>
<given-names>D.A.</given-names>
</name>
</person-group>
<article-title>Neurobiology of Disease Nicotinamide Pre-Treatment Ameliorates NAD (H) Hyperoxidation and Improves Neuronal Function after Severe Hypoxia</article-title>
<source/>Neurobiol. Dis.
          <year>2014</year>
<volume>62</volume>
<fpage>469</fpage>
<lpage>478</lpage>
<pub-id pub-id-type="doi">10.1016/j.nbd.2013.10.025</pub-id>
<pub-id pub-id-type="pmid">24184921</pub-id>
</element-citation>
</ref>
<ref id="B222-ijms-20-05797">
<label>222.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Suzuki</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Okuda</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Nishida</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Fujimoto</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Nagasawa</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Protective Effect of Nicotinamide against Poly (ADP-Ribose) Polymerase-1-Mediated Astrocyte Death Depends on Its Transporter-Mediated Uptake</article-title>
<source/>Life Sci.
          <year>2010</year>
<volume>86</volume>
<fpage>676</fpage>
<lpage>682</lpage>
<pub-id pub-id-type="doi">10.1016/j.lfs.2010.02.019</pub-id>
<pub-id pub-id-type="pmid">20188745</pub-id>
</element-citation>
</ref>
<ref id="B223-ijms-20-05797">
<label>223.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ungerstedt</surname>
<given-names>J.S.</given-names>
</name>
<name>
<surname>Blombäck</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Södeström</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Nicotinamide Is a Potent Inhibitor of Proinflammatory Cytokines</article-title>
<source/>Clin. Exp. Immunol.
          <year>2003</year>
<volume>6</volume>
<fpage>48</fpage>
<lpage>52</lpage>
<pub-id pub-id-type="doi">10.1046/j.1365-2249.2003.02031.x</pub-id>
</element-citation>
</ref>
<ref id="B224-ijms-20-05797">
<label>224.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vaur</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Brugg</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Mericskay</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Schmidt</surname>
<given-names>M.S.</given-names>
</name>
<name>
<surname>Vivien</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Orset</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Jacotot</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Brenner</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Duplus</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Nicotinamide Riboside, a Form of Vitamin B3, Protects against Excitotoxicity-Induced Axonal Degeneration</article-title>
<source/>FASEB J.
          <year>2017</year>
<volume>31</volume>
<fpage>5440</fpage>
<lpage>5452</lpage>
<pub-id pub-id-type="doi">10.1096/fj.201700221RR</pub-id>
<pub-id pub-id-type="pmid">28842432</pub-id>
</element-citation>
</ref>
<ref id="B225-ijms-20-05797">
<label>225.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gasperi</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Sibilano</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Savini</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Catani</surname>
<given-names>M.V.</given-names>
</name>
</person-group>
<article-title>Niacin in the Central Nervous System: An Update of Biological Aspects and Clinical Applications</article-title>
<source/>Int. J. Mol. Sci.
          <year>2019</year>
<volume>20</volume>
<elocation-id>974</elocation-id>
<pub-id pub-id-type="doi">10.3390/ijms20040974</pub-id>
</element-citation>
</ref>
<ref id="B226-ijms-20-05797">
<label>226.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hathorn</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Synder-Keller</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Messer</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Nicotinamide Improves Motor Deficits and Upregulates PGC-1α and BDNF Gene Expression in a Mouse Model of Huntington’s Disease</article-title>
<source/>Neurobiol. Disord.
          <year>2011</year>
<volume>41</volume>
<fpage>43</fpage>
<lpage>50</lpage>
<pub-id pub-id-type="doi">10.1016/j.nbd.2010.08.017</pub-id>
</element-citation>
</ref>
<ref id="B227-ijms-20-05797">
<label>227.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fukushima</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kaetsu</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Lim</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Moriyama</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Possible Role of 1-Methylnicotinamide in the Pathogenesis of Parkinson’s Disease</article-title>
<source/>Exp. Toxic Pathol.
          <year>2001</year>
<volume>43</volume>
<fpage>469</fpage>
<lpage>473</lpage>
<pub-id pub-id-type="doi">10.1078/0940-2993-00214</pub-id>
</element-citation>
</ref>
<ref id="B228-ijms-20-05797">
<label>228.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gong</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Pan</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Vempati</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Knable</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Ho</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Sastre</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ono</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Sauve</surname>
<given-names>A.A.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Nicotinamide Riboside Restores Cognition through an Upregulation of Proliferator-Activated Receptor-g Coactivator 1 a Regulated b -Secretase 1 Degradation and Mitochondrial Gene Expression in Alzheimer’s Mouse Models</article-title>
<source/>Neurobiol. Aging
          <year>2013</year>
<volume>34</volume>
<fpage>1581</fpage>
<lpage>1588</lpage>
<pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2012.12.005</pub-id>
<pub-id pub-id-type="pmid">23312803</pub-id>
</element-citation>
</ref>
<ref id="B229-ijms-20-05797">
<label>229.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fricker</surname>
<given-names>R.A.</given-names>
</name>
<name>
<surname>Green</surname>
<given-names>E.L.</given-names>
</name>
<name>
<surname>Jenkins</surname>
<given-names>S.I.</given-names>
</name>
<name>
<surname>Griffin</surname>
<given-names>S.M.</given-names>
</name>
</person-group>
<article-title>The Influence of Nicotinamide on Health and Disease in the Central Nervous System</article-title>
<source/>Int. J. Tryptophan. Res.
          <year>2018</year>
<volume>11</volume>
<pub-id pub-id-type="doi">10.1177/1178646918776658</pub-id>
<pub-id pub-id-type="pmid">29844677</pub-id>
</element-citation>
</ref>
<ref id="B230-ijms-20-05797">
<label>230.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wakade</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Chong</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Bradley</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Morgan</surname>
<given-names>J.C.</given-names>
</name>
</person-group>
<article-title>Low-Dose Niacin Supplementation Modulates GPR109A, Niacin Index and Ameliorates Parkinson’s Disease Symptoms without Side Effects</article-title>
<source/>Clin. Case Rep.
          <year>2015</year>
<volume>3</volume>
<fpage>635</fpage>
<lpage>637</lpage>
<pub-id pub-id-type="doi">10.1002/ccr3.232</pub-id>
<pub-id pub-id-type="pmid">26273459</pub-id>
</element-citation>
</ref>
<ref id="B231-ijms-20-05797">
<label>231.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lehmann</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Loh</surname>
<given-names>S.H.</given-names>
</name>
<name>
<surname>Martins</surname>
<given-names>L.M.</given-names>
</name>
</person-group>
<article-title>Enhancing NAD+ salvage metabolism is neuroprotective in a PINK1 model of Parkinson’s disease</article-title>
<source/>Biol. Open
          <year>2017</year>
<volume>6</volume>
<fpage>141</fpage>
<lpage>147</lpage>
<pub-id pub-id-type="doi">10.1242/bio.022186</pub-id>
<pub-id pub-id-type="pmid">28011627</pub-id>
</element-citation>
</ref>
<ref id="B232-ijms-20-05797">
<label>232.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aaseth</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Dusek</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Roos</surname>
<given-names>P.M.</given-names>
</name>
</person-group>
<article-title>Prevention of progression in Parkinson’s disease</article-title>
<source/>BioMetals
          <year>2018</year>
<volume>31</volume>
<fpage>737</fpage>
<lpage>747</lpage>
<pub-id pub-id-type="doi">10.1007/s10534-018-0131-5</pub-id>
<pub-id pub-id-type="pmid">30030679</pub-id>
</element-citation>
</ref>
<ref id="B233-ijms-20-05797">
<label>233.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Tran</surname>
<given-names>N.D.</given-names>
</name>
</person-group>
<article-title>Chemical Hypoxia-Ischemia Induces Apoptosis in Cerebromicrovascular Endothelial Cells</article-title>
<source/>Brain Res.
          <year>2000</year>
<volume>877</volume>
<fpage>134</fpage>
<lpage>140</lpage>
<pub-id pub-id-type="doi">10.1016/S0006-8993(00)02666-4</pub-id>
<pub-id pub-id-type="pmid">10986325</pub-id>
</element-citation>
</ref>
<ref id="B234-ijms-20-05797">
<label>234.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chong</surname>
<given-names>Z.Z.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>S.H.</given-names>
</name>
<name>
<surname>Maiese</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Nicotinamide modulates membrane potential and cysteine protease activity during cerebral vascular endothelial cell injury</article-title>
<source/>J. Vasc. Res.
          <year>2002</year>
<volume>39</volume>
<fpage>131</fpage>
<lpage>147</lpage>
<pub-id pub-id-type="doi">10.1159/000057762</pub-id>
<pub-id pub-id-type="pmid">12011585</pub-id>
</element-citation>
</ref>
<ref id="B235-ijms-20-05797">
<label>235.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Niu</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>Y.H.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L.J.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>L.M.</given-names>
</name>
</person-group>
<article-title>Combined Effects of Niacin and Chromium Treatment on Vascular Endothelial Dysfunction in Hyperlipidemic Rats</article-title>
<source/>Mol. Biol. Rep.
          <year>2009</year>
<volume>36</volume>
<fpage>1275</fpage>
<lpage>1281</lpage>
<pub-id pub-id-type="doi">10.1007/s11033-008-9309-1</pub-id>
<pub-id pub-id-type="pmid">18622720</pub-id>
</element-citation>
</ref>
<ref id="B236-ijms-20-05797">
<label>236.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stamatovic</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Martinez-revollar</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Decline in Sirtuin-1 Expression and Activity Plays a Critical Role in Blood-Brain Barrier Permeability in Aging Neurobiology of Disease</article-title>
<source/>Neurobiol. Dis.
          <year>2018</year>
<volume>126</volume>
<fpage>105</fpage>
<lpage>116</lpage>
<pub-id pub-id-type="doi">10.1016/j.nbd.2018.09.006</pub-id>
<pub-id pub-id-type="pmid">30196051</pub-id>
</element-citation>
</ref>
<ref id="B237-ijms-20-05797">
<label>237.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guo</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>SIRT1 in Endothelial Cells as a Novel Target for the Prevention of Early Vascular Aging</article-title>
<source/>J. Cardiovasc. Pharmacol.
          <year>2016</year>
<volume>67</volume>
<fpage>465</fpage>
<lpage>473</lpage>
<pub-id pub-id-type="doi">10.1097/FJC.0000000000000344</pub-id>
<pub-id pub-id-type="pmid">26657715</pub-id>
</element-citation>
</ref>
<ref id="B238-ijms-20-05797">
<label>238.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Jackson</surname>
<given-names>C.W.</given-names>
</name>
<name>
<surname>Khoury</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Escobar</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Perez-pinzon</surname>
<given-names>M.A.</given-names>
</name>
</person-group>
<article-title>Brain SIRT1 Mediates Metabolic Homeostasis and Neuroprotection</article-title>
<source/>Front. Endocrinol.
          <year>2018</year>
<volume>9</volume>
<fpage>702</fpage>
<pub-id pub-id-type="doi">10.3389/fendo.2018.00702</pub-id>
</element-citation>
</ref>
<ref id="B239-ijms-20-05797">
<label>239.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Picciotto</surname>
<given-names>N.E.</given-names>
</name>
<name>
<surname>Gano</surname>
<given-names>L.B.</given-names>
</name>
<name>
<surname>Johnson</surname>
<given-names>L.C.</given-names>
</name>
<name>
<surname>Martens</surname>
<given-names>C.R.</given-names>
</name>
<name>
<surname>Sindler</surname>
<given-names>A.L.</given-names>
</name>
<name>
<surname>Mills</surname>
<given-names>K.F.</given-names>
</name>
<name>
<surname>Imai</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Seals</surname>
<given-names>D.R.</given-names>
</name>
</person-group>
<article-title>Nicotinamide Mononucleotide Supplementation Reverses Vascular Dysfunction and Oxidative Stress with Aging in Mice</article-title>
<source/>Aging Cell
          <year>2016</year>
<volume>15</volume>
<fpage>522</fpage>
<lpage>530</lpage>
<pub-id pub-id-type="doi">10.1111/acel.12461</pub-id>
<pub-id pub-id-type="pmid">26970090</pub-id>
</element-citation>
</ref>
<ref id="B240-ijms-20-05797">
<label>240.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sawda</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Moussa</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Turner</surname>
<given-names>R.S.</given-names>
</name>
</person-group>
<article-title>Resveratrol for Alzheimer’s Disease</article-title>
<source/>Ann. N. Y. Acad. Sci.
          <year>2017</year>
<volume>1403</volume>
<fpage>142</fpage>
<lpage>149</lpage>
<pub-id pub-id-type="doi">10.1111/nyas.13431</pub-id>
<pub-id pub-id-type="pmid">28815614</pub-id>
</element-citation>
</ref>
<ref id="B241-ijms-20-05797">
<label>241.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>T.S.</given-names>
</name>
<name>
<surname>Chung</surname>
<given-names>J.W.</given-names>
</name>
</person-group>
<article-title>Associations of Dietary Riboflavin, Niacin, and Retinol with Age-related Hearing Loss: An Analysis of Korean National Health and Nutrition Examination Survey Data</article-title>
<source/>Nutrients
          <year>2019</year>
<volume>11</volume>
<elocation-id>896</elocation-id>
<pub-id pub-id-type="doi">10.3390/nu11040896</pub-id>
<pub-id pub-id-type="pmid">31010085</pub-id>
</element-citation>
</ref>
<ref id="B242-ijms-20-05797">
<label>242.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bayrakdar</surname>
<given-names>E.T.</given-names>
</name>
<name>
<surname>Uyanikgil</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Kanit</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Koylu</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Yalcin</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Nicotinamide Treatment Reduces the Levels of Oxidative Stress, Apoptosis, and PARP-1 Activity in Aβ (1–42)-Induced Rat Model of Alzheimer’s Disease</article-title>
<source/>Free Rad. Res.
          <year>2014</year>
<volume>48</volume>
<fpage>146</fpage>
<lpage>158</lpage>
<pub-id pub-id-type="doi">10.3109/10715762.2013.857018</pub-id>
</element-citation>
</ref>
<ref id="B243-ijms-20-05797">
<label>243.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Benavente</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Jacobson</surname>
<given-names>E.L.</given-names>
</name>
</person-group>
<article-title>Niacin Restriction Upregulates NADPH Oxidase and ROS in Human Keratinocytes</article-title>
<source/>Free Radic. Biol. Med.
          <year>2009</year>
<volume>44</volume>
<fpage>527</fpage>
<lpage>537</lpage>
<pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2007.10.006</pub-id>
</element-citation>
</ref>
<ref id="B244-ijms-20-05797">
<label>244.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tarafdar</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Pula</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>The Role of NADPH Oxidases and Oxidative Stress in Neurodegenerative Disorders</article-title>
<source/>Int. J. Mol. Sci.
          <year>2018</year>
<volume>19</volume>
<elocation-id>3824</elocation-id>
<pub-id pub-id-type="doi">10.3390/ijms19123824</pub-id>
</element-citation>
</ref>
<ref id="B245-ijms-20-05797">
<label>245.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Konior</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Schramm</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Czesnikiewicz-Guzik</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Guzik</surname>
<given-names>T.J.</given-names>
</name>
</person-group>
<article-title>NADPH Oxidases in Vascular Pathology</article-title>
<source/>Antioxid. Redox Signal.
          <year>2014</year>
<volume>20</volume>
<fpage>2794</fpage>
<lpage>2814</lpage>
<pub-id pub-id-type="doi">10.1089/ars.2013.5607</pub-id>
<pub-id pub-id-type="pmid">24180474</pub-id>
</element-citation>
</ref>
<ref id="B246-ijms-20-05797">
<label>246.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xie</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zeng</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>T.F.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>Y.B.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>W.P.</given-names>
</name>
</person-group>
<article-title>Nicotinamide Ribose Ameliorates Cognitive Impairment of Aged and Alzheimer’s Disease Model Mice</article-title>
<source/>Metab. Brain Dis.
          <year>2019</year>
<volume>34</volume>
<fpage>353</fpage>
<lpage>366</lpage>
<pub-id pub-id-type="doi">10.1007/s11011-018-0346-8</pub-id>
<pub-id pub-id-type="pmid">30523581</pub-id>
</element-citation>
</ref>
<ref id="B247-ijms-20-05797">
<label>247.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hou</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Lautrup</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Cordonnier</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Croteau</surname>
<given-names>D.L.</given-names>
</name>
<name>
<surname>Zavala</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Moritoh</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>O’Connell</surname>
<given-names>J.F.</given-names>
</name>
<name>
<surname>Baptiste</surname>
<given-names>B.A.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>NAD<sup>+</sup> Supplementation Normalizes Key Alzheimer’s Features and DNA Damage Responses in a New AD Mouse Model with Introduced DNA Repair Deficiency</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2018</year>
<volume>115</volume>
<fpage>E1876</fpage>
<lpage>E1885</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1718819115</pub-id>
<pub-id pub-id-type="pmid">29432159</pub-id>
</element-citation>
</ref>
<ref id="B248-ijms-20-05797">
<label>248.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morris</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Evans</surname>
<given-names>D.A.</given-names>
</name>
<name>
<surname>Bienias</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Scherr</surname>
<given-names>P.A.</given-names>
</name>
<name>
<surname>Tangney</surname>
<given-names>C.C.</given-names>
</name>
<name>
<surname>Hebert</surname>
<given-names>L.E.</given-names>
</name>
<name>
<surname>Bennett</surname>
<given-names>D.A.</given-names>
</name>
<name>
<surname>Wilson</surname>
<given-names>R.S.</given-names>
</name>
<name>
<surname>Aggarwal</surname>
<given-names>N.</given-names>
</name>
</person-group>
<article-title>Dietary Niacin and the Risk of Incident Alzheimer’s Disease and of Cognitive Decline</article-title>
<source/>J. Neurol. Neurosur. Psychiatry
          <year>2004</year>
<volume>75</volume>
<fpage>1093</fpage>
<lpage>1100</lpage>
<pub-id pub-id-type="doi">10.1136/jnnp.2003.025858</pub-id>
</element-citation>
</ref>
<ref id="B249-ijms-20-05797">
<label>249.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Csiszar</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Tarantini</surname>
<given-names>S.S.</given-names>
</name>
<name>
<surname>Yabluchanskiy</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Balasubramanian</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Kiss</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Farkas</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Baur</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Ungvari</surname>
<given-names>Z.</given-names>
</name>
</person-group>
<article-title>Role of endothelial NAD+ deficiency in age-related vascular dysfunction</article-title>
<source/>Am. J. Physiol. Heart Circ. Physiol.
          <year>2019</year>
<volume>316</volume>
<fpage>H1253</fpage>
<lpage>H1266</lpage>
<pub-id pub-id-type="doi">10.1152/ajpheart.00039.2019</pub-id>
<pub-id pub-id-type="pmid">30875255</pub-id>
</element-citation>
</ref>
<ref id="B250-ijms-20-05797">
<label>250.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Venco</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Dusi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Valletta</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Tiranti</surname>
<given-names>V.</given-names>
</name>
</person-group>
<article-title>Alteration of the Coenzyme a Biosynthetic Pathway in Neurodegeneration with Brain Iron Accumulation Syndromes</article-title>
<source/>Biochem. Soc. Trans.
          <year>2014</year>
<volume>42</volume>
<fpage>1069</fpage>
<lpage>1074</lpage>
<pub-id pub-id-type="doi">10.1042/BST20140106</pub-id>
<pub-id pub-id-type="pmid">25110004</pub-id>
</element-citation>
</ref>
<ref id="B251-ijms-20-05797">
<label>251.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kunugi</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ali</surname>
<given-names>A.M.</given-names>
</name>
</person-group>
<article-title>Royal Jelly and Its Components Promote Healthy Aging and Longevity: From Animal Models to Humans</article-title>
<source/>Int. J. Mol. Sci.
          <year>2019</year>
<volume>20</volume>
<elocation-id>4662</elocation-id>
<pub-id pub-id-type="doi">10.3390/ijms20194662</pub-id>
<pub-id pub-id-type="pmid">31547049</pub-id>
</element-citation>
</ref>
<ref id="B252-ijms-20-05797">
<label>252.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Patassini</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Begley</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Church</surname>
<given-names>S.J.</given-names>
</name>
<name>
<surname>Kureishy</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Reid</surname>
<given-names>S.J.</given-names>
</name>
<name>
<surname>Waldvogel</surname>
<given-names>H.J.</given-names>
</name>
<name>
<surname>Faull</surname>
<given-names>R.L.M.</given-names>
</name>
<name>
<surname>Snell</surname>
<given-names>R.G.</given-names>
</name>
<name>
<surname>Unwin</surname>
<given-names>R.D.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Cerebral Vitamin B5 (D-Pantothenic Acid) Deficiency as a Potential Cause of Metabolic Perturbation and Neurodegeneration in Huntington’s Disease</article-title>
<source/>Metabolites
          <year>2019</year>
<volume>9</volume>
<elocation-id>113</elocation-id>
<pub-id pub-id-type="doi">10.3390/metabo9060113</pub-id>
</element-citation>
</ref>
<ref id="B253-ijms-20-05797">
<label>253.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Leonardi</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Rock</surname>
<given-names>C.O.</given-names>
</name>
<name>
<surname>Jackowski</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Progress in Lipid Research Coenzyme A: Back in Action</article-title>
<source/>Prog. Lipid Res.
          <year>2005</year>
<volume>44</volume>
<fpage>125</fpage>
<lpage>153</lpage>
<pub-id pub-id-type="doi">10.1016/j.plipres.2005.04.001</pub-id>
<pub-id pub-id-type="pmid">15893380</pub-id>
</element-citation>
</ref>
<ref id="B254-ijms-20-05797">
<label>254.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Slyshenkov</surname>
<given-names>V.S.</given-names>
</name>
<name>
<surname>Dymkowska</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Wojtczak</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Pantothenic Acid and Pantothenol Increase Biosynthesis of Glutathione by Boosting Cell Energetics</article-title>
<source/>FEBS Lett.
          <year>2004</year>
<volume>569</volume>
<fpage>169</fpage>
<lpage>172</lpage>
<pub-id pub-id-type="doi">10.1016/j.febslet.2004.05.044</pub-id>
<pub-id pub-id-type="pmid">15225628</pub-id>
</element-citation>
</ref>
<ref id="B255-ijms-20-05797">
<label>255.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shedid</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Saada</surname>
<given-names>H.N.</given-names>
</name>
<name>
<surname>Eltahawy</surname>
<given-names>N.A.</given-names>
</name>
<name>
<surname>Hammad</surname>
<given-names>A.S.</given-names>
</name>
</person-group>
<article-title>Curative Role of Pantothenic Acid in Brain Damage of Gamma Irradiated Rats</article-title>
<source/>Indian J. Clin. Biochem.
          <year>2018</year>
<volume>33</volume>
<fpage>314</fpage>
<lpage>321</lpage>
<pub-id pub-id-type="doi">10.1007/s12291-017-0683-0</pub-id>
<pub-id pub-id-type="pmid">30072831</pub-id>
</element-citation>
</ref>
<ref id="B256-ijms-20-05797">
<label>256.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wojtczak</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Slyshenkov</surname>
<given-names>V.S.</given-names>
</name>
</person-group>
<article-title>Protection by Pantothenic Acid against Apoptosis and Cell Damage by Oxygen Free Radicals—The Role of Glutathione</article-title>
<source/>Biofactors
          <year>2003</year>
<volume>17</volume>
<fpage>61</fpage>
<lpage>73</lpage>
<pub-id pub-id-type="doi">10.1002/biof.5520170107</pub-id>
<pub-id pub-id-type="pmid">12897429</pub-id>
</element-citation>
</ref>
<ref id="B257-ijms-20-05797">
<label>257.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jung</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>M.K.</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>B.Y.</given-names>
</name>
</person-group>
<article-title>The Long-Term Relationship between Dietary Pantothenic Acid (Vitamin B 5) Intake and C-Reactive Protein Concentration in Adults Aged 40 Years and Older</article-title>
<source/>Nutr. Metab. Cardiovasc. Dis.
          <year>2017</year>
<volume>27</volume>
<fpage>806</fpage>
<lpage>816</lpage>
<pub-id pub-id-type="doi">10.1016/j.numecd.2017.05.008</pub-id>
<pub-id pub-id-type="pmid">28739188</pub-id>
</element-citation>
</ref>
<ref id="B258-ijms-20-05797">
<label>258.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Naruta</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Buko</surname>
<given-names>V.</given-names>
</name>
</person-group>
<article-title>Hypolipidemic Effect of Pantothenic Acid Derivatives in Mice with Hypothalamic Obesity Induced by Aurothioglucose</article-title>
<source/>Exp. Toxic Pathol.
          <year>2001</year>
<volume>53</volume>
<fpage>393</fpage>
<lpage>398</lpage>
<pub-id pub-id-type="doi">10.1078/0940-2993-00205</pub-id>
</element-citation>
</ref>
<ref id="B259-ijms-20-05797">
<label>259.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Evans</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Rumberger</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Azumano</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Napolitano</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>Citrolo</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Kamiya</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Pantethine, a Derivative of Vitamin B5, Favorably Alters Total, LDL and Non-HDL Cholesterol in Low to Moderate Cardiovascular Risk Subjects Eligible for Statin Therapy: A Triple-Blinded Placebo and Diet-Controlled Investigation</article-title>
<source/>Vasc. Health Risk Manag.
          <year>2014</year>
<volume>10</volume>
<fpage>89</fpage>
<lpage>100</lpage>
<pub-id pub-id-type="doi">10.2147/VHRM.S57116</pub-id>
<pub-id pub-id-type="pmid">24600231</pub-id>
</element-citation>
</ref>
<ref id="B260-ijms-20-05797">
<label>260.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mcrae</surname>
<given-names>M.P.</given-names>
</name>
</person-group>
<article-title>Treatment of Hyperlipoproteinemia with Pantethine: A Review and Analysis of Efficacy and Tolerability</article-title>
<source/>Nutr. Res.
          <year>2005</year>
<volume>25</volume>
<fpage>319</fpage>
<lpage>333</lpage>
<pub-id pub-id-type="doi">10.1016/j.nutres.2004.12.009</pub-id>
</element-citation>
</ref>
<ref id="B261-ijms-20-05797">
<label>261.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lanska</surname>
<given-names>D.J.</given-names>
</name>
</person-group>
<article-title>The Discovery of Niacin, Biotin, and Pantothenic Acid</article-title>
<source/>Ann. Nutr. Metab.
          <year>2012</year>
<volume>61</volume>
<fpage>246</fpage>
<lpage>253</lpage>
<pub-id pub-id-type="doi">10.1159/000343115</pub-id>
<pub-id pub-id-type="pmid">23183297</pub-id>
</element-citation>
</ref>
<ref id="B262-ijms-20-05797">
<label>262.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Uchida</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ito</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Ohtsuki</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kubo</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Suzuki</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Terasaki</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Major Involvement of Na+ -Dependent Multivitamin Transporter (SLC5A6/SMVT) in Uptake of Biotin and Pantothenic Acid by Human Brain Capillary Endothelial Cells</article-title>
<source/>J. Neurochem.
          <year>2015</year>
<volume>134</volume>
<fpage>97</fpage>
<lpage>112</lpage>
<pub-id pub-id-type="doi">10.1111/jnc.13092</pub-id>
<pub-id pub-id-type="pmid">25809983</pub-id>
</element-citation>
</ref>
<ref id="B263-ijms-20-05797">
<label>263.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Spector</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Development and Characterization of Pantothenic Acid Transport in Brain</article-title>
<source/>J. Neurochem.
          <year>1986</year>
<volume>47</volume>
<fpage>563</fpage>
<lpage>568</lpage>
<pub-id pub-id-type="doi">10.1111/j.1471-4159.1986.tb04536.x</pub-id>
<pub-id pub-id-type="pmid">3734794</pub-id>
</element-citation>
</ref>
<ref id="B264-ijms-20-05797">
<label>264.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Spector</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Boose</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>Accumulation of Pantothenic Acid by the Isolated Choroid Plexus and Brain Slices In Vitro</article-title>
<source/>J. Neurochem.
          <year>1984</year>
<volume>43</volume>
<fpage>472</fpage>
<lpage>478</lpage>
<pub-id pub-id-type="doi">10.1111/j.1471-4159.1984.tb00923.x</pub-id>
<pub-id pub-id-type="pmid">6736962</pub-id>
</element-citation>
</ref>
<ref id="B265-ijms-20-05797">
<label>265.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Spector</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Pantothenic Acid Transport and Metabolism in the Central Nervous System</article-title>
<source/>Am. J. Physiol.
          <year>1986</year>
<volume>250</volume>
<fpage>292</fpage>
<lpage>297</lpage>
<pub-id pub-id-type="doi">10.1152/ajpregu.1986.250.2.R292</pub-id>
</element-citation>
</ref>
<ref id="B266-ijms-20-05797">
<label>266.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Spector</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Sivesind</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Kinzenbaw</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>Pantothenic Acid Transport Through the Blood-Barrier</article-title>
<source/>J. Neurochem.
          <year>1986</year>
<volume>47</volume>
<fpage>966</fpage>
<lpage>971</lpage>
<pub-id pub-id-type="doi">10.1111/j.1471-4159.1986.tb00705.x</pub-id>
<pub-id pub-id-type="pmid">3734807</pub-id>
</element-citation>
</ref>
<ref id="B267-ijms-20-05797">
<label>267.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rajalakshmi</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Nakhasi</surname>
<given-names>H.L.</given-names>
</name>
</person-group>
<article-title>Effects of neonatal pantothenic acid deficiency on brain lipid composition in rats</article-title>
<source/>J. Neurochem.
          <year>1975</year>
<volume>24</volume>
<fpage>979</fpage>
<lpage>981</lpage>
<pub-id pub-id-type="doi">10.1111/j.1471-4159.1975.tb03665.x</pub-id>
<pub-id pub-id-type="pmid">1170283</pub-id>
</element-citation>
</ref>
<ref id="B268-ijms-20-05797">
<label>268.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Elbaum</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Beconi</surname>
<given-names>M.G.</given-names>
</name>
<name>
<surname>Monteagudo</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Di Marco</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Quinton</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lyons</surname>
<given-names>K.A.</given-names>
</name>
<name>
<surname>Vaino</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Harper</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Fosmetpantotenate (RE-024), a Phosphopantothenate Replacement Therapy for Pantothenate Kinase-Associated Neurodegeneration: Mechanism of Action and Efficacy in Nonclinical Models</article-title>
<source/>PLoS ONE
          <year>2018</year>
<volume>13</volume>
<elocation-id>e0192028</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0192028</pub-id>
<pub-id pub-id-type="pmid">29522513</pub-id>
</element-citation>
</ref>
<ref id="B269-ijms-20-05797">
<label>269.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hayflick</surname>
<given-names>S.J.</given-names>
</name>
</person-group>
<article-title>Defective Pantothenate Metabolism and Neurodegenration</article-title>
<source/>Biochem. Soc. Trans.
          <year>2018</year>
<volume>42</volume>
<fpage>1063</fpage>
<lpage>1068</lpage>
<pub-id pub-id-type="doi">10.1042/BST20140098</pub-id>
<pub-id pub-id-type="pmid">25110003</pub-id>
</element-citation>
</ref>
<ref id="B270-ijms-20-05797">
<label>270.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Di Meo</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Carecchio</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tiranti</surname>
<given-names>V.</given-names>
</name>
</person-group>
<article-title>Inborn Errors of Coenzyme a Metabolism and Neurodegeneration</article-title>
<source/>J. Inherit. Metab. Dis.
          <year>2019</year>
<volume>42</volume>
<fpage>49</fpage>
<lpage>56</lpage>
<pub-id pub-id-type="doi">10.1002/jimd.12026</pub-id>
<pub-id pub-id-type="pmid">30740736</pub-id>
</element-citation>
</ref>
<ref id="B271-ijms-20-05797">
<label>271.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zizioli</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Tiso</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Guglielmi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Saraceno</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Busolin</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Giuliani</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Khatri</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Monti</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Borsani</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Argenton</surname>
<given-names>F.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Neurobiology of Disease Knock-down of Pantothenate Kinase 2 Severely Affects the Development of the Nervous and Vascular System in Zebra Fish, Providing New Insights into PKAN Disease</article-title>
<source/>Neurobiol. Dis.
          <year>2016</year>
<volume>85</volume>
<fpage>35</fpage>
<lpage>48</lpage>
<pub-id pub-id-type="doi">10.1016/j.nbd.2015.10.010</pub-id>
<pub-id pub-id-type="pmid">26476142</pub-id>
</element-citation>
</ref>
<ref id="B272-ijms-20-05797">
<label>272.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Ahn</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>H.A.</given-names>
</name>
<name>
<surname>Won</surname>
<given-names>K.S.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>H.W.</given-names>
</name>
<name>
<surname>Oh</surname>
<given-names>J.S.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>H.W.</given-names>
</name>
</person-group>
<article-title>Dietary Intake of Pantothenic Acid Is Associated with Cerebral Amyloid Burden in Patients with Cognitive Impairment</article-title>
<source/>Food Nutr. Res.
          <year>2018</year>
<volume>62</volume>
<pub-id pub-id-type="doi">10.29219/fnr.v62.1415</pub-id>
</element-citation>
</ref>
<ref id="B273-ijms-20-05797">
<label>273.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Leonardi</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Jackowski</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Biosynthesis of Pantothenic Acid and Coenzyme A</article-title>
<source/>EcoSal Plus
          <year>2007</year>
<volume>2</volume>
<pub-id pub-id-type="doi">10.1128/ecosalplus.3.6.3.4</pub-id>
</element-citation>
</ref>
<ref id="B274-ijms-20-05797">
<label>274.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nakahiro</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Mochizuki</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Uchida</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yoshida</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Effect of the ‘antidementia drug’ pantoyl-GABA on high affinity transport of choline and on the contents of choline and acetylcholine in rat brain</article-title>
<source/>Br. J. Pharmacol.
          <year>1988</year>
<volume>95</volume>
<fpage>1303</fpage>
<lpage>1307</lpage>
<pub-id pub-id-type="doi">10.1111/j.1476-5381.1988.tb11768.x</pub-id>
<pub-id pub-id-type="pmid">3219489</pub-id>
</element-citation>
</ref>
<ref id="B275-ijms-20-05797">
<label>275.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stover</surname>
<given-names>P.J.</given-names>
</name>
<name>
<surname>Fields</surname>
<given-names>M.S.</given-names>
</name>
</person-group>
<article-title>Vitamin B-6</article-title>
<source/>Adv. Nutr.
          <year>2015</year>
<volume>6</volume>
<fpage>132</fpage>
<lpage>133</lpage>
<pub-id pub-id-type="doi">10.3945/an.113.005207</pub-id>
<pub-id pub-id-type="pmid">25593152</pub-id>
</element-citation>
</ref>
<ref id="B276-ijms-20-05797">
<label>276.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ueland</surname>
<given-names>P.M.</given-names>
</name>
<name>
<surname>Mccann</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Midttun</surname>
<given-names>Ø.</given-names>
</name>
<name>
<surname>Ulvik</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Inflammation, Vitamin B6 and Related Pathway</article-title>
<source/>Mol. Asp. Med.
          <year>2016</year>
<volume>53</volume>
<fpage>20</fpage>
<lpage>27</lpage>
<pub-id pub-id-type="doi">10.1016/j.mam.2016.08.001</pub-id>
</element-citation>
</ref>
<ref id="B277-ijms-20-05797">
<label>277.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lotto</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Friso</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Vitamin B6: A Challenging Link between Nutrition and Inflammation in CVD</article-title>
<source/>Br. J. Nutr.
          <year>2011</year>
<volume>106</volume>
<fpage>183</fpage>
<lpage>195</lpage>
<pub-id pub-id-type="doi">10.1017/S0007114511000407</pub-id>
<pub-id pub-id-type="pmid">21486513</pub-id>
</element-citation>
</ref>
<ref id="B278-ijms-20-05797">
<label>278.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meydani</surname>
<given-names>N.S.</given-names>
</name>
<name>
<surname>Ribaya-mercado</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Russel</surname>
<given-names>M.R.</given-names>
</name>
<name>
<surname>Sahyoun</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Morrow</surname>
<given-names>D.F.</given-names>
</name>
<name>
<surname>Gershoff</surname>
<given-names>N.S.</given-names>
</name>
</person-group>
<article-title>Vitamin B-6 Deficiency Impairs Interleukin 2 Production and Lymphocyte Proliferation in Elderly Adults</article-title>
<source/>Am. J. Clin. Nutr.
          <year>1991</year>
<volume>53</volume>
<fpage>1275</fpage>
<lpage>1280</lpage>
<pub-id pub-id-type="doi">10.1093/ajcn/53.5.1275</pub-id>
<pub-id pub-id-type="pmid">2021134</pub-id>
</element-citation>
</ref>
<ref id="B279-ijms-20-05797">
<label>279.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Brown</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Beier</surname>
<given-names>K.</given-names>
</name>
</person-group>
<source/>Vitamin B6 Deficiency (Pyridoxine)
          <publisher-name>StatPearls Publishing</publisher-name>
<publisher-loc>Treasure Island, FL, USA</publisher-loc>
<year>2019</year>
</element-citation>
</ref>
<ref id="B280-ijms-20-05797">
<label>280.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sudduth</surname>
<given-names>T.L.</given-names>
</name>
<name>
<surname>Powell</surname>
<given-names>D.K.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>C.D.</given-names>
</name>
<name>
<surname>Greenstein</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Wilcock</surname>
<given-names>D.M.</given-names>
</name>
</person-group>
<article-title>Induction of Hyperhomocysteinemia Models Vascular Dementia by Induction of Cerebral Microhemorrhages and Neuroinflammation</article-title>
<source/>J. Cereb. Blood Flow Metab.
          <year>2013</year>
<volume>33</volume>
<fpage>708</fpage>
<lpage>715</lpage>
<pub-id pub-id-type="doi">10.1038/jcbfm.2013.1</pub-id>
<pub-id pub-id-type="pmid">23361394</pub-id>
</element-citation>
</ref>
<ref id="B281-ijms-20-05797">
<label>281.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jungert</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Neuhauser-Berthold</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Longitudinal Analysis on Determinants of Vitamin B6 Status in Community-Dwelling Older Adults over a Period of 18 Years</article-title>
<source/>J. Gerontol. A Biol. Sci. Med. Sci.
          <year>2019</year>
<pub-id pub-id-type="doi">10.1093/gerona/glz010</pub-id>
<pub-id pub-id-type="pmid">30657862</pub-id>
</element-citation>
</ref>
<ref id="B282-ijms-20-05797">
<label>282.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morris</surname>
<given-names>M.S.</given-names>
</name>
<name>
<surname>Picciano</surname>
<given-names>M.F.</given-names>
</name>
<name>
<surname>Jacques</surname>
<given-names>P.F.</given-names>
</name>
<name>
<surname>Selhub</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Plasma Pyridoxal 5′-Phosphate in the US Population: The National Health and Nutrition Examination Survey, 2003–2004</article-title>
<source/>Am. J. Clin. Nutr.
          <year>2008</year>
<volume>87</volume>
<fpage>1446</fpage>
<lpage>1454</lpage>
<pub-id pub-id-type="doi">10.1093/ajcn/87.5.1446</pub-id>
<pub-id pub-id-type="pmid">18469270</pub-id>
</element-citation>
</ref>
<ref id="B283-ijms-20-05797">
<label>283.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ullegaddi</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Powers</surname>
<given-names>H.J.</given-names>
</name>
<name>
<surname>Gariballa</surname>
<given-names>S.E.</given-names>
</name>
</person-group>
<article-title>B-Group Vitamin Supplementation Mitigates Oxidative Damage after Acute Ischaemic Stroke</article-title>
<source/>Clin. Sci.
          <year>2004</year>
<volume>484</volume>
<fpage>477</fpage>
<lpage>484</lpage>
<pub-id pub-id-type="doi">10.1042/CS20040134</pub-id>
</element-citation>
</ref>
<ref id="B284-ijms-20-05797">
<label>284.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shen</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Associations between B Vitamins and Parkinson’s Disease</article-title>
<source/>Nutrients
          <year>2015</year>
<volume>7</volume>
<fpage>7197</fpage>
<lpage>7208</lpage>
<pub-id pub-id-type="doi">10.3390/nu7095333</pub-id>
<pub-id pub-id-type="pmid">26343714</pub-id>
</element-citation>
</ref>
<ref id="B285-ijms-20-05797">
<label>285.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Friso</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Jacques</surname>
<given-names>P.F.</given-names>
</name>
<name>
<surname>Wilson</surname>
<given-names>P.W.F.</given-names>
</name>
<name>
<surname>Rosenberg</surname>
<given-names>I.H.</given-names>
</name>
<name>
<surname>Selhub</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Clinical Investigation and Reports Low Circulating Vitamin B 6 Is Associated with Elevation of the Inflammation Marker C-Reactive Protein Independently of Plasma Homocysteine Levels</article-title>
<source/>Circulation
          <year>2015</year>
<volume>103</volume>
<fpage>2788</fpage>
<lpage>2791</lpage>
<pub-id pub-id-type="doi">10.1161/01.CIR.103.23.2788</pub-id>
</element-citation>
</ref>
<ref id="B286-ijms-20-05797">
<label>286.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Höhn</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Weber</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Jung</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Ott</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Hugo</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kochlik</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Kehm</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>König</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Grune</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Castro</surname>
<given-names>J.P.</given-names>
</name>
</person-group>
<article-title>Happily (n)ever after: Aging in the context of oxidative stress, proteostasis loss and cellular senescence</article-title>
<source/>Redox Biol.
          <year>2017</year>
<volume>11</volume>
<fpage>482</fpage>
<lpage>501</lpage>
<pub-id pub-id-type="doi">10.1016/j.redox.2016.12.001</pub-id>
<pub-id pub-id-type="pmid">28086196</pub-id>
</element-citation>
</ref>
<ref id="B287-ijms-20-05797">
<label>287.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Potter</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Wozniak</surname>
<given-names>K.M.</given-names>
</name>
<name>
<surname>Callizot</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Slusher</surname>
<given-names>B.S.</given-names>
</name>
</person-group>
<article-title>Glutamate carboxypeptidase II inhibition behaviorally and physiologically improves pyridoxine-induced neuropathy in rats</article-title>
<source/>PLoS One.
          <year>2014</year>
<volume>9</volume>
<elocation-id>e102936</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0102936</pub-id>
<pub-id pub-id-type="pmid">25254647</pub-id>
</element-citation>
</ref>
<ref id="B288-ijms-20-05797">
<label>288.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wilson</surname>
<given-names>M.P.</given-names>
</name>
<name>
<surname>Plecko</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Mills</surname>
<given-names>P.B.</given-names>
</name>
<name>
<surname>Clayton</surname>
<given-names>P.T.</given-names>
</name>
<name>
<surname>Medicine</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>Disorders Affecting Vitamin B 6 Metabolism</article-title>
<source/>J. Inherit. Metab. Dis.
          <year>2019</year>
<volume>42</volume>
<fpage>629</fpage>
<lpage>646</lpage>
<pub-id pub-id-type="doi">10.1002/jimd.12060</pub-id>
<pub-id pub-id-type="pmid">30671974</pub-id>
</element-citation>
</ref>
<ref id="B289-ijms-20-05797">
<label>289.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barichello</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Generoso</surname>
<given-names>J.S.</given-names>
</name>
<name>
<surname>Simões</surname>
<given-names>L.R.</given-names>
</name>
<name>
<surname>Ceretta</surname>
<given-names>R.A.</given-names>
</name>
<name>
<surname>Dominguini</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Ferrari</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Gubert</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Jornada</surname>
<given-names>L.K.</given-names>
</name>
<name>
<surname>Budni</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kapczinski</surname>
<given-names>F.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Vitamin B6 Prevents Cognitive Impairment in Experimental Pneumococcal Meningitis</article-title>
<source/>Exp. Biol. Med.
          <year>2014</year>
<volume>239</volume>
<fpage>1360</fpage>
<lpage>1365</lpage>
<pub-id pub-id-type="doi">10.1177/1535370214535896</pub-id>
</element-citation>
</ref>
<ref id="B290-ijms-20-05797">
<label>290.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zysset-Burri</surname>
<given-names>D.C.</given-names>
</name>
<name>
<surname>Bellac</surname>
<given-names>C.L.</given-names>
</name>
<name>
<surname>Leib</surname>
<given-names>S.L.</given-names>
</name>
<name>
<surname>Wittwer</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Vitamin B6 Reduces Hippocampal Apoptosis in Experimental Pneumococcal Meningitis</article-title>
<source/>BMC Infect. Dis.
          <year>2013</year>
<volume>13</volume>
<elocation-id>393</elocation-id>
<pub-id pub-id-type="doi">10.1186/1471-2334-13-393</pub-id>
<pub-id pub-id-type="pmid">23977941</pub-id>
</element-citation>
</ref>
<ref id="B291-ijms-20-05797">
<label>291.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Murakami</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Miyake</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Sasaki</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Tanaka</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Fukushima</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Kiyohara</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Tsuboi</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yamada</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Oeda</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Miki</surname>
<given-names>T.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Dietary Intake of Folate, Vitamin B6, Vitamin B12 and Riboflavin and Risk of Parkinson’s Disease: A Case-Control Study in Japan</article-title>
<source/>Br. J. Nutr.
          <year>2010</year>
<volume>104</volume>
<fpage>757</fpage>
<lpage>764</lpage>
<pub-id pub-id-type="doi">10.1017/S0007114510001005</pub-id>
<pub-id pub-id-type="pmid">20338075</pub-id>
</element-citation>
</ref>
<ref id="B292-ijms-20-05797">
<label>292.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Lau</surname>
<given-names>L.M.L.</given-names>
</name>
<name>
<surname>Koudstaal</surname>
<given-names>P.J.</given-names>
</name>
<name>
<surname>Witteman</surname>
<given-names>J.C.M.</given-names>
</name>
<name>
<surname>Hofman</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Dietary Folate, Vitamin B 12, and Vitamin B 6 and the Risk of Parkinson Disease</article-title>
<source/>Neurology
          <year>2006</year>
<volume>67</volume>
<fpage>315</fpage>
<lpage>318</lpage>
<pub-id pub-id-type="doi">10.1212/01.wnl.0000225050.57553.6d</pub-id>
<pub-id pub-id-type="pmid">16864826</pub-id>
</element-citation>
</ref>
<ref id="B293-ijms-20-05797">
<label>293.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hassan</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Hunt</surname>
<given-names>B.J.</given-names>
</name>
<name>
<surname>O’Sullivan</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Bell</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>D’Souza</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Jeffery</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Bamford</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Markus</surname>
<given-names>H.S.</given-names>
</name>
</person-group>
<article-title>Homocysteine Is a Risk Factor for Cerebral Small Vessel Disease, Acting via Endothelial Dysfunction</article-title>
<source/>Brain
          <year>2004</year>
<volume>127</volume>
<fpage>212</fpage>
<lpage>219</lpage>
<pub-id pub-id-type="doi">10.1093/brain/awh023</pub-id>
<pub-id pub-id-type="pmid">14607791</pub-id>
</element-citation>
</ref>
<ref id="B294-ijms-20-05797">
<label>294.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bertsch</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Mielke</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Höly</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Casarin</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Aufenanger</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Walter</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Muehlhauser</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Kuehl</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ragoschke</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Fassbender</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Homocysteine in Cerebrovascular Disease: An Independent Risk Factor for Subcortical Vascular Encephalopathy</article-title>
<source/>Clin. Chem.
          <year>2001</year>
<volume>39</volume>
<fpage>721</fpage>
<lpage>724</lpage>
<pub-id pub-id-type="doi">10.1515/CCLM.2001.120</pub-id>
</element-citation>
</ref>
<ref id="B295-ijms-20-05797">
<label>295.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nuru</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Muradashvili</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Kalani</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Lominadze</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Tyagi</surname>
<given-names>N.</given-names>
</name>
</person-group>
<article-title>High Methionine, Low Folate and Low Vitamin B6/B12 (HM-LF-LV) Diet Causes Neurodegeneration and Subsequent Short-Term Memory Loss</article-title>
<source/>Metab. Brain Dis.
          <year>2018</year>
<volume>33</volume>
<fpage>1923</fpage>
<lpage>1924</lpage>
<pub-id pub-id-type="doi">10.1007/s11011-018-0298-z</pub-id>
<pub-id pub-id-type="pmid">30094804</pub-id>
</element-citation>
</ref>
<ref id="B296-ijms-20-05797">
<label>296.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moretti</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Caruso</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>The Controversial Role of Homocysteine in Neurology: From Labs to Clinical Practice</article-title>
<source/>Int. J. Mol. Sci.
          <year>2019</year>
<volume>20</volume>
<elocation-id>231</elocation-id>
<pub-id pub-id-type="doi">10.3390/ijms20010231</pub-id>
</element-citation>
</ref>
<ref id="B297-ijms-20-05797">
<label>297.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ansari</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Mahta</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Mallack</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Hyperhomocysteinemia and Neurologic Disorders: A Review</article-title>
<source/>J. Clin. Neurol.
          <year>2014</year>
<volume>10</volume>
<fpage>281</fpage>
<lpage>288</lpage>
<pub-id pub-id-type="doi">10.3988/jcn.2014.10.4.281</pub-id>
<pub-id pub-id-type="pmid">25324876</pub-id>
</element-citation>
</ref>
<ref id="B298-ijms-20-05797">
<label>298.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Toda</surname>
<given-names>N.</given-names>
</name>
</person-group>
<article-title>Hyperhomocysteinemia Impairs Regional Blood Flow: Involvements of Endothelial and Neuronal Nitric Oxide</article-title>
<source/>Pflügers Arch.
          <year>2016</year>
<volume>468</volume>
<fpage>1517</fpage>
<lpage>1525</lpage>
<pub-id pub-id-type="doi">10.1007/s00424-016-1849-y</pub-id>
<pub-id pub-id-type="pmid">27417104</pub-id>
</element-citation>
</ref>
<ref id="B299-ijms-20-05797">
<label>299.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Endo</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Nishiyama</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Okabe</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Matsumoto</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kanouchi</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Oka</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Vitamin B 6 Suppresses Apoptosis of NM-1 Bovine Endothelial Cells Induced by Homocysteine and Copper</article-title>
<source/>Biochim. Biophys. Acta
          <year>2007</year>
<volume>1770</volume>
<fpage>571</fpage>
<lpage>577</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbagen.2006.11.009</pub-id>
<pub-id pub-id-type="pmid">17208380</pub-id>
</element-citation>
</ref>
<ref id="B300-ijms-20-05797">
<label>300.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alam</surname>
<given-names>M.M.</given-names>
</name>
<name>
<surname>Mohammad</surname>
<given-names>A.A.</given-names>
</name>
<name>
<surname>Shuaib</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Ghani</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Schwindt</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Todd</surname>
<given-names>K.G.</given-names>
</name>
<name>
<surname>Shuaib</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Homocysteine Reduces Endothelial Progenitor Cells in Stroke Patients through Apoptosis</article-title>
<source/>J. Cereb. Blood Flow Metab.
          <year>2009</year>
<volume>29</volume>
<fpage>157</fpage>
<lpage>165</lpage>
<pub-id pub-id-type="doi">10.1038/jcbfm.2008.99</pub-id>
<pub-id pub-id-type="pmid">18766198</pub-id>
</element-citation>
</ref>
<ref id="B301-ijms-20-05797">
<label>301.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mahfouz</surname>
<given-names>M.M.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>S.Q.</given-names>
</name>
<name>
<surname>Kummerow</surname>
<given-names>F.A.</given-names>
</name>
</person-group>
<article-title>Vitamin B 6 Compounds Are Capable of Reducing the Superoxide Radical and Lipid Peroxide Levels Induced by H<sub>2</sub>O<sub>2</sub> in Vascular Endothelial Cells in Culture</article-title>
<source/>Int. J. Vitam. Nutr. Res.
          <year>2009</year>
<volume>79</volume>
<fpage>218</fpage>
<lpage>229</lpage>
<pub-id pub-id-type="doi">10.1024/0300-9831.79.4.218</pub-id>
<pub-id pub-id-type="pmid">20209473</pub-id>
</element-citation>
</ref>
<ref id="B302-ijms-20-05797">
<label>302.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xie</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Mi</surname>
<given-names>Q.</given-names>
</name>
</person-group>
<article-title>Pyridoxine Inhibits Endothelial NOS Uncoupling Induced by Oxidized Low-Density Lipoprotein via the PKC Signaling Pathway in Human Umbilical Vein Endothelial Cells</article-title>
<source/>Br. J. Pharmacol.
          <year>2012</year>
<volume>165</volume>
<fpage>754</fpage>
<lpage>764</lpage>
<pub-id pub-id-type="doi">10.1111/j.1476-5381.2011.01607.x</pub-id>
<pub-id pub-id-type="pmid">21797845</pub-id>
</element-citation>
</ref>
<ref id="B303-ijms-20-05797">
<label>303.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ji</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Diao</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Bai</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Ferro</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Pyridoxine Prevents Dysfunction of Endothelial Cell Nitric Oxide Production in Response to Low-Density Lipoprotein</article-title>
<source/>Atherosclerosis
          <year>2006</year>
<volume>188</volume>
<fpage>84</fpage>
<lpage>94</lpage>
<pub-id pub-id-type="doi">10.1016/j.atherosclerosis.2005.10.035</pub-id>
<pub-id pub-id-type="pmid">16300769</pub-id>
</element-citation>
</ref>
<ref id="B304-ijms-20-05797">
<label>304.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ford</surname>
<given-names>T.C.</given-names>
</name>
<name>
<surname>Downey</surname>
<given-names>L.A.</given-names>
</name>
<name>
<surname>Simpson</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Mcphee</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Oliver</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Stough</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>The Effect of a High-Dose Vitamin B Multivitamin Supplement on the Relationship between Brain Metabolism and Blood Biomarkers of Oxidative Stress: A Randomized Control Trial</article-title>
<source/>Nutrients
          <year>2018</year>
<volume>10</volume>
<elocation-id>1860</elocation-id>
<pub-id pub-id-type="doi">10.3390/nu10121860</pub-id>
<pub-id pub-id-type="pmid">30513795</pub-id>
</element-citation>
</ref>
<ref id="B305-ijms-20-05797">
<label>305.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Onorato</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Jenkins</surname>
<given-names>A.J.</given-names>
</name>
<name>
<surname>Thorpe</surname>
<given-names>S.R.</given-names>
</name>
<name>
<surname>Baynes</surname>
<given-names>J.W.</given-names>
</name>
</person-group>
<article-title>Pyridoxamine, an Inhibitor of Advanced Glycation Reactions, Also Inhibits Advanced Lipoxidation Reactions</article-title>
<source/>J. Biol. Chem.
          <year>2000</year>
<volume>275</volume>
<fpage>21177</fpage>
<lpage>21184</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M003263200</pub-id>
<pub-id pub-id-type="pmid">10801874</pub-id>
</element-citation>
</ref>
<ref id="B306-ijms-20-05797">
<label>306.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kelso</surname>
<given-names>B.G.</given-names>
</name>
<name>
<surname>Brower</surname>
<given-names>J.B.</given-names>
</name>
<name>
<surname>Targovnik</surname>
<given-names>J.H.</given-names>
</name>
<name>
<surname>Caplan</surname>
<given-names>M.R.</given-names>
</name>
</person-group>
<article-title>Pyridoxine Restores Endothelial Cell Function in High Glucose</article-title>
<source/>Metab. Syndr. Relat. Disord.
          <year>2011</year>
<volume>9</volume>
<fpage>63</fpage>
<lpage>68</lpage>
<pub-id pub-id-type="doi">10.1089/met.2010.0085</pub-id>
<pub-id pub-id-type="pmid">21034273</pub-id>
</element-citation>
</ref>
<ref id="B307-ijms-20-05797">
<label>307.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morris</surname>
<given-names>M.S.</given-names>
</name>
<name>
<surname>Sakakeeny</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Jacques</surname>
<given-names>P.F.</given-names>
</name>
<name>
<surname>Picciano</surname>
<given-names>M.F.</given-names>
</name>
<name>
<surname>Selhub</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Vitamin B-6 Intake Is Inversely Related to, and the Requirement Is Affected by Inflammation Status</article-title>
<source/>J. Nutr.
          <year>2009</year>
<volume>140</volume>
<fpage>103</fpage>
<lpage>110</lpage>
<pub-id pub-id-type="doi">10.3945/jn.109.114397</pub-id>
<pub-id pub-id-type="pmid">19906811</pub-id>
</element-citation>
</ref>
<ref id="B308-ijms-20-05797">
<label>308.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ifrea</surname>
<given-names>R.A.T.</given-names>
</name>
<name>
<surname>Ozlea</surname>
<given-names>L.C.</given-names>
</name>
<name>
<surname>Arașca</surname>
<given-names>E.C.</given-names>
</name>
</person-group>
<article-title>The Impact of C Reactive Protein on Global Cardiovascular Risk on Patients with Coronary Artery Disease</article-title>
<source/>Curr. Health Sci. J.
          <year>2013</year>
<volume>39</volume>
<fpage>225</fpage>
<lpage>231</lpage>
<pub-id pub-id-type="pmid">24778862</pub-id>
</element-citation>
</ref>
<ref id="B309-ijms-20-05797">
<label>309.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rall</surname>
<given-names>L.C.</given-names>
</name>
<name>
<surname>Meydani</surname>
<given-names>S.N.</given-names>
</name>
</person-group>
<article-title>Vitamin B, and Immune Competence</article-title>
<source/>Nutr. Rev.
          <year>1993</year>
<volume>51</volume>
<fpage>217</fpage>
<lpage>225</lpage>
<pub-id pub-id-type="doi">10.1111/j.1753-4887.1993.tb03109.x</pub-id>
<pub-id pub-id-type="pmid">8302491</pub-id>
</element-citation>
</ref>
<ref id="B310-ijms-20-05797">
<label>310.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kelly</surname>
<given-names>P.J.</given-names>
</name>
<name>
<surname>Shih</surname>
<given-names>V.E.</given-names>
</name>
<name>
<surname>Kistler</surname>
<given-names>J.P.</given-names>
</name>
<name>
<surname>Barron</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Mandell</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Furie</surname>
<given-names>K.L.</given-names>
</name>
</person-group>
<article-title>Low Vitamin B6 but Not Homocyst(e)ine Is Associated with Increased Risk of Stroke and Transient Ischemic Attack in the Era of Folic Acid Grain Fortification</article-title>
<source/>Stroke
          <year>2003</year>
<volume>34</volume>
<fpage>51</fpage>
<lpage>54</lpage>
<pub-id pub-id-type="doi">10.1161/01.STR.0000071109.23410.AB</pub-id>
<pub-id pub-id-type="pmid">12738890</pub-id>
</element-citation>
</ref>
<ref id="B311-ijms-20-05797">
<label>311.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Polyak</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Berner</surname>
<given-names>Y.N.</given-names>
</name>
<name>
<surname>Sela</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Gomori</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Doolman</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Hyperhomocysteinemia and Vitamin Score: Correlations with Silent Brain Ischemic Lesions and Brain Atrophy</article-title>
<source/>Dement. Geriatr. Cogn. Disord.
          <year>2003</year>
<volume>16</volume>
<fpage>39</fpage>
<lpage>45</lpage>
<pub-id pub-id-type="doi">10.1159/000069992</pub-id>
<pub-id pub-id-type="pmid">12714799</pub-id>
</element-citation>
</ref>
<ref id="B312-ijms-20-05797">
<label>312.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mulder</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Scheltens</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Barkhof</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Gundy</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Verstraeten</surname>
<given-names>R.A.</given-names>
</name>
<name>
<surname>de Leeuw</surname>
<given-names>F.E.</given-names>
</name>
</person-group>
<article-title>Low B Vitamin B6 Levels Are Associated with White Matter Lesions in Alzheimer’s Disease</article-title>
<source/>J. Am. Geriatr. Soc.
          <year>2005</year>
<volume>53</volume>
<fpage>1073</fpage>
<lpage>1084</lpage>
<pub-id pub-id-type="doi">10.1111/j.1532-5415.2005.53338_1.x</pub-id>
<pub-id pub-id-type="pmid">15935040</pub-id>
</element-citation>
</ref>
<ref id="B313-ijms-20-05797">
<label>313.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mulder</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>van der Flier</surname>
<given-names>W.M.</given-names>
</name>
<name>
<surname>Veerhuis</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Bouwman</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Jakobs</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Verhoeven</surname>
<given-names>N.M.</given-names>
</name>
<name>
<surname>Barkhof</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Scheltens</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Blankenstein</surname>
<given-names>M.A.</given-names>
</name>
</person-group>
<article-title>Association Between Vitamin B6 and White Matter Hyperintensities in Patients with Alzheimer’s Disease Not Mediated by Homocysteine Metabolism</article-title>
<source/>J. Am. Geriatr. Soc.
          <year>2007</year>
<volume>55</volume>
<fpage>956</fpage>
<lpage>958</lpage>
<pub-id pub-id-type="doi">10.1111/j.1532-5415.2007.01174.x</pub-id>
<pub-id pub-id-type="pmid">17537101</pub-id>
</element-citation>
</ref>
<ref id="B314-ijms-20-05797">
<label>314.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miller</surname>
<given-names>J.W.</given-names>
</name>
<name>
<surname>Green</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Mungas</surname>
<given-names>D.M.</given-names>
</name>
<name>
<surname>Reed</surname>
<given-names>B.R.</given-names>
</name>
<name>
<surname>Jagust</surname>
<given-names>W.J.</given-names>
</name>
</person-group>
<article-title>Homocysteine, Vitamin B 6, and Vascular Disease in AD Patients</article-title>
<source/>Neurology
          <year>2002</year>
<volume>58</volume>
<fpage>1471</fpage>
<lpage>1476</lpage>
<pub-id pub-id-type="doi">10.1212/WNL.58.10.1471</pub-id>
<pub-id pub-id-type="pmid">12034781</pub-id>
</element-citation>
</ref>
<ref id="B315-ijms-20-05797">
<label>315.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Malaguarnera</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ferri</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Alagona</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Carnemolla</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Pennisi</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>Homocysteine, Vitamin B 12 and Folate in Vascular Dementia and in Alzheimer Disease</article-title>
<source/>Clin. Chem. Lab. Med.
          <year>2004</year>
<volume>42</volume>
<fpage>1032</fpage>
<lpage>1035</lpage>
<pub-id pub-id-type="doi">10.1515/CCLM.2004.208</pub-id>
<pub-id pub-id-type="pmid">15497469</pub-id>
</element-citation>
</ref>
<ref id="B316-ijms-20-05797">
<label>316.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nelson</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Wengreen</surname>
<given-names>H.J.</given-names>
</name>
<name>
<surname>Munger</surname>
<given-names>R.G.</given-names>
</name>
<name>
<surname>Corcoran</surname>
<given-names>C.D.</given-names>
</name>
</person-group>
<article-title>Dietary folate, vitamin B-12, vitamin B-6 and incident Alzheimer’s disease: The cache county memory, health, and aging study</article-title>
<source/>J. Nutr. Health Ageing
          <year>2009</year>
<volume>13</volume>
<fpage>899</fpage>
<lpage>905</lpage>
<pub-id pub-id-type="doi">10.1007/s12603-009-0249-9</pub-id>
</element-citation>
</ref>
<ref id="B317-ijms-20-05797">
<label>317.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Toole</surname>
<given-names>J.F.</given-names>
</name>
<name>
<surname>Malinow</surname>
<given-names>M.R.</given-names>
</name>
<name>
<surname>Chambless</surname>
<given-names>L.E.</given-names>
</name>
<name>
<surname>Spence</surname>
<given-names>J.D.</given-names>
</name>
<name>
<surname>Pettigrew</surname>
<given-names>L.C.</given-names>
</name>
<name>
<surname>Howard</surname>
<given-names>V.J.</given-names>
</name>
<name>
<surname>Sides</surname>
<given-names>E.G.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>C.H.</given-names>
</name>
<name>
<surname>Stampfer</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Lowering Homocysteine in Patients with Ischemic Stroke to Prevent Recurrent Stroke, Myocardial Infarction, and Death. The Vitamin Intervention for Stroke Prevention (VISP) Randomized Controlled Trial</article-title>
<source/>JAMA
          <year>2004</year>
<volume>291</volume>
<fpage>565</fpage>
<lpage>575</lpage>
<pub-id pub-id-type="doi">10.1001/jama.291.5.565</pub-id>
<pub-id pub-id-type="pmid">14762035</pub-id>
</element-citation>
</ref>
<ref id="B318-ijms-20-05797">
<label>318.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schwammenthal</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Tanne</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>Homocysteine, B-Vitamin Supplementation, and Stroke Prevention: From Observational to Interventional Trials</article-title>
<source/>Lancet Neurol.
          <year>2004</year>
<volume>3</volume>
<fpage>493</fpage>
<lpage>495</lpage>
<pub-id pub-id-type="doi">10.1016/S1474-4422(04)00826-9</pub-id>
<pub-id pub-id-type="pmid">15261610</pub-id>
</element-citation>
</ref>
<ref id="B319-ijms-20-05797">
<label>319.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<collab>The VITATOPS Trial Study Group</collab>
</person-group>
<article-title>B Vitamins in Patients with Recent Transient Ischemic Attack or Stroke in the VITAmins TO Prevent Stroke (VITATOPS) Trial: A Randomized, Double-Blind, Parallel, Placebo-Controlled Trial</article-title>
<source/>Lancet Neurol.
          <year>2010</year>
<volume>9</volume>
<fpage>855</fpage>
<lpage>865</lpage>
<pub-id pub-id-type="doi">10.1016/S1474-4422(10)70187-3</pub-id>
<pub-id pub-id-type="pmid">20688574</pub-id>
</element-citation>
</ref>
<ref id="B320-ijms-20-05797">
<label>320.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cavalieri</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Schmidt</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Mok</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>De Freitas</surname>
<given-names>G.R.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yi</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Ropele</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Grazer</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Homayoon</surname>
<given-names>N.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>B Vitamins and Magnetic Resonance Imaging—Detected Ischemic Brain Lesions in Patients with Recent Transient Ischemic Attack or Stroke</article-title>
<source/>Stroke
          <year>2012</year>
<volume>43</volume>
<fpage>3266</fpage>
<lpage>3270</lpage>
<pub-id pub-id-type="doi">10.1161/STROKEAHA.112.665703</pub-id>
<pub-id pub-id-type="pmid">23093615</pub-id>
</element-citation>
</ref>
<ref id="B321-ijms-20-05797">
<label>321.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Erickson</surname>
<given-names>I.K.</given-names>
</name>
<name>
<surname>Suever</surname>
<given-names>L.B.</given-names>
</name>
<name>
<surname>Prakash</surname>
<given-names>S.R.</given-names>
</name>
<name>
<surname>Colcombe</surname>
<given-names>S.J.</given-names>
</name>
<name>
<surname>McAuley</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Kramer</surname>
<given-names>A.F.</given-names>
</name>
</person-group>
<article-title>Greater Intake of Vitamins B6 and B12 Spares Gray Matter in Healthy Elderly: A Voxel-Based Morphometry Study</article-title>
<source/>Brain Res.
          <year>2009</year>
<volume>1553</volume>
<fpage>20</fpage>
<lpage>26</lpage>
<pub-id pub-id-type="doi">10.1016/j.brainres.2008.01.030</pub-id>
<pub-id pub-id-type="pmid">18281020</pub-id>
</element-citation>
</ref>
<ref id="B322-ijms-20-05797">
<label>322.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jannusch</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Jockwitz</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Bidmon</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Moebus</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Amunts</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Caspers</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>A Complex Interplay of Vitamin B1 and B6 Metabolism with Cognition, Brain Structure, and Functional Connectivity in Older Adults</article-title>
<source/>Front. Neurosci.
          <year>2017</year>
<volume>11</volume>
<fpage>596</fpage>
<pub-id pub-id-type="doi">10.3389/fnins.2017.00596</pub-id>
<pub-id pub-id-type="pmid">29163003</pub-id>
</element-citation>
</ref>
<ref id="B323-ijms-20-05797">
<label>323.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Twisk</surname>
<given-names>J.W.R.</given-names>
</name>
<name>
<surname>Prevoo</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Rauwerda</surname>
<given-names>J.A.</given-names>
</name>
</person-group>
<article-title>Effect of Homocysteine-Lowering Treatment with Folic Acid plus Vitamin B 6 on Cerebrovascular Atherosclerosis and White Matter Abnormalities as Determined by MRA and MRI: A Placebo-Controlled, Randomized Trial</article-title>
<source/>Eur. J. Clin. Investig.
          <year>2004</year>
<volume>34</volume>
<fpage>256</fpage>
<lpage>261</lpage>
<pub-id pub-id-type="pmid">15086356</pub-id>
</element-citation>
</ref>
<ref id="B324-ijms-20-05797">
<label>324.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Palacios</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Scott</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Sahasrabudhe</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Tucker</surname>
<given-names>K.L.</given-names>
</name>
</person-group>
<article-title>Lower Plasma Vitamin B-6 Is Associated with 2-Year Cognitive Decline in the Boston Puerto Rican Health Study</article-title>
<source/>J. Nutr.
          <year>2019</year>
<volume>149</volume>
<fpage>635</fpage>
<lpage>641</lpage>
<pub-id pub-id-type="doi">10.1093/jn/nxy268</pub-id>
<pub-id pub-id-type="pmid">30949683</pub-id>
</element-citation>
</ref>
<ref id="B325-ijms-20-05797">
<label>325.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Riggs</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Relations of Vitamin B-12, Homocysteine to Cognitive Aging Study1 Performance in the Normative</article-title>
<source/>Am. J. Clin. Nutr.
          <year>1996</year>
<volume>63</volume>
<fpage>306</fpage>
<lpage>314</lpage>
<pub-id pub-id-type="doi">10.1093/ajcn/63.3.306</pub-id>
<pub-id pub-id-type="pmid">8602585</pub-id>
</element-citation>
</ref>
<ref id="B326-ijms-20-05797">
<label>326.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qin</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Xun</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Jacobs</surname>
<given-names>D.R.</given-names>
<suffix>Jr.</suffix>
</name>
<name>
<surname>Zhu</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Daviglus</surname>
<given-names>M.L.</given-names>
</name>
<name>
<surname>Reis</surname>
<given-names>J.P.</given-names>
</name>
<name>
<surname>Steffen</surname>
<given-names>L.M.</given-names>
</name>
<name>
<surname>van Horn</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Sidney</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Intake of Niacin, Folate, Vitamin B-6, and Vitamin B-12 through Young Adulthood and Cognitive Function in Midlife: The Coronary Artery Risk Development in Young Adults (CARDIA) Study</article-title>
<source/>Am. J. Clin. Nutr.
          <year>2017</year>
<volume>106</volume>
<fpage>1032</fpage>
<lpage>1040</lpage>
<pub-id pub-id-type="doi">10.3945/ajcn.117.157834</pub-id>
<pub-id pub-id-type="pmid">28768650</pub-id>
</element-citation>
</ref>
<ref id="B327-ijms-20-05797">
<label>327.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tucker</surname>
<given-names>K.L.</given-names>
</name>
<name>
<surname>Qiao</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Scott</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Rosenberg</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Iii</surname>
<given-names>A.S.</given-names>
</name>
</person-group>
<article-title>High Homocysteine and Low B Vitamins Predict Cognitive Decline in Aging Men: The Veterans Affairs Normative Aging Study</article-title>
<source/>Am. J. Clin. Nutr.
          <year>2005</year>
<volume>82</volume>
<fpage>627</fpage>
<lpage>635</lpage>
<pub-id pub-id-type="doi">10.1093/ajcn/82.3.627</pub-id>
<pub-id pub-id-type="pmid">16155277</pub-id>
</element-citation>
</ref>
<ref id="B328-ijms-20-05797">
<label>328.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aisen</surname>
<given-names>P.S.</given-names>
</name>
<name>
<surname>Schneider</surname>
<given-names>L.S.</given-names>
</name>
<name>
<surname>Sano</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Diaz-Arrastia</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>van Dyck</surname>
<given-names>C.H.</given-names>
</name>
<name>
<surname>Weiner</surname>
<given-names>M.F.</given-names>
</name>
<name>
<surname>Bottiglieri</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Stokes</surname>
<given-names>K.T.</given-names>
</name>
<name>
<surname>Thomas</surname>
<given-names>R.G.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: A randomized controlled trial</article-title>
<source/>JAMA
          <year>2012</year>
<volume>300</volume>
<fpage>1774</fpage>
<lpage>1783</lpage>
<pub-id pub-id-type="doi">10.1001/jama.300.15.1774</pub-id>
</element-citation>
</ref>
<ref id="B329-ijms-20-05797">
<label>329.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>C.J.</given-names>
</name>
<name>
<surname>Chien</surname>
<given-names>K.L.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>S.T.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>R.C.</given-names>
</name>
</person-group>
<article-title>Efficacy of Multivitamin Supplementation Containing Vitamins B6 and B12 and Folic Acid as Adjunctive Treatment with a Cholinesterase Inhibitor in Alzheimer’s Disease: A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study in Taiwanese Patients</article-title>
<source/>Clin. Ther.
          <year>2007</year>
<volume>29</volume>
<pub-id pub-id-type="doi">10.1016/j.clinthera.2007.10.012</pub-id>
</element-citation>
</ref>
<ref id="B330-ijms-20-05797">
<label>330.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stott</surname>
<given-names>D.J.</given-names>
</name>
<name>
<surname>MacIntosh</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Lowe</surname>
<given-names>G.D.</given-names>
</name>
<name>
<surname>Rumley</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>McMahon</surname>
<given-names>A.D.</given-names>
</name>
<name>
<surname>Langhorne</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Tait</surname>
<given-names>R.C.</given-names>
</name>
<name>
<surname>O’Reilly</surname>
<given-names>D.S.J.</given-names>
</name>
<name>
<surname>Spilg</surname>
<given-names>E.G.</given-names>
</name>
<name>
<surname>MacDonald</surname>
<given-names>J.B.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Randomized Controlled Trial of Homocysteine-Lowering Vitamin Treatment in Elderly Patients with Vascular Disease</article-title>
<source/>Am. J. Clin. Nutr.
          <year>2005</year>
<volume>82</volume>
<fpage>1320</fpage>
<lpage>1326</lpage>
<pub-id pub-id-type="doi">10.1093/ajcn/82.6.1320</pub-id>
<pub-id pub-id-type="pmid">16332666</pub-id>
</element-citation>
</ref>
<ref id="B331-ijms-20-05797">
<label>331.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Ye</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Mu</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Efficacy of Vitamin B Supplementation on Cognition in Elderly Patients with Cognitive-Related Diseases: A Systematic Review and Meta-Analysis</article-title>
<source/>J. Geriatr. Psychiatry
          <year>2017</year>
<volume>30</volume>
<fpage>50</fpage>
<lpage>59</lpage>
<pub-id pub-id-type="doi">10.1177/0891988716673466</pub-id>
<pub-id pub-id-type="pmid">28248558</pub-id>
</element-citation>
</ref>
<ref id="B332-ijms-20-05797">
<label>332.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bryan</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Calvaresi</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Hughes</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>Short-Term Folate, Vitamin B-12 or Vitamin B-6 Supplementation Slightly Affects Memory Performance but Not Mood in Women of Various Ages</article-title>
<source/>J. Nutr.
          <year>2002</year>
<volume>132</volume>
<fpage>1345</fpage>
<lpage>1356</lpage>
<pub-id pub-id-type="doi">10.1093/jn/132.6.1345</pub-id>
<pub-id pub-id-type="pmid">12042457</pub-id>
</element-citation>
</ref>
<ref id="B333-ijms-20-05797">
<label>333.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Deijen</surname>
<given-names>J.B.</given-names>
</name>
<name>
<surname>van der Beck</surname>
<given-names>E.J.</given-names>
</name>
<name>
<surname>Orlebeke</surname>
<given-names>J.F.</given-names>
</name>
<name>
<surname>van der Berg</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Vitamin B-6 Supplementation in Elderly Men: Effects on Mood, Memory, Performance and Mental Effort</article-title>
<source/>Psychopharmacology
          <year>1992</year>
<volume>109</volume>
<fpage>489</fpage>
<lpage>496</lpage>
<pub-id pub-id-type="doi">10.1007/BF02247729</pub-id>
<pub-id pub-id-type="pmid">1365868</pub-id>
</element-citation>
</ref>
<ref id="B334-ijms-20-05797">
<label>334.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Malouf</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Evans</surname>
<given-names>J.G.</given-names>
</name>
</person-group>
<article-title>The Effect of Vitamin B6 on Cognition</article-title>
<source/>Cochrane Database Syst. Rev.
          <year>2003</year>
<volume>4</volume>
<elocation-id>CD004393</elocation-id>
<pub-id pub-id-type="doi">10.1002/14651858.CD004393</pub-id>
</element-citation>
</ref>
<ref id="B335-ijms-20-05797">
<label>335.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hassel</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Rogne</surname>
<given-names>A.G.</given-names>
</name>
<name>
<surname>Hope</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Intellectual Disability Associated with Pyridoxine-Responsive Epilepsies: The Need to Protect Cognitive Development</article-title>
<source/>Front. Psychiatry
          <year>2019</year>
<volume>10</volume>
<fpage>116</fpage>
<pub-id pub-id-type="doi">10.3389/fpsyt.2019.00116</pub-id>
<pub-id pub-id-type="pmid">30930802</pub-id>
</element-citation>
</ref>
<ref id="B336-ijms-20-05797">
<label>336.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tourbah</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Lebrun-Frenay</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Edan</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Clanet</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Papeix</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Vukusic</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>De Sèze</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Debouverie</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Gout</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Clavelou</surname>
<given-names>P.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>MD1003 (High-Dose Biotin) for the Treatment of Progressive Multiple Sclerosis: A Randomised, Double-Blind, Placebo-Controlled Study</article-title>
<source/>Mult. Scler. J.
          <year>2016</year>
<volume>22</volume>
<fpage>1719</fpage>
<lpage>1731</lpage>
<pub-id pub-id-type="doi">10.1177/1352458516667568</pub-id>
</element-citation>
</ref>
<ref id="B337-ijms-20-05797">
<label>337.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mikkelsen</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Stojanovska</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Apostolopoulos</surname>
<given-names>V.</given-names>
</name>
</person-group>
<article-title>The Effects of Vitamin B in Depression</article-title>
<source/>Curr. Med. Chem.
          <year>2016</year>
<volume>23</volume>
<fpage>4317</fpage>
<lpage>4337</lpage>
<pub-id pub-id-type="doi">10.2174/0929867323666160920110810</pub-id>
<pub-id pub-id-type="pmid">27655070</pub-id>
</element-citation>
</ref>
<ref id="B338-ijms-20-05797">
<label>338.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zempleni</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wijeratne</surname>
<given-names>S.S.K.</given-names>
</name>
<name>
<surname>Hassan</surname>
<given-names>Y.I.</given-names>
</name>
</person-group>
<article-title>Biotin</article-title>
<source/>Biofactors
          <year>2016</year>
<volume>35</volume>
<fpage>36</fpage>
<lpage>46</lpage>
<pub-id pub-id-type="doi">10.1002/biof.8</pub-id>
</element-citation>
</ref>
<ref id="B339-ijms-20-05797">
<label>339.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dakshinamurti</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Biotin—A Regulator of Gene Expression B</article-title>
<source/>J. Nutr. Biochem.
          <year>2005</year>
<volume>16</volume>
<fpage>419</fpage>
<lpage>423</lpage>
<pub-id pub-id-type="doi">10.1016/j.jnutbio.2005.03.015</pub-id>
<pub-id pub-id-type="pmid">15992682</pub-id>
</element-citation>
</ref>
<ref id="B340-ijms-20-05797">
<label>340.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zempleni</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Uptake, Localization and Noncarboxylase Roles of Biotin</article-title>
<source/>Annu. Rev. Nutr.
          <year>2005</year>
<volume>25</volume>
<fpage>175</fpage>
<lpage>196</lpage>
<pub-id pub-id-type="doi">10.1146/annurev.nutr.25.121304.131724</pub-id>
<pub-id pub-id-type="pmid">16011464</pub-id>
</element-citation>
</ref>
<ref id="B341-ijms-20-05797">
<label>341.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mccarty</surname>
<given-names>M.F.</given-names>
</name>
<name>
<surname>Dinicolantonio</surname>
<given-names>J.J.</given-names>
</name>
</person-group>
<article-title>Neuroprotective Potential of High-Dose Biotin</article-title>
<source/>Med. Hypotheses
          <year>2017</year>
<volume>109</volume>
<fpage>145</fpage>
<lpage>149</lpage>
<pub-id pub-id-type="doi">10.1016/j.mehy.2017.10.012</pub-id>
<pub-id pub-id-type="pmid">29150274</pub-id>
</element-citation>
</ref>
<ref id="B342-ijms-20-05797">
<label>342.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abdel-Magied</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Shedid</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Ahmed</surname>
<given-names>A.G.</given-names>
</name>
</person-group>
<article-title>Mitigating Effect of Biotin against Irradiation-Induced Cerebral Cortical and Hippocampal Damage in the Rat Brain Tissue</article-title>
<source/>Environ. Sci. Pollut. Res.
          <year>2019</year>
<volume>26</volume>
<fpage>13441</fpage>
<lpage>13452</lpage>
<pub-id pub-id-type="doi">10.1007/s11356-019-04806-x</pub-id>
<pub-id pub-id-type="pmid">30911963</pub-id>
</element-citation>
</ref>
<ref id="B343-ijms-20-05797">
<label>343.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Madsen</surname>
<given-names>C.T.</given-names>
</name>
<name>
<surname>Sylvestersen</surname>
<given-names>K.B.</given-names>
</name>
<name>
<surname>Young</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Larsen</surname>
<given-names>S.C.</given-names>
</name>
<name>
<surname>Poulsen</surname>
<given-names>J.W.</given-names>
</name>
<name>
<surname>Andersen</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Palmqvist</surname>
<given-names>E.A.</given-names>
</name>
<name>
<surname>Hey-Mogensen</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Jensen</surname>
<given-names>P.B.</given-names>
</name>
<name>
<surname>Treebak</surname>
<given-names>J.T.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Biotin starvation causes mitochondrial protein hyperacetylation and partial rescue by the SIRT3-like deacetylase Hst4p</article-title>
<source/>Nat. Commun.
          <year>2015</year>
<volume>6</volume>
<fpage>7726</fpage>
<pub-id pub-id-type="doi">10.1038/ncomms8726</pub-id>
<pub-id pub-id-type="pmid">26158509</pub-id>
</element-citation>
</ref>
<ref id="B344-ijms-20-05797">
<label>344.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Watanabe-Kamiyama</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kamiyama</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Horiuchi</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Ohinata</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Shirakawa</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Furukawa</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Komai</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Antihypertensive Effect of Biotin in Stroke-Prone Spontaneously Hypertensive Rats</article-title>
<source/>Br. J. Nutr.
          <year>2008</year>
<volume>99</volume>
<fpage>756</fpage>
<lpage>763</lpage>
<pub-id pub-id-type="doi">10.1017/S0007114507841122</pub-id>
<pub-id pub-id-type="pmid">18179728</pub-id>
</element-citation>
</ref>
<ref id="B345-ijms-20-05797">
<label>345.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Suormala</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Wiesmann</surname>
<given-names>U.N.</given-names>
</name>
<name>
<surname>Cruz</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Wolf</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Daschner</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Limat</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Fowler</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Baumgartner</surname>
<given-names>E.R.</given-names>
</name>
</person-group>
<article-title>Biotin-Dependent Carboxylase Activities in Different CNS and Skin-Derived Cells, and Their Sensitivity to Biotin-Depletion</article-title>
<source/>Int. J. Vitam. Nutr. Res.
          <year>2002</year>
<volume>72</volume>
<fpage>278</fpage>
<lpage>286</lpage>
<pub-id pub-id-type="doi">10.1024/0300-9831.72.4.278</pub-id>
<pub-id pub-id-type="pmid">12214565</pub-id>
</element-citation>
</ref>
<ref id="B346-ijms-20-05797">
<label>346.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fukuwatari</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Wada</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Shibata</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Ukuwatari</surname>
<given-names>T.F.</given-names>
</name>
<name>
<surname>Ada</surname>
<given-names>H.W.</given-names>
</name>
<name>
<surname>Hibata</surname>
<given-names>K.S.</given-names>
</name>
</person-group>
<article-title>Age-Related Alterations of B-Group Vitamin Contents in Urine, Blood and Liver from Rats</article-title>
<source/>J. Nutr. Sci. Vitaminol.
          <year>2008</year>
<volume>54</volume>
<fpage>357</fpage>
<lpage>362</lpage>
<pub-id pub-id-type="doi">10.3177/jnsv.54.357</pub-id>
<pub-id pub-id-type="pmid">19001766</pub-id>
</element-citation>
</ref>
<ref id="B347-ijms-20-05797">
<label>347.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Watanabe</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Yasumura</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Shibata</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Biotin Status and Its Correlation with Other Biochemical Parameters in the Elderly People of Japan</article-title>
<source/>J. Am. Coll. Nutr.
          <year>1998</year>
<volume>17</volume>
<fpage>37</fpage>
<lpage>41</lpage>
<pub-id pub-id-type="doi">10.1080/07315724.1998.10720454</pub-id>
</element-citation>
</ref>
<ref id="B348-ijms-20-05797">
<label>348.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McKay</surname>
<given-names>B.E.</given-names>
</name>
<name>
<surname>Molineux</surname>
<given-names>M.L.</given-names>
</name>
<name>
<surname>Turner</surname>
<given-names>R.W.</given-names>
</name>
</person-group>
<article-title>Biotin Is Endogenously Expressed in Select Regions of the Rat Central Nervous System</article-title>
<source/>J. Comp. Neurol.
          <year>2004</year>
<volume>473</volume>
<fpage>86</fpage>
<lpage>96</lpage>
<pub-id pub-id-type="doi">10.1002/cne.20109</pub-id>
<pub-id pub-id-type="pmid">15067720</pub-id>
</element-citation>
</ref>
<ref id="B349-ijms-20-05797">
<label>349.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Spector</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Mock</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>Biotin Transport Through the Blood-Brain Barrier</article-title>
<source/>J. Neurochem.
          <year>1987</year>
<volume>48</volume>
<fpage>400</fpage>
<lpage>404</lpage>
<pub-id pub-id-type="doi">10.1111/j.1471-4159.1987.tb04107.x</pub-id>
<pub-id pub-id-type="pmid">3098919</pub-id>
</element-citation>
</ref>
<ref id="B350-ijms-20-05797">
<label>350.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lo</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Kaldleck</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Packman</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Biotin Transport in the Rat Central Nervous System</article-title>
<source/>J. Nutr. Sci. Vitaminol.
          <year>1991</year>
<volume>37</volume>
<fpage>567</fpage>
<lpage>572</lpage>
<pub-id pub-id-type="doi">10.3177/jnsv.37.567</pub-id>
<pub-id pub-id-type="pmid">1819645</pub-id>
</element-citation>
</ref>
<ref id="B351-ijms-20-05797">
<label>351.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kassem</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Wafaie</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Alsuhibani</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Farid</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Biotin-Responsive Basal Ganglia Disease: Neuroimaging Features before and after Treatment</article-title>
<source/>AJNR Am. J. Neuroradiol.
          <year>2014</year>
<volume>35</volume>
<fpage>1990</fpage>
<lpage>1995</lpage>
<pub-id pub-id-type="doi">10.3174/ajnr.A3966</pub-id>
<pub-id pub-id-type="pmid">24812013</pub-id>
</element-citation>
</ref>
<ref id="B352-ijms-20-05797">
<label>352.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yatzidis</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Kutsicos</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Agroyannis</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Papastephanidis</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Francos-Plemenos</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Delatola</surname>
<given-names>Z.</given-names>
</name>
</person-group>
<article-title>Biotin in the Managment of Uremic Neurologic Disorders</article-title>
<source/>Nephron
          <year>1984</year>
<volume>36</volume>
<fpage>183</fpage>
<lpage>186</lpage>
<pub-id pub-id-type="doi">10.1159/000183149</pub-id>
<pub-id pub-id-type="pmid">6322032</pub-id>
</element-citation>
</ref>
<ref id="B353-ijms-20-05797">
<label>353.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koutsikos</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Agroyannis</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Tzanatos-Exarchou</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Biotin for Diabetic Peripheral Neuropathy</article-title>
<source/>Biomed. Pharmacother.
          <year>1990</year>
<volume>44</volume>
<fpage>511</fpage>
<lpage>514</lpage>
<pub-id pub-id-type="doi">10.1016/0753-3322(90)90171-5</pub-id>
<pub-id pub-id-type="pmid">2085665</pub-id>
</element-citation>
</ref>
<ref id="B354-ijms-20-05797">
<label>354.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Birnbaum</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Stulc</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>High Dose Biotin as Treatment for Progressive Multiple Sclerosis</article-title>
<source/>Mult. Scler. Relat. Disord.
          <year>2017</year>
<volume>18</volume>
<fpage>141</fpage>
<lpage>143</lpage>
<pub-id pub-id-type="doi">10.1016/j.msard.2017.09.030</pub-id>
<pub-id pub-id-type="pmid">29141796</pub-id>
</element-citation>
</ref>
<ref id="B355-ijms-20-05797">
<label>355.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sedel</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Bernard</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Mock</surname>
<given-names>D.M.</given-names>
</name>
<name>
<surname>Tourbah</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Targeting Demyelination and Virtual Hypoxia with High-Dose Biotin as a Treatment for Progressive Multiple Sclerosis</article-title>
<source/>Neuropharmacology
          <year>2015</year>
<volume>110</volume>
<fpage>644</fpage>
<lpage>653</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuropharm.2015.08.028</pub-id>
<pub-id pub-id-type="pmid">26327679</pub-id>
</element-citation>
</ref>
<ref id="B356-ijms-20-05797">
<label>356.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Melichar</surname>
<given-names>V.O.</given-names>
</name>
<name>
<surname>Behr-Roussel</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Zabel</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Uttenthal</surname>
<given-names>L.O.</given-names>
</name>
<name>
<surname>Rodrigo</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Rupin</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Verbeuren</surname>
<given-names>T.J.</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>H.S.A.</given-names>
</name>
<name>
<surname>Schmidt</surname>
<given-names>H.H.H.W.</given-names>
</name>
</person-group>
<article-title>Reduced cGMP Signaling Associated with Neointimal Proliferation and Vascular Dysfunction in Late-Stage Atherosclerosis</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2004</year>
<volume>101</volume>
<fpage>16671</fpage>
<lpage>16676</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0405509101</pub-id>
<pub-id pub-id-type="pmid">15546990</pub-id>
</element-citation>
</ref>
<ref id="B357-ijms-20-05797">
<label>357.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ahluwalia</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Foster</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Scotland</surname>
<given-names>R.S.</given-names>
</name>
<name>
<surname>Mclean</surname>
<given-names>P.G.</given-names>
</name>
<name>
<surname>Mathur</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Perretti</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Moncada</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Hobbs</surname>
<given-names>A.J.</given-names>
</name>
</person-group>
<article-title>Antiinflammatory Activity of Soluble Guanylate Cyclase: cGMP-Dependent Down-Regulation of P-Selectin Expression and Leukocyte Recruitment</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2004</year>
<volume>101</volume>
<fpage>1386</fpage>
<lpage>1391</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0304264101</pub-id>
<pub-id pub-id-type="pmid">14742866</pub-id>
</element-citation>
</ref>
<ref id="B358-ijms-20-05797">
<label>358.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Su</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>NF-kB Activation and Cell Death after Intracerebral Hemorrhage in Patients</article-title>
<source/>Neurol. Sci.
          <year>2014</year>
<volume>35</volume>
<fpage>1097</fpage>
<lpage>1102</lpage>
<pub-id pub-id-type="doi">10.1007/s10072-014-1657-0</pub-id>
<pub-id pub-id-type="pmid">24510152</pub-id>
</element-citation>
</ref>
<ref id="B359-ijms-20-05797">
<label>359.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gonos</surname>
<given-names>E.S.</given-names>
</name>
<name>
<surname>Kapetanou</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sereikaite</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Bartosz</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Naparło</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Grzesik</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sadowska-Bartosz</surname>
<given-names>I.</given-names>
</name>
</person-group>
<article-title>Origin and pathophysiology of protein carbonylation, nitration and chlorination in age-related brain diseases and aging</article-title>
<source/>Aging
          <year>2018</year>
<volume>10</volume>
<fpage>868</fpage>
<lpage>901</lpage>
<pub-id pub-id-type="doi">10.18632/aging.101450</pub-id>
<pub-id pub-id-type="pmid">29779015</pub-id>
</element-citation>
</ref>
<ref id="B360-ijms-20-05797">
<label>360.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moretti</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Dal Ben</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Gazzin</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Tiribelli</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Homocysteine in Neurology: From Endothelium to Neurodegeneration</article-title>
<source/>Curr. Nutr. Food Sci.
          <year>2017</year>
<volume>13</volume>
<fpage>163</fpage>
<lpage>175</lpage>
<pub-id pub-id-type="doi">10.2174/1573401313666170213155338</pub-id>
</element-citation>
</ref>
<ref id="B361-ijms-20-05797">
<label>361.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barber</surname>
<given-names>R.C.</given-names>
</name>
<name>
<surname>Lammer</surname>
<given-names>E.J.</given-names>
</name>
<name>
<surname>Shaw</surname>
<given-names>G.M.</given-names>
</name>
<name>
<surname>Greer</surname>
<given-names>K.A.</given-names>
</name>
<name>
<surname>Finnell</surname>
<given-names>R.H.</given-names>
</name>
</person-group>
<article-title>The role of folate transport and metabolism in neural tube defect risk</article-title>
<source/>Mol. Genet. Metab.
          <year>1999</year>
<volume>66</volume>
<fpage>1</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="doi">10.1006/mgme.1998.2787</pub-id>
<pub-id pub-id-type="pmid">9973541</pub-id>
</element-citation>
</ref>
<ref id="B362-ijms-20-05797">
<label>362.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kamen</surname>
<given-names>B.A.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>A.K.</given-names>
</name>
</person-group>
<article-title>A review of folate receptor alpha cycling and 5-methyltetrahydrofolate accumulation with an emphasis on cell models in vitro</article-title>
<source/>Adv. Drug Deliv. Rev.
          <year>2004</year>
<volume>56</volume>
<fpage>1085</fpage>
<lpage>1097</lpage>
<pub-id pub-id-type="doi">10.1016/j.addr.2004.01.002</pub-id>
<pub-id pub-id-type="pmid">15094208</pub-id>
</element-citation>
</ref>
<ref id="B363-ijms-20-05797">
<label>363.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mahmood</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Folic acid and vitamin B12 deficiency</article-title>
<source/>J. Health Res. Rev. Dev. Ctries.
          <year>2014</year>
<volume>1</volume>
<fpage>5</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="doi">10.4103/2394-2010.143318</pub-id>
</element-citation>
</ref>
<ref id="B364-ijms-20-05797">
<label>364.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Qin</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Demirtas</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Mao</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Huo</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>X.</given-names>
</name>
</person-group>
<article-title>Efficacy of folic acid supplementation in stroke prevention: A meta-analysis</article-title>
<source/>Lancet
          <year>2007</year>
<volume>369</volume>
<fpage>1876</fpage>
<lpage>1882</lpage>
<pub-id pub-id-type="doi">10.1016/S0140-6736(07)60854-X</pub-id>
<pub-id pub-id-type="pmid">17544768</pub-id>
</element-citation>
</ref>
<ref id="B365-ijms-20-05797">
<label>365.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McNulty</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Folate requirements for health in different population groups</article-title>
<source/>Br. J. Biomed. Sci.
          <year>1995</year>
<volume>52</volume>
<fpage>110</fpage>
<lpage>119</lpage>
<pub-id pub-id-type="pmid">8520248</pub-id>
</element-citation>
</ref>
<ref id="B366-ijms-20-05797">
<label>366.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stolzenberg</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Possible folate deficiency with postsurgical infection</article-title>
<source/>Nutr. Clin. Pract. Off. Publ. Am. Soc. Parenter. Nutr.
          <year>1994</year>
<volume>9</volume>
<fpage>247</fpage>
<lpage>250</lpage>
<pub-id pub-id-type="doi">10.1177/0115426594009006247</pub-id>
</element-citation>
</ref>
<ref id="B367-ijms-20-05797">
<label>367.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pietrzik</surname>
<given-names>K.F.</given-names>
</name>
<name>
<surname>Thorand</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>Folate economy in pregnancy</article-title>
<source/>Nutrition
          <year>1997</year>
<volume>13</volume>
<fpage>975</fpage>
<lpage>977</lpage>
<pub-id pub-id-type="doi">10.1016/S0899-9007(97)00340-7</pub-id>
<pub-id pub-id-type="pmid">9433714</pub-id>
</element-citation>
</ref>
<ref id="B368-ijms-20-05797">
<label>368.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoffbrand</surname>
<given-names>A.V.</given-names>
</name>
<name>
<surname>Weir</surname>
<given-names>D.G.</given-names>
</name>
</person-group>
<article-title>The history of folic acid</article-title>
<source/>Br. J. Haematol.
          <year>2001</year>
<volume>113</volume>
<fpage>579</fpage>
<lpage>589</lpage>
<pub-id pub-id-type="doi">10.1046/j.1365-2141.2001.02822.x</pub-id>
<pub-id pub-id-type="pmid">11380441</pub-id>
</element-citation>
</ref>
<ref id="B369-ijms-20-05797">
<label>369.</label>
<element-citation publication-type="web">
<person-group person-group-type="author">
<name>
<surname>Folate Evidence—Mayo Clinic</surname>
<given-names>N.D.</given-names>
</name>
</person-group>
<article-title>Available online</article-title>
<comment>Available online: <ext-link ext-link-type="uri" xlink:href="http://www.mayoclinic.org/drugs-supplements/folate/evidence/hrb-20059475">http://www.mayoclinic.org/drugs-supplements/folate/evidence/hrb-20059475</ext-link></comment>
<date-in-citation content-type="access-date" iso-8601-date="2019-08-15">(accessed on 15 August 2019)</date-in-citation>
</element-citation>
</ref>
<ref id="B370-ijms-20-05797">
<label>370.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bailey</surname>
<given-names>L.B.</given-names>
</name>
<name>
<surname>Stover</surname>
<given-names>P.J.</given-names>
</name>
<name>
<surname>McNulty</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Fenech</surname>
<given-names>M.F.</given-names>
</name>
<name>
<surname>Gregory</surname>
<given-names>J.F.</given-names>
</name>
<name>
<surname>Mills</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Pfeiffer</surname>
<given-names>C.M.</given-names>
</name>
<name>
<surname>Fazili</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ueland</surname>
<given-names>P.M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Biomarkers of Nutrition for Development-Folate Review</article-title>
<source/>J. Nutr.
          <year>2015</year>
<volume>145</volume>
<fpage>1636S</fpage>
<lpage>1680S</lpage>
<pub-id pub-id-type="doi">10.3945/jn.114.206599</pub-id>
<pub-id pub-id-type="pmid">26451605</pub-id>
</element-citation>
</ref>
<ref id="B371-ijms-20-05797">
<label>371.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Froese</surname>
<given-names>D.S.</given-names>
</name>
<name>
<surname>Fowler</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Baumgartner</surname>
<given-names>M.R.</given-names>
</name>
</person-group>
<article-title>Vitamin B12, folate and the methionine remethylation cycle-biochemistry, pathways and regulation</article-title>
<source/>J. Inher. Metab. Disord.
          <year>2019</year>
<volume>42</volume>
<fpage>673</fpage>
<lpage>685</lpage>
<pub-id pub-id-type="doi">10.1002/jimd.12009</pub-id>
<pub-id pub-id-type="pmid">30693532</pub-id>
</element-citation>
</ref>
<ref id="B372-ijms-20-05797">
<label>372.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Van Overbeek</surname>
<given-names>E.C.</given-names>
</name>
<name>
<surname>Staals</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>van Oostenbrugge</surname>
<given-names>R.J.</given-names>
</name>
</person-group>
<article-title>Vitamin B12 and Progression of White Matter Lesions. A 2-Year Follow-Up Study in First-Ever Lacunar Stroke Patients</article-title>
<source/>PLoS ONE
          <year>2013</year>
<volume>8</volume>
<elocation-id>e78100</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0078100</pub-id>
<pub-id pub-id-type="pmid">24155983</pub-id>
</element-citation>
</ref>
<ref id="B373-ijms-20-05797">
<label>373.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Obeid</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Herrmann</surname>
<given-names>W.</given-names>
</name>
</person-group>
<article-title>Mechanisms of homocysteine neurotoxicity in neurodegenerative diseases with special reference to dementia</article-title>
<source/>FEBS Lett.
          <year>2006</year>
<volume>580</volume>
<fpage>2994</fpage>
<lpage>3005</lpage>
<pub-id pub-id-type="doi">10.1016/j.febslet.2006.04.088</pub-id>
<pub-id pub-id-type="pmid">16697371</pub-id>
</element-citation>
</ref>
<ref id="B374-ijms-20-05797">
<label>374.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nilsson-Ehle</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Age-related changes in cobalamin (vitamin B12) handling. Implications for therapy</article-title>
<source/>Drugs Aging
          <year>1998</year>
<volume>12</volume>
<fpage>277</fpage>
<lpage>292</lpage>
<pub-id pub-id-type="doi">10.2165/00002512-199812040-00003</pub-id>
<pub-id pub-id-type="pmid">9571392</pub-id>
</element-citation>
</ref>
<ref id="B375-ijms-20-05797">
<label>375.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miles</surname>
<given-names>L.M.</given-names>
</name>
<name>
<surname>Allen</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Mills</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Clarke</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Uauy</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Dangour</surname>
<given-names>A.D.</given-names>
</name>
</person-group>
<article-title>Vitamin B-12 status and neurologic function in older people: A cross-sectional analysis of baseline trial data from the Older People and Enhanced Neurological Function (OPEN) study</article-title>
<source/>Am. J. Clin. Nutr.
          <year>2016</year>
<volume>104</volume>
<fpage>790</fpage>
<lpage>796</lpage>
<pub-id pub-id-type="doi">10.3945/ajcn.116.137927</pub-id>
<pub-id pub-id-type="pmid">27534645</pub-id>
</element-citation>
</ref>
<ref id="B376-ijms-20-05797">
<label>376.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Tamparo</surname>
<given-names>C.D.</given-names>
</name>
<name>
<surname>Marcia</surname>
<given-names>L.A.</given-names>
</name>
</person-group>
<source/>Diseases of the Human Body
          <edition>5th ed.</edition>
<publisher-name>F. A. Davis Company</publisher-name>
<publisher-loc>Philadelphia, PA, USA</publisher-loc>
<year>2011</year>
</element-citation>
</ref>
<ref id="B377-ijms-20-05797">
<label>377.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dowd</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Shapiro</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Letter: The mechanisms of action of vitamin B12</article-title>
<source/>J. Am. Chem. Soc.
          <year>1975</year>
<volume>97</volume>
<fpage>4754</fpage>
<lpage>4757</lpage>
<pub-id pub-id-type="doi">10.1021/ja00849a048</pub-id>
<pub-id pub-id-type="pmid">1159228</pub-id>
</element-citation>
</ref>
<ref id="B378-ijms-20-05797">
<label>378.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reynolds</surname>
<given-names>E.H.</given-names>
</name>
</person-group>
<article-title>Benefits and risks of folic acid to the nervous system</article-title>
<source/>J. Neurol. Neurosurg. Psychiatry
          <year>2002</year>
<volume>72</volume>
<fpage>567</fpage>
<lpage>571</lpage>
<pub-id pub-id-type="doi">10.1136/jnnp.72.5.567</pub-id>
<pub-id pub-id-type="pmid">11971038</pub-id>
</element-citation>
</ref>
<ref id="B379-ijms-20-05797">
<label>379.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Ford</surname>
<given-names>E.S.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Greenlund</surname>
<given-names>K.J.</given-names>
</name>
<name>
<surname>Croft</surname>
<given-names>J.B.</given-names>
</name>
<name>
<surname>Balluz</surname>
<given-names>L.S.</given-names>
</name>
</person-group>
<article-title>Use of folic Acid and vitamin supplementation among adults with depression and anxiety: A cross-sectional, population-based survey</article-title>
<source/>Nutr. J.
          <year>2011</year>
<volume>10</volume>
<fpage>102</fpage>
<pub-id pub-id-type="doi">10.1186/1475-2891-10-102</pub-id>
<pub-id pub-id-type="pmid">21962075</pub-id>
</element-citation>
</ref>
<ref id="B380-ijms-20-05797">
<label>380.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moretti</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Torre</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Antonello</surname>
<given-names>R.M.</given-names>
</name>
<name>
<surname>Cazzato</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>Is isolated vitamin B12 deficiency a sufficient causative factor of dementia?</article-title>
<source/>Eur. J. Neurol.
          <year>2001</year>
<volume>8</volume>
<fpage>87</fpage>
<lpage>88</lpage>
<pub-id pub-id-type="doi">10.1046/j.1468-1331.2001.00163.x</pub-id>
<pub-id pub-id-type="pmid">11509087</pub-id>
</element-citation>
</ref>
<ref id="B381-ijms-20-05797">
<label>381.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ubbink</surname>
<given-names>J.B.</given-names>
</name>
</person-group>
<article-title>Should all elderly people receive folate supplements?</article-title>
<source/>Drugs Aging
          <year>1998</year>
<volume>13</volume>
<fpage>415</fpage>
<lpage>420</lpage>
<pub-id pub-id-type="doi">10.2165/00002512-199813060-00001</pub-id>
<pub-id pub-id-type="pmid">9883397</pub-id>
</element-citation>
</ref>
<ref id="B382-ijms-20-05797">
<label>382.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mollin</surname>
<given-names>D.L.</given-names>
</name>
<name>
<surname>Ross</surname>
<given-names>G.I.</given-names>
</name>
</person-group>
<article-title>Serum vitamin B12 concentrations of patients with megaloblastic anemia after treatment with vitamin B12, folic acid, or folinic acid</article-title>
<source/>Br. Med. J.
          <year>1953</year>
<volume>2</volume>
<fpage>640</fpage>
<lpage>645</lpage>
<pub-id pub-id-type="doi">10.1136/bmj.2.4837.640</pub-id>
<pub-id pub-id-type="pmid">13082065</pub-id>
</element-citation>
</ref>
<ref id="B383-ijms-20-05797">
<label>383.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lucock</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Is folic acid the ultimate functional food component for disease prevention?</article-title>
<source/>BMJ
          <year>2004</year>
<volume>328</volume>
<fpage>211</fpage>
<lpage>214</lpage>
<pub-id pub-id-type="doi">10.1136/bmj.328.7433.211</pub-id>
<pub-id pub-id-type="pmid">14739191</pub-id>
</element-citation>
</ref>
<ref id="B384-ijms-20-05797">
<label>384.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Malnick</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Goland</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Folic acid as ultimate in disease prevention: Beware of vitamin B12 deficiency</article-title>
<source/>BMJ
          <year>2004</year>
<volume>328</volume>
<fpage>769</fpage>
<pub-id pub-id-type="doi">10.1136/bmj.328.7442.769</pub-id>
<pub-id pub-id-type="pmid">15044308</pub-id>
</element-citation>
</ref>
<ref id="B385-ijms-20-05797">
<label>385.</label>
<element-citation publication-type="gov">
<article-title>Dietary Supplement Fact Sheet: Vitamin B12—Health Professional Fact Sheet, N.D.</article-title>
<comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://ods.od.nih.gov/factsheets/VitaminB12-HealthProfessional/">https://ods.od.nih.gov/factsheets/VitaminB12-HealthProfessional/</ext-link></comment>
<date-in-citation content-type="access-date" iso-8601-date="2019-08-15">(accessed on 15 August 2019)</date-in-citation>
</element-citation>
</ref>
<ref id="B386-ijms-20-05797">
<label>386.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Elmadfa</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Singer</surname>
<given-names>I.</given-names>
</name>
</person-group>
<article-title>Vitamin B12 and homocysteine status among vegetarians: A global perspective</article-title>
<source/>Am. J. Clin. Nut.
          <year>2009</year>
<volume>89</volume>
<fpage>S1693</fpage>
<lpage>S1698</lpage>
<pub-id pub-id-type="doi">10.3945/ajcn.2009.26736Y</pub-id>
<pub-id pub-id-type="pmid">19357223</pub-id>
</element-citation>
</ref>
<ref id="B387-ijms-20-05797">
<label>387.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<collab>Institute of Medicine</collab>
</person-group>
<source/>Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Panthotenic Acid, Biotin, and Choline
          <publisher-name>National Academy Press</publisher-name>
<publisher-loc>Washington, DC, USA</publisher-loc>
<year>1999</year>
</element-citation>
</ref>
<ref id="B388-ijms-20-05797">
<label>388.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meadows</surname>
<given-names>M.E.</given-names>
</name>
<name>
<surname>Kaplan</surname>
<given-names>R.F.</given-names>
</name>
<name>
<surname>Bromfield</surname>
<given-names>E.B.</given-names>
</name>
</person-group>
<article-title>Cognitive recovery with vitamin B12 therapy: A longitudinal neuropsychological assessment</article-title>
<source/>Neurology
          <year>1994</year>
<volume>44</volume>
<fpage>1764</fpage>
<lpage>1765</lpage>
<pub-id pub-id-type="doi">10.1212/WNL.44.9.1764</pub-id>
<pub-id pub-id-type="pmid">7936315</pub-id>
</element-citation>
</ref>
<ref id="B389-ijms-20-05797">
<label>389.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eastley</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Wilcock</surname>
<given-names>G.K.</given-names>
</name>
<name>
<surname>Bucks</surname>
<given-names>R.S.</given-names>
</name>
</person-group>
<article-title>Vitamin B12 deficiency in dementia and cognitive impairment: The effects of treatment on neuropsychological function</article-title>
<source/>Int. J. Geriatr. Psychiatry
          <year>2000</year>
<volume>15</volume>
<fpage>226</fpage>
<lpage>233</lpage>
<pub-id pub-id-type="doi">10.1002/(SICI)1099-1166(200003)15:3&lt;226::AID-GPS98&gt;3.0.CO;2-K</pub-id>
<pub-id pub-id-type="pmid">10713580</pub-id>
</element-citation>
</ref>
<ref id="B390-ijms-20-05797">
<label>390.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Teunisse</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Bollen</surname>
<given-names>A.E.</given-names>
</name>
<name>
<surname>van Gool</surname>
<given-names>W.A.</given-names>
</name>
<name>
<surname>Walstra</surname>
<given-names>G.J.</given-names>
</name>
</person-group>
<article-title>Dementia and subnormal levels of vitamin B12: Effects of replacement therapy on dementia</article-title>
<source/>J. Neurol.
          <year>1996</year>
<volume>243</volume>
<fpage>522</fpage>
<lpage>529</lpage>
<pub-id pub-id-type="doi">10.1007/BF00886874</pub-id>
<pub-id pub-id-type="pmid">8836942</pub-id>
</element-citation>
</ref>
<ref id="B391-ijms-20-05797">
<label>391.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wahlin</surname>
<given-names>T.B.R.</given-names>
</name>
<name>
<surname>Wahlin</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Winblad</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Bäckman</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>The influence of serum vitamin B12 and folate status on cognitive functioning in very old age</article-title>
<source/>Biol. Psychol.
          <year>2001</year>
<volume>56</volume>
<fpage>247</fpage>
<lpage>265</lpage>
<pub-id pub-id-type="doi">10.1016/S0301-0511(01)00079-5</pub-id>
<pub-id pub-id-type="pmid">11399353</pub-id>
</element-citation>
</ref>
<ref id="B392-ijms-20-05797">
<label>392.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fioravanti</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ferrario</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Massaia</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Cappa</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Rivolta</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Grossi</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Buckley</surname>
<given-names>A.E.</given-names>
</name>
</person-group>
<article-title>Low folate levels in the cognitive decline of elderly patients and the efficacy of folate as a treatment for improving memory deficits</article-title>
<source/>Arch. Gerontol. Geriatr.
          <year>1998</year>
<volume>26</volume>
<fpage>1</fpage>
<lpage>13</lpage>
<pub-id pub-id-type="doi">10.1016/S0167-4943(97)00028-9</pub-id>
<pub-id pub-id-type="pmid">18653121</pub-id>
</element-citation>
</ref>
<ref id="B393-ijms-20-05797">
<label>393.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hassing</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Wahlin</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Winblad</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Bäckman</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Further evidence on the effects of vitamin B12 and folate levels on episodic memory functioning: A population-based study of healthy very old adults</article-title>
<source/>Biol. Psychiatry
          <year>1999</year>
<volume>45</volume>
<fpage>1472</fpage>
<lpage>1480</lpage>
<pub-id pub-id-type="doi">10.1016/S0006-3223(98)00234-0</pub-id>
<pub-id pub-id-type="pmid">10356630</pub-id>
</element-citation>
</ref>
<ref id="B394-ijms-20-05797">
<label>394.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eussen</surname>
<given-names>S.J.P.M.</given-names>
</name>
<name>
<surname>Ferry</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hininger</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Haller</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Matthys</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Dirren</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Five year changes in mental health and associations with vitamin B12/folate status of elderly Europeans</article-title>
<source/>J. Nutr. Health Aging
          <year>2002</year>
<volume>6</volume>
<fpage>43</fpage>
<lpage>50</lpage>
<pub-id pub-id-type="pmid">11813081</pub-id>
</element-citation>
</ref>
<ref id="B395-ijms-20-05797">
<label>395.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nilsson</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Gustafson</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Hultberg</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>Improvement of cognitive functions after cobalamin/folate supplementation in elderly patients with dementia and elevated plasma homocysteine</article-title>
<source/>Int. J. Geriatr. Psychiatry
          <year>2001</year>
<volume>16</volume>
<fpage>609</fpage>
<lpage>614</lpage>
<pub-id pub-id-type="doi">10.1002/gps.388</pub-id>
<pub-id pub-id-type="pmid">11424170</pub-id>
</element-citation>
</ref>
<ref id="B396-ijms-20-05797">
<label>396.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reynolds</surname>
<given-names>E.H.</given-names>
</name>
</person-group>
<article-title>Folic acid, ageing, depression, and dementia</article-title>
<source/>BMJ
          <year>2002</year>
<volume>324</volume>
<fpage>1512</fpage>
<lpage>1515</lpage>
<pub-id pub-id-type="doi">10.1136/bmj.324.7352.1512</pub-id>
<pub-id pub-id-type="pmid">12077044</pub-id>
</element-citation>
</ref>
<ref id="B397-ijms-20-05797">
<label>397.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Blom</surname>
<given-names>H.J.</given-names>
</name>
</person-group>
<article-title>Folic acid, methylation and neural tube closure in humans</article-title>
<source/>Birth Defects Res. A Clin. Mol. Teratol.
          <year>2009</year>
<volume>85</volume>
<fpage>295</fpage>
<lpage>302</lpage>
<pub-id pub-id-type="doi">10.1002/bdra.20581</pub-id>
<pub-id pub-id-type="pmid">19301298</pub-id>
</element-citation>
</ref>
<ref id="B398-ijms-20-05797">
<label>398.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pitkin</surname>
<given-names>R.M.</given-names>
</name>
</person-group>
<article-title>Folate and neural tube defects</article-title>
<source/>Am. J. Clin. Nutr.
          <year>2007</year>
<volume>85</volume>
<fpage>285S</fpage>
<lpage>288S</lpage>
<pub-id pub-id-type="doi">10.1093/ajcn/85.1.285S</pub-id>
<pub-id pub-id-type="pmid">17209211</pub-id>
</element-citation>
</ref>
<ref id="B399-ijms-20-05797">
<label>399.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Frosst</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Blom</surname>
<given-names>H.J.</given-names>
</name>
<name>
<surname>Milos</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Goyette</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Sheppard</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Matthews</surname>
<given-names>R.G.</given-names>
</name>
<name>
<surname>Boers</surname>
<given-names>G.J.</given-names>
</name>
<name>
<surname>den Heijer</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kluijtmans</surname>
<given-names>L.A.</given-names>
</name>
<name>
<surname>van den Heuvel</surname>
<given-names>L.P.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase</article-title>
<source/>Nat. Genet.
          <year>1995</year>
<volume>10</volume>
<fpage>111</fpage>
<lpage>113</lpage>
<pub-id pub-id-type="doi">10.1038/ng0595-111</pub-id>
<pub-id pub-id-type="pmid">7647779</pub-id>
</element-citation>
</ref>
<ref id="B400-ijms-20-05797">
<label>400.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bottiglieri</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Laundy</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Crellin</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Toone</surname>
<given-names>B.K.</given-names>
</name>
</person-group>
<article-title>Homocysteine, folate, methylation, and monoamine metabolism in depression</article-title>
<source/>J. Neurol. Neurosurg. Psychiatry
          <year>2000</year>
<volume>69</volume>
<fpage>228</fpage>
<lpage>232</lpage>
<pub-id pub-id-type="doi">10.1136/jnnp.69.2.228</pub-id>
<pub-id pub-id-type="pmid">10896698</pub-id>
</element-citation>
</ref>
<ref id="B401-ijms-20-05797">
<label>401.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Bottiglieri</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Crellin</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Reynolds</surname>
<given-names>E.H.</given-names>
</name>
</person-group>
<article-title>Folate and neuropsychiatry</article-title>
<source/>Folate Health Dis.
          <publisher-name>Marcel Dekker</publisher-name>
<publisher-loc>New York, NY, USA</publisher-loc>
<year>1995</year>
<fpage>435</fpage>
<lpage>462</lpage>
</element-citation>
</ref>
<ref id="B402-ijms-20-05797">
<label>402.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Botez</surname>
<given-names>M.I.</given-names>
</name>
<name>
<surname>Reynolds</surname>
<given-names>E.H.</given-names>
</name>
</person-group>
<source/>Folic Acid in Neurology, Psychiatry and Internal Medicine
          <publisher-name>Raven Press</publisher-name>
<publisher-loc>New York, NY, USA</publisher-loc>
<year>1979</year>
</element-citation>
</ref>
<ref id="B403-ijms-20-05797">
<label>403.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maxwell</surname>
<given-names>C.J.</given-names>
</name>
<name>
<surname>Hogan</surname>
<given-names>D.B.</given-names>
</name>
<name>
<surname>Ebly</surname>
<given-names>E.M.</given-names>
</name>
</person-group>
<article-title>Serum folate levels and subsequent adverse cerebrovascular outcomes in elderly persons</article-title>
<source/>Dement. Geriatr. Cogn. Disord.
          <year>2002</year>
<volume>13</volume>
<fpage>225</fpage>
<lpage>234</lpage>
<pub-id pub-id-type="doi">10.1159/000057701</pub-id>
<pub-id pub-id-type="pmid">12006733</pub-id>
</element-citation>
</ref>
<ref id="B404-ijms-20-05797">
<label>404.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Snowdon</surname>
<given-names>D.A.</given-names>
</name>
<name>
<surname>Tully</surname>
<given-names>C.L.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>C.D.</given-names>
</name>
<name>
<surname>Riley</surname>
<given-names>K.P.</given-names>
</name>
<name>
<surname>Markesbery</surname>
<given-names>W.R.</given-names>
</name>
</person-group>
<article-title>Serum folate and the severity of atrophy of the neocortex in Alzheimer disease: Findings from the Nun study</article-title>
<source/>Am. J. Clin. Nutr.
          <year>2000</year>
<volume>71</volume>
<fpage>993</fpage>
<lpage>998</lpage>
<pub-id pub-id-type="doi">10.1093/ajcn/71.4.993</pub-id>
<pub-id pub-id-type="pmid">10731508</pub-id>
</element-citation>
</ref>
<ref id="B405-ijms-20-05797">
<label>405.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stanhewicz</surname>
<given-names>A.E.</given-names>
</name>
<name>
<surname>Kenney</surname>
<given-names>W.L.</given-names>
</name>
</person-group>
<article-title>Role of folic acid in nitric oxide bioavailability and vascular endothelial function</article-title>
<source/>Nutr. Rev.
          <year>2017</year>
<volume>75</volume>
<fpage>61</fpage>
<lpage>70</lpage>
<pub-id pub-id-type="doi">10.1093/nutrit/nuw053</pub-id>
<pub-id pub-id-type="pmid">27974600</pub-id>
</element-citation>
</ref>
<ref id="B406-ijms-20-05797">
<label>406.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ma</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>Folic acid supplementation improves cognitive function by reducing the levels of peripheral inflammatory cytokines in elderly Chinese subjects with MCI</article-title>
<source/>Sci Rep.
          <year>2016</year>
<volume>6</volume>
<elocation-id>37486</elocation-id>
<pub-id pub-id-type="doi">10.1038/srep37486</pub-id>
<pub-id pub-id-type="pmid">27876835</pub-id>
</element-citation>
</ref>
<ref id="B407-ijms-20-05797">
<label>407.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mudd</surname>
<given-names>S.H.</given-names>
</name>
<name>
<surname>Cantoni</surname>
<given-names>G.L.</given-names>
</name>
</person-group>
<article-title>Activation of methionine for transmethylation. III. The methionine-activating enzyme of Bakers’ yeast</article-title>
<source/>J. Biol. Chem.
          <year>1958</year>
<volume>231</volume>
<fpage>481</fpage>
<lpage>492</lpage>
<pub-id pub-id-type="pmid">13538985</pub-id>
</element-citation>
</ref>
<ref id="B408-ijms-20-05797">
<label>408.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mato</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Alvarez</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Ortiz</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Pajares</surname>
<given-names>M.A.</given-names>
</name>
</person-group>
<article-title>S-adenosylmethionine synthesis: Molecular mechanisms and clinical implications</article-title>
<source/>Pharmacol. Ther.
          <year>1997</year>
<volume>73</volume>
<fpage>265</fpage>
<lpage>280</lpage>
<pub-id pub-id-type="doi">10.1016/S0163-7258(96)00197-0</pub-id>
<pub-id pub-id-type="pmid">9175157</pub-id>
</element-citation>
</ref>
<ref id="B409-ijms-20-05797">
<label>409.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Blom</surname>
<given-names>H.J.</given-names>
</name>
<name>
<surname>Smulders</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Overview of homocysteine and folate metabolism. With special references to cardiovascular disease and neural tube defects</article-title>
<source/>J. Inherit. Metab. Dis.
          <year>2011</year>
<volume>34</volume>
<fpage>75</fpage>
<lpage>81</lpage>
<pub-id pub-id-type="doi">10.1007/s10545-010-9177-4</pub-id>
<pub-id pub-id-type="pmid">20814827</pub-id>
</element-citation>
</ref>
<ref id="B410-ijms-20-05797">
<label>410.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Loscalzo</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Handy</surname>
<given-names>D.E.</given-names>
</name>
</person-group>
<article-title>Epigenetic modifications: Basic mechanisms and role in cardiovascular disease. 2013 Grover Conference Series</article-title>
<source/>Pulm. Circ.
          <year>2014</year>
<volume>482</volume>
<fpage>169</fpage>
<lpage>174</lpage>
<pub-id pub-id-type="doi">10.1086/675979</pub-id>
</element-citation>
</ref>
<ref id="B411-ijms-20-05797">
<label>411.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weir</surname>
<given-names>D.G.</given-names>
</name>
<name>
<surname>Keating</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Molloy</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>McPartlin</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kennedy</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Blachflower</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kennedy</surname>
<given-names>D.G.</given-names>
</name>
<name>
<surname>Rice</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Scott</surname>
<given-names>J.M.</given-names>
</name>
</person-group>
<article-title>Methylation deficiency causes vitamin B12-associated neuropathy in the pig</article-title>
<source/>J. Neurochem.
          <year>1988</year>
<volume>51</volume>
<fpage>1949</fpage>
<lpage>1952</lpage>
<pub-id pub-id-type="doi">10.1111/j.1471-4159.1988.tb01184.x</pub-id>
<pub-id pub-id-type="pmid">3183671</pub-id>
</element-citation>
</ref>
<ref id="B412-ijms-20-05797">
<label>412.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Harvey</surname>
<given-names>R.A.</given-names>
</name>
<name>
<surname>Ferrier</surname>
<given-names>D.R.</given-names>
</name>
</person-group>
<article-title>Biochemistry</article-title>
<source/>Lippincott’s Illustrated Reviews
          <edition>5th ed.</edition>
<person-group person-group-type="editor">
<name>
<surname>Rhyner</surname>
<given-names>S.</given-names>
</name>
</person-group>
<publisher-name>Wolters Kluwer Health</publisher-name>
<publisher-loc>Philadelphia, PA, USA</publisher-loc>
<year>2011</year>
<fpage>264</fpage>
<lpage>265</lpage>
</element-citation>
</ref>
<ref id="B413-ijms-20-05797">
<label>413.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khan</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Crossley</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Kalra</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Rudd</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Wolfe</surname>
<given-names>C.D.</given-names>
</name>
<name>
<surname>Collinson</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Markus</surname>
<given-names>H.S.</given-names>
</name>
</person-group>
<article-title>Homocysteine and its relationship to stroke subtypes in a UK black population: The South London Ethnicity and Stroke Study</article-title>
<source/>Stroke
          <year>2008</year>
<volume>39</volume>
<fpage>2943</fpage>
<lpage>2949</lpage>
<pub-id pub-id-type="doi">10.1161/STROKEAHA.107.513416</pub-id>
<pub-id pub-id-type="pmid">18757289</pub-id>
</element-citation>
</ref>
<ref id="B414-ijms-20-05797">
<label>414.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Selhub</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Bagley</surname>
<given-names>L.C.</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Rosenberg</surname>
<given-names>I.H.</given-names>
</name>
</person-group>
<article-title>B vitamins, homocysteine, and neurocognitive function in the elderly</article-title>
<source/>Am. J. Clin. Nutr.
          <year>2000</year>
<volume>71</volume>
<fpage>614S</fpage>
<lpage>620S</lpage>
<pub-id pub-id-type="doi">10.1093/ajcn/71.2.614s</pub-id>
<pub-id pub-id-type="pmid">10681269</pub-id>
</element-citation>
</ref>
<ref id="B415-ijms-20-05797">
<label>415.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Liao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>Y.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Elevated plasma homocysteine was associated with hemorrhagic and ischemic stroke, but methylenetetrahydrofolate reductase gene c677t polymorphism was a risk factor for thrombotic stroke a multicenter case-control study in China</article-title>
<source/>Stroke
          <year>2003</year>
<volume>34</volume>
<fpage>2085</fpage>
<lpage>2090</lpage>
<pub-id pub-id-type="doi">10.1161/01.STR.0000086753.00555.0D</pub-id>
<pub-id pub-id-type="pmid">12907815</pub-id>
</element-citation>
</ref>
<ref id="B416-ijms-20-05797">
<label>416.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ali</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Troncoso</surname>
<given-names>J.C.</given-names>
</name>
<name>
<surname>Fowler</surname>
<given-names>D.R.</given-names>
</name>
</person-group>
<article-title>Recurrent cerebral venous thrombosis associated with heterozygote methylenetetrahydrofolate reductase C677T mutation and sickle cell trait without homocysteinemia: An autopsy case report and review of literature</article-title>
<source/>Forensic Sci. Int.
          <year>2014</year>
<volume>242</volume>
<fpage>e52</fpage>
<lpage>e55</lpage>
<pub-id pub-id-type="doi">10.1016/j.forsciint.2014.07.007</pub-id>
<pub-id pub-id-type="pmid">25074331</pub-id>
</element-citation>
</ref>
<ref id="B417-ijms-20-05797">
<label>417.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Que</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Hung</surname>
<given-names>M.Y.</given-names>
</name>
<name>
<surname>Yeang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Gonen</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Prohaska</surname>
<given-names>T.A.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Diehl</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Määttä</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Gaddis</surname>
<given-names>D.E.</given-names>
</name>
<name>
<surname>Bowden</surname>
<given-names>K.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Oxidized phospholipids are proinflammatory and proatherogenic in hypercholesterolaemic mice</article-title>
<source/>Nature
          <year>2018</year>
<volume>558</volume>
<fpage>301</fpage>
<lpage>306</lpage>
<pub-id pub-id-type="doi">10.1038/s41586-018-0198-8</pub-id>
<pub-id pub-id-type="pmid">29875409</pub-id>
</element-citation>
</ref>
<ref id="B418-ijms-20-05797">
<label>418.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Da Costa</surname>
<given-names>K.A.</given-names>
</name>
<name>
<surname>Sanders</surname>
<given-names>L.M.</given-names>
</name>
<name>
<surname>Fischer</surname>
<given-names>L.M.</given-names>
</name>
<name>
<surname>Zeisel</surname>
<given-names>S.H.</given-names>
</name>
</person-group>
<article-title>Docosahexaenoic acid in plasma phosphatidylcholine may be a potential marker for in vivo phosphatidylethanolamine N-methyltransferase activity in humans</article-title>
<source/>Am. J. Clin. Nutr.
          <year>2011</year>
<volume>93</volume>
<fpage>968</fpage>
<lpage>974</lpage>
<pub-id pub-id-type="doi">10.3945/ajcn.110.011064</pub-id>
<pub-id pub-id-type="pmid">21411618</pub-id>
</element-citation>
</ref>
<ref id="B419-ijms-20-05797">
<label>419.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>DeLong</surname>
<given-names>C.J.</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>Y.J.</given-names>
</name>
<name>
<surname>Thomas</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>Z.</given-names>
</name>
</person-group>
<article-title>Molecular distinction of phosphatidylcholine synthesis between the CDP-choline pathway and phosphatidylethanolamine methylation pathway</article-title>
<source/>J. Biol. Chem.
          <year>1999</year>
<volume>274</volume>
<fpage>29683</fpage>
<lpage>29688</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.274.42.29683</pub-id>
<pub-id pub-id-type="pmid">10514439</pub-id>
</element-citation>
</ref>
<ref id="B420-ijms-20-05797">
<label>420.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pynn</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Henderson</surname>
<given-names>N.G.</given-names>
</name>
<name>
<surname>Clark</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Koster</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Bernhard</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Postle</surname>
<given-names>A.D.</given-names>
</name>
</person-group>
<article-title>The specificity and rate of human and mouse liver and plasma phosphatidylcholine synthesis analysed in vivo</article-title>
<source/>J. Lipid Res.
          <year>2011</year>
<volume>52</volume>
<fpage>399</fpage>
<lpage>407</lpage>
<pub-id pub-id-type="doi">10.1194/jlr.D011916</pub-id>
<pub-id pub-id-type="pmid">21068006</pub-id>
</element-citation>
</ref>
<ref id="B421-ijms-20-05797">
<label>421.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Blusztajn</surname>
<given-names>J.K.</given-names>
</name>
<name>
<surname>Zeisel</surname>
<given-names>S.H.</given-names>
</name>
<name>
<surname>Wurtman</surname>
<given-names>R.J.</given-names>
</name>
</person-group>
<article-title>Synthesis of lecithin (phosphatidylcholine) from phosphatidylethanolamine in bovine brain</article-title>
<source/>Brain Res.
          <year>1979</year>
<volume>179</volume>
<fpage>319</fpage>
<lpage>327</lpage>
<pub-id pub-id-type="doi">10.1016/0006-8993(79)90447-5</pub-id>
<pub-id pub-id-type="pmid">509240</pub-id>
</element-citation>
</ref>
<ref id="B422-ijms-20-05797">
<label>422.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Blusztajn</surname>
<given-names>J.K.</given-names>
</name>
<name>
<surname>Holbrook</surname>
<given-names>P.G.</given-names>
</name>
<name>
<surname>Lakher</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Liscovitch</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Maire</surname>
<given-names>J.-C.</given-names>
</name>
<name>
<surname>Mauron</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Richardson</surname>
<given-names>U.I.</given-names>
</name>
<name>
<surname>Tacconi</surname>
<given-names>M.T.</given-names>
</name>
<name>
<surname>Wurtman</surname>
<given-names>R.J.</given-names>
</name>
</person-group>
<article-title>Relationships between acetylcholine release and membrane phosphatidylcholine turnover in brain and in cultured cholinergic neurons</article-title>
<source/>Phospholipids in the Nervous System: Biochemical and Molecular Pharmacology
          <publisher-name>Springer</publisher-name>
<publisher-loc>Berlin, Germany</publisher-loc>
<year>1986</year>
<fpage>283</fpage>
<lpage>290</lpage>
</element-citation>
</ref>
<ref id="B423-ijms-20-05797">
<label>423.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vance</surname>
<given-names>D.E.</given-names>
</name>
</person-group>
<article-title>Phospholipid methylation in mammals: From biochemistry to physiological function</article-title>
<source/>Biochim. Biophys. Acta
          <year>2014</year>
<volume>1838</volume>
<fpage>1477</fpage>
<lpage>1487</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbamem.2013.10.018</pub-id>
<pub-id pub-id-type="pmid">24184426</pub-id>
</element-citation>
</ref>
<ref id="B424-ijms-20-05797">
<label>424.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mudd</surname>
<given-names>S.H.</given-names>
</name>
<name>
<surname>Brosnan</surname>
<given-names>J.T.</given-names>
</name>
<name>
<surname>Brosnan</surname>
<given-names>M.E.</given-names>
</name>
<name>
<surname>Jacobs</surname>
<given-names>R.L.</given-names>
</name>
<name>
<surname>Stabler</surname>
<given-names>S.P.</given-names>
</name>
<name>
<surname>Allen</surname>
<given-names>R.H.</given-names>
</name>
<name>
<surname>Vance</surname>
<given-names>D.E.</given-names>
</name>
<name>
<surname>Wagner</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Methyl balance and transmethylation fluxes in humans</article-title>
<source/>Am. J. Clin. Nutr.
          <year>2007</year>
<volume>85</volume>
<fpage>19</fpage>
<lpage>25</lpage>
<pub-id pub-id-type="doi">10.1093/ajcn/85.1.19</pub-id>
<pub-id pub-id-type="pmid">17209172</pub-id>
</element-citation>
</ref>
<ref id="B425-ijms-20-05797">
<label>425.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Selley</surname>
<given-names>M.L.</given-names>
</name>
</person-group>
<article-title>A metabolic link between S-adenosylhomocysteine and polyunsaturated fatty acid metabolism in Alzheimer’s disease</article-title>
<source/>Neurobiol. Aging
          <year>2007</year>
<volume>28</volume>
<fpage>1834</fpage>
<lpage>1839</lpage>
<pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2006.08.003</pub-id>
<pub-id pub-id-type="pmid">16996649</pub-id>
</element-citation>
</ref>
<ref id="B426-ijms-20-05797">
<label>426.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Clark</surname>
<given-names>W.M.</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>B.J.</given-names>
</name>
<name>
<surname>Selzer</surname>
<given-names>K.A.</given-names>
</name>
<name>
<surname>Zweifler</surname>
<given-names>R.M.</given-names>
</name>
<name>
<surname>Sabounjian</surname>
<given-names>L.A.</given-names>
</name>
<name>
<surname>Gammans</surname>
<given-names>R.E.</given-names>
</name>
</person-group>
<article-title>A randomized efficacy trial of citicoline in patients with acute ischemic stroke</article-title>
<source/>Stroke
          <year>1999</year>
<volume>30</volume>
<fpage>2592</fpage>
<lpage>2597</lpage>
<pub-id pub-id-type="doi">10.1161/01.STR.30.12.2592</pub-id>
<pub-id pub-id-type="pmid">10582983</pub-id>
</element-citation>
</ref>
<ref id="B427-ijms-20-05797">
<label>427.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Clark</surname>
<given-names>W.M.</given-names>
</name>
<name>
<surname>Wechsler</surname>
<given-names>L.R.</given-names>
</name>
<name>
<surname>Sabounjian</surname>
<given-names>L.A.</given-names>
</name>
<name>
<surname>Schwiderski</surname>
<given-names>U.E.</given-names>
</name>
</person-group>
<article-title>Citicoline Stroke Study Group. A phase III randomized efficacy trial of 2000 mg citicolie in acute ischemic stroke patients</article-title>
<source/>Neurology
          <year>2001</year>
<volume>57</volume>
<fpage>1595</fpage>
<lpage>1602</lpage>
<pub-id pub-id-type="doi">10.1212/WNL.57.9.1595</pub-id>
<pub-id pub-id-type="pmid">11706098</pub-id>
</element-citation>
</ref>
<ref id="B428-ijms-20-05797">
<label>428.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Warach</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Pettigrew</surname>
<given-names>L.C.</given-names>
</name>
<name>
<surname>Dashe</surname>
<given-names>J.F.</given-names>
</name>
<name>
<surname>Pullicino</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Lefkowitz</surname>
<given-names>D.M.</given-names>
</name>
<name>
<surname>Sabounjian</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Harnett</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Schwiderski</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Gammans</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Effect of citicoline on ischemic lesions as measured by diffusion-weighted magnetic resonance imaging. Citicoline 010 Investigators</article-title>
<source/>Ann. Neurol.
          <year>2000</year>
<volume>48</volume>
<fpage>713</fpage>
<lpage>722</lpage>
<pub-id pub-id-type="doi">10.1002/1531-8249(200011)48:5&lt;713::AID-ANA4&gt;3.0.CO;2-#</pub-id>
<pub-id pub-id-type="pmid">11079534</pub-id>
</element-citation>
</ref>
<ref id="B429-ijms-20-05797">
<label>429.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ivarez-Sabin</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Roman</surname>
<given-names>G.C.</given-names>
</name>
</person-group>
<article-title>Citicoline in Vascular Cognitive Impairment and Vascular Dementia After Stroke</article-title>
<source/>Stroke
          <year>2011</year>
<volume>42</volume>
<fpage>S40</fpage>
<lpage>S43</lpage>
<pub-id pub-id-type="doi">10.1161/STROKEAHA.110.606509</pub-id>
<pub-id pub-id-type="pmid">21164117</pub-id>
</element-citation>
</ref>
<ref id="B430-ijms-20-05797">
<label>430.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ylilauri</surname>
<given-names>M.P.T.</given-names>
</name>
<name>
<surname>Voutilainen</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lönnroos</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Virtanen</surname>
<given-names>H.E.K.</given-names>
</name>
<name>
<surname>Tuomainen</surname>
<given-names>T.P.</given-names>
</name>
<name>
<surname>Salonen</surname>
<given-names>J.T.</given-names>
</name>
<name>
<surname>Virtanen</surname>
<given-names>J.K.</given-names>
</name>
</person-group>
<article-title>Associations of dietary choline intake with risk of incident dementia and with cognitive performance: The Kuopio Ischaemic Heart Disease Risk Factor Study</article-title>
<source/>Am. J. Clin. Nutr.
          <year>2019</year>
<pub-id pub-id-type="doi">10.1093/ajcn/nqz148</pub-id>
<pub-id pub-id-type="pmid">31360988</pub-id>
</element-citation>
</ref>
<ref id="B431-ijms-20-05797">
<label>431.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Klancnik</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Cuénod</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Gähwiler</surname>
<given-names>B.H.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>Z.P.</given-names>
</name>
<name>
<surname>Do</surname>
<given-names>K.Q.</given-names>
</name>
</person-group>
<article-title>Release of endogenous amino acids, including homocysteic acid and cysteine sulphinic acid, from rat hippocampal slices evoked by electrical stimulation of Schaffer collateral-commissural fibres</article-title>
<source/>Neuroscience
          <year>1992</year>
<volume>49</volume>
<fpage>557</fpage>
<lpage>570</lpage>
<pub-id pub-id-type="doi">10.1016/0306-4522(92)90226-R</pub-id>
<pub-id pub-id-type="pmid">1354337</pub-id>
</element-citation>
</ref>
<ref id="B432-ijms-20-05797">
<label>432.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lipton</surname>
<given-names>S.A.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>W.K.</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>Y.B.</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>D’Emilia</surname>
<given-names>D.M.</given-names>
</name>
<name>
<surname>Rayudu</surname>
<given-names>P.V.</given-names>
</name>
<name>
<surname>Arnelle</surname>
<given-names>D.R.</given-names>
</name>
<name>
<surname>Stamler</surname>
<given-names>J.S.</given-names>
</name>
</person-group>
<article-title>Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>1997</year>
<volume>94</volume>
<fpage>5923</fpage>
<lpage>5928</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.94.11.5923</pub-id>
<pub-id pub-id-type="pmid">9159176</pub-id>
</element-citation>
</ref>
<ref id="B433-ijms-20-05797">
<label>433.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zieminska</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Stafiej</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Lazarewicz</surname>
<given-names>J.W.</given-names>
</name>
</person-group>
<article-title>Role of group I metabotropic glutamate receptors and NMDA receptors in homocysteine-evoked acute neurodegeneration of cultured cerebellar granule neurons</article-title>
<source/>Neurochem. Int.
          <year>2003</year>
<volume>43</volume>
<fpage>481</fpage>
<lpage>492</lpage>
<pub-id pub-id-type="doi">10.1016/S0197-0186(03)00038-X</pub-id>
<pub-id pub-id-type="pmid">12742095</pub-id>
</element-citation>
</ref>
<ref id="B434-ijms-20-05797">
<label>434.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Scarpa</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Fuso</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>D’Anselmi</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Cavallaro</surname>
<given-names>R.A.</given-names>
</name>
</person-group>
<article-title>Presenilin 1 gene silencing by S-adenosylmethionine: A treatment for Alzheimer disease?</article-title>
<source/>FEBS Lett.
          <year>2003</year>
<volume>541</volume>
<fpage>145</fpage>
<lpage>148</lpage>
<pub-id pub-id-type="doi">10.1016/S0014-5793(03)00277-1</pub-id>
<pub-id pub-id-type="pmid">12706835</pub-id>
</element-citation>
</ref>
<ref id="B435-ijms-20-05797">
<label>435.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ferreira</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Orecchio</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Kosik</surname>
<given-names>K.S.</given-names>
</name>
</person-group>
<article-title>Selective phosphorylation of adult tau isoforms in mature hippocampal neurons exposed to fibrillar A beta</article-title>
<source/>Mol. Cell. Neurosci.
          <year>1997</year>
<volume>9</volume>
<fpage>220</fpage>
<lpage>234</lpage>
<pub-id pub-id-type="doi">10.1006/mcne.1997.0615</pub-id>
<pub-id pub-id-type="pmid">9245504</pub-id>
</element-citation>
</ref>
<ref id="B436-ijms-20-05797">
<label>436.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hasegawa</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Ukai</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Jo</surname>
<given-names>D.G.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Mattson</surname>
<given-names>M.P.</given-names>
</name>
<name>
<surname>Nakagawa</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Araki</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Saito</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Yamada</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Homocysteic acid induces intraneuronal accumulation of neurotoxic Abeta42: Implications for the pathogenesis of Alzheimer’s disease</article-title>
<source/>J. Neurosci. Res.
          <year>2005</year>
<volume>80</volume>
<fpage>869</fpage>
<lpage>876</lpage>
<pub-id pub-id-type="doi">10.1002/jnr.20514</pub-id>
<pub-id pub-id-type="pmid">15898106</pub-id>
</element-citation>
</ref>
<ref id="B437-ijms-20-05797">
<label>437.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sai</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Kawamura</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Kokame</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Yamaguchi</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Hirohisa Shiraishi</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Suzuki</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Suzuki</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kawaichi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Miyata</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kitamura</surname>
<given-names>T.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Endoplasmic reticulum stress-inducible protein, Herp, enhances presenilin-mediated generation of amyloid beta-protein</article-title>
<source/>J. Biol. Chem.
          <year>2002</year>
<volume>277</volume>
<fpage>12915</fpage>
<lpage>12920</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M112372200</pub-id>
<pub-id pub-id-type="pmid">11799129</pub-id>
</element-citation>
</ref>
<ref id="B438-ijms-20-05797">
<label>438.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Mao</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>Homocysteine induces the expression of C-reactive protein via NMDAr-ROS-MAPK-NF-KB signal pathway in rat vascular smooth muscle cells</article-title>
<source/>Atherosclerosis
          <year>2014</year>
<volume>236</volume>
<fpage>73</fpage>
<lpage>81</lpage>
<pub-id pub-id-type="doi">10.1016/j.atherosclerosis.2014.06.021</pub-id>
<pub-id pub-id-type="pmid">25016361</pub-id>
</element-citation>
</ref>
<ref id="B439-ijms-20-05797">
<label>439.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Curro</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Gugliandolo</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Gangemi</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Risitano</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Ientile</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Caccamo</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>Toxic effects of mildy elevated homocysteine conncetrations in neuronal-like cells</article-title>
<source/>Neurochem. Res.
          <year>2014</year>
<volume>39</volume>
<fpage>1485</fpage>
<lpage>1495</lpage>
<pub-id pub-id-type="doi">10.1007/s11064-014-1338-7</pub-id>
<pub-id pub-id-type="pmid">24867323</pub-id>
</element-citation>
</ref>
<ref id="B440-ijms-20-05797">
<label>440.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pushpakumar</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kundu</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sen</surname>
<given-names>U.</given-names>
</name>
</person-group>
<article-title>Endothelial Dysfunction: The Link Between Homocysteine and Hydrogen Sulfide</article-title>
<source/>Curr. Med. Chem.
          <year>2014</year>
<volume>21</volume>
<fpage>3662</fpage>
<lpage>3672</lpage>
<pub-id pub-id-type="doi">10.2174/0929867321666140706142335</pub-id>
<pub-id pub-id-type="pmid">25005183</pub-id>
</element-citation>
</ref>
<ref id="B441-ijms-20-05797">
<label>441.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vallance</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Chan</surname>
<given-names>N.</given-names>
</name>
</person-group>
<article-title>Endothelial function and nitric oxide: Clinical relevance</article-title>
<source/>Heart
          <year>2001</year>
<volume>85</volume>
<fpage>342</fpage>
<lpage>350</lpage>
<pub-id pub-id-type="doi">10.1136/heart.85.3.342</pub-id>
<pub-id pub-id-type="pmid">11179281</pub-id>
</element-citation>
</ref>
<ref id="B442-ijms-20-05797">
<label>442.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>James</surname>
<given-names>S.J.</given-names>
</name>
<name>
<surname>Cutler</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Melnyk</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Jernigan</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Janak</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Gaylor</surname>
<given-names>D.W.</given-names>
</name>
<name>
<surname>Neubrander</surname>
<given-names>J.A.</given-names>
</name>
</person-group>
<article-title>Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism</article-title>
<source/>Am. J. Clin. Nutr.
          <year>2004</year>
<volume>80</volume>
<fpage>1611</fpage>
<lpage>1617</lpage>
<pub-id pub-id-type="doi">10.1093/ajcn/80.6.1611</pub-id>
<pub-id pub-id-type="pmid">15585776</pub-id>
</element-citation>
</ref>
<ref id="B443-ijms-20-05797">
<label>443.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Perna</surname>
<given-names>A.F.</given-names>
</name>
<name>
<surname>Ingrosso</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>De Santo</surname>
<given-names>N.G.</given-names>
</name>
</person-group>
<article-title>Homocysteine and oxidative stress</article-title>
<source/>Amino Acids
          <year>2003</year>
<volume>25</volume>
<fpage>409</fpage>
<lpage>417</lpage>
<pub-id pub-id-type="doi">10.1007/s00726-003-0026-8</pub-id>
<pub-id pub-id-type="pmid">14661100</pub-id>
</element-citation>
</ref>
<ref id="B444-ijms-20-05797">
<label>444.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoffman</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Hypothesis: Hyperhomocysteinemia is an indicator of oxidant stress</article-title>
<source/>Med Hypotheses
          <year>2011</year>
<volume>77</volume>
<fpage>1088</fpage>
<lpage>1093</lpage>
<pub-id pub-id-type="doi">10.1016/j.mehy.2011.09.009</pub-id>
<pub-id pub-id-type="pmid">21963358</pub-id>
</element-citation>
</ref>
<ref id="B445-ijms-20-05797">
<label>445.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sawle</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Foresti</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Green</surname>
<given-names>C.J.</given-names>
</name>
<name>
<surname>Motterlini</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Homocysteine attenuates endothelial heme oxygenase-1 induction by nitric oxide (NO) and hypoxia</article-title>
<source/>FEBS Lett.
          <year>2001</year>
<volume>508</volume>
<fpage>403</fpage>
<lpage>406</lpage>
<pub-id pub-id-type="doi">10.1016/S0014-5793(01)03117-9</pub-id>
<pub-id pub-id-type="pmid">11728461</pub-id>
</element-citation>
</ref>
<ref id="B446-ijms-20-05797">
<label>446.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stuhlinger</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Tsao</surname>
<given-names>P.S.</given-names>
</name>
<name>
<surname>Her</surname>
<given-names>J.H.</given-names>
</name>
<name>
<surname>Kimoto</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Balint</surname>
<given-names>R.F.</given-names>
</name>
<name>
<surname>Cooke</surname>
<given-names>J.P.</given-names>
</name>
</person-group>
<article-title>Homocysteine impairs the nitric oxide synthase pathway: Role of asymmetric dimethylarginine</article-title>
<source/>Circulation
          <year>2001</year>
<volume>104</volume>
<fpage>2569</fpage>
<lpage>2575</lpage>
<pub-id pub-id-type="doi">10.1161/hc4601.098514</pub-id>
<pub-id pub-id-type="pmid">11714652</pub-id>
</element-citation>
</ref>
<ref id="B447-ijms-20-05797">
<label>447.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wakita</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Tomimoto</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Akiguchi</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Kimura</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Glial activation and white matter changes in the rat brain induced by chronic cerebral hypoperfusion: An immunoistochemical study</article-title>
<source/>Acta Neuropathol.
          <year>1994</year>
<volume>87</volume>
<fpage>484</fpage>
<lpage>492</lpage>
<pub-id pub-id-type="doi">10.1007/BF00294175</pub-id>
<pub-id pub-id-type="pmid">8059601</pub-id>
</element-citation>
</ref>
<ref id="B448-ijms-20-05797">
<label>448.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Farkas</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Donka</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>de Vous</surname>
<given-names>R.A.I.</given-names>
</name>
<name>
<surname>Mihaly</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Bari</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Luiten</surname>
<given-names>P.G.M.</given-names>
</name>
</person-group>
<article-title>Experimental cerebral hypoperfusion induces white matter injury and microglial activation in the rat brain</article-title>
<source/>Acta Neuropathol.
          <year>2004</year>
<volume>108</volume>
<fpage>57</fpage>
<lpage>64</lpage>
<pub-id pub-id-type="doi">10.1007/s00401-004-0864-9</pub-id>
<pub-id pub-id-type="pmid">15138777</pub-id>
</element-citation>
</ref>
<ref id="B449-ijms-20-05797">
<label>449.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iadecola</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>The neurovascular unit coming of age: A journey through neurovascular coupling in health and disease</article-title>
<source/>Neuron
          <year>2017</year>
<volume>98</volume>
<fpage>17</fpage>
<lpage>42</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2017.07.030</pub-id>
<pub-id pub-id-type="pmid">28957666</pub-id>
</element-citation>
</ref>
<ref id="B450-ijms-20-05797">
<label>450.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ploder</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kurz</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Splitter</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Neurauter</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Roth</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Fuch</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>Early increase of plasma Hcy in sepsis patients with poor outcome</article-title>
<source/>Mol. Med.
          <year>2010</year>
<volume>16</volume>
<fpage>498</fpage>
<lpage>504</lpage>
<pub-id pub-id-type="doi">10.2119/molmed.2010.00008</pub-id>
<pub-id pub-id-type="pmid">20386870</pub-id>
</element-citation>
</ref>
<ref id="B451-ijms-20-05797">
<label>451.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>H.P.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.L.</given-names>
</name>
<name>
<surname>You</surname>
<given-names>S.J.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>X.S.</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>Y.J.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>C.F.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Homocysteine Triggers inflammatory responses in macrophages through inhibiting CSE-H2S signaling via DNA hypermethylation of CSE promoter</article-title>
<source/>Int. J. Mol. Sci.
          <year>2015</year>
<volume>16</volume>
<fpage>12560</fpage>
<lpage>12577</lpage>
<pub-id pub-id-type="doi">10.3390/ijms160612560</pub-id>
<pub-id pub-id-type="pmid">26047341</pub-id>
</element-citation>
</ref>
<ref id="B452-ijms-20-05797">
<label>452.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jiang</surname>
<given-names>Y.-D.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>H.-P.</given-names>
</name>
<name>
<surname>Xiong</surname>
<given-names>J.-T.</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>G.-Z.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>S.-R.</given-names>
</name>
</person-group>
<article-title>Folate and ApoE DNA methylation induced by homocysteine in human monocytes</article-title>
<source/>DNA Cell Biol.
          <year>2007</year>
<volume>26</volume>
<fpage>737</fpage>
<lpage>744</lpage>
<pub-id pub-id-type="pmid">17764386</pub-id>
</element-citation>
</ref>
<ref id="B453-ijms-20-05797">
<label>453.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boldyrev</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Bryshkova</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Mashkina</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Vladychenskaya</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Why is homocysteine toxic for the nervous and immune systems?</article-title>
<source/>Curr. Aging Sci.
          <year>2013</year>
<volume>6</volume>
<fpage>29</fpage>
<lpage>36</lpage>
<pub-id pub-id-type="doi">10.2174/18746098112059990007</pub-id>
<pub-id pub-id-type="pmid">23237596</pub-id>
</element-citation>
</ref>
<ref id="B454-ijms-20-05797">
<label>454.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ying</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Cen</surname>
<given-names>X.M.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>Q.B.</given-names>
</name>
</person-group>
<article-title>Lipid peroxidation-mediated inflammation promotes cell apoptosis through activation of NFK-B pathway in rheumatoid arthritis synovial cells</article-title>
<source/>Med. Infalmm.
          <year>2015</year>
<volume>2015</volume>
<fpage>460310</fpage>
</element-citation>
</ref>
<ref id="B455-ijms-20-05797">
<label>455.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chang</surname>
<given-names>P.Y.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>S.C.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>C.M.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y.J.</given-names>
</name>
<name>
<surname>Dugan</surname>
<given-names>T.A.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>W.H.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>S.F.</given-names>
</name>
<name>
<surname>Liao</surname>
<given-names>W.S.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>C.H.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>Y.T.</given-names>
</name>
</person-group>
<article-title>Homocysteine inhibits arterial endothelial cell growth through transcriptional downregulation of fibroblast growth factor-2 involving G protein and DNA methylation</article-title>
<source/>Circ. Res.
          <year>2008</year>
<volume>102</volume>
<fpage>933</fpage>
<lpage>941</lpage>
<pub-id pub-id-type="doi">10.1161/CIRCRESAHA.108.171082</pub-id>
<pub-id pub-id-type="pmid">18309099</pub-id>
</element-citation>
</ref>
<ref id="B456-ijms-20-05797">
<label>456.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nichols</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Testing for homocysteine in clinical practice</article-title>
<source/>Nutr. Health
          <year>2017</year>
<volume>23</volume>
<fpage>13</fpage>
<lpage>15</lpage>
<pub-id pub-id-type="doi">10.1177/0260106016686094</pub-id>
<pub-id pub-id-type="pmid">28068865</pub-id>
</element-citation>
</ref>
<ref id="B457-ijms-20-05797">
<label>457.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vidoni</surname>
<given-names>M.L.</given-names>
</name>
<name>
<surname>Gabriel</surname>
<given-names>K.P.</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>S.T.</given-names>
</name>
<name>
<surname>Simonsick</surname>
<given-names>E.M.</given-names>
</name>
<name>
<surname>Day</surname>
<given-names>R.S.</given-names>
</name>
</person-group>
<article-title>Vitamin B12 and Homocysteine Associations with Gait Speed in Older Adults: The Baltimore Longitudinal Study of Aging</article-title>
<source/>J. Nutr. Health Aging
          <year>2017</year>
<volume>21</volume>
<fpage>1321</fpage>
<lpage>1328</lpage>
<pub-id pub-id-type="doi">10.1007/s12603-017-0893-4</pub-id>
<pub-id pub-id-type="pmid">29188896</pub-id>
</element-citation>
</ref>
<ref id="B458-ijms-20-05797">
<label>458.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kramer</surname>
<given-names>C.S.</given-names>
</name>
<name>
<surname>Szmidt</surname>
<given-names>M.K.</given-names>
</name>
<name>
<surname>Sicinska</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Brzozowska</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Santoro</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Franceschi</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>de Groot</surname>
<given-names>L.C.P.G.M.</given-names>
</name>
<name>
<surname>Berendsen</surname>
<given-names>A.A.M.</given-names>
</name>
</person-group>
<article-title>The Elderly-Nutrient Rich Food Score Is Associated with Biochemical Markers of Nutritional Status in European Older Adults</article-title>
<source/>Front. Nutr.
          <year>2019</year>
<volume>6</volume>
<fpage>150</fpage>
<pub-id pub-id-type="doi">10.3389/fnut.2019.00150</pub-id>
<pub-id pub-id-type="pmid">31572729</pub-id>
</element-citation>
</ref>
<ref id="B459-ijms-20-05797">
<label>459.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hankey</surname>
<given-names>G.J.</given-names>
</name>
<name>
<surname>Ford</surname>
<given-names>A.H.</given-names>
</name>
<name>
<surname>Yi</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Eikelboom</surname>
<given-names>J.W.</given-names>
</name>
<name>
<surname>Lees</surname>
<given-names>K.R.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Xavier</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Navarro</surname>
<given-names>J.C.</given-names>
</name>
<name>
<surname>Ranawaka</surname>
<given-names>U.K.</given-names>
</name>
<name>
<surname>Uddin</surname>
<given-names>W.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Effect of B-vitamins and lowering homocysteine on cognitive impairment in patients with previous stroke or transient ischemic attack: A prespecified secondary analysis of a randomized, placebo-controlled trial and meta-analysis</article-title>
<source/>Stroke
          <year>2013</year>
<volume>44</volume>
<fpage>2232</fpage>
<lpage>2239</lpage>
<pub-id pub-id-type="doi">10.1161/STROKEAHA.113.001886</pub-id>
<pub-id pub-id-type="pmid">23765945</pub-id>
</element-citation>
</ref>
<ref id="B460-ijms-20-05797">
<label>460.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ting</surname>
<given-names>S.K.S.</given-names>
</name>
<name>
<surname>Earnest</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Hameed</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>H.M.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>C.L.H.</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>E.K.</given-names>
</name>
</person-group>
<article-title>B vitamins and cognition in subjects with small vessel disease: A substudy of VITATOPS, a randomized, placebo-controlled trial</article-title>
<source/>J. Neurol. Sci.
          <year>2017</year>
<volume>379</volume>
<fpage>124</fpage>
<lpage>126</lpage>
<pub-id pub-id-type="doi">10.1016/j.jns.2017.05.061</pub-id>
<pub-id pub-id-type="pmid">28716224</pub-id>
</element-citation>
</ref>
<ref id="B461-ijms-20-05797">
<label>461.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tao</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>An</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Qin</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Dietary Intake of Riboflavin and Unsaturated Fatty Acid Can Improve the Multi-Domain Cognitive Function in Middle-Aged and Elderly Populations: A 2-Year Prospective Cohort Study</article-title>
<source/>Front. Aging Neurosci.
          <year>2019</year>
<volume>11</volume>
<fpage>226</fpage>
<pub-id pub-id-type="doi">10.3389/fnagi.2019.00226</pub-id>
<pub-id pub-id-type="pmid">31555120</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
<floats-group>
<fig id="ijms-20-05797-f001" orientation="portrait" position="float">
<label>Figure 1</label>
<caption>
<p>A synopsis of the different biochemical pathways supported by vitamins B.</p>
</caption>
<graphic xlink:href="ijms-20-05797-g001"></graphic>
</fig>
</floats-group>
</article>
</pmc-articleset>